Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.54877543906844,-1.8767912882385003,0.0,1.0,0.58,8/17,17.81%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POLR2E;POLR3K;POLR3H
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.474265278208021,1.8647903855470531,0.020833333333333332,1.0,0.66,11/23,21.52%,CTSL;COL9A1;MMP9;COL9A3;MMP28;COL13A1;ADAM9;ADAM17;COL9A2;MMP8;COL17A1
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.45443766433701904,-1.8532879086771243,0.0,0.7396074431498698,0.66,8/35,3.12%,UBB;CHD8;XPO1;PROC;BCL9;AKT1;KMT2D;YWHAZ
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,-0.45876983994935716,-1.8013008798757906,0.0,0.8487875895196126,0.86,14/29,24.77%,CDK5R1;CREB1;SRF;EP300;CHD4;MEF2D;FOS;TRIB1;NAB2;JUND;FOSL1;DNM2;CDK5;ID2
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.5044053572380712,-1.7796114553581712,0.018518518518518517,0.8056438220025369,0.92,12/20,30.12%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POLR2E;POLR3K;POLR3H;NFIA;POLR2L;SSB;POLR2F
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,-0.5319294838338715,-1.7553794436383399,0.014925373134328358,0.7860970538621473,0.96,6/15,11.18%,FUT1;RHCE;B3GALT2;ABO;B4GALNT2;RHD
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,0.37062953038558993,1.7375533476362264,0.044444444444444446,1.0,0.96,8/38,7.52%,RAD9B;RAD51AP1;DNA2;RBBP8;RFC3;RFC5;EXO1;BLM
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.49091355555067323,-1.7042542475700861,0.041666666666666664,0.9949481080468487,0.97,7/21,12.46%,CREB1;XPO1;AKT1;SRF;TGFA;MAPK1;FOS
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,0.38498855584858216,1.6908007038559787,0.02127659574468085,1.0,1.0,8/34,7.52%,RAD9B;DNA2;RBBP8;RFC3;RFC5;EXO1;ERCC4;BLM
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.5369982248832139,-1.6875920381242553,0.03773584905660377,0.993187137944111,0.98,4/15,6.82%,AKT1;YWHAZ;BAD;REXO2
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.42749748546982264,-1.6874651293938043,0.014285714285714285,0.8690387457010972,0.98,14/29,22.92%,MAP2K7;NRAS;MAPK1;FOS;PKN1;MAP2K4;SPNS1;LCP2;VAV2;PLCG2;PKN2;MAPK8;MAPK9;HRAS
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,0.3821625076494927,1.6683221948042168,0.047619047619047616,1.0,1.0,12/31,16.19%,RFC3;RFC5;UBA52;REV1;UBA7;POLI;PCLAF;RPS27A;USP32;SLC19A1;ISG15;POLH
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,0.36061405100080907,1.667900019117103,0.04878048780487805,1.0,1.0,8/40,7.52%,RAD9B;RAD51AP1;DNA2;RBBP8;RFC3;RFC5;EXO1;BLM
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,0.3770499349553766,1.6612020285125886,0.0,1.0,1.0,7/32,7.52%,RAD9B;DNA2;RBBP8;RFC3;RFC5;EXO1;BLM
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.4886011042321051,-1.6549246338706163,0.0,0.9990570382865703,0.99,8/21,17.40%,PPA2;CARS2;FARS2;AARS2;RARS2;DTD1;EARS2;GARS1
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.3632739076924333,-1.6485778753739881,0.0,0.9424711989852627,0.99,23/50,26.26%,CDK5R1;CREB1;DUSP6;SRF;EP300;MAPK1;CHD4;MEF2D;FOS;TRIB1;DUSP7;NAB2;PPP2CA;JUND;FOSL1;PPP2R1A;DNM2;CDK5;MAPK7;MAPK14;ID2;PPP2R1B;MAPKAPK2
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.33031684142550477,1.6312030599716716,0.02564102564102564,1.0,1.0,15/47,16.64%,UBE2B;RFC3;RFC5;DDB1;UBA52;REV1;UBA7;POLI;PCLAF;RPS27A;USP32;SLC19A1;ISG15;POLH;REV3L
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.4798942767217886,1.6145820937074686,0.04878048780487805,1.0,1.0,7/20,14.13%,NKIRAS2;DTX4;DHX9;ZBP1;MYD88;RELA;TICAM1
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.42312565836206467,-1.6080659486595652,0.0392156862745098,1.0,0.99,10/27,18.39%,PIK3CA;FGFR1;NRAS;CNTRL;TRIM24;FRS2;PIK3R1;STAT5A;CPSF6;STAT5B
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.48654740516177486,-1.60453913455258,0.05555555555555555,1.0,0.99,7/17,18.39%,PIK3CA;CNTRL;TRIM24;PIK3R1;STAT5A;CPSF6;STAT5B
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.3700476966134082,-1.5941927947458037,0.0,1.0,1.0,17/54,17.04%,RAB22A;RAB6A;RAB18;RAB11A;RAB37;RAB35;RAB39B;RAB4A;RAB40C;RAB27A;RAB10;RAB33B;RABGGTB;RAB12;RAB33A;RAB2A;RAB14
prerank,KEGG_2021_Human__Olfactory transduction,0.3315801854875899,1.5884707671606444,0.02857142857142857,1.0,1.0,11/60,8.57%,PDE2A;OR4K17;CAMK2A;OR2L2;OR10H5;OR4F17;OR14J1;ADCY3;OR52K2;OR10H1;GRK3
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,0.3192726480995883,1.5867641837116255,0.0,1.0,1.0,16/53,15.32%,ZDHHC5;MGAT5;MAN2A1;SRPK2;ZDHHC2;UBA52;ST6GALNAC4;PARP9;ZDHHC11;PRKCSH;ZDHHC3;DDOST;RPS27A;GOLGA7;ST6GALNAC2;SRPK1
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.43407560101369935,1.5852621061799448,0.07142857142857142,1.0,1.0,12/21,27.04%,COL9A1;PRNP;COL9A3;COL6A1;COL4A3;AGRN;COL9A2;CACNB3;CACNB2;PSPN;ST8SIA4;COL6A2
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.36881752646078236,-1.5789361153537012,0.05357142857142857,1.0,1.0,21/39,31.12%,SPTLC1;ORMDL1;DEGS1;SAMD8;VAPB;PPM1L;CERS2;PRKD3;ORMDL3;SGMS1;SPNS2;VAPA;SPHK1;ORMDL2;SPTSSA;ACER1;CERS4;SPTSSB;SGPP2;ACER2;ALDH3A2
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.3711353295259025,-1.5785876546950839,0.01818181818181818,1.0,1.0,15/45,20.31%,POLR2I;PIK3CA;FGFR1;NRAS;POLR2D;CNTRL;TRIM24;POLR2A;FRS2;PIK3R1;STAT5A;CPSF6;POLR2E;STAT5B;FGFR4
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.39001124624341815,1.5753255500158805,0.04,0.9982443592867948,1.0,9/28,12.48%,SQSTM1;ULK1;ATG5;UBA52;MTERF3;TOMM70;FUNDC1;TOMM6;RPS27A
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.35403997142660615,-1.573493957561578,0.017543859649122806,1.0,1.0,7/34,5.93%,ACYP2;PCK2;ADH5;ACSS2;ALDH7A1;HAGH;DLAT
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,0.39636734596544393,1.5698819779920001,0.023809523809523808,0.9569789350282754,1.0,6/33,4.74%,CDC25C;RAD9B;ORC3;CDC6;RFC3;RFC5
prerank,KEGG_2021_Human__AMPK signaling pathway,-0.3016123703218924,-1.5696964193045684,0.017857142857142856,1.0,1.0,41/102,27.32%,PCK2;CAB39;CREB1;CPT1B;PFKL;CAB39L;AKT1;PPP2R5B;PIK3CA;CRTC2;SREBF1;TSC2;LIPE;ELAVL1;RPS6KB1;RPTOR;STRADB;RAB10;FBP1;PIK3R1;SLC2A4;SCD;RAB2A;RAB14;PPP2CA;PRKAG2;RAB11B;PPP2R3A;CREB3L4;PFKP;ADRA1A;PPP2R1A;PRKAG1;RHEB;PPP2R1B;EIF4EBP1;PPP2R2A;STK11;PPP2R3C;CCNA2;FOXO3
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.3401241667396141,-1.5690064449552683,0.0,0.9732294767797494,1.0,15/61,12.58%,CAV2;CREB1;XPO1;AKT1;GNG10;SRF;PIK3CA;ZDHHC21;GNG5;NRAS;TGFA;MAPK1;PRKCZ;FOS;PIK3R1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.33848685622982994,-1.563862715751351,0.030303030303030304,0.9603774844509965,1.0,13/51,12.59%,HEY1;UBB;NCOR2;SKP1;MAML2;CUL1;HDAC11;JAG1;EP300;TBL1X;NCSTN;NCOR1;MAMLD1
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.44156726923738304,1.5623217036160413,0.045454545454545456,0.9308444482566368,1.0,6/18,12.44%,PTPN4;PTPN2;SIGIRR;PTPN23;PTPN11;IL18R1
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.3260097110408002,-1.5548122621443392,0.016666666666666666,0.9752252428961856,1.0,26/59,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;MAPK1;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;MAPKAPK2;UBC
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.32637651551003244,-1.5518592308730252,0.015873015873015872,0.9458925123277248,1.0,27/62,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;IL17RA;MAPK1;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;MAPKAPK2;UBC
prerank,KEGG_2021_Human__Prion disease,-0.25560498057061204,-1.5468169756454957,0.016666666666666666,0.936035653700712,1.0,75/221,25.29%,CAV2;SLC25A5;NDUFS2;CREB1;IL6;PRKCD;NDUFS7;PIK3CA;ATP5F1E;NCF2;NDUFB7;COX7B;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;COX6A1;SDHD;EIF2S1;BAD;PPIF;ADRM1;MAPK1;CSNK2A1;NDUFC1;PSMB4;LAMC1;KLC1;NDUFA8;UQCRHL;PSMD8;RYR3;DDIT3;APAF1;NDUFS3;PIK3R1;PSMB5;TUBB6;CSNK2A2;ITPR1;NDUFAB1;TUBB4B;ATP5PO;SEM1;PSMD6;TUBA1A;HSPA6;ATF4;KIF5B;PSMD9;KIF5A;NDUFA12;CREB3L4;SDHB;NDUFC2;RYR1;MAPK8;MAPK9;PSMA6;NDUFB6;PSMA4;PSMD13;MAPK14;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;STIP1;C1QA;NDUFA2;ATP5MC2;PSMC1;PSMD3
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.302607322655514,-1.5467406092510954,0.016666666666666666,0.8967166018810844,1.0,39/80,32.39%,TUBGCP4;CEP63;HAUS8;ALMS1;NME7;ACTR1A;CNTRL;CDK11A;CETN2;AKAP9;NEDD1;CEP192;CEP290;CDK11B;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;TUBA1A;CEP76;CEP164;TUBGCP2;CEP70;SDCCAG8;HAUS2;MAPRE1;PPP2R1A;MZT1;CEP78;PAFAH1B1;ODF2;MZT2B;HAUS7;CDK5RAP2;CKAP5;DYNC1H1;PCNT;TUBGCP6
prerank,KEGG_2021_Human__RNA polymerase,-0.402633822389309,-1.5448676587302463,0.05357142857142857,0.8690387457010972,1.0,10/31,17.81%,POLR2I;POLR3GL;POLR3D;POLR2D;POLR3C;POLR3G;POLR2A;POLR2E;POLR3K;POLR3H
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.4362705572021485,-1.5417552476862237,0.06896551724137931,0.8545635714565926,1.0,8/21,18.39%,PIK3CA;FGFR1;CNTRL;TRIM24;PIK3R1;STAT5A;CPSF6;STAT5B
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.3425941850490242,-1.5353103860656327,0.04918032786885246,0.8566442253625965,1.0,12/45,12.59%,HEY1;UBB;NCOR2;SKP1;MAML2;CUL1;HDAC11;NBEA;EP300;TBL1X;NCOR1;MAMLD1
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.3004677947459346,-1.5287973431824773,0.0,0.8640493304100066,1.0,36/95,24.91%,CDK5R1;CREB1;DUSP6;SRF;MAPKAPK3;PIK3CA;AP2B1;DNAL4;NRAS;EP300;MAPK1;CHD4;MEF2D;CRK;FRS2;FOS;PIK3R1;TRIB1;AP2M1;DUSP7;NAB2;RALB;DNM3;RAP1A;PPP2CA;JUND;FOSL1;PPP2R1A;DNM2;HRAS;CDK5;MAP2K5;MAPK7;MAPK14;ID2;PPP2R1B
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.4813272325527873,-1.5221633080053223,0.03278688524590164,0.877340461899718,1.0,3/16,1.59%,KLKB1;GP9;PROC
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.4242255259107868,-1.5161964593368595,0.0851063829787234,0.8806064975828748,1.0,8/18,25.28%,CDK5R1;PIK3CA;NRAS;FRS2;PIK3R1;HRAS;CDK5;TIAM1
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.44960931284621913,1.515834207485444,0.047619047619047616,1.0,1.0,5/19,6.73%,MGAT5;B4GALT4;B4GALT2;MAN2A1;ST8SIA6
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.3468455337855023,1.5122951166135024,0.07317073170731707,1.0,1.0,5/39,1.91%,PLCB4;INPPL1;NUDT4;IMPA1;IP6K2
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.410892386226577,-1.5109527237795846,0.08695652173913043,0.8815416334305355,1.0,10/22,26.42%,UBB;PIK3CA;NRAS;TGFA;PIK3R1;CBL;EPGN;HRAS;HBEGF;UBC
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.38496356509359175,-1.5070326416075892,0.043478260869565216,0.8783264428558593,1.0,12/28,22.92%,UBB;PIK3CA;NRAS;MAPK1;FRS2;PIK3R1;MKNK1;CBL;PPP2CA;FGFR4;PPP2R1A;HRAS
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,-0.44036571877079933,-1.5068203504098465,0.06896551724137931,0.8531900147764571,1.0,6/18,16.15%,CA2;PCK2;CA4;ATP1A3;ATP1B2;FXYD2
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,0.33244615119909976,1.5042645732820492,0.04878048780487805,1.0,1.0,7/37,7.52%,RAD9B;DNA2;RBBP8;RFC3;RFC5;EXO1;BLM
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.4290279119198042,1.4954974469279432,0.05714285714285714,1.0,1.0,9/17,20.18%,RFC3;RFC5;UBA52;REV1;POLI;RPS27A;SLC19A1;REV3L;POLR1A
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,0.33308798203030515,1.4947362179960144,0.04081632653061224,1.0,1.0,8/40,8.87%,YKT6;COG2;MAN2A1;NAPG;RIC1;TRIP11;RGPD1;SNAP29
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.33470227433265304,1.4889494266961685,0.02564102564102564,1.0,1.0,7/37,7.31%,OR4K17;OR2L2;OR10H5;OR4F17;OR14J1;OR52K2;OR10H1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.36625983746382473,-1.4872660621898652,0.08163265306122448,0.9397176820973455,1.0,12/31,22.92%,UBB;PIK3CA;FGFR1;NRAS;MAPK1;FRS2;PIK3R1;MKNK1;CBL;PPP2CA;PPP2R1A;HRAS
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,-0.35029217536218615,-1.4850181896621144,0.016666666666666666,0.9310352519651303,1.0,18/44,24.12%,ABCC9;GNG10;KCNK7;GNG5;KCNG1;KCNC4;KCNJ2;KCNH2;KCND3;KCNMB1;KCNJ15;KCNN1;KCNA7;KCNK13;HCN2;KCNK6;KCNH3;GNG3
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.445770540609357,-1.4836576419508638,0.018518518518518517,0.9159057071496757,1.0,8/16,20.21%,AKT1;PTS;GCHFR;DHFR;COQ9;COQ7;COQ5;COQ6
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.38247276874298775,-1.483377806571277,0.07017543859649122,0.8936923271394261,1.0,8/27,16.32%,CLSTN1;PIK3CA;RAP1GAP;GRB10;FRS2;DOK2;PIK3R1;DOK4
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.4053623217550355,-1.4833213056523484,0.08928571428571429,0.869824043179345,1.0,10/27,21.21%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POU2F1;POLR2E;POLR3K;POLR3H;SNAPC1
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.4255973337034349,-1.4822682364657804,0.08,0.8524948949990606,1.0,9/23,15.03%,LPIN1;CHPT1;ABHD3;CEPT1;PCYT1A;CHKB;CSNK2A2;PEMT;STARD7
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,0.3119183090418676,1.4798768090291563,0.023809523809523808,1.0,1.0,10/48,10.13%,RAD9B;RAD51AP1;DNA2;RBBP8;RFC3;RFC5;EXO1;BLM;MLH1;OGG1
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.2861274197008441,-1.477480114794797,0.017543859649122806,0.8585406547040064,1.0,14/83,9.81%,VAMP3;COPS2;UBB;CLTCL1;AGFG1;AP2B1;M6PR;TGFA;SLC2A8;SCARB2;REPS1;STON1;FCHO2;IGF2R
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.4180229263651164,-1.4699452481896709,0.04,0.8811894394099877,1.0,8/20,19.42%,GGT1;CYP27A1;FMO3;SLC35D1;OPLAH;AHCY;TBXAS1;CYP4F22
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,0.4542812591009743,1.4684417003997425,0.10256410256410256,1.0,1.0,9/17,24.83%,NKIRAS2;DHX9;ZBP1;MYD88;RELA;TICAM1;IKBKG;NFKBIA;NFKBIB
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.3577262744130607,1.4681548398448185,0.08571428571428572,1.0,1.0,15/29,24.14%,VCAN;COL9A1;COL9A3;TGFB1;HSPG2;ITGAV;AGRN;SERPINE1;ITGA7;COL9A2;LMNB2;ITGA2B;ITGA9;DCN;TNXB
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.3884652073565286,-1.4671591512019788,0.0392156862745098,0.8712936464424077,1.0,9/23,22.92%,CLSTN1;PIK3CA;NRAS;PIK3R5;PIK3R1;STAT5A;STAT5B;PLCG2;HRAS
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,-0.3909171523449467,-1.4650543023979796,0.037037037037037035,0.8598565444511073,1.0,7/27,12.58%,POLR2I;PIK3CA;NRAS;POLR2D;POLR2A;FRS2;PIK3R1
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.3248955158500672,1.4554117084848914,0.02702702702702703,1.0,1.0,7/39,7.31%,OR4K17;OR2L2;OR10H5;OR4F17;OR14J1;OR52K2;OR10H1
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.29924251896616205,-1.454784115580038,0.04838709677419355,0.8934261339843611,1.0,18/78,12.70%,HEY1;UBB;SKP1;AKT1;MAML2;YWHAZ;ACTA2;CUL1;PSMD11;PSMB7;JAG1;EP300;NCSTN;PSMB4;PSMD8;PSMB10;MAMLD1;PSMB5
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.35874769352467983,1.4532447989673825,0.044444444444444446,1.0,1.0,8/29,7.85%,MGST2;GSTM1;MGST1;AKR1A1;CNDP2;GSTZ1;PRNP;GSTO2
prerank,KEGG_2021_Human__Other glycan degradation,-0.4592002266914625,-1.451869058667184,0.08620689655172414,0.885607873485948,1.0,7/15,23.89%,MANBA;ENGASE;HEXA;FUCA1;MAN2C1;MAN2B1;HEXD
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.29989184133473823,-1.4495700662185766,0.05555555555555555,0.8734411709579416,1.0,34/85,26.42%,UBB;SKP1;CEP63;CUL1;HAUS8;ALMS1;ACTR1A;CNTRL;CETN2;AKAP9;NEDD1;CEP192;FBXW11;CEP290;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;TUBA1A;CEP76;AURKA;CEP164;CEP70;SDCCAG8;HAUS2;BORA;MAPRE1;PPP2R1A;CCNB2;CEP78;PAFAH1B1;ODF2;UBC
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.43945361204984545,-1.4453643472063602,0.05555555555555555,0.8762740359058241,1.0,6/16,15.19%,UBB;MAP3K8;SKP1;CUL1;FBXW11;MAP2K4
prerank,KEGG_2021_Human__Ferroptosis,0.3417502466984958,1.4433195357171478,0.045454545454545456,1.0,1.0,17/39,25.33%,SLC39A8;CYBB;ATG5;GSS;ACSL5;ACSL6;PRNP;FTL;ACSL3;GCLM;ACSL4;ALOX15;SAT2;PCBP1;TF;VDAC3;SLC11A2
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,-0.3450125682037246,-1.4404877218472052,0.08,0.8879785411677769,1.0,17/39,25.80%,CAB39;CAB39L;AKT1;SLC38A9;TSC2;RPS6KB1;RPTOR;STRADB;LAMTOR2;EIF4E;PRKAG2;EIF4B;PRKAG1;RRAGC;RHEB;EIF4EBP1;STK11
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.3210920743405904,1.4384592997163832,0.058823529411764705,1.0,1.0,13/38,16.64%,RFC3;RFC5;UBA52;REV1;UBA7;POLI;PCLAF;RPS27A;USP32;SLC19A1;ISG15;POLH;REV3L
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.34503342798779835,-1.4300878873823217,0.0851063829787234,0.9295720929827086,1.0,13/42,19.71%,PPA1;PPA2;CARS2;FARS2;AARS2;CARS1;RARS2;AIMP2;DTD1;TARS1;EARS2;GARS1;LARS1
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.3830871521936979,1.429426947896714,0.08,1.0,1.0,9/22,18.18%,SQSTM1;ATG5;UBA52;MTERF3;TOMM70;TOMM6;RPS27A;TOMM7;TOMM22
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.24970216543046928,-1.4290032893300935,0.015625,0.9168544747152323,1.0,67/179,27.07%,UBB;HMMR;XPO1;SKP1;TUBGCP4;CEP63;CUL1;PSMD11;PSMB7;LIN52;HAUS8;ALMS1;LIN9;NME7;FOXM1;E2F3;ACTR1A;EP300;CNTRL;CDK11A;PSMB4;CETN2;AKAP9;PSMD8;GTSE1;NEDD1;PSMB10;PSMB5;CEP192;FBXW11;CEP290;CDK11B;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;SEM1;PSMD6;TUBA1A;CEP76;PPP2CA;AURKA;PSMD9;CEP164;TUBGCP2;CEP70;SDCCAG8;HAUS2;BORA;MAPRE1;PPP2R1A;PSMA6;PSMA4;MZT1;PSMD13;CCNB2;PPP2R1B;PSMC1;CEP78;PSMD3;PPP2R2A;PAFAH1B1;ODF2;UBC;MZT2B;CCNA2
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.40073156050300496,1.4276420327073576,0.12195121951219512,1.0,1.0,8/16,20.18%,RFC3;RFC5;UBA52;REV1;RPS27A;SLC19A1;REV3L;POLR1A
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.2826768267000327,-1.425657131338656,0.05,0.9152113817948819,1.0,37/79,32.39%,TUBGCP4;CEP63;HAUS8;ALMS1;NME7;ACTR1A;CNTRL;CETN2;AKAP9;NEDD1;CEP192;CEP290;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;TUBA1A;CEP76;CEP164;TUBGCP2;CEP70;SDCCAG8;HAUS2;MAPRE1;PPP2R1A;MZT1;CEP78;PAFAH1B1;ODF2;MZT2B;HAUS7;CDK5RAP2;CKAP5;DYNC1H1;PCNT;TUBGCP6
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.29753399609665143,1.4233733961412478,0.02564102564102564,1.0,1.0,12/71,7.52%,CDC25C;RAD9B;H2BC11;DNA2;H2BC15;RBBP8;RFC3;RFC5;H2BC5;EXO1;CHEK2;BLM
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.4561835105159229,-1.4158461523404131,0.15,0.9521668931979838,1.0,8/15,28.80%,FES;PLXNA4;PKN1;PLXNA2;NRP1;PKN2;PLXNA3;PLXNA1
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.38814380704788876,1.4143916188343115,0.1282051282051282,1.0,1.0,8/23,17.48%,RAD51AP1;DNA2;RBBP8;EXO1;BLM;RAD51D;PALB2;WRN
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,-0.2917189086306982,-1.4134578042841544,0.038461538461538464,0.9472664560342564,1.0,29/71,26.90%,ABCC9;CACNG8;CACNG6;KCNK7;SCN11A;KCNJ2;KCNH2;KCND3;AKAP9;RYR3;ATP2A1;ORAI2;ATP1A3;ITPR1;ATP1B2;FXYD2;FGF11;KCNK13;KCNE4;ATP2A2;RYR1;KCNK6;SRI;FKBP1B;CES1;ATP1B3;RANGRF;ATP2A3;AHCYL1
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.37216428668218154,-1.413409348494228,0.10526315789473684,0.9297922142455506,1.0,7/30,12.28%,POLR2I;TCEA1;ELOC;ELOA;POLR2D;POLR2A;CDK9
prerank,KEGG_2021_Human__Circadian rhythm,-0.3921750993892327,-1.4118784190417386,0.03389830508474576,0.9217700171108563,1.0,11/26,24.64%,CREB1;SKP1;CUL1;BHLHE41;FBXW11;CRY2;CSNK1E;CSNK1D;PRKAG2;PRKAG1;CLOCK
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.40139725295885514,1.4107816474732398,0.10204081632653061,1.0,1.0,2/16,0.75%,AMOT;NPHP4
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.31898599337454775,1.4101285500772647,0.06818181818181818,1.0,1.0,11/33,14.41%,DAND5;TNRC6C;AGO4;CDKN2B;UBA52;MOV10;CDK4;RPS27A;MDM4;TFDP2;MAPK3
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.3475559180065884,-1.407563154459136,0.11475409836065574,0.9315211667100568,1.0,16/35,30.76%,CTSG;ATOX1;RO60;RNASE3;TLR1;SLC11A1;TLR2;S100A9;ELANE;TSPAN32;GNLY;ATP7A;RNASE6;CHAMP1;DEFA4;EPPIN
prerank,KEGG_2021_Human__Arginine biosynthesis,0.44398467290526383,1.4074032740914706,0.06976744186046512,0.9969314160050442,1.0,5/15,15.82%,ARG1;GOT1;GLUD1;ASL;GLUL
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.4390488762405699,-1.4073242124364453,0.09090909090909091,0.9154528862661144,1.0,10/17,33.11%,PRKCD;NRAS;PRKCZ;ITPR1;SPHK1;HRAS;VEGFA;AHCYL1;SRC;ITPR3
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.24673990460100964,-1.4070522780835955,0.015873015873015872,0.9014313273277738,1.0,66/177,27.07%,UBB;HMMR;XPO1;SKP1;TUBGCP4;CEP63;CUL1;PSMD11;PSMB7;LIN52;HAUS8;ALMS1;LIN9;NME7;FOXM1;ACTR1A;EP300;CNTRL;CDK11A;PSMB4;CETN2;AKAP9;PSMD8;GTSE1;NEDD1;PSMB10;PSMB5;CEP192;FBXW11;CEP290;CDK11B;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;SEM1;PSMD6;TUBA1A;CEP76;PPP2CA;AURKA;PSMD9;CEP164;TUBGCP2;CEP70;SDCCAG8;HAUS2;BORA;MAPRE1;PPP2R1A;PSMA6;PSMA4;MZT1;PSMD13;CCNB2;PPP2R1B;PSMC1;CEP78;PSMD3;PPP2R2A;PAFAH1B1;ODF2;UBC;MZT2B;CCNA2
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.3012976600462335,-1.4068064134690124,0.06779661016949153,0.8866180851749796,1.0,28/71,25.91%,HMMR;CEP63;HAUS8;ALMS1;ACTR1A;CNTRL;CETN2;AKAP9;NEDD1;CEP192;CEP290;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;TUBA1A;CEP76;AURKA;CEP164;CEP70;SDCCAG8;HAUS2;MAPRE1;PPP2R1A;CEP78;PAFAH1B1;ODF2
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,0.42549303963262913,1.4050120278016631,0.10638297872340426,0.9805862423023848,1.0,4/15,7.06%,SFTPD;PGA4;ZDHHC2;ADORA2A
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.26226074618891393,-1.4033329106218593,0.038461538461538464,0.887708013485207,1.0,37/107,25.28%,CDK5R1;CREB1;DUSP6;SRF;MAPKAPK3;PIK3CA;AP2B1;DNAL4;NRAS;EP300;MAPK1;CHD4;MEF2D;CRK;FRS2;FOS;PIK3R1;TRIB1;AP2M1;DUSP7;NAB2;RALB;DNM3;RAP1A;PPP2CA;JUND;FOSL1;PPP2R1A;DNM2;HRAS;CDK5;MAP2K5;MAPK7;MAPK14;ID2;PPP2R1B;TIAM1
prerank,KEGG_2021_Human__Cell cycle,0.25339923844461015,1.4020635868003788,0.05263157894736842,0.9664318944830008,1.0,25/120,14.08%,CDC25B;CDC25C;ORC3;CDC6;ANAPC11;CDC16;TTK;CDKN2B;CHEK2;E2F5;TGFB1;CDC14B;GADD45B;SMAD4;SMC1A;CDK4;CDKN1C;MCM7;CCND2;SMAD2;SFN;CCNH;ABL1;GADD45G;TFDP2
prerank,KEGG_2021_Human__Morphine addiction,0.2841100052057946,1.393559459919882,0.047619047619047616,0.9867411162376462,1.0,21/51,23.34%,PDE2A;GNAI1;GNB5;ADCY3;PDE10A;GRK3;PDE7A;PRKACA;GABRG2;GNG4;GRK2;GNAO1;GRK5;GNAI3;GNG11;CACNA1A;GABRP;ADCY9;GNGT2;GRK6;ADCY7
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.32338312278141257,-1.388942569218073,0.06,0.951804340529773,1.0,19/49,23.57%,AKT1;TBC1D4;YWHAZ;RAB11A;REXO2;RAB4A;RAB10;RHOQ;EXOC2;SLC2A4;KIF3A;RAB14;C2CD5;STX4;PRKAG2;STXBP3;SNAP23;PRKAG1;MYH9
prerank,KEGG_2021_Human__Insulin resistance,-0.2796795523033076,-1.386963754676128,0.05454545454545454,0.947806072345688,1.0,31/91,26.86%,PCK2;CREB1;CPT1B;IL6;AKT1;PRKCD;TBC1D4;PIK3CA;CRTC2;SREBF1;SLC27A1;RPS6KB1;PRKCZ;PIK3R1;SLC2A4;PPARGC1B;OGA;OGT;PYGB;PPP1R3D;PRKAG2;CREB3L4;TNFRSF1A;MAPK8;MAPK9;MLXIP;PRKAG1;PPP1R3E;MLXIPL;TRIB3;PTPRF
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,-0.41594463870243736,-1.3861396272950133,0.12698412698412698,0.9362680397846509,1.0,5/18,10.17%,ABCC9;GNG10;GNG5;KCNJ2;KCNJ15
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.31349638689454457,1.3831769821048092,0.09302325581395349,1.0,1.0,20/48,20.54%,ITGA3;ITGA4;COL9A1;THBS1;COL9A3;FN1;COL13A1;ICAM4;COL4A3;HSPG2;ITGAV;AGRN;MADCAM1;ICAM1;ITGA5;ITGA7;COL9A2;FZR1;ITGA2B;ITGA9
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.3030208072821363,1.3828415375220067,0.05128205128205128,0.9929751731189208,1.0,16/54,18.48%,B3GLCT;THBS1;POFUT2;ST6GALNAC4;B3GNT8;GALNT14;LARGE1;B3GNT9;POMGNT1;LARGE2;ST6GALNAC2;ADAMTS10;CFP;ADAMTSL5;POMK;GALNT3
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.3243982884301789,1.380957123610912,0.07272727272727272,0.980619227576951,1.0,8/37,9.51%,UBXN11;KIDINS220;VANGL1;ARHGAP35;FNBP1;LRRC1;PLXND1;TXNL1
prerank,KEGG_2021_Human__Bile secretion,-0.31498300083219166,-1.3759060176724498,0.07692307692307693,0.9792670885605647,1.0,13/43,17.35%,CA2;SCT;SLC22A1;NCEH1;ADCY4;SLC4A5;AQP9;ATP1A3;ABCC3;ATP1B2;ABCB1;FXYD2;ABCB4
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.35358755908398526,-1.3735630972992876,0.13333333333333333,0.9789893164907876,1.0,11/28,22.92%,UBB;PIK3CA;NRAS;MAPK1;FRS2;PIK3R1;MKNK1;CBL;PPP2CA;PPP2R1A;HRAS
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.36270789525488667,1.3723532757197456,0.175,1.0,1.0,8/24,17.48%,RAD51AP1;DNA2;RBBP8;EXO1;BLM;RAD51D;PALB2;WRN
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,0.3967436209873091,1.3721086084488476,0.17647058823529413,0.9796626546145327,1.0,8/16,25.75%,MEFV;PANX1;RELA;P2RX7;CASP1;APP;NLRP3;PYCARD
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.3833485243013367,1.3703824497713195,0.16666666666666666,0.9676191939008467,1.0,8/17,20.18%,RFC3;RFC5;UBA52;REV1;RPS27A;SLC19A1;REV3L;POLR1A
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.369344004596676,1.36962661282202,0.04,0.9500358807314853,1.0,6/25,9.97%,TECR;ACOX1;FADS2;HACD1;FADS1;BAAT
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.35836607810201193,-1.3648757857075158,0.14754098360655737,1.0,1.0,9/30,11.52%,PARP1;UBB;NCOR2;SMAD7;SMURF2;TRIM33;MAPK1;TGIF1;NCOR1
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.30425483222774014,1.3632162049261645,0.11538461538461539,0.9636098209923417,1.0,14/50,15.44%,UCKL1;CMPK2;CAD;TK2;ENPP3;ENTPD6;ENTPD4;RRM2;NME3;ENTPD5;CANT1;UPP1;UMPS;NT5C1A
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.39346768137562255,1.3625707744706415,0.11904761904761904,0.9448703606591111,1.0,3/17,3.29%,GSTM1;SLC28A2;SLC29A1
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.2864560688356513,-1.3604790987620183,0.08333333333333333,1.0,1.0,31/68,32.30%,CEP63;HAUS8;ALMS1;ACTR1A;CNTRL;CETN2;AKAP9;NEDD1;CEP192;CEP290;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;TUBA1A;CEP76;CEP164;CEP70;SDCCAG8;HAUS2;MAPRE1;PPP2R1A;CEP78;PAFAH1B1;ODF2;HAUS7;CDK5RAP2;CKAP5;DYNC1H1;PCNT
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.3506687792581469,-1.3602282448399883,0.12727272727272726,1.0,1.0,7/32,12.28%,POLR2I;TCEA1;ELOC;ELOA;POLR2D;POLR2A;CDK9
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.28482601091311094,-1.358606317560162,0.03225806451612903,1.0,1.0,34/85,26.42%,EXOSC2;UBB;XPO1;AKT1;PRKCD;YWHAZ;PSMD11;PSMB7;EXOSC9;ELAVL1;TNPO1;PSMB4;EXOSC6;EXOSC4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;ENPP2;ZFP36L1;PSMA6;PSMA4;PSMD13;MAPK14;EXOSC5;HSPB1;PSMC1;PSMD3;DCP2;SET;MAPKAPK2;UBC
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.41584064842545654,-1.357835067022515,0.1702127659574468,0.9945652884592969,1.0,5/15,16.08%,MTHFD1;MTHFR;DHFR;ST20-MTHFS;MTHFD2
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.28250005567604924,1.3562534254855123,0.08888888888888889,0.9567975430110213,1.0,13/54,14.70%,H2BC11;RNF20;UBE2B;BCL10;PEX2;H2BC15;UBA52;H2BC5;RNF144A;RNF181;RPS27A;H2BC14;TMEM129
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.30603556575578206,-1.3553484958438766,0.06557377049180328,0.9925833767660295,1.0,9/52,10.25%,POLR2I;TCEA1;COPS2;UBB;AQR;GTF2H3;POLR2D;EP300;POLR2A
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,0.26541236181855404,1.345305685403437,0.13043478260869565,0.994203663152442,1.0,12/74,7.52%,RAD9B;H2BC11;PPP4R2;DNA2;H2BC15;RBBP8;RFC3;RFC5;UBA52;H2BC5;EXO1;BLM
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.4235964260298488,-1.344623786381916,0.1896551724137931,1.0,1.0,6/17,10.78%,EXOSC2;AKT1;YWHAZ;EXOSC9;EXOSC6;EXOSC4
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.2675806283197466,1.3431725977029654,0.11904761904761904,0.9865424404526146,1.0,12/74,7.48%,H2BC11;RNF20;USP9X;UBE2B;BCL10;PEX2;H2BC15;USP7;UBE2R2;UBA52;H2BC5;RNF144A
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.24392513541877678,-1.3399477454878066,0.08333333333333333,1.0,1.0,44/128,25.67%,VAMP3;ARHGAP42;FLOT2;LMAN1;BCAP31;SLK;STBD1;DAAM1;RHPN2;JUP;ARHGAP24;ANLN;VAPB;ARHGAP6;KALRN;ARHGAP45;PIK3R1;FAM13A;PKN1;AKAP13;RACGAP1;DDRGK1;PLEKHG5;FARP1;PRPF38B;GMIP;ARHGEF40;VAV2;ATP6AP1;ARHGAP10;ARHGEF15;ERBIN;PKN2;RHPN1;SNAP23;DLC1;ARHGAP32;ARHGEF19;TRIO;ARHGAP1;ARHGDIA;ARHGAP26;TIAM1;ARHGAP5
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.3527897471796616,-1.3396142378304199,0.1016949152542373,1.0,1.0,8/26,17.81%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POLR2E;POLR3K;POLR3H
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,-0.3011265333062747,-1.3390885663605947,0.10344827586206896,1.0,1.0,9/44,10.26%,PGAM1;PCK2;PFKL;ADH5;ACSS2;ALDH7A1;DLAT;ENO1;FBP1
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.3823005856900942,-1.3388258371194417,0.14,1.0,1.0,7/17,22.92%,PIK3CA;NRAS;PIK3R1;STAT5A;STAT5B;SPTBN1;HRAS
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.2462276666146398,-1.3381138759646707,0.08196721311475409,1.0,1.0,22/129,12.47%,POLR2I;NUP37;TCEA1;ELOC;UBB;XPO1;VPS37B;GTF2A1;RAN;ELOA;GTF2H3;GTF2E1;POLR2D;TAF10;CHMP4B;RNMT;NMT2;POLR2A;VPS28;NUP88;CDK9;NUP93
prerank,KEGG_2021_Human__Axon guidance,-0.25382953861652147,-1.337180602067733,0.058823529411764705,1.0,1.0,40/126,24.31%,PAK1;SEMA4B;MYL9;FES;PIK3CA;EPHB4;PLXNC1;SEMA6A;L1CAM;BMP7;NRAS;RASA1;EPHB3;SEMA6C;TRPC6;SSH3;MAPK1;PLXNA4;PRKCZ;PLXNB2;MYL12B;SRGAP2;PIK3R1;EPHA4;SEMA5B;PLXNA2;EPHB1;CXCR4;NRP1;EPHB6;NCK2;PLCG2;ROBO3;ITGB1;RRAS;SSH2;HRAS;CDK5;SEMA4F;CDC42
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.2655753555775051,1.3337919337161444,0.05555555555555555,1.0,1.0,9/66,6.42%,PLCB4;INPPL1;IMPA1;PI4KA;INPP5E;PIK3CG;PIP5KL1;MTM1;ISYNA1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.3206185649444935,-1.3329414501258408,0.08928571428571429,1.0,1.0,24/51,33.14%,UBB;AMN;AP2B1;MBTPS2;NCEH1;CETP;ZDHHC8;TRNP1;AP2M1;ABCG1;LDLRAP1;BMP1;LMF2;NPC2;PLTP;UBC;LPL;CUBN;LIPC;LCAT;CLTA;SOAT1;VLDLR;LIPG
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.24376791752174853,-1.331094802115767,0.10526315789473684,1.0,1.0,24/142,12.47%,POLR2I;NUP37;TCEA1;ELOC;UBB;XPO1;VPS37B;XRCC5;GTF2A1;RAN;ELOA;GTF2H3;GTF2E1;POLR2D;TAF10;CHMP4B;RNMT;XRCC4;NMT2;POLR2A;VPS28;NUP88;CDK9;NUP93
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.291771753535643,-1.3289621649474093,0.07142857142857142,1.0,1.0,7/46,4.46%,H1-4;PROC;PRKCD;BCAP31;DFFB;CASP3;CLSPN
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.30767769170247933,-1.326791342506687,0.125,1.0,1.0,8/44,12.28%,POLR2I;TCEA1;ELOC;ELOA;GTF2H3;POLR2D;POLR2A;CDK9
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,0.29221949775489775,1.3260603508349287,0.13636363636363635,1.0,1.0,13/48,13.84%,H2BC11;H2BC15;RBBP8;H2BC5;BLM;H3-3B;MLH1;CDK4;H2AC7;HID1;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.28657295155935986,-1.3208844267201723,0.1111111111111111,1.0,1.0,12/66,12.28%,POLR2I;TCEA1;ELOC;GTF2A1;ELOA;GTF2H3;GTF2E1;POLR2D;TAF10;RNMT;POLR2A;CDK9
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.323489256815548,-1.3189103270272413,0.11764705882352941,1.0,1.0,8/42,12.28%,POLR2I;TCEA1;ELOC;ELOA;GTF2H3;POLR2D;POLR2A;CDK9
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,-0.2966731643665865,-1.3189056852791428,0.125,1.0,1.0,24/55,25.67%,VAMP3;ARHGAP17;MPP7;CDC42BPB;JUP;ARL13B;CDC42EP1;GIT1;RHOQ;TRIP10;SRGAP2;PKN1;ARHGAP33;WWP2;CDC42EP2;PKN2;WASL;SNAP23;DLC1;ARHGAP32;ARHGAP1;CDC42;ARHGAP26;ARHGAP5
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,0.31373981530003003,1.3169573084730142,0.125,1.0,1.0,8/35,12.79%,TTC21B;IFT172;IFT20;IFT80;IFT88;TRIP11;IFT140;DYNLL2
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.23687620489662223,-1.3147445665418436,0.07017543859649122,1.0,1.0,35/156,16.89%,SLC25A26;SLC9A4;SLC22A15;SLC25A5;SLC39A6;CTNS;SLC26A6;SLC45A3;ARL2BP;SLC27A1;SLC33A1;SLC22A1;SLC2A8;SLC2A6;SLC22A16;SLC35D1;SLC4A5;SLC35B4;SLC13A5;SLC6A15;SLC5A2;SLC29A3;SLC2A4;SLC11A1;SLC35C1;SLC30A6;SLC6A13;SLC43A2;SLC39A14;SLC2A14;SLC12A6;SLC39A7;BSG;RUNX1;SLC7A8
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.28085261892016355,-1.3129374288225786,0.14814814814814814,1.0,1.0,17/65,18.39%,ITGAM;AKT1;DUSP6;PIK3CA;SPI1;JUP;NRAS;CD14;BAD;RPS6KB1;MAPK1;PIK3R1;PIM2;STAT5A;PPARD;RUNX1;STAT5B
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.31238920065716236,1.3123868572716584,0.1951219512195122,1.0,1.0,10/43,12.23%,PTPN4;CAMK2A;HIPK2;TNRC6C;PVALB;AGO4;HDAC3;MOV10;PPARG;MECP2
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.3969623280203617,-1.3121306792505238,0.16981132075471697,1.0,1.0,5/18,16.10%,CLSTN1;PIK3CA;CRK;PIK3R1;CBL
prerank,KEGG_2021_Human__Folate biosynthesis,-0.38905029741796915,-1.311509170560698,0.19298245614035087,1.0,1.0,11/18,40.96%,PTS;SPR;AKR1C3;DHFR;AKR1B1;ALPL;PCBD1;GCH1;MOCS2;GGH;DHFR2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.2534354244800012,1.3032891394972896,0.09302325581395349,1.0,1.0,20/78,14.41%,H2BC11;CXCL8;ANAPC11;H2BC15;CDC16;CDKN2B;UBA52;H2BC5;H3-3B;VENTX;ANAPC15;CDK4;H2AC7;CEBPB;RPS27A;RELA;H4C15;H2BC14;H3C13;MAPK3
prerank,KEGG_2021_Human__Retinol metabolism,-0.3611862828538532,-1.3028385545024868,0.1694915254237288,1.0,1.0,9/19,28.29%,ADH5;ALDH1A2;DGAT1;RETSAT;DHRS3;RDH11;DHRS9;CYP3A5;CYP2C9
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.30157547476390734,1.300704663698062,0.1276595744680851,1.0,1.0,13/35,17.29%,DAND5;YBX1;CDKN2B;UBA52;E2F5;SMAD4;CCNK;SMAD2;RPS27A;TFDP2;MAPK3;RBL1;SERPINE1
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.3452490490944485,1.2944988789400567,0.1702127659574468,1.0,1.0,3/20,4.74%,DNA2;RFC3;RFC5
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.3045074039197668,-1.293405766445,0.21311475409836064,1.0,1.0,4/36,1.57%,PARP1;COPS2;UBB;INO80
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.3821607541591953,-1.2901289436425825,0.14754098360655737,1.0,1.0,8/19,21.42%,FGFR1;L1CAM;MAPK1;CSNK2A2;PKN1;NRP1;VAV2;ITGB1
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,0.323411522053101,1.288094545844807,0.15217391304347827,1.0,1.0,9/33,14.08%,PHC3;RBBP8;RING1;PHC1;RRM2;PCGF6;CBX5;MAX;TFDP2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.29712095045164205,-1.2878413519208607,0.15789473684210525,1.0,1.0,15/48,19.41%,CREB1;ACSS2;CRTC2;LIN9;TBL1X;MEF2D;NCOR1;SIRT3;NRF1;TFAM;POLRMT;PPARGC1B;TFB2M;CAMK4;IDH2
prerank,KEGG_2021_Human__Ether lipid metabolism,0.318364101027801,1.28452381544599,0.14705882352941177,1.0,1.0,10/35,14.06%,PLB1;PLA2G7;GDPD3;PLPP1;PAFAH1B2;PLD1;PEDS1;PLPP2;PLA2G2C;PLA2G12A
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,0.24760221588087422,1.2844217011781074,0.17647058823529413,1.0,1.0,15/80,9.65%,MRPS16;MRPL1;CHCHD1;MRPL20;MRPS25;MRPL43;MRPS23;MRPS7;TUFM;MRPL53;MRPS35;MRPS18C;MRPS11;MRPS30;MRPL52
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,-0.27409631106876664,-1.2843443625562478,0.13114754098360656,1.0,1.0,14/65,12.59%,HEY1;UBB;NCOR2;SKP1;MAML2;CUL1;HDAC11;NBEA;JAG1;EP300;TBL1X;NCSTN;NCOR1;MAMLD1
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,-0.2771962841531232,-1.2840541804295087,0.13793103448275862,1.0,1.0,21/58,25.67%,VAMP3;FLOT2;SLK;DAAM1;RHPN2;JUP;ANLN;PIK3R1;PKN1;AKAP13;RACGAP1;PRPF38B;VAV2;ERBIN;PKN2;SNAP23;DLC1;ARHGAP32;ARHGAP1;ARHGAP26;ARHGAP5
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.332200383407951,-1.283184027281579,0.1694915254237288,1.0,1.0,8/27,17.81%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POLR2E;POLR3K;POLR3H
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,-0.25671827149374454,-1.2807819691200326,0.1016949152542373,1.0,1.0,29/79,25.28%,VAMP3;ARHGAP17;ARHGAP42;MPP7;LMAN1;PIK3CA;STBD1;NCF2;MTX1;VAPB;CDC42EP1;GIT1;PIK3R1;PKN1;RACGAP1;VAV2;DSG2;BAIAP2L1;LEMD3;ERBIN;PKN2;ITGB1;ARHGAP32;TRIO;ARHGAP1;CDC42;ARHGDIA;ARHGAP26;TIAM1
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.2727250298769192,1.2807210045840414,0.13333333333333333,1.0,1.0,12/51,13.21%,CTSL;COL9A1;P3H1;P3H2;PLOD1;MMP9;COL9A3;MMP28;COL13A1;COL6A1;COL4A3;PLEC
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.389764829810218,-1.280385033567676,0.17857142857142858,1.0,1.0,8/19,29.04%,PROC;AMN;LMBRD1;PCCA;MMUT;MMADHC;PCCB;CUBN
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.37455059338283525,-1.2794195980570073,0.15254237288135594,1.0,1.0,9/16,25.70%,EPHB4;EPHB3;GIT1;PKN1;EPHB1;EPHB6;NCK2;PKN2;SDCBP
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.2842593383596527,-1.278230661841508,0.05454545454545454,1.0,1.0,18/59,22.92%,POLR2I;UBB;PIK3CA;FGFR1;NRAS;POLR2D;MAPK1;POLR2A;FRS2;HNRNPA1;PIK3R1;MKNK1;CBL;POLR2E;PPP2CA;FGFR4;PPP2R1A;HRAS
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.29004982476327573,1.276576143156248,0.1951219512195122,1.0,1.0,10/33,17.48%,DNA2;RFC3;RFC5;BLM;CHTF8;POT1;POLA1;TINF2;SLC19A1;WRN
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,-0.252138095117132,-1.275345310624929,0.05660377358490566,1.0,1.0,39/101,30.23%,PFKL;AKT1;TBC1D4;PIK3CA;NRAS;MED1;MED24;BAD;TSC2;EP300;MAPK1;NCOR1;PIK3R1;ATP2A1;ATP1A3;ATP1B2;MED16;PLCB2;FXYD2;MED12L;PLCD1;THRA;MED30;ATP2A2;HDAC2;PLCG2;PFKP;HRAS;ACTB;HIF1A;NCOA3;MED17;RHEB;ATP1B3;ATP2A3;MED14;MED13L;MED12;PFKFB2
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.4053681202190311,-1.2739310273167608,0.16071428571428573,1.0,1.0,8/16,24.33%,EXOSC2;NT5C3B;EXOSC9;EXOSC6;EXOSC4;SKIC8;EXOSC5;HBS1L
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.38353189789742326,-1.27271513582055,0.1694915254237288,1.0,1.0,5/18,12.59%,HEY1;MAML2;ACTA2;EP300;MAMLD1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.2680084965517657,-1.2700195667057892,0.125,1.0,1.0,21/71,22.36%,LYPLA2;AP2B1;ANK2;FGFR1;ITGA10;NRP2;L1CAM;SCN11A;MAPK1;LAMC1;DLG1;CSNK2A2;PKN1;AP2M1;ITGA1;DNM3;SPTBN1;NRP1;VAV2;ITGB1;DNM2
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.2726916690079729,-1.269671942231019,0.11475409836065574,1.0,1.0,11/59,13.63%,POLR2I;TCEA1;ELOC;ELOA;GTF2H3;POLR2D;MDC1;POLR2A;CDK9;FOS;FANCD2
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.3209117575571732,1.2683620514671807,0.19047619047619047,1.0,1.0,4/24,6.44%,XRCC1;RFC3;RFC5;UBA52
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.28383691487881063,-1.2682349092406804,0.10714285714285714,1.0,1.0,14/53,18.52%,POLR2I;UBB;PIK3CA;NRAS;POLR2D;MAPK1;POLR2A;FRS2;HNRNPA1;PIK3R1;MKNK1;CBL;POLR2E;PPP2CA
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.2713693797034085,-1.2674858130225102,0.18518518518518517,1.0,1.0,22/66,26.14%,PXN;CAV2;SEPTIN6;CLTCL1;PIK3CA;SHC4;CRK;ACTR3;PIK3R1;CTTN;CBL;WASF1;DNM3;ARHGAP10;HCLS1;WASL;ITGB1;DNM2;ACTB;CDC42;GAB1;SEPTIN1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.3481611375054757,1.267009609962355,0.07894736842105263,1.0,1.0,2/21,0.44%,PLCB4;INPPL1
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.33253547246300935,1.2665386613254455,0.19607843137254902,1.0,1.0,2/25,0.09%,CDC25B;CDC25C
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.37669974950897156,1.266280421076943,0.14583333333333334,1.0,1.0,10/19,22.63%,MEF2A;BNIP2;ABL1;MAP2K6;CDH15;MAPK11;TCF7L2;CTNNA1;NEO1;MEF2B
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.3259987319349602,-1.2653456655492008,0.20408163265306123,1.0,1.0,12/27,25.80%,CAB39;CAB39L;SLC38A9;TSC2;RPTOR;STRADB;LAMTOR2;PRKAG2;PRKAG1;RRAGC;RHEB;STK11
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.3651132973664657,-1.2610113594584043,0.22,1.0,1.0,8/19,22.08%,UBB;FGFR1;MAPK1;FRS2;MKNK1;CBL;PPP2CA;PPP2R1A
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,-0.2641217029141343,-1.2600344080115717,0.12962962962962962,1.0,1.0,36/83,25.67%,VAMP3;ARHGAP17;ARHGAP42;MPP7;LMAN1;STBD1;NCF2;JAG1;ARHGAP6;CDC42EP1;GIT1;SRGAP2;ARHGAP15;PIK3R1;PKN1;RACGAP1;WASF1;NOXA1;VAV2;DSG2;BAIAP2L1;LEMD3;FERMT2;ERBIN;PKN2;ITGB1;SNAP23;AMIGO2;ARHGAP32;TRIO;NCOA3;ARHGAP1;CDC42;ARHGAP26;TIAM1;ARHGAP5
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.19943940198215057,1.2572302447062877,0.04878048780487805,1.0,1.0,64/249,19.12%,ZDHHC5;MGAT5;CTSL;SFTPD;RPS20;SIKE1;DDX20;MAN2A1;SRPK2;GEMIN8;KPNA2;UVRAG;RPS15;RPS25;ZDHHC2;HAVCR1;MAVS;TLR8;NUP58;UBA52;NOD2;ST6GALNAC4;POM121;TUFM;RPS19;TOMM70;FAU;PIK3R4;RPS10;VPS39;TAB3;PARP9;ZDHHC11;TRIM4;PTPN11;ATG14;RPS21;RNF135;PRKCSH;ZDHHC3;DDOST;RPS27A;NUP210;IRAK2;RPS28;GOLGA7;HSPG2;ST6GALNAC2;SRPK1;AGRN;ISG15;STAT1;SEC13;RPS23;NUP155;VPS33A;NOD1;NUP62;SNRPE;PDPK1;NLRP12;TLR7;SEC23A;GEMIN2
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.25398808912637255,-1.2567772294916013,0.1111111111111111,1.0,1.0,30/90,23.95%,CREB1;AKT1;PIK3CA;SSTR2;NRAS;SHC4;EP300;ADCY4;MAPK1;CRK;GNA11;FOS;PIK3R1;STAT5A;ITPR1;MAP2K4;PLCB2;GNAQ;IGFBP3;JUNB;STAT5B;ATF4;MAP2K3;PLCG2;CREB3L4;MAPK8;MAPK9;HRAS;GHRL;MAPK14
prerank,KEGG_2021_Human__Malaria,0.2767472831949814,1.254351549881503,0.18181818181818182,1.0,1.0,9/43,10.44%,CXCL8;THBS1;CR1L;IL10;IL12A;THBS4;TGFB1;CD40LG;MYD88
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.2780070394115046,-1.2500299530100456,0.13793103448275862,1.0,1.0,19/66,21.15%,AKT1;PIK3CA;KIF5C;NRAS;TGFA;BAD;E2F3;RASSF5;MAPK1;CDK6;PIK3R1;STAT5A;JAK3;STAT5B;KIF5B;KIF5A;HGF;RARB;PLCG2
prerank,KEGG_2021_Human__TGF-beta signaling pathway,-0.2637779134878662,-1.2492457885368338,0.11764705882352941,1.0,1.0,15/64,13.76%,LTBP1;SKP1;CUL1;SMAD7;BMP7;SMURF2;RPS6KB1;EP300;ACVR1B;MAPK1;E2F4;ACVR2B;TGIF1;TGFBR2;ZFYVE16
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,0.24978382241222344,1.2483575267697782,0.10204081632653061,1.0,1.0,23/77,18.23%,EMG1;SNORD3A;REXO1;TBL3;REXO5;EIF6;NOL6;WDR36;PWP2;AK6;RPP25L;BMS1;FCF1;RNA5-8SN2;UTP14A;GNL3;POP4;SNORD3B-1;GNL2;POP7;WDR3;RMRP;XRN1
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.28180846810151533,-1.2479117919425535,0.19642857142857142,1.0,1.0,7/44,10.25%,POLR2I;GTF2A1;GTF2H3;GTF2E1;POLR2D;TAF10;POLR2A
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.28642206005952614,-1.2458750752983418,0.13559322033898305,1.0,1.0,11/64,9.44%,PAK1;ELOC;AKT1;PIK3CA;ETS1;NRAS;TGFA;BAD;EP300;MAPK1;CRK
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.34032495960399584,-1.245348692491133,0.15517241379310345,1.0,1.0,6/25,8.57%,CREB1;PDE1B;PRKCD;NBEA;ADCY4;MAPK1
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.3254536111299815,-1.245268471822568,0.21153846153846154,1.0,1.0,5/27,10.25%,POLR2I;GTF2H3;POLR2D;RNMT;POLR2A
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.3594249592432951,-1.2450449589666588,0.2,1.0,1.0,3/18,4.83%,CACNG8;CACNG6;SCN11A
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.29936727202312224,-1.2448732439919057,0.203125,1.0,1.0,15/35,28.61%,KIF5C;KIF13B;KIF18A;KLC1;KIF21B;RACGAP1;KIF3A;KIF21A;KIF5B;KIF5A;KIF6;KIF11;KIF1C;CENPE;KIF2A
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.29594760765142164,1.2433681243144843,0.11904761904761904,1.0,1.0,5/30,6.44%,UBE2B;RFC3;RFC5;DDB1;UBA52
prerank,KEGG_2021_Human__Starch and sucrose metabolism,0.3437655313419294,1.2429735693393151,0.17777777777777778,1.0,1.0,7/24,11.99%,PGM2L1;ENPP3;GANC;GYG1;GBE1;G6PC3;PYGL
prerank,KEGG_2021_Human__GnRH secretion,-0.27124749520020586,-1.242559141724139,0.1694915254237288,1.0,1.0,12/44,18.59%,AKT1;CACNA1I;PIK3CA;NRAS;MAPK1;GNA11;PIK3R1;KCNN1;ITPR1;PLCB2;GNAQ;HCN2
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.3112823660462287,-1.2413258328751093,0.20689655172413793,1.0,1.0,7/29,11.51%,E2F6;FBXO5;LIN52;LIN9;E2F4;DHFR;CDC45
prerank,KEGG_2021_Human__Parkinson disease,-0.21954355236034903,-1.2402110316909645,0.058823529411764705,1.0,1.0,67/208,25.29%,DUSP1;UBB;SLC25A5;NDUFS2;UBA1;NDUFS7;ATP5F1E;NDUFB7;COX7B;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;SNCA;UCHL1;COX6A1;SDHD;EIF2S1;PPIF;ADRM1;UBE2J1;NDUFC1;PSMB4;KLC1;CALML4;NDUFA8;UQCRHL;PSMD8;RYR3;SEPTIN5;DDIT3;APAF1;NDUFS3;PSMB5;TUBB6;UBE2G1;ITPR1;NDUFAB1;TUBB4B;ATP5PO;SEM1;PSMD6;TUBA1A;ATF4;KIF5B;PSMD9;KIF5A;NDUFA12;CALM3;SDHB;NDUFC2;MAPK8;MAPK9;PSMA6;NDUFB6;PSMA4;PSMD13;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;NDUFA2;ATP5MC2;PSMC1;PSMD3
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.315415360953066,-1.2396845204716114,0.16666666666666666,1.0,1.0,19/33,35.56%,CYP27A1;NCEH1;VAPB;CETP;STAR;LRP1;VAPA;LDLRAP1;LRPAP1;NPC2;PLTP;LPL;TSPO;LIPC;LCAT;SOAT1;LIPG;OSBPL5;STARD3
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.3185218826750952,-1.2382643499748658,0.21568627450980393,1.0,1.0,7/27,11.87%,UBB;VPS37B;ARL13B;CHMP4B;VPS28;PLIN3;PLIN2
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.2552839864247041,1.2346310760048216,0.2,1.0,1.0,12/60,12.87%,UTP20;EMG1;TBL3;NOL6;SPPL2A;UTP3;WDR36;PWP2;BMS1;FCF1;RRP36;UTP14A
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.328817798423242,-1.2340791609025608,0.23728813559322035,1.0,1.0,13/27,26.26%,CREB1;DUSP6;MAPK1;FOS;DUSP7;PPP2CA;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;MAPKAPK2
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.35853217649096064,-1.2327929609341817,0.17857142857142858,1.0,1.0,6/24,11.49%,POLR2I;RAN;POLR2D;PRKRA;POLR2A;DGCR8
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.3754409125786387,1.2317194420360016,0.2558139534883721,1.0,1.0,5/15,13.59%,ABL2;UBA52;SLA2;RPS27A;FLT3LG
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.21758605767925182,-1.231622972921074,0.15,1.0,1.0,64/182,26.77%,NUP37;XPO1;TUBGCP4;PPP2R5B;CEP63;HAUS8;ITGB3BP;ALMS1;NME7;ACTR1A;CENPN;NUDC;CNTRL;KIF18A;SMC4;CLASP2;CENPU;CETN2;ZW10;AKAP9;RAB33B;NEDD1;CEP192;CSNK2A2;MAD1L1;ZWINT;STAG2;CEP290;CENPM;NCAPG;PLK1;TUBB4B;RCC2;CSNK1E;CSNK1D;CCP110;B9D2;TUBA1A;CEP76;PPP2CA;PMF1-BGLAP;CEP164;RPS27;TUBGCP2;CEP70;SDCCAG8;CENPA;HAUS2;MAPRE1;NCAPD2;PPP2R1A;MZT1;SGO1;CCNB2;PPP2R1B;NUP43;CENPH;CEP78;PAFAH1B1;ODF2;NCAPH;NUP85;NUP107;MZT2B
prerank,KEGG_2021_Human__Butanoate metabolism,0.34469355322791073,1.2314882405057683,0.20454545454545456,1.0,1.0,10/19,28.43%,OXCT1;AACS;ACSM2B;EHHADH;ECHS1;ALDH5A1;ACAT1;BDH1;BDH2;ACSM3
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.3659813472654824,1.2312784977844493,0.2608695652173913,1.0,1.0,9/20,19.49%,CDC25C;CNOT2;CNOT9;BTG2;PLK2;CNOT7;NPM1;CNOT1;PLK3
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.20581970887536974,1.2305318622389694,0.06666666666666667,1.0,1.0,37/177,14.52%,UTP20;EMG1;RPL4;PES1;RPS20;TBL3;NOL6;RPL31;EXOSC8;SPPL2A;RPS15;RPS25;EXOSC10;RPLP0;UBA52;EXOSC3;UTP3;RPS19;EBNA1BP2;WDR36;FAU;PWP2;RPS10;RPL29;BMS1;RPS21;FCF1;RPS27A;RRP36;RPL37A;UTP14A;RSL24D1;RPL39;RPS28;DDX56;RPL3;GNL3
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,0.2964428396165201,1.227536106529963,0.16279069767441862,1.0,1.0,10/35,15.11%,H2BC11;ORC3;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13;KPNA1
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.35513751227084656,1.2263167132839208,0.17073170731707318,1.0,1.0,5/19,7.08%,USP8;STAM;PTPN2;UBA52;SH3GL1
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.325336102306263,-1.2248954415382103,0.22413793103448276,1.0,1.0,20/20,67.51%,AHCY;SLC25A10;VSIG2;MRI1;ETHE1;MTR;ENOPH1;ADI1;MPST;TSTD1;ADO;SQOR;BHMT2;SUOX;MTRR;MTAP;APIP;TXN2;GOT2;CSAD
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.20036353925388772,1.2246367434066323,0.06666666666666667,1.0,1.0,40/197,14.52%,UTP20;EMG1;RPL4;PES1;RPS20;TBL3;NOL6;RPL31;EXOSC8;SPPL2A;RPS15;RPS25;EXOSC10;RPLP0;UBA52;EXOSC3;UTP3;MRM1;ELAC2;RPS19;EBNA1BP2;WDR36;FAU;PWP2;RPS10;RPL29;BMS1;RPS21;FCF1;RPS27A;RRP36;RPL37A;UTP14A;RSL24D1;MRM2;RPL39;RPS28;DDX56;RPL3;GNL3
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,0.22876148176118655,1.223640927729462,0.23529411764705882,1.0,1.0,15/86,9.65%,MRPS16;MRPL1;CHCHD1;MRPL20;MRPS25;MRPL43;MRPS23;MRPS7;TUFM;MRPL53;MRPS35;MRPS18C;MRPS11;MRPS30;MRPL52
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.28913198031250376,-1.2223821620478494,0.11666666666666667,1.0,1.0,22/53,29.13%,UBB;SKP1;AKT1;YWHAZ;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.21072258061501362,-1.222291676993161,0.1111111111111111,1.0,1.0,46/203,18.59%,ABCC9;CACNG8;FLOT2;CREB1;GNG10;BEGAIN;KCNK7;AP2B1;GNG5;KCNG1;KCNC4;NRAS;NBEA;KCNJ2;CHRNB4;KCNH2;COMT;CACNA2D3;HOMER3;SLC22A1;KCND3;PPM1F;ADCY4;MAPK1;KCNMB1;NEFL;GIT1;KCNJ15;CACNA1E;DLG1;CHRNE;KCNN1;AP2M1;PPFIBP2;SLC6A13;SNAP25;PRKX;KCNA7;RTN3;PLCB2;CHRNA5;KCNK13;CAMK4;HTR3B;DBNL;HCN2
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.2794906954396945,1.222010802368475,0.25,1.0,1.0,9/40,9.85%,PHC3;NRIP1;HIPK2;RING1;PIAS2;PHC1;ZNF350;NCOA2;PIAS1
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.34387582078804824,-1.2218510726961753,0.14545454545454545,1.0,1.0,5/21,8.88%,UBB;CTSG;RNF213;MAPK1;ENO1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.24734870465807499,-1.2208212300480288,0.1509433962264151,1.0,1.0,24/99,13.86%,PARP1;UBB;LTBP1;NCOR2;XPO1;UBE2M;SMAD7;SMURF2;ITGB5;SRFBP1;TRIM33;EP300;ACVR1B;MAPK1;E2F4;ACVR2B;TGIF1;PRKCZ;NCOR1;CDK9;ITGB8;TGFBR2;ZFYVE16;FSTL3
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.24484181772435462,1.220255233905311,0.1794871794871795,1.0,1.0,21/64,22.53%,RAD9B;RAD51AP1;DNA2;RBBP8;RFC3;RFC5;UBA52;EXO1;BLM;RPS27A;RAD51D;GEN1;SLC19A1;PALB2;POLH;WRN;POLR1A;POLE2;RHNO1;SLX4;CHEK1
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.2824123345661665,-1.2201551219358104,0.18518518518518517,1.0,1.0,10/43,14.39%,COPS2;UBB;PIK3CA;NRAS;GFAP;NCSTN;NCOR1;SPARC;PIK3R1;STAT5A
prerank,KEGG_2021_Human__One carbon pool by folate,-0.36147611893182585,-1.219129273688487,0.19607843137254902,1.0,1.0,5/17,16.08%,MTHFD1;MTHFR;DHFR;ST20-MTHFS;MTHFD2
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,-0.23528602337708338,-1.2185668301164794,0.15384615384615385,1.0,1.0,42/121,26.90%,ABCC9;CACNG8;CACNG6;MYL9;CALD1;KCNK7;ACTA2;SCN11A;TMOD4;ITGB5;KCNJ2;KCNH2;KCND3;MYL12B;AKAP9;RYR3;ATP2A1;PKN1;ORAI2;ATP1A3;ITPR1;ATP1B2;ITGA1;FXYD2;FGF11;MYH3;KCNK13;KCNE4;ATP2A2;PKN2;RYR1;TPM1;KCNK6;TNNC2;TCAP;SRI;FKBP1B;CES1;ATP1B3;RANGRF;ATP2A3;AHCYL1
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.28436445266979776,1.2184463087968516,0.20930232558139536,1.0,1.0,9/39,12.54%,ANAPC11;CDC16;TNRC6C;AGO4;MOV10;VENTX;ANAPC15;CEBPB;RELA
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.25252157432496364,-1.217640345096118,0.17857142857142858,1.0,1.0,34/91,26.92%,UBB;SKP1;LTBR;UBE2M;CUL1;PSMD11;PSMB7;TNFSF14;FASLG;PSMB4;TNFSF13B;TNFRSF9;TNFSF9;PSMD8;PSMB10;PSMB5;FBXW11;TNFRSF4;TNFSF4;SEM1;PSMD6;PSMD9;TANK;TRAF3;TNFRSF1A;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;TNFRSF18;TNFSF12;UBC;TNFRSF13C
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,0.30664183423961533,1.215148767339189,0.225,1.0,1.0,5/24,12.54%,C3AR1;P2RX4;MEFV;ENTPD5;RELA
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.3918461029553264,-1.2150681959162826,0.2857142857142857,1.0,1.0,9/17,26.26%,EXOSC2;AKT1;EXOSC9;EXOSC6;EXOSC4;ZFP36L1;EXOSC5;DCP2;MAPKAPK2
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.2889361525952248,1.214567085525151,0.25,1.0,1.0,14/31,22.15%,VCAN;NDST2;HSPG2;NAGLU;HS2ST1;XYLT2;HS3ST3A1;AGRN;SLC35D2;B3GALT6;IDUA;GLB1;SGSH;DCN
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,0.3452791398086411,1.21270810668276,0.23809523809523808,1.0,1.0,5/20,14.43%,NUS1;MVD;ZMPSTE24;FNTB;PCYOX1
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.21637337842460333,1.2115374717011262,0.13333333333333333,1.0,1.0,22/108,14.03%,SQSTM1;ULK1;ATG9A;ATG5;TSC1;MTOR;UVRAG;RRAGD;UBA52;WIPI1;IFT88;MTERF3;TOMM70;FUNDC1;GABARAPL2;PIK3R4;TOMM6;ATG14;RPS27A;DYNLL2;PRKAB2;LAMTOR3
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,-0.26894522385792463,-1.210973452660062,0.1956521739130435,1.0,1.0,20/50,25.67%,VAMP3;MPP7;CDC42BPB;JUP;ARL13B;CDC42EP1;GIT1;PIK3R1;PKN1;WWP2;PKN2;WASL;SNAP23;ARHGAP32;WIPF2;TRIO;ARHGAP1;CDC42;ARHGAP26;ARHGAP5
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.20960591078362203,1.2102823080757656,0.07692307692307693,1.0,1.0,18/157,7.31%,OR4K17;EPS8L2;PJVK;PLB1;OR2L2;TRIOBP;OR10H5;TAS2R13;BCO2;SCNN1D;OR4F17;OR14J1;APOE;GNB5;OR52K2;PDE6B;RDH10;OR10H1
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.2326289511314664,1.2099493587703538,0.15789473684210525,1.0,1.0,23/89,14.97%,H2BC11;PHC3;H2BC15;TNRC6C;MAP3K5;AGO4;RING1;CDKN2B;UBA52;H2BC5;PHC1;H3-3B;MOV10;CDK4;H2AC7;RPS27A;H4C15;MDM4;H2BC14;H3C13;TFDP2;MAPK3;MAP2K6
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.23575020894918344,-1.2098994948584907,0.11764705882352941,1.0,1.0,37/115,25.26%,PCK2;FLOT2;AKT1;PIK3CA;SREBF1;NRAS;BAD;TSC2;SHC4;LIPE;RPS6KB1;RPTOR;MAPK1;CRK;RHOQ;CALML4;FBP1;PRKCZ;TRIP10;PIK3R1;SLC2A4;EIF4E;MKNK1;PDE3B;CBL;PYGB;PPP1R3D;PRKAG2;CALM3;MAPK8;HK3;MAPK9;HRAS;PRKAG1;RHEB;EIF4EBP1;PPP1R3E
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.20708608163716133,-1.2094504541252116,0.15384615384615385,1.0,1.0,78/246,26.42%,RASGRP4;UBB;IL6;XPO1;DUSP6;PPP2R5B;PIK3CA;FGFR1;PSMD11;PSMB7;NRAS;TGFA;RNASE3;MRAS;ABHD17A;KSR1;KALRN;MAPK1;IL2RB;PSMB4;NEFL;RNMT;PEA15;PSMD8;DLG1;FRS2;PSMB10;LAMTOR2;PIK3R1;PSMB5;SEPTIN7;LYPLA1;PKN1;SHOC2;DUSP7;IGF2BP1;ZDHHC9;CNKSR2;SPNS1;WDR83;JAK3;SEM1;CDC42EP2;PHB1;PSMD6;NF1;RAP1A;SPTBN1;PPP2CA;IL17RD;EPGN;CSF2RB;PSMD9;RASAL3;FGFR4;KBTBD7;PKN2;ZNF367;PPP2R1A;PSMA6;IL2RA;HRAS;PSMA4;NCOA3;ICMT;PSMD13;HSPB1;HBEGF;CDC42;PPP2R1B;IL3RA;PSMC1;PSMD3;MAPKAPK5;GFRA2;CUL3;TYK2;UBC
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.3654107993868059,-1.207146285375475,0.23255813953488372,1.0,1.0,7/17,26.42%,UBB;PIK3CA;NRAS;PIK3R1;CBL;HRAS;UBC
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.3272067816133333,-1.2070464150676432,0.22727272727272727,1.0,1.0,10/27,22.92%,PIK3CA;KLRK1;NRAS;KLRC2;PIK3R1;SPNS1;LCP2;VAV2;PLCG2;HRAS
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.27240916466906523,-1.2058630401775736,0.18867924528301888,1.0,1.0,12/40,19.04%,CLSTN1;PIK3CA;YWHAZ;IL2RB;CRK;PIK3R1;STAT5A;INPP5D;CBL;JAK3;STAT5B;CSF2RB
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,-0.37445483034738797,-1.2058230780830261,0.2653061224489796,1.0,1.0,7/15,26.92%,LTBR;TNFSF14;TNFSF13B;TANK;TRAF3;TNFSF12;TNFRSF13C
prerank,KEGG_2021_Human__Cell adhesion molecules,0.22802849169071177,1.2056125626959018,0.18421052631578946,1.0,1.0,26/109,16.74%,ITGA4;VCAN;CD99L2;CLDN4;NRXN2;CD2;CLDN7;OCLN;CNTN1;PVR;ICOS;ICOSLG;SIGLEC1;ALCAM;CD40LG;CTLA4;CLDN10;NRXN1;CNTNAP1;CD99;ITGAV;MADCAM1;HLA-DOB;CDH15;ESAM;ICAM1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.3215917994917238,1.204649517583717,0.21621621621621623,1.0,1.0,8/26,17.48%,RAD51AP1;DNA2;RBBP8;EXO1;BLM;RAD51D;PALB2;WRN
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.32063128605933394,-1.2035016298395864,0.32,1.0,1.0,6/25,10.26%,PCK2;PROC;PCNX4;LOC112694756;ENO1;FBP1
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,-0.29036639815846665,-1.202075636075176,0.2545454545454545,1.0,1.0,8/33,14.77%,PIK3CA;FGFR1;NRAS;MAPK1;GRB10;FRS2;PIK3R1;PDE3B
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.26000384295652107,-1.2012340605160663,0.19047619047619047,1.0,1.0,22/56,29.13%,UBB;SKP1;UBE2M;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.31463486945511926,-1.2011726601400503,0.25,1.0,1.0,7/27,12.59%,UBB;CREB1;MAML2;JAG1;EP300;NCSTN;MAMLD1
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.3010013661121289,-1.20114666259082,0.25,1.0,1.0,5/25,10.03%,CREB1;AKT1;BAD;TSC2;MAPKAP1
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.27436618956905423,-1.1975110641477746,0.234375,1.0,1.0,21/52,29.13%,UBB;SKP1;FBXO5;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.3306165453703023,-1.1972128932576027,0.2,1.0,1.0,9/24,23.46%,DHCR7;SREBF1;NSDHL;ARV1;SH3D19;LMBR1;PMVK;SC5D;GGPS1
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,0.22425139249933077,1.1970725107696047,0.1951219512195122,1.0,1.0,16/112,8.42%,XRCC1;RAD9B;H2BC11;PPP4R2;RAD51AP1;DNA2;H2BC15;RBBP8;RFC3;RFC5;UBA52;H2BC5;EXO1;ERCC4;BLM;PARP2
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.21033163636278124,-1.1949019257289604,0.12307692307692308,1.0,1.0,34/220,12.70%,POLR2I;NUP37;TCEA1;ELOC;UBB;SLC25A5;XPO1;VPS37B;SKP1;XRCC5;GTF2A1;AP1S1;RAN;AP2B1;ELOA;PSMD11;PSMB7;GTF2H3;GTF2E1;POLR2D;TAF10;CHMP4B;PSMB4;RNMT;XRCC4;NMT2;POLR2A;VPS28;PSMD8;NUP88;CDK9;NUP93;PSMB10;PSMB5
prerank,KEGG_2021_Human__cAMP signaling pathway,-0.22186395909781198,-1.194340178922711,0.15517241379310345,1.0,1.0,35/125,22.48%,PAK1;CREB1;MYL9;AKT1;PIK3CA;RRAS2;HCAR1;SSTR2;BAD;PDE3A;LIPE;EP300;ADCY4;MAPK1;CALML4;FOS;PIK3R1;ATP2A1;ATP1A3;PDE3B;ADRB2;ATP1B2;FXYD2;F2R;CAMK4;PTGER2;RAP1A;HCN2;ATP2A2;VAV2;CREB3L4;CALM3;RRAS;MAPK8;MAPK9
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,0.22897360118033783,1.1938594990651668,0.24489795918367346,1.0,1.0,14/80,9.65%,MRPS16;MRPL1;CHCHD1;MRPL20;MRPS25;MRPL43;MRPS23;MRPS7;MRPL53;MRPS35;MRPS18C;MRPS11;MRPS30;MRPL52
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.28584029963690316,1.1938077753570226,0.2608695652173913,1.0,1.0,12/34,20.49%,WASF3;CYFIP2;ABI1;BAIAP2;ARPC3;ABL1;BRK1;MAPK3;NCKAP1L;NCKIPSD;ARPC5;RNASE1
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.22132248185531606,-1.1911217438293336,0.19117647058823528,1.0,1.0,40/128,25.29%,RASGRP4;UBB;SKP1;PIK3CA;CUL1;MAP2K7;PSMD11;PSMB7;UBE2N;NRAS;MAPK1;PSMB4;PSMD8;FOS;PSMB10;PIK3R1;PSMB5;FBXW11;PKN1;TRAF6;ITPR1;MAP2K4;SPNS1;SLC7A8;SEM1;PSMD6;LCP2;UBE2D1;PSMD9;VAV2;PLCG2;PKN2;MAPK8;MAPK9;PSMA6;HRAS;PSMA4;PSMD13;PSMC1;PSMD3
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.2635110786548265,1.1901027841740224,0.2727272727272727,1.0,1.0,19/55,20.66%,WASF3;CYFIP2;ABI1;BAIAP2;FGR;ELMO2;ARPC3;MYO1E;ABL1;YES1;BRK1;MAPK3;NCKAP1L;VAV3;MYO9B;NCKIPSD;ARPC5;RNASE1;TARP
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.3320949697839366,-1.1896523310228528,0.21428571428571427,1.0,1.0,8/22,23.36%,PIK3CA;PRDM1;EP300;FRS2;PIK3R1;JAK3;HDAC2;HIF1A
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.28567950582924095,-1.1891158636690402,0.25925925925925924,1.0,1.0,18/36,33.11%,ABCC9;RYR3;ATP2A1;ORAI2;ATP1A3;ITPR1;ATP1B2;FXYD2;ATP2A2;RYR1;SRI;FKBP1B;ATP1B3;ATP2A3;AHCYL1;TRPC1;CAMK2G;ITPR3
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.2657331027763146,-1.1885871320102381,0.2,1.0,1.0,15/52,24.31%,PXN;AKT1;MAPKAPK3;PIK3CA;NRAS;BAD;MAPK1;PIK3R1;SPHK1;PLCG2;HRAS;VEGFA;MAPK14;HSPB1;CDC42
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,0.22698488941982098,1.1878694119613236,0.30434782608695654,1.0,1.0,14/80,9.65%,MRPS16;MRPL1;CHCHD1;MRPL20;MRPS25;MRPL43;MRPS23;MRPS7;MRPL53;MRPS35;MRPS18C;MRPS11;MRPS30;MRPL52
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.30336926981188456,-1.1875511535520924,0.24528301886792453,1.0,1.0,5/29,10.25%,POLR2I;GTF2H3;POLR2D;RNMT;POLR2A
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.18908548616692028,-1.1862311477864271,0.12121212121212122,1.0,1.0,120/403,26.05%,CDK5R1;UPF3B;ELOC;RPS24;UBB;CLTCL1;CREB1;LYPLA2;MYL9;CLSTN1;FES;RPS15A;PIK3CA;AP2B1;ANK2;EPHB4;PLXNC1;FGFR1;ITGA10;NRP2;PSMD11;PSMB7;SEMA6A;L1CAM;SCN11A;NRAS;RPL38;RPL26;EPHB3;RPL23A;RPS3A;TRPC6;RAP1GAP;DAG1;KALRN;MAPK1;RPL26L1;GRB10;NCSTN;PSMB4;RNMT;CLASP2;LAMC1;GIT1;PLXNA4;RPL8;ACTR3;MYL12B;RPL15;PSMD8;RPS3;RPL36A;DLG1;FRS2;SRGAP2;DOK2;RPL32;RPL7;PSMB10;PIK3R1;PSMB5;CSNK2A2;PKN1;AP2M1;GSPT2;RPL19;RPL22;PFN2;EPHA4;RPL18A;RPL5;ITGA1;DOK4;SEM1;PLXNA2;RPL21;RPS2;PSMD6;DNM3;SPTBN1;EPHB1;CXCR4;NRP1;RPSA;COL6A3;PSMD9;RPL36AL;VAV2;RPS27;PTPRC;EPHB6;NCK2;RELN;PKN2;WASL;ROBO3;ITGB1;RRAS;MAPK8;DNM2;PSMA6;HRAS;CDK5;PSMA4;TRIO;MYH9;MAPK7;PSMD13;MAPK14;CDC42;PSMC1;SIAH1;TIAM1;PSMD3;PLXNA3;RPS29;CASC3;SDCBP;SEMA4D;GFRA2
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.2138339802650875,-1.1853274474858067,0.15492957746478872,1.0,1.0,35/123,24.12%,GPR132;CREB1;LPAR2;GNG10;PRKCD;PIK3CA;AGXT;GNG5;LPAR6;NRAS;TRPC6;KALRN;MAPK1;PRKCH;GNA11;GPR68;UTS2R;PIK3R1;ITPR1;PLCB2;GNAQ;DHX34;F2R;RGS5;RGS1;ABHD12;CD200R1;DGKQ;ADRA1A;HRAS;GHRL;TRIO;MAPK7;HBEGF;GNG3
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.37390227440134305,1.1847965807736538,0.2549019607843137,1.0,1.0,3/20,3.88%,CDC25B;CDC25C;GOLGA2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.26335215050455724,1.1830379103716562,0.20833333333333334,1.0,1.0,16/47,19.49%,CDC25C;CNOT2;ZNF385A;CNOT9;BTG2;PLK2;CNOT7;TFDP2;ARID3A;CARM1;CDKN1B;RBL1;NPM1;CNOT1;RBL2;PLK3
prerank,Reactome_2022__Circadian Clock R-HSA-400253,-0.25568631897647426,-1.1828542615381994,0.22950819672131148,1.0,1.0,16/64,16.33%,UBB;CREB1;SKP1;CUL1;CRTC2;SREBF1;LIN9;EP300;TBL1X;MEF2D;HSD17B4;NCOR1;BHLHE41;CRY2;CSNK1E;CSNK1D
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.29802277010552725,-1.1823371024225187,0.2857142857142857,1.0,1.0,14/35,26.33%,NUP37;ALYREF;NXF1;NUP88;NUP93;EIF4E;SLBP;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.2468328297133433,-1.1816617650588852,0.20754716981132076,1.0,1.0,27/83,25.02%,CREB1;ACSS2;ATP5F1E;CRTC2;MICOS13;LIN9;MTX1;TBL1X;DNAJC11;MEF2D;NCOR1;SIRT3;NRF1;TFAM;POLRMT;PPARGC1B;TFB2M;ATP5PO;CAMK4;IDH2;PRKAG2;TBL1XR1;PRKAG1;MAPK14;IMMT;ATP5PB;ATP5MC2
prerank,Reactome_2022__RAS Processing R-HSA-9648002,-0.3427659217878607,-1.1800756677421758,0.2978723404255319,1.0,1.0,10/17,36.35%,NRAS;ABHD17A;LYPLA1;ZDHHC9;HRAS;ICMT;ARL2;ABHD17C;PRKCQ;ABHD17B
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.30400398930681527,-1.178040535583567,0.23728813559322035,1.0,1.0,6/31,9.80%,GNG10;AQP10;RAB11A;GNG5;ADCY4;AQP9
prerank,KEGG_2021_Human__Thermogenesis,-0.2063554796381012,-1.1770334968742906,0.14035087719298245,1.0,1.0,57/187,25.02%,NDUFS2;CREB1;CPT1B;SMARCD1;NDUFS7;ATP5F1E;FGFR1;NDUFB7;ACSL1;COX7B;SDHC;NDUFB3;NDUFAF1;COX6A1;NRAS;SDHD;TSC2;LIPE;PNPLA2;RPS6KB1;RPTOR;ADCY4;NDUFC1;COA3;NDUFA8;UQCRHL;FRS2;NDUFS3;COX17;NDUFAB1;COX19;ARID1B;ATP5PO;SLC25A20;PRDM16;NDUFA12;PRKAG2;MAP2K3;BMP8A;CREB3L4;SDHB;COX10;NDUFC2;COA4;NDUFB6;HRAS;ACTB;SMARCE1;PRKAG1;MAPK14;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;RHEB;NDUFA2;ATP5MC2
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.32244526866134227,1.1768515968735893,0.24,1.0,1.0,4/19,8.78%,TECR;ACSL5;ACSL6;HACD1
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.18387818090644645,1.1767691733566283,0.1111111111111111,1.0,1.0,79/331,19.12%,ZDHHC5;MGAT5;CTSL;SFTPD;ITGA4;SAP30;RPS20;SIKE1;IL1R1;DDX20;MTA2;MAN2A1;NFE2L2;SRPK2;GEMIN8;KPNA2;UVRAG;RPS15;RPS25;ZDHHC2;HAVCR1;KEAP1;MAVS;ZBP1;TLR8;NUP58;UBA52;NOD2;ST6GALNAC4;POM121;TUFM;RPS19;SIGMAR1;TOMM70;FAU;PIK3R4;RPS10;VPS39;TAB3;PARP9;ZDHHC11;TRIM4;FXYD1;PTPN11;ATG14;RPS21;RNF135;PRKCSH;ZDHHC3;CHURC1-FNTB;DDOST;RPS27A;NUP210;IRAK2;RPS28;GOLGA7;HSPG2;ST6GALNAC2;SRPK1;AGRN;SUDS3;ISG15;STAT1;SEC13;RPS23;JAK2;NUP155;CD79B;VPS33A;NOD1;NUP62;SH3KBP1;SNRPE;PDPK1;KDM1A;NLRP12;TLR7;SEC23A;GEMIN2
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.34509914965624994,-1.1767576726146043,0.2857142857142857,1.0,1.0,9/19,26.42%,UBB;MAPK1;FRS2;MKNK1;CBL;PPP2CA;FGFR4;PPP2R1A;UBC
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.18623541577841807,-1.1759253225043762,0.11594202898550725,1.0,1.0,123/420,26.05%,CDK5R1;UPF3B;ELOC;RPS24;UBB;CLTCL1;CREB1;LYPLA2;MYL9;CLSTN1;FES;RPS15A;PIK3CA;AP2B1;ANK2;EPHB4;PLXNC1;FGFR1;ITGA10;NRP2;PSMD11;PSMB7;SEMA6A;L1CAM;SCN11A;NRAS;RPL38;RPL26;EPHB3;RPL23A;RPS3A;TRPC6;RAP1GAP;DAG1;KALRN;MAPK1;RPL26L1;GRB10;NCSTN;PSMB4;RNMT;CLASP2;LAMC1;GIT1;PLXNA4;RPL8;ACTR3;MYL12B;RPL15;PSMD8;RPS3;RPL36A;DLG1;FRS2;SRGAP2;DOK2;RPL32;RPL7;PSMB10;PIK3R1;PSMB5;CSNK2A2;PKN1;AP2M1;GSPT2;RPL19;RPL22;PFN2;EPHA4;RPL18A;PXMP2;RPL5;ITGA1;NAB2;DOK4;SEM1;PLXNA2;RPL21;RPS2;PSMD6;DNM3;SPTBN1;EPHB1;CXCR4;NRP1;RPSA;COL6A3;PSMD9;RPL36AL;HDAC2;VAV2;RPS27;PTPRC;EPHB6;NCK2;RELN;PKN2;WASL;ROBO3;ITGB1;RRAS;MAPK8;DNM2;PSMA6;HRAS;CDK5;PSMA4;TRIO;MYH9;MAPK7;PSMD13;MAPK14;CDC42;PSMC1;SIAH1;TIAM1;PSMD3;PLXNA3;RPS29;CASC3;SDCBP;SEMA4D;GFRA2
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.2911344112147012,-1.1758383970324235,0.16666666666666666,1.0,1.0,10/43,11.90%,RAB6A;TBC1D17;RAB11A;RAB35;GGA3;TBC1D2;TSC2;RAB4A;TBC1D10A;RAB33B
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.2468421348334811,-1.1749499885695394,0.18181818181818182,1.0,1.0,10/77,6.94%,POLR2I;TCEA1;ELOC;GTF2A1;ELOA;GTF2H3;GTF2E1;CTR9;POLR2D;TAF10
prerank,KEGG_2021_Human__Huntington disease,-0.19497224880692504,-1.1730912055985856,0.11290322580645161,1.0,1.0,74/247,25.29%,POLR2I;SLC25A5;CLTCL1;NDUFS2;CREB1;NDUFS7;AP2B1;ATP5F1E;NDUFB7;COX7B;MAP2K7;DNAL4;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;COX6A1;SDHD;POLR2D;PPIF;ACTR1A;ADRM1;EP300;NDUFC1;PSMB4;KLC1;POLR2A;NDUFA8;UQCRHL;PSMD8;NRF1;APAF1;TFAM;NDUFS3;PSMB5;TBPL1;TUBB6;AP2M1;ITPR1;NDUFAB1;PLCB2;GNAQ;TUBB4B;ATP5PO;SEM1;POLR2E;PSMD6;TUBA1A;KIF5B;PSMD9;KIF5A;NDUFA12;HDAC2;CREB3L4;SDHB;NDUFC2;MAPK8;MAPK9;PSMA6;NDUFB6;PSMA4;TBPL2;PSMD13;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;BECN1;NDUFA2;ATP5MC2;PSMC1;PSMD3
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.34738545523076564,1.172540196035527,0.23809523809523808,1.0,1.0,6/15,12.55%,SMURF1;UBA52;TGFB1;ARHGEF18;RPS27A;TGFBR1
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.3918833376489368,-1.1725111567965034,0.2857142857142857,1.0,1.0,9/15,28.80%,PLXNC1;SEMA6A;PLXNA4;ITGA1;PLXNA2;PTPRC;ITGB1;SEMA4D;PLXNA1
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.2370565279043855,-1.1724191637590549,0.23728813559322035,1.0,1.0,30/96,22.08%,CEP63;RAB11A;HAUS8;AHI1;ALMS1;ACTR1A;CNTRL;CETN2;AKAP9;C2CD3;NEDD1;MKS1;CEP192;CEP290;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;CEP89;B9D2;TUBA1A;CEP76;CEP164;B9D1;CEP70;SDCCAG8;HAUS2;MAPRE1;PPP2R1A
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.2841949821318788,-1.1717030449130592,0.23636363636363636,1.0,1.0,8/31,13.19%,SLC25A5;ARL2BP;SLC27A1;SLC33A1;SLC35D1;SLC35B4;SLC29A3;SLC35C1
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.3134590445742644,1.171290186800885,0.19444444444444445,1.0,1.0,9/26,14.78%,PDIA3;OS9;DERL2;UBA52;RNF103;TRIM13;PRKCSH;RPS27A;RNF139
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.28074853301870156,1.1711105650900793,0.22,1.0,1.0,6/34,9.84%,FN3KRP;STS;GGCX;EIF5A2;DPH7;SUMF1
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.3444523163269727,1.1704236549736164,0.26,1.0,1.0,3/23,3.88%,CDC25B;CDC25C;GOLGA2
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.19511760681089932,1.1691942999388345,0.1282051282051282,1.0,1.0,34/157,15.37%,H2BC11;CXCL8;PHC3;DAND5;ANAPC11;H2BC15;CDC16;TNRC6C;MAP3K5;AGO4;RING1;CDKN2B;UBA52;H2BC5;PHC1;H3-3B;MOV10;VENTX;POT1;ANAPC15;CDK4;H2AC7;ASF1A;CEBPB;RPS27A;RELA;H4C15;MDM4;H2BC14;H3C13;TFDP2;MAPK3;MAP2K6;TINF2
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.23858596314495203,-1.1687858821711283,0.22413793103448276,1.0,1.0,19/71,19.95%,SPTLC1;ORMDL1;DEGS1;SUMF2;SAMD8;VAPB;PPM1L;CERS2;PRKD3;ORMDL3;SGMS1;HEXA;UGT8;GLTP;SPNS2;VAPA;B3GALNT1;SPHK1;ORMDL2
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,-0.21866119097141992,-1.1684598019005557,0.20634920634920634,1.0,1.0,30/119,22.79%,VAMP3;COPS2;UBB;CLTCL1;AGFG1;AP2B1;M6PR;SNX18;TGFA;GAPVD1;SLC2A8;SCARB2;REPS1;STON1;FCHO2;IGF2R;ACTR3;TRIP10;AP2M1;ADRB2;CTTN;CBL;DNM3;EPGN;LDLRAP1;WASL;COPS3;TGOLN2;DNM2;HGS
prerank,KEGG_2021_Human__Alzheimer disease,-0.19356566019554097,-1.1683545115709133,0.12903225806451613,1.0,1.0,89/292,25.29%,CDK5R1;SLC25A5;NDUFS2;IL6;AKT1;BACE2;NDUFS7;PIK3CA;ATP5F1E;NDUFB7;COX7B;MAP2K7;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;SNCA;COX6A1;NRAS;SDHD;EIF2S1;BAD;EIF2AK2;PPIF;ADRM1;LRP6;MAPK1;CSNK2A1;NDUFC1;NCSTN;PSMB4;KLC1;CALML4;FAS;NDUFA8;UQCRHL;PSMD8;RYR3;DDIT3;APAF1;NDUFS3;PIK3R1;PSMB5;ATP2A1;TUBB6;CSNK2A2;ITPR1;LRP1;NAE1;RTN3;NDUFAB1;PLCB2;GNAQ;TUBB4B;CSNK1E;ATP5PO;SEM1;PSMD6;TUBA1A;ATF4;KIF5B;PSMD9;KIF5A;NDUFA12;ATP2A2;CALM3;SDHB;TNFRSF1A;NDUFC2;MAPK8;MAPK9;PSMA6;NDUFB6;HRAS;CDK5;PSMA4;PSMD13;NDUFB8;WNT10B;NDUFA9;NDUFC2-KCTD14;ATP5PB;BECN1;NDUFA2;ATP5MC2;PSMC1;PSMD3
prerank,KEGG_2021_Human__Lysine degradation,-0.24737981851496396,-1.1680110149906857,0.22058823529411764,1.0,1.0,19/58,22.18%,KMT5B;ALDH7A1;KMT2D;DOT1L;SUV39H1;SETDB2;PLOD3;KMT2B;AASS;HADHA;SETD7;SETD1A;SMYD3;PRDM16;COLGALT2;COLGALT1;ACAT2;KMT5C;SETDB1
prerank,KEGG_2021_Human__Autophagy,0.20251017266237117,1.1672886321359293,0.11363636363636363,1.0,1.0,20/129,10.92%,SQSTM1;CTSL;SMCR8;VMP1;ULK1;ATG9A;ATG5;TSC1;EIF2AK4;MTOR;UVRAG;RRAGD;WIPI1;CFLAR;SNAP29;GABARAPL2;PIK3R4;ATG16L2;DAPK2;ATG14
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.19454624536981005,1.166490679286143,0.17777777777777778,1.0,1.0,37/187,14.52%,UTP20;EMG1;RPL4;PES1;RPS20;TBL3;NOL6;RPL31;EXOSC8;SPPL2A;RPS15;RPS25;EXOSC10;RPLP0;UBA52;EXOSC3;UTP3;RPS19;EBNA1BP2;WDR36;FAU;PWP2;RPS10;RPL29;BMS1;RPS21;FCF1;RPS27A;RRP36;RPL37A;UTP14A;RSL24D1;RPL39;RPS28;DDX56;RPL3;GNL3
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.19870449271686258,-1.166159256181414,0.16666666666666666,1.0,1.0,60/225,24.31%,PAK1;MAP4K1;CACNG8;DUSP1;RASGRP4;CACNG6;TAOK2;MAP3K8;AKT1;DUSP6;SRF;MAPKAPK3;CACNA1I;RRAS2;FGFR1;MAP2K7;CASP3;NRAS;CD14;TGFA;FASLG;RASA1;MRAS;CACNA2D3;MAPK1;CRK;FAS;CACNA1E;DDIT3;FOS;MKNK1;IRAK1;TGFBR2;TRAF6;DUSP7;MAP2K4;NF1;RAP1A;HSPA6;ATF4;MAP3K3;FLNA;HGF;TRADD;JUND;FGFR4;MAP2K3;MAP3K12;TNFRSF1A;RRAS;NLK;MAPK8;MAPK9;HRAS;MAP2K5;VEGFA;MAPK7;MAPK14;HSPB1;CDC42
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.35882451964588735,-1.1660224354907818,0.3125,1.0,1.0,5/16,16.89%,UBB;VPS37B;NMT2;VPS28;TSG101
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.3494289998029906,-1.165311400889867,0.2,1.0,1.0,5/21,12.59%,AKT1;HNF1A;MAML2;EP300;MAMLD1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.2784827678504697,-1.1650558193274347,0.25862068965517243,1.0,1.0,5/33,4.46%,PROC;PRKCD;BCAP31;CASP3;CLSPN
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.24363766410647247,-1.1649285919625676,0.18333333333333332,1.0,1.0,20/85,13.31%,PARP1;UBB;LTBP1;NCOR2;XPO1;UBE2M;SMAD7;SMURF2;ITGB5;SRFBP1;TRIM33;EP300;MAPK1;E2F4;TGIF1;PRKCZ;NCOR1;CDK9;ITGB8;TGFBR2
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,-0.2835474338414145,-1.163923896093606,0.21666666666666667,1.0,1.0,12/36,18.05%,CREB1;PDE1B;PRKCD;NBEA;ADCY4;MAPK1;GNA11;ITPR1;PRKX;PLCB2;GNAQ;CAMK4
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,-0.2632153787205339,-1.1624665152527471,0.2,1.0,1.0,20/55,25.86%,CDK5R1;MYL9;FES;PLXNC1;SEMA6A;RNMT;PLXNA4;MYL12B;PKN1;ITGA1;PLXNA2;NRP1;PTPRC;PKN2;ITGB1;RRAS;CDK5;MYH9;PLXNA3;SEMA4D
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.34543615106091996,1.1608581898824188,0.2222222222222222,1.0,1.0,8/17,22.61%,ACSL5;ACSL6;MECR;ACSL3;OXSM;ACSL4;FASN;HSD17B8
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.3209757817520478,1.1594189205983423,0.175,1.0,1.0,7/18,21.52%,COL9A1;COL9A3;COL13A1;COL6A1;COL4A3;COL9A2;COL17A1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.3506627452511148,1.1584379898065809,0.34146341463414637,1.0,1.0,5/17,11.49%,TNRC6C;AGO4;MOV10;PTPN11;CCND2
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,-0.33150164133494353,-1.1583880839699507,0.23529411764705882,1.0,1.0,8/20,24.31%,MYL9;MYL12B;PKN1;CTTN;FLNA;PKN2;MYH9;CDC42
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.20186210999339213,1.1551010129034613,0.2631578947368421,1.0,1.0,17/139,7.52%,CDC25C;RAD9B;H2BC11;ORC3;DNA2;CDC6;H2BC15;RBBP8;RFC3;RFC5;PSMD7;PSMA5;UBA52;H2BC5;EXO1;CHEK2;BLM
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.2051673882078477,-1.1537796371142812,0.2,1.0,1.0,35/190,12.89%,RAB6A;HEY1;UBB;NCOR2;CREB1;SKP1;AKT1;MAML2;YWHAZ;H2AC14;ACTA2;CUL1;H2AZ2;HDAC11;PSMD11;PSMB7;PBX1;NBEA;POFUT1;JAG1;LFNG;E2F3;EP300;TBL1X;B4GALT1;NCSTN;PSMB4;PSMD8;NCOR1;H2AC6;POGLUT1;PSMB10;MAMLD1;PSMB5;ATP2A1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.25189372899165774,-1.152914691106442,0.2222222222222222,1.0,1.0,15/71,13.86%,KLKB1;LTBP1;IL6;PROC;CTSG;MELTF;HSP90B1;KLK1;PNPLA2;MIA3;LAMC1;MXRA8;APOL1;TIMP1;FSTL3
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.24166625009994971,-1.1505300763098982,0.24528301886792453,1.0,1.0,24/73,25.71%,PAK1;AKT1;PIK3CA;MAP2K7;NRAS;TGFA;BAD;SHC4;RPS6KB1;MAPK1;CRK;PIK3R1;STAT5A;MAP2K4;CBL;STAT5B;NCK2;PLCG2;MAPK8;MAPK9;HRAS;HBEGF;EIF4EBP1;GAB1
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.22181411541856036,-1.1500903517897538,0.2222222222222222,1.0,1.0,32/92,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;TLR10;S100A12;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;TLR5;TANK;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.25547092365222906,1.1489050786540718,0.1956521739130435,1.0,1.0,17/68,15.89%,CDC25B;CDC25C;H2BC11;H2BC15;GOLGA2;GSDME;H2BC5;H3-3B;H2AC7;FADD;DNMT3A;H4C15;H2BC14;H3C13;LMNA;POLA1;BCL2L11
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,0.269965779560854,1.1479645563755996,0.25,1.0,1.0,11/40,13.84%,H2BC11;H2BC15;H2BC5;JARID2;PHF19;H3-3B;H2AC7;DNMT3A;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.27742675281071344,-1.1473972379402653,0.2641509433962264,1.0,1.0,9/40,11.52%,CREB1;XPO1;CRTC2;CLEC1B;LIN9;EP300;TBL1X;MEF2D;NCOR1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.29819090713878493,-1.1470657254168224,0.32653061224489793,1.0,1.0,8/26,18.40%,UBB;PIK3CA;NRAS;PIK3R1;STAT5A;CBL;STAT5B;SPTBN1
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.19641742891125602,-1.1430296960999184,0.19117647058823528,1.0,1.0,49/210,19.67%,HRG;GP9;CHID1;AKT1;GNG10;PHACTR2;PRKCD;PIK3CA;YWHAZ;NHLRC2;PIKFYVE;GNG5;CLEC1B;LOC112694756;RNASE3;FAM3C;A1BG;SRGN;SYTL4;PIK3R5;TRPC6;MAPK1;MAGED2;CRK;PRKCH;TMSB4X;PRKCZ;GNA11;SPARC;MPL;TIMP1;PIK3R1;SCCPDH;TEX264;ITPR1;MMRN1;GNAQ;SPNS1;F2R;VTI1B;ABHD12;STX4;CYB5R1;LCP2;RAP1A;TOR4A;FLNA;PCYOX1L;VAV2
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,0.3657745480434443,1.1415316029625282,0.26666666666666666,1.0,1.0,2/15,1.52%,IFI16;DTX4
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.20498509322970504,-1.140863608280745,0.22033898305084745,1.0,1.0,66/213,26.42%,RASGRP4;UBB;IL6;DUSP6;PPP2R5B;PIK3CA;FGFR1;PSMD11;PSMB7;NRAS;TGFA;RNASE3;MRAS;ABHD17A;KSR1;MAPK1;IL2RB;PSMB4;NEFL;RNMT;PEA15;PSMD8;DLG1;FRS2;PSMB10;LAMTOR2;PIK3R1;PSMB5;LYPLA1;SHOC2;DUSP7;ZDHHC9;CNKSR2;SPNS1;WDR83;JAK3;SEM1;PHB1;PSMD6;NF1;RAP1A;SPTBN1;PPP2CA;IL17RD;EPGN;CSF2RB;PSMD9;RASAL3;FGFR4;KBTBD7;PPP2R1A;PSMA6;IL2RA;HRAS;PSMA4;ICMT;PSMD13;HBEGF;PPP2R1B;IL3RA;PSMC1;PSMD3;GFRA2;CUL3;TYK2;UBC
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,-0.28614355545057363,-1.1399037203590863,0.2923076923076923,1.0,1.0,15/29,34.85%,AKT1;GNG10;GNG5;PIK3R5;PKN1;PLCB2;GNG3;CDC42;GNB4;ARHGEF6;GNG8;RHOA;GNG7;PLCB3;BTK
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,-0.24676390208259433,-1.1396744924317477,0.3191489361702128,1.0,1.0,22/64,25.67%,VAMP3;FLOT2;LMAN1;SLK;DAAM1;JUP;ANLN;VAPB;PIK3R1;PKN1;AKAP13;RACGAP1;ARHGEF40;VAV2;ERBIN;PKN2;DLC1;ARHGAP32;ARHGAP1;ARHGDIA;ARHGAP26;ARHGAP5
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.2493159846664702,-1.1377927269673025,0.25,1.0,1.0,22/57,29.13%,UBB;SKP1;UBE2M;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.20394116836798248,-1.1373044715153617,0.2318840579710145,1.0,1.0,50/166,26.42%,UBB;NCOR2;SKP1;SRXN1;AKT1;PRKCD;ATOX1;NCF2;CUL1;COX7B;UBL4A;PSMD11;PSMB7;COX6A1;PTK6;LIN9;EP300;TBL1X;CCS;PSMB4;PSMD8;NCOR1;PSMB10;PSMB5;CSNK2A2;BLVRA;NPLOC4;COX19;PHGDH;SEM1;PRDX2;PSMD6;BRIP1;PRDX3;ATF4;PSMD9;GSTP1;NQO1;PSMA6;TBL1XR1;PSMA4;PSMD13;PRDX5;PSMC1;ATP7A;PSMD3;STAP2;SIN3B;CUL3;UBC
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.21359858369092583,-1.1366764995095868,0.22580645161290322,1.0,1.0,34/103,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;RIPK3;MAPK1;S100A12;TMED7-TICAM2;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;UBE2D1;TANK;TRAF3;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;MAPKAPK2;UBC
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.35072060064471855,-1.1364937640026602,0.2807017543859649,1.0,1.0,7/15,32.39%,XRCC5;XRCC4;CXCR4;FEN1;PSIP1;LIG4;BANF1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.291677908629391,1.1364424945725804,0.21951219512195122,1.0,1.0,10/30,20.14%,B3GLCT;THBS1;LARGE1;POMGNT1;ADAMTS10;CFP;ADAMTSL5;GALNT3;NOTCH4;NOTCH3
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.20387810930788688,1.13592132484487,0.24242424242424243,1.0,1.0,38/145,20.53%,COPZ2;MGAT5;ACTR10;YKT6;B4GALT4;COG2;B4GALT2;SEC22B;MAN2A1;NAPG;GOLGA2;COPZ1;ST8SIA6;RAB1B;SEC22A;TMED3;LMAN2;DYNLL2;TRAPPC4;SEC22C;CHST8;PPP6R3;SEC13;TMED7;DCTN2;GOSR1;GOSR2;TMED2;DCTN1;COPG2;TRAPPC6A;SEC23A;COG4;CHST10;TMED9;TRAPPC2;SERPINA1;CNIH1
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.27911608434652424,1.1358022377933676,0.25,1.0,1.0,9/41,12.42%,URM1;CTU2;TRMT11;FTSJ1;NSUN6;LCMT2;ADAT3;NSUN2;TRMT44
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.31097718152566456,-1.1351782281336285,0.3137254901960784,1.0,1.0,5/22,12.58%,MAP3K8;AKT1;PIK3CA;MAPKAP1;PIK3R1
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,-0.36239193855006446,-1.1338542696974407,0.3469387755102041,1.0,1.0,4/16,7.13%,KCNG1;KCNC4;KCNH2;KCND3
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,-0.22709318777254991,-1.133461140009012,0.3,1.0,1.0,24/75,25.70%,CLTCL1;MYL9;AP2B1;EPHB4;EPHB3;KALRN;NCSTN;GIT1;ACTR3;MYL12B;PKN1;AP2M1;EPHA4;EPHB1;VAV2;EPHB6;NCK2;PKN2;WASL;HRAS;MYH9;CDC42;TIAM1;SDCBP
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.3412125811801562,-1.133415532555072,0.28846153846153844,1.0,1.0,5/17,11.61%,CREB1;NRAS;MAPK1;NEFL;DLG1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.2520489755380647,-1.1332489449575196,0.22807017543859648,1.0,1.0,18/69,18.38%,CLCN6;DUSP6;NRAS;RNASE3;MRAS;TENT4A;KSR1;MAPK1;TRIM24;MPRIP;AKAP9;AGGF1;SHOC2;DUSP7;CNKSR2;PHB1;NF1;RAP1A
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.2633671706518877,-1.132289576019857,0.3617021276595745,1.0,1.0,20/55,25.85%,EXOSC2;EIF4A1;CNOT6L;CNOT10;NT5C3B;EXOSC9;CNOT6;LSM6;EXOSC6;EXOSC4;EIF4E;CNOT11;SKIC8;PAN3;LSM4;EIF4B;EXOSC5;HBS1L;TUT7;DCP2
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.23473777328981985,-1.1319149552985475,0.26229508196721313,1.0,1.0,39/91,31.83%,UBB;INO80;H2AC14;PSMD11;PSMB7;SMAD7;UCHL1;ADRM1;PSMB4;PSMD8;H2AC6;PSMB10;PSMB5;FOXK1;TGFBR2;OGT;SEM1;ASXL2;PSMD6;ASXL1;CNKSR3;PSMD9;MCRS1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;MBD6;UBC;SENP8;PSMA2;H2AC19;PSMA7;INO80C;TFPT;UCHL5;FOXK2;H2AC4
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.20162164580063868,-1.1309345922962912,0.234375,1.0,1.0,64/207,26.42%,RASGRP4;UBB;DUSP6;PPP2R5B;PIK3CA;FGFR1;PSMD11;PSMB7;NRAS;TGFA;RNASE3;MRAS;ABHD17A;KSR1;MAPK1;IL2RB;PSMB4;NEFL;RNMT;PEA15;PSMD8;DLG1;FRS2;PSMB10;LAMTOR2;PIK3R1;PSMB5;LYPLA1;SHOC2;DUSP7;ZDHHC9;CNKSR2;SPNS1;WDR83;JAK3;SEM1;PHB1;PSMD6;NF1;RAP1A;SPTBN1;PPP2CA;IL17RD;EPGN;CSF2RB;PSMD9;RASAL3;FGFR4;KBTBD7;PPP2R1A;PSMA6;IL2RA;HRAS;PSMA4;ICMT;PSMD13;HBEGF;PPP2R1B;IL3RA;PSMC1;PSMD3;GFRA2;CUL3;UBC
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.3085590589460712,-1.1308692701968317,0.34615384615384615,1.0,1.0,6/24,13.48%,EIF4A1;CNOT6L;CNOT10;CNOT6;EIF4E;CNOT11
prerank,KEGG_2021_Human__Renin secretion,-0.24929853539303323,-1.130519243799438,0.2692307692307692,1.0,1.0,13/40,21.34%,CREB1;PDE1B;KCNJ2;PDE3A;CALML4;ITPR1;PDE3B;ADRB2;PLCB2;GNAQ;PTGER2;CALM3;CTSB
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.2333068141763876,-1.130445902301214,0.3125,1.0,1.0,32/80,29.13%,UBB;XPO1;PSMD11;PSMB7;KALRN;PSMB4;PSMD8;PSMB10;PSMB5;SEPTIN7;PKN1;IGF2BP1;SEM1;CDC42EP2;PSMD6;PSMD9;PKN2;ZNF367;PSMA6;PSMA4;NCOA3;PSMD13;HSPB1;CDC42;PSMC1;PSMD3;MAPKAPK5;UBC;FOXO3;TNRC6A;PSMA2;PSMA7
prerank,KEGG_2021_Human__Basal cell carcinoma,0.26372388255516743,1.1303662492607487,0.2765957446808511,1.0,1.0,33/34,69.57%,WNT7B;GADD45B;FZD6;GADD45G;WNT5B;LEF1;TCF7L2;APC;WNT10A;BAK1;POLK;AXIN1;SUFU;GSK3B;DDB2;FZD3;CTNNB1;GADD45A;TCF7L1;DVL3;FZD2;DVL1;TCF7;BAX;FZD5;WNT7A;FZD1;CDKN1A;GLI1;PTCH1;TP53;DVL2;AXIN2
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.2332009511563433,1.1303383890506868,0.3076923076923077,1.0,1.0,19/73,19.46%,COPZ2;ACTR10;YKT6;COG2;NAPG;GOLGA2;COPZ1;RAB1B;TMED3;DYNLL2;TMED7;DCTN2;GOSR1;GOSR2;TMED2;DCTN1;COPG2;COG4;TMED9
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.2665994431657549,-1.1301862464790555,0.2857142857142857,1.0,1.0,13/48,16.88%,SLC22A15;SLC39A6;SLC22A1;SLC22A16;SLC13A5;SLC6A15;SLC11A1;SLC30A6;SLC6A13;SLC39A14;SLC39A7;BSG;RUNX1
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.27198107102662195,-1.1301630809427072,0.22807017543859648,1.0,1.0,21/51,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;AURKA;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.20010374428307628,-1.1293690107656447,0.20689655172413793,1.0,1.0,31/183,14.47%,PXN;PAK1;ELOC;SKP1;AKT1;GNG10;AP1S1;PIK3CA;CUL1;MAP2K7;GNG5;CASP3;NRAS;FASLG;BAD;RPS6KB1;MAPK1;CRK;CALML4;FAS;AP1G2;GNA11;APOBEC3H;FOS;PIK3R1;APOBEC3F;FBXW11;IRAK1;TRAF6;TLR2;ITPR1
prerank,KEGG_2021_Human__Melanoma,-0.2464238692026547,-1.1283719808809847,0.38333333333333336,1.0,1.0,9/51,12.58%,AKT1;PIK3CA;FGFR1;NRAS;BAD;E2F3;MAPK1;CDK6;PIK3R1
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.2593227057791826,-1.1263008661860752,0.25806451612903225,1.0,1.0,36/67,39.18%,ELOC;UBB;PSMD11;PSMB7;WTIP;EP300;MIA3;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;HIF1A;VEGFA;PSMD13;PSMC1;PSMD3;UBC;CUL2;PSMA2;PSMA7;ELOB;HIGD1A;PSMC5;PSMC2;PSMC3;CREBBP;PSME1;UBE2D3;EGLN3;HIF1AN
prerank,KEGG_2021_Human__Collecting duct acid secretion,-0.3348875559630534,-1.1252942568474038,0.3157894736842105,1.0,1.0,4/19,7.52%,CA2;ATP6V1E1;ATP6V0A1;ATP6V1D
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.31767262853064243,1.1239953612596425,0.3125,1.0,1.0,6/18,19.16%,CDC25C;ZNF385A;TFDP2;CARM1;RBL1;RBL2
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.2567576139677695,1.1239663892261913,0.2894736842105263,1.0,1.0,8/37,13.08%,COL9A1;P3H1;P3H2;PLOD1;COL9A3;COL13A1;COL6A1;COL4A3
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,0.2890393789699954,1.123503260255686,0.2682926829268293,1.0,1.0,9/30,14.41%,H2BC11;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13;MAPK3
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.24587833244614937,-1.123500832144106,0.29411764705882354,1.0,1.0,15/43,26.66%,UBB;PIK3CA;PAG1;NRAS;TGFA;SPRY1;PIK3R1;CBL;EPGN;HGS;HRAS;HBEGF;CDC42;UBC;PTPRK
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.24210258560843867,-1.1234236964636763,0.27586206896551724,1.0,1.0,10/53,11.78%,AKT1;CCNG2;YWHAZ;SREBF1;FASLG;REXO2;EP300;PLXNA4;SIRT3;DDIT3
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.33057973830976994,-1.122671022426325,0.3018867924528302,1.0,1.0,6/18,22.92%,NRAS;RNASE3;EP300;PKN1;PKN2;HRAS
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,-0.26695390114272033,-1.1221623395452316,0.2898550724637681,1.0,1.0,13/46,18.12%,KMT5B;KMT2D;DOT1L;SUV39H1;SETDB2;KMT2B;SETD6;SETD7;ASH2L;EED;SETD1A;SMYD3;PRDM16
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,0.20596427616816138,1.1214566303504176,0.2647058823529412,1.0,1.0,34/139,17.54%,XRCC1;RAD9B;H2BC11;PPP4R2;RAD51AP1;DNA2;H2BC15;RBBP8;KPNA2;RFC3;RFC5;UBA52;H2BC5;EXO1;CHEK2;ERCC4;BLM;PARP2;APBB1;UBXN1;RPS27A;H4C15;RAD51D;GEN1;LRIF1;ABL1;H2BC14;TDP1;SLC19A1;PALB2;POLH;HERC2;WRN;PPP5C
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.21755009887968346,1.1214220879030095,0.16666666666666666,1.0,1.0,9/47,13.89%,CTSL;UVRAG;UBA52;ST6GALNAC4;PIK3R4;PARP9;PRKCSH;RPS27A;ST6GALNAC2
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.2954751420531183,-1.1213306649209083,0.3275862068965517,1.0,1.0,6/24,14.58%,PRKCD;PIK3CA;PIK3R1;PLPP5;ITPR1;PLD4
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.20600759888983583,1.1212666747868991,0.19444444444444445,1.0,1.0,33/145,14.63%,ATP6V0B;RPL4;RPS20;EIF2AK4;IMPACT;MTOR;RPL31;RPS15;RPS25;RPLP0;TCIRG1;RRAGD;UBA52;NPRL3;RPS19;ATP6V1F;NPRL2;FAU;WDR59;RPS10;SH3BP4;RPL29;RPS21;CEBPB;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;FNIP2;LAMTOR3;RPL3;EIF2S2
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.3412914372723202,-1.1212547393496948,0.3541666666666667,1.0,1.0,6/18,19.04%,SKP1;CUL1;MAPK1;ZC3HC1;STAT5A;KIF5B
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.18621161411942067,1.120750380555341,0.15151515151515152,1.0,1.0,73/255,22.79%,COPZ2;MGAT5;ACTR10;NUS1;PDIA3;ST8SIA1;YKT6;B4GALT4;OS9;COG2;DERL2;B4GALT2;ALG8;SEC22B;MAN2A1;NAPG;GOLGA2;MVD;COPZ1;UBA52;ST8SIA6;ST6GALNAC4;RNF103;SLC35A1;RAB1B;SEC22A;TMED3;TRIM13;LMAN2;UBXN1;NAGK;PRKCSH;DDOST;RPS27A;DYNLL2;TRAPPC4;ST6GALNAC2;SEC22C;RNF139;CHST8;PPP6R3;SLPI;SEC13;TMED7;PMM1;DCTN2;ST3GAL6;GOSR1;DOLK;GOSR2;TMED2;DCTN1;COPG2;TRAPPC6A;SEC23A;COG4;CHST10;TMED9;TRAPPC2;SERPINA1;CNIH1;DPAGT1;MARCHF6;ALG3;MLEC;GLB1;ALG2;MGAT4A;EDEM1;COPE;ST3GAL1;DYNC1LI1;ALG14
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.22224120936188888,-1.1206586847040676,0.28125,1.0,1.0,31/95,27.00%,UBB;SKP1;SRXN1;AKT1;PRKCD;CUL1;UBL4A;PSMD11;PSMB7;EP300;PSMB4;PSMD8;PSMB10;PSMB5;CSNK2A2;NPLOC4;PHGDH;SEM1;PSMD6;BRIP1;ATF4;PSMD9;NQO1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;CUL3;UBC;UBXN7
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.280324544192712,1.120502991855917,0.3191489361702128,1.0,1.0,8/31,13.21%,CTSL;COL9A1;MMP9;COL9A3;MMP28;COL6A1;COL4A3;PLEC
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.20988876681802496,-1.1203177838171305,0.26666666666666666,1.0,1.0,22/124,13.77%,CAB39;CAB39L;AKT1;SLC38A9;PIK3CA;ATP6V1E1;LPIN1;TELO2;NRAS;TSC2;RPS6KB1;ATP6V1D;LRP6;RPTOR;MAPK1;STRADB;GRB10;MAPKAP1;LAMTOR2;PIK3R1;EIF4E;CASTOR1
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.3273289705395005,-1.1202101029643274,0.2962962962962963,1.0,1.0,14/19,51.24%,DAG1;LAMC1;PXMP2;NAB2;HDAC2;ADGRV1;CYP51A1;WWTR1;HMGCR;NAB1;SREBF2;PRX;SCD5;GJB1
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.20871235143059336,-1.1195450224317742,0.2463768115942029,1.0,1.0,38/127,26.42%,NUP37;ELOC;UBB;SLC25A5;XPO1;SKP1;AP1S1;RAN;AP2B1;PSMD11;PSMB7;PSMB4;PSMD8;NUP88;CDK9;NUP93;PSMB10;PSMB5;AP2M1;SEM1;PSMD6;PSMD9;NUP35;PKN2;NUP54;NUP42;PSMA6;AP1M2;PSMA4;CD8B;PSMD13;NUP43;PSMC1;PSMD3;NDC1;NUP85;NUP107;UBC
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.32624207607065625,-1.1189899899666098,0.3333333333333333,1.0,1.0,5/18,11.87%,UBB;ARL13B;GFAP;PLIN3;PLIN2
prerank,KEGG_2021_Human__ECM-receptor interaction,0.24618083725073617,1.1188556096131708,0.23076923076923078,1.0,1.0,20/55,20.54%,ITGA3;ITGA4;COL9A1;THBS1;COL9A3;FN1;THBS4;GP1BA;COL6A1;COL4A3;HSPG2;GP1BB;ITGAV;AGRN;LAMB3;ITGA5;ITGA7;COL9A2;ITGA2B;ITGA9
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.19576078454592533,-1.1187071699356925,0.22727272727272727,1.0,1.0,52/200,25.17%,SLC25A5;CREB1;IL6;XPO1;POLB;AKT1;LTBR;SRF;RAN;PIK3CA;IL15;SPI1;CRTC2;IL15RA;ETS1;NRAS;E2F3;ANAPC7;EP300;ADCY4;MAPK1;IL2RB;TRRAP;DLG1;FOS;PIK3R1;TBPL1;ANAPC5;MAD1L1;TCF3;TGFBR2;STAT5A;MAP2K4;JAK3;STAT5B;NRP1;ATF4;MAP3K3;FOSL1;CREB3L4;CALR;TNFRSF1A;MAPK8;MAPK9;IL2RA;HRAS;GPS2;TBPL2;PTTG1;CCNB2;CDKN2C;ITGB2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,0.21405572625153194,1.118078837468304,0.23684210526315788,1.0,1.0,14/108,7.52%,RAD9B;H2BC11;PPP4R2;RAD51AP1;DNA2;H2BC15;RBBP8;RFC3;RFC5;UBA52;H2BC5;EXO1;ERCC4;BLM
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.23055781398247435,1.117881015481513,0.18604651162790697,1.0,1.0,14/57,14.08%,H2BC11;H2BC15;CEBPE;RARA;H2BC5;H3-3B;CEBPA;CDK4;H2AC7;CEBPB;H4C15;H2BC14;H3C13;TFDP2
prerank,KEGG_2021_Human__Ras signaling pathway,-0.2021635046735444,-1.1171526503998848,0.22807017543859648,1.0,1.0,21/159,8.57%,PAK1;RALBP1;RASGRP4;AKT1;GNG10;PIK3CA;RRAS2;FGFR1;GNG5;ETS1;NRAS;RAPGEF5;TGFA;FASLG;RASA1;BAD;MRAS;SHC4;KSR1;RASSF5;MAPK1
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.3410667227659338,1.1169444257023302,0.32653061224489793,1.0,1.0,3/15,9.85%,SP3;PIAS2;PIAS1
prerank,KEGG_2021_Human__RNA degradation,-0.24516325085910443,-1.116936540103707,0.3333333333333333,1.0,1.0,20/68,19.96%,PAN2;EXOSC2;PFKL;CNOT6L;NUDT16;CNOT10;EXOSC9;TENT4A;CNOT6;LSM6;ENO1;EXOSC6;EXOSC4;DIS3L;MPHOSPH6;XRN2;PABPC1L;PAN3;LSM4;PABPC4
prerank,KEGG_2021_Human__Phagosome,0.2037635575417341,1.1161341838217138,0.3125,1.0,1.0,17/127,10.65%,ATP6V0B;SEC61B;CTSL;CLEC7A;MARCO;SFTPD;CYBB;STX18;THBS1;SEC22B;TCIRG1;CORO1A;ATP6V1F;THBS4;EEA1;RAB5A;FCGR2C
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.2636386223851675,-1.1161188247482903,0.25,1.0,1.0,12/49,12.28%,PARP1;UBB;NCOR2;SMAD7;SMURF2;TRIM33;EP300;MAPK1;E2F4;TGIF1;NCOR1;CDK9
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,0.270374849580911,1.1159167629243973,0.3333333333333333,1.0,1.0,7/31,15.99%,DNA2;RFC3;RFC5;GINS4;MCM7;POLA1;SLC19A1
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.22046449085148315,-1.1157644601744405,0.2542372881355932,1.0,1.0,35/106,25.55%,PPA1;NDUFS2;PPA2;NDUFS7;ATP6V1E1;ATP5F1E;NDUFB7;COX7B;SDHC;NDUFB3;COX6A1;SDHD;ATP6V0A1;ATP6V1D;NDUFC1;NDUFA8;UQCRHL;NDUFS3;COX17;ATP6V1E2;NDUFAB1;ATP5PO;NDUFA12;ATP6AP1;SDHB;COX10;NDUFC2;NDUFB6;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;NDUFA2;ATP5MC2;ATP6V0C
prerank,Reactome_2022__DNA Repair R-HSA-73894,0.17730379011426622,1.115446564697341,0.1935483870967742,1.0,1.0,62/298,16.90%,ALKBH2;PPIE;XRCC1;RAD9B;H2BC11;PPP4R2;RAD51AP1;FAAP100;DNA2;ALKBH5;MGMT;UBE2B;UNG;USP45;H2BC15;RBBP8;USP7;KPNA2;RFC3;RFC5;FANCE;RUVBL1;DDB1;UBA52;REV1;H2BC5;EXO1;CHEK2;ERCC4;BLM;UBA7;PARP2;POLI;MLH1;PCLAF;PIAS1;OGG1;POT1;H2AC7;APBB1;UBXN1;RPS27A;H4C15;RAD51D;GEN1;LRIF1;CCNH;ABL1;UVSSA;H2BC14;TINF2;USP32;RAD23A;TDP1;SLC19A1;FAAP24;PALB2;ISG15;POLH;TDG;REV3L;HERC2
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.28176864513575617,-1.1152671075668916,0.2916666666666667,1.0,1.0,13/34,26.33%,NUP37;ALYREF;NXF1;NUP88;NUP93;EIF4E;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,KEGG_2021_Human__Measles,-0.21768565969399034,-1.1143677650363657,0.2786885245901639,1.0,1.0,32/117,22.77%,IL6;AKT1;PIK3CA;CASP3;FASLG;EIF2S1;OAS3;BAD;EIF2AK2;CSNK2A1;IL2RB;MX1;FAS;CDK6;APAF1;FOS;PIK3R1;CSNK2A2;IRAK1;TRAF6;CLEC4M;TLR2;STAT5A;JAK3;STAT5B;HSPA6;TRAF3;TRADD;MAPK8;MAPK9;IL2RA;ADAR
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.32349445589318276,-1.1137362584685828,0.34,1.0,1.0,8/18,26.42%,UBB;MAPK1;FRS2;MKNK1;CBL;PPP2CA;PPP2R1A;UBC
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.24961163322493493,-1.1127372592861773,0.38596491228070173,1.0,1.0,11/46,17.81%,IL6;POLR3GL;POLR3D;POLR3C;RIPK3;POLR3G;AIM2;TREX1;POLR2E;POLR3K;POLR3H
prerank,Reactome_2022__CaM Pathway R-HSA-111997,-0.3182023773808035,-1.1126023828399305,0.3448275862068966,1.0,1.0,5/23,8.35%,CREB1;PDE1B;PRKCD;NBEA;ADCY4
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.2116013464090075,1.1125975863539161,0.29411764705882354,1.0,1.0,17/79,18.30%,TRIM35;TRIM14;IRF5;CAMK2A;PTPN2;IRF8;GBP5;PIAS1;MID1;PTPN11;FCGR1A;STAT1;ICAM1;JAK2;TRIM38;CIITA;IRF1
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,-0.3291907115260425,-1.1117530469710666,0.3220338983050847,1.0,1.0,4/17,5.96%,LTBP1;MFAP5;BMP7;ITGB5
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.26470472138809503,-1.110873694638689,0.2549019607843137,1.0,1.0,17/45,27.38%,GMDS;UAP1L1;NANS;CHIT1;UAP1;UGDH;CYB5RL;HEXA;GALK1;CYB5R2;CYB5R1;GALT;HK3;GMPPB;PGM3;HK1;GNPDA1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.25976814354959776,1.110556828481715,0.2391304347826087,1.0,1.0,11/40,14.87%,H2BC11;H2BC15;GSDME;H2BC5;H3-3B;H2AC7;DNMT3A;H4C15;H2BC14;H3C13;POLA1
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.21605978948680624,-1.1104193450890452,0.24444444444444444,1.0,1.0,32/113,21.66%,SLC25A5;CREB1;MYL9;AKT1;SRF;BAD;PDE3A;PIK3R5;PPIF;TRPC6;ADCY4;MAPK1;KCNMB1;MEF2D;CALML4;GNA11;ATP2A1;ATP1A3;ITPR1;PDE3B;ADRB2;ATP1B2;PLCB2;GNAQ;FXYD2;RGS2;ATF4;ATP2A2;BORCS8-MEF2B;CREB3L4;CALM3;ADRA1A
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.2823954959299313,1.109684707801842,0.2857142857142857,1.0,1.0,9/32,17.48%,RAD51AP1;DNA2;RBBP8;EXO1;BLM;RAD51D;GEN1;PALB2;WRN
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.22598246688939078,-1.1092167539428202,0.35,1.0,1.0,21/69,23.95%,IL6;TRAF4;TRAF3IP2;HSP90B1;CASP3;ELAVL1;IL17RA;MAPK1;FOS;ANAPC5;TRAF6;TRAF3;S100A9;TRADD;JUND;FOSL1;CXCL5;MAPK8;MAPK9;MAPK7;MAPK14
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.3517885365979394,-1.1091385599558965,0.3148148148148148,0.9969855941161323,1.0,5/17,10.78%,EXOSC2;EXOSC9;TNPO1;EXOSC6;EXOSC4
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.2962786678946522,-1.1083901373768428,0.26153846153846155,0.9962742707168118,1.0,4/22,7.32%,AKT1;GNG10;GNG5;PIK3R5
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.17623760701295021,-1.1080792355381477,0.16176470588235295,0.9934469532051706,1.0,115/459,21.45%,HRG;KLKB1;GP9;CHID1;PROC;ITGAM;AKT1;GNG10;PHACTR2;PDE1B;PRKCD;PPP2R5B;PIK3CA;YWHAZ;GATA1;NHLRC2;ITGA10;PIKFYVE;GNG5;KIF5C;CARMIL1;L1CAM;NRAS;VPREB3;CLEC1B;AK3;LOC112694756;RNASE3;FAM3C;JAM3;A1BG;CABLES2;SRGN;KIF13B;SYTL4;PIK3R5;TRPC6;MAPK1;CD48;KIF18A;MAGED2;KCNMB1;SERPINB8;GLG1;CAPZA2;CRK;JMJD1C;KLC1;PRKCH;TMSB4X;PRKCZ;PF4V1;CEACAM6;GNA11;SPARC;MPL;DOK2;TIMP1;KIF21B;PIK3R1;ATP2A1;JCHAIN;SCCPDH;ORAI2;DOCK5;TEX264;ITPR1;HBG2;CAPZB;CABLES1;RACGAP1;EPCAM;ATP1B2;MMRN1;ITGA1;JAML;INPP5D;GNAQ;SPNS1;F2R;BSG;SLC7A8;KIF3A;SERPINB2;VTI1B;PLAT;ABHD12;STX4;CYB5R1;LCP2;RAP1A;PPP2CA;TOR4A;KIF21A;FLNA;KIF5B;SIRPG;HBE1;KIF5A;ATP2A2;HDAC2;PCYOX1L;VAV2;S100A9;TREM1;PRCP;TNFRSF10D;PHF21A;PLAUR;KIF6;ZFPM1;STXBP3;PLCG2;ITGB1;DGKQ
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,-0.3273752943092783,-1.107042055289156,0.36065573770491804,0.9933165153394142,1.0,5/20,11.97%,AVEN;CASP3;MAPK1;CARD8;APAF1
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.24874329784770327,1.1054473070780193,0.3333333333333333,1.0,1.0,10/44,13.29%,CCT2;EXOC7;INPP5E;CCT3;EXOC5;RAB11FIP3;BBS7;EXOC4;TCP1;BBS9
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.30667305822964025,-1.1054242287843201,0.35714285714285715,0.9964084247174119,1.0,3/27,1.59%,KLKB1;GP9;PROC
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.22618967258878442,-1.1047196876228436,0.3064516129032258,0.9951548616216642,1.0,35/75,39.03%,NUP37;UBB;HSPA4L;MAPK1;HSPA12A;NUP88;MRPL18;SERPINH1;NUP93;BAG3;HSPA6;HSPA4;NUP35;CCAR2;NUP54;NUP42;DNAJB6;NUP43;NDC1;HIKESHI;NUP85;MAPKAPK2;NUP107;BAG4;NUP214;ST13;DNAJC2;HSPA8;RPS19BP1;NUP160;SEH1L;AAAS;BAG5;HSBP1;BAG1
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.20678906083240214,-1.1046294725920318,0.30357142857142855,0.9916107856747247,1.0,32/106,23.17%,AKT1;GNG10;RRAS2;ACTA2;GNG5;NRAS;MRAS;JAG1;LIPE;PIK3R5;RPS6KB1;ADCY4;MAPK1;MEF2D;CALML4;RYR3;NRF1;TFAM;ITPR1;PDE3B;PLCB2;GNAQ;PLAT;CAMK4;SPHK1;PRKAG2;BORCS8-MEF2B;CALM3;RYR1;RRAS;HRAS;PRKAG1
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.21900578274792443,1.1038864578549374,0.32432432432432434,1.0,1.0,14/63,13.84%,H2BC11;THBS1;RBBP5;H2BC15;TNRC6C;AGO4;H2BC5;H3-3B;MOV10;GP1BA;H2AC7;H4C15;H2BC14;H3C13
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.21045833477479062,-1.1035308243581403,0.3142857142857143,0.9925082097117301,1.0,34/111,26.42%,UBB;SKP1;PIK3CA;PAG1;CUL1;PSMD11;PSMB7;UBE2N;PSMB4;PSMD8;PSMB10;PIK3R1;PSMB5;FBXW11;PKN1;TRAF6;INPP5D;SPNS1;SEM1;PSMD6;LCP2;UBE2D1;PSMD9;PTPRC;PLCG2;PKN2;PSMA6;PSMA4;PTPN22;PSMD13;PSMC1;PSMD3;PTPRJ;UBC
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.21110270879905874,-1.102842415440748,0.3389830508474576,0.9916233964928799,1.0,32/99,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;RIPK3;MAPK1;S100A12;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;UBE2D1;TANK;TRAF3;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;MAPKAPK2;UBC
prerank,KEGG_2021_Human__Bladder cancer,0.25478316783007504,1.1025746681967274,0.2127659574468085,1.0,1.0,9/37,14.41%,CXCL8;THBS1;MMP9;ERBB2;DAPK2;CDK4;RPS6KA5;RASSF1;MAPK3
prerank,KEGG_2021_Human__Gastric acid secretion,-0.25410916671322215,-1.1017126426558292,0.3090909090909091,0.9929345685269851,1.0,13/49,15.98%,CA2;SLC9A4;HRH2;SSTR2;KCNJ2;ADCY4;KCNJ15;CALML4;ATP1A3;ITPR1;ATP1B2;PLCB2;GNAQ
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.30447900251298876,1.1002306760679565,0.3584905660377358,1.0,1.0,7/23,15.71%,PLB1;BCO2;VKORC1;APOE;HSPG2;AGRN;AKR1C1
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.2394817777958199,1.0981026218696799,0.32,1.0,1.0,6/47,5.82%,CPNE8;VRK2;ADD3;VANGL1;ARHGAP35;TOR1AIP1
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.21767376763166438,-1.0970318222353663,0.3050847457627119,1.0,1.0,29/98,24.39%,CACNG8;CREB1;GNG10;AP2B1;GNG5;NRAS;NBEA;KCNJ2;CHRNB4;PPM1F;ADCY4;MAPK1;NEFL;GIT1;KCNJ15;DLG1;CHRNE;AP2M1;PRKX;PLCB2;CHRNA5;CAMK4;HTR3B;PRKAG2;CHRNA2;HRAS;PRKAG1;GNG3;NRGN
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.2550907969116012,-1.0965695662398927,0.34545454545454546,1.0,1.0,10/54,12.01%,AVEN;AKT1;YWHAZ;CASP3;BAD;REXO2;MAPK1;CARD8;APAF1;PMAIP1
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.2780573104378731,1.095481800936705,0.3902439024390244,1.0,1.0,10/26,25.42%,ST8SIA1;ST8SIA6;ST6GALNAC4;SLC35A1;ST6GALNAC2;ST3GAL6;GLB1;ST3GAL1;CMAS;ST8SIA4
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.27301581863769286,-1.0938148718788436,0.26785714285714285,1.0,1.0,8/41,7.53%,UBB;LTBP1;XPO1;UBE2M;SMAD7;SMURF2;ITGB5;SRFBP1
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,-0.282368540051299,-1.0926001322864003,0.2786885245901639,1.0,1.0,8/29,18.05%,CREB1;PDE1B;PRKCD;NBEA;ADCY4;ITPR1;PRKX;CAMK4
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.17345478542627857,-1.0925919340756527,0.30158730158730157,1.0,1.0,100/500,17.68%,SLC25A26;ABCC9;CA2;ANO9;SLC9A4;SLC22A15;CLCN6;UBB;SLC25A5;SLC39A6;CTNS;SKP1;AMN;GNG10;TRPM7;SLC26A6;ATP6V1E1;AQP10;AP2B1;SLC45A3;ATP10D;CUL1;ARL2BP;ATP11A;RAB11A;PSMD11;PSMB7;GNG5;SLC27A1;ATP6V0A1;EIF2S1;RNASE3;MBTPS2;SLC33A1;SLC22A1;SLC2A8;BPNT1;NCEH1;ABCA7;TRPC6;ATP6V1D;SLC2A6;CETP;ABCC5;SLC22A16;ADCY4;STOML2;ZDHHC8;MCOLN2;SLC35D1;TRNP1;SLC4A5;PSMB4;CA4;AQP9;BEST1;SLC35B4;SLC13A5;SLC6A15;PSMD8;RYR3;SLC5A2;SLC29A3;PSMB10;PSMB5;SLC2A4;ATP2A1;SLC11A1;SLC35C1;LRRC8E;AP2M1;CYB5RL;SLC30A6;ATP1A3;SLC6A13;SLC43A2;SLC39A14;FLVCR1;SLC2A14;ATP6V1E2;ABCC3;SLC12A6;ATP1B2;SLC39A7;ABCB1;FXYD2;SLC9B1;ATP8B2;BSG;RUNX1;SLC7A8;SEM1;ANO10;ABCB4;ABCB9;CYB5R2;PHB2;ANO5;PHB1;PSMD6
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,-0.19190288541959252,-1.090818337473123,0.35,1.0,1.0,64/219,24.17%,POLR2I;CAV2;NCOR2;CREB1;XPO1;GTF2A1;AKT1;GNG10;SRF;ALDH1A2;PIK3CA;H2AC14;H2AZ2;PDK4;SREBF1;ZDHHC21;GNG5;NRAS;TGFA;DLAT;POLR2D;AKR1C3;CETP;EP300;TBL1X;MAPK1;POU2F1;POLR2A;PRKCZ;NCOR1;H2AC6;CDK9;FOS;PIK3R1;DHRS3;STAG2;SCD;H2BC13;TFF3;PPARD;RUNX1;DDX5;H2BC3;POLR2E;RDH11;ABCG1;GREB1;EPGN;H2BC12;RARB;SPHK1;JUND;DHRS9;CHD1;ALDH8A1;HRAS;TBL1XR1;GPS2;GTF2A2;NCOA3;H2BC4;HBEGF;GNG3;CBFB
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.27631161713706515,-1.0905312920383097,0.3392857142857143,1.0,1.0,9/35,17.81%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POU2F1;POLR2E;POLR3K;POLR3H
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.18548397772014621,1.0897415590770094,0.275,1.0,1.0,39/175,17.33%,CAPN3;LTBP4;CTSL;ITGA3;ITGA4;VCAN;TIMP2;COL9A1;P3H1;THBS1;P3H2;PLOD1;MMP9;COL9A3;FN1;MMP28;TGFB1;COL13A1;ICAM4;ADAM9;COL6A1;NRXN1;KLK2;DMD;COL4A3;LTBP3;PLEC;TRAPPC4;HSPG2;FBN2;ITGAV;ADAM17;AGRN;MADCAM1;LAMB3;ICAM1;ITGA5;SERPINE1;PLG
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.1975759156545766,-1.0893985958906958,0.25,1.0,1.0,38/141,21.35%,MTHFD1;PROC;AMN;AKT1;NADK2;PTS;MTHFR;NT5E;THTPA;LMBRD1;PARP4;AKR1C3;GSTO1;GCHFR;NAXD;RETSAT;GPC2;DHFR;ST20-MTHFS;LRP10;PCCA;ENPP1;QPRT;NMNAT1;COQ9;PARP6;COQ7;MMUT;MTHFD2;SLC52A2;RDH11;VKORC1L1;COQ5;LDLRAP1;NAXE;COQ6;ENPP2;PANK3
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.33769652909508907,-1.08901001776137,0.40384615384615385,1.0,1.0,4/18,8.02%,SREBF1;LIN9;EP300;TBL1X
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.2409711157809708,-1.0886875774084304,0.32142857142857145,1.0,1.0,7/57,6.87%,POLR2I;TCEA1;ELOC;ELOA;GTF2H3;CTR9;POLR2D
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.3289042789744791,-1.0877702871511414,0.33962264150943394,1.0,1.0,7/17,23.50%,PIGL;PIGO;PIGW;PIGQ;PIGV;PIGC;PIGM
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.22831250147255497,1.0869499925870685,0.3541666666666667,1.0,1.0,18/57,20.66%,WASF3;CYFIP2;ABI1;BAIAP2;ELMO2;ARPC3;MYO1E;ABL1;BRK1;FCGR1A;MAPK3;NCKAP1L;VAV3;MYO9B;NCKIPSD;ARPC5;RNASE1;TARP
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.2517202665372733,-1.0861704685728577,0.29508196721311475,1.0,1.0,9/49,14.63%,POLR2I;SNRNP35;SNRPB;PDCD7;POLR2D;RNPC3;POLR2A;SNRNP48;TXNL4A
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.31265441479634726,1.0857476235972423,0.37254901960784315,1.0,1.0,7/20,12.48%,PHKG1;UBA52;GYG1;GBE1;PHKA2;PYGL;RPS27A
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.26476624932197734,-1.0836133202408769,0.34545454545454546,1.0,1.0,8/33,15.08%,AKT1;PIK3CA;LIPE;PNPLA2;ADCY4;PIK3R1;PDE3B;ADRB2
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.20933361470560463,1.0834009426245377,0.3611111111111111,1.0,1.0,8/83,6.54%,PLCB4;INPPL1;IMPA1;IP6K2;PI4KA;INPP5E;MTM1;BPNT2
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.24837365325832053,-1.0829328454799654,0.29508196721311475,1.0,1.0,24/60,29.13%,UBB;PSMD11;PSMB7;NRAS;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;NF1;PSMD9;RASAL3;KBTBD7;PSMA6;HRAS;PSMA4;PSMD13;PSMC1;PSMD3;CUL3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.2375129066760346,-1.0825293954705204,0.3333333333333333,1.0,1.0,8/55,8.02%,SCAP;DHCR7;RAN;SREBF1;LIN9;MBTPS2;INSIG2;TBL1X
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,-0.2648772904041603,-1.0813238165459722,0.3333333333333333,1.0,1.0,12/38,21.15%,CREB1;CACNA1I;PBX1;NCEH1;ADCY4;STAR;GNA11;ITPR1;PLCB2;GNAQ;ATF4;CREB3L4
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.19303154520203572,1.0812032961004996,0.20930232558139536,1.0,1.0,23/121,14.03%,SQSTM1;ULK1;ATG9A;ATG5;TSC1;MTOR;UVRAG;RRAGD;UBAP1;UBA52;WIPI1;IFT88;MTERF3;TOMM70;FUNDC1;GABARAPL2;PIK3R4;TOMM6;ATG14;RPS27A;DYNLL2;PRKAB2;LAMTOR3
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.17214447991640786,1.0809986958293991,0.28888888888888886,1.0,1.0,34/185,13.84%,H2BC11;CTSL;PHC3;THBS1;RBBP5;HIPK2;H2BC15;TNRC6C;PBRM1;AGO4;RING1;PSMD7;PSMA5;UBA52;H2BC5;PHC1;H3-3B;OCLN;MOV10;KCTD6;CTLA4;GP1BA;PTPN11;H2AC7;CCND2;PSMF1;RPS27A;H4C15;CCNH;PSMA3;GPAM;ABL1;H2BC14;H3C13
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.3024425663231271,1.0802001627905893,0.38636363636363635,1.0,1.0,5/24,10.50%,NR3C2;RARA;PIAS2;PIAS1;PPARG
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.29342245517416393,1.079017947312183,0.358974358974359,1.0,1.0,5/20,10.42%,B4GALT2;LARGE1;POMGNT1;LARGE2;FKTN
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.19620806974078814,1.078703310491772,0.3409090909090909,1.0,1.0,18/145,7.52%,RAD9B;DNA2;SSRP1;HIPK2;MTA2;RBBP8;TTC5;RICTOR;USP7;MTOR;RFC3;ZNF385A;RFC5;UBA52;TP53BP2;EXO1;CHEK2;BLM
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.26998077737693815,-1.078072671865675,0.38461538461538464,1.0,1.0,12/37,22.92%,PIK3CA;KLRK1;NRAS;KLRC2;PIK3R1;CD300LB;SPNS1;LCP2;VAV2;TREM1;PLCG2;HRAS
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,0.23114916176743244,1.0772537615787534,0.3953488372093023,1.0,1.0,13/60,14.08%,H2BC11;MAML3;H2BC15;TNRC6C;AGO4;H2BC5;H3-3B;MOV10;H2AC7;H4C15;H2BC14;H3C13;TFDP2
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.22614233117264831,-1.077189927513604,0.36363636363636365,1.0,1.0,21/77,21.62%,PGAM1;PCK2;CREB1;CPT1B;PFKL;AKT1;CRTC2;SIK1;EP300;CALML4;FBP1;ITPR1;PDE3B;PLCB2;GNAQ;PYGB;ATF4;PRKAG2;CREB3L4;CALM3;PFKP
prerank,KEGG_2021_Human__Base excision repair,-0.28389828843554243,-1.0753580338932147,0.38095238095238093,1.0,1.0,9/33,15.65%,PARP1;POLB;NEIL1;LIG1;PARP4;POLD2;POLL;NEIL3;APEX1
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.279780094179022,-1.0750876118186903,0.38461538461538464,1.0,1.0,6/32,9.17%,RAB6A;BICD1;RAB18;GALNT2;ACTR1A;CAPZA2
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.17015183661382358,-1.0750561803049759,0.2542372881355932,1.0,1.0,113/386,26.66%,POLR2I;CDK5R1;COPS2;UBB;RANBP10;CREB1;AKT1;DUSP6;SRF;FES;PRKCD;MAPKAPK3;PIK3CA;PAG1;ATP6V1E1;AP2B1;FGFR1;NCF2;NRP2;DNAL4;JUP;NRAS;GGA3;ATP6V0A1;TGFA;PTK6;PRDM1;POLR2D;RAB4A;ATP6V1D;SPRY1;EP300;SPINT2;MAPK1;GFAP;CHD4;GRB10;NCSTN;MEF2D;CRK;RNMT;LAMC1;MAPKAP1;POLR2A;PRKCZ;RNF41;NCOR1;SPARC;FRS2;LAMC3;FOS;HNRNPA1;PIK3R1;MKNK1;PKN1;TRIB1;AP2M1;DUSP7;STAT5A;ITPR1;PDE3B;ATP6V1E2;NAB2;FER;RALB;CBL;JAK3;MATK;POLR2E;PLAT;WASF1;DNM3;RAP1A;STAT5B;PPP2CA;NRP1;EPGN;COL6A3;HDAC2;SPHK1;VAV2;ATP6AP1;JUND;FOSL1;FGFR4;NCK2;ERBIN;PKN2;ITGB1;PPP2R1A;NEDD4;DNM2;HGS;HRAS;CDK5;HIF1A;MAP2K5;VEGFA;MAPK7;MAPK14;HSPB1;HBEGF;CDC42;ID2;PPP2R1B;TIAM1;ATP6V0C;PTPRJ;MAPKAPK2;UBC;TRIB3;CXXC1;PTPRK
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.2824782547319895,1.074798750619396,0.3181818181818182,1.0,1.0,9/21,25.75%,MEFV;PANX1;RELA;NLRP1;P2RX7;CASP1;APP;NLRP3;PYCARD
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.3197499240568807,-1.0745771716809038,0.3333333333333333,1.0,1.0,8/22,25.88%,ANTXR2;MAP2K7;VAMP1;SNAP25;MAP2K4;MAP2K3;HBEGF;CD9
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.3093144273624451,-1.0739911772757633,0.38181818181818183,1.0,1.0,5/21,13.74%,IL6;DUSP6;MAPK1;PEA15;DUSP7
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.2555158058089519,-1.0733887984398391,0.3333333333333333,1.0,1.0,18/42,31.47%,NUP37;ALYREF;NXF1;NUP88;NUP93;EIF4E;SLBP;NUP35;NUP54;NUP42;NUP43;NDC1;SYMPK;NUP85;NUP107;CPSF1;CPSF2;NUP214
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.23613478395800236,-1.0729798347065818,0.265625,1.0,1.0,29/57,38.11%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;GTSE1;PSMB10;PSMB5;PLK1;SEM1;PSMD6;PSMD9;MAPRE1;PSMA6;PSMA4;PSMD13;CCNB2;PSMC1;PSMD3;UBC;PSMA2;PSMA7;PSMC5;PSMC2;TP53;PSMC3;FKBPL;PSME1;CDKN1A
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.28657037851145767,1.0724474088133855,0.2765957446808511,1.0,1.0,12/22,30.23%,CCT2;CCT3;BBS7;TCP1;BBS9;CCT5;TTC8;BBS1;MKKS;BBS10;SSTR3;BBS12
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.2865373296084274,1.0721346104524896,0.35,1.0,1.0,6/29,8.54%,CAMK2A;HIPK2;TNRC6C;AGO4;HDAC3;MOV10
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,0.25483408384312556,1.0716241909581001,0.36585365853658536,1.0,1.0,9/37,17.81%,CXCL8;IL1R1;CSF1;IL10;IL12A;CCL3;IL1R2;ICAM1;CCR1
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.2845979219913494,-1.070718985767771,0.3333333333333333,1.0,1.0,13/30,32.71%,UBB;AMN;AP2B1;NCEH1;AP2M1;LDLRAP1;NPC2;UBC;CUBN;LIPC;CLTA;SOAT1;VLDLR
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.2893949480851559,-1.0706092544160513,0.3448275862068966,1.0,1.0,6/25,14.39%,COPS2;GFAP;NCSTN;NCOR1;SPARC;STAT5A
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.18970758712061306,1.0702653673087936,0.3611111111111111,1.0,1.0,31/103,21.88%,SFTPD;SIKE1;KPNA2;MAVS;TLR8;NUP58;NOD2;POM121;TOMM70;PIK3R4;TAB3;TRIM4;PTPN11;ATG14;RNF135;NUP210;IRAK2;ISG15;STAT1;SEC13;NUP155;NOD1;NUP62;NLRP12;TLR7;SEC23A;IFNAR2;IKBKG;B2M;NUP98;NUP205
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.25177304989233307,-1.0696596693635545,0.3125,1.0,1.0,21/50,29.38%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;ARHGAP10;PKN2;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7;MED12
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.20141677691945425,-1.0693029986502738,0.29310344827586204,1.0,1.0,42/138,25.42%,NDUFS2;IL6;AKT1;NDUFS7;PIK3CA;NDUFB7;COX7B;SREBF1;CASP3;SDHC;NDUFB3;COX6A1;SDHD;FASLG;EIF2S1;NDUFC1;FAS;NDUFA8;UQCRHL;DDIT3;NDUFS3;FOS;PIK3R1;NDUFAB1;ATF4;NDUFA12;PRKAG2;SDHB;TNFRSF1A;NDUFC2;MAPK8;MAPK9;NDUFB6;MLXIP;PRKAG1;MAPK14;NDUFB8;NDUFA9;NDUFC2-KCTD14;CDC42;NDUFA2;MLXIPL
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.2112145683094969,1.0690491882512865,0.3488372093023256,1.0,1.0,11/82,7.52%,RAD9B;DNA2;SSRP1;HIPK2;RBBP8;RFC3;RFC5;UBA52;EXO1;CHEK2;BLM
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.2201352910114163,1.0686297402742622,0.34,1.0,1.0,13/63,11.26%,MGST2;GSTM1;MGST1;AKR1A1;CNDP2;GSTZ1;PRNP;BPNT2;GSTO2;MAT2B;SULT1A2;ACSM2B;UGT2B4
prerank,KEGG_2021_Human__Viral carcinogenesis,-0.19240987888246697,-1.0673876515500538,0.36666666666666664,1.0,1.0,54/188,27.07%,PXN;CCR8;CREB1;GTF2A1;POLB;LTBR;SRF;PIK3CA;YWHAZ;H4C3;HDAC11;CASP3;GTF2H3;NRAS;GTF2E1;BAD;EIF2AK2;EP300;MAPK1;CHD4;H2BC10;CDK6;DLG1;PMAIP1;PIK3R1;TBPL1;MAD1L1;STAT5A;H2BC13;JAK3;H2BC3;STAT5B;ATF4;H2BC12;HDAC2;TRAF3;TRADD;H4C5;H4C9;CREB3L4;UBE3A;TRAF1;HRAS;TBPL2;GTF2A2;H2BC4;H2BC8;CDC42;PSMC1;H2BC6;HDAC6;MAPKAPK2;HDAC5;CCNA2
prerank,KEGG_2021_Human__TNF signaling pathway,-0.2174225154888296,-1.0659071944885994,0.39655172413793105,1.0,1.0,27/100,22.78%,CREB1;MAP3K8;IL6;AKT1;PIK3CA;IL15;MAP2K7;CASP3;JAG1;RIPK3;MAPK1;FAS;FOS;PIK3R1;MLKL;MAP2K4;JUNB;ATF4;TRAF3;TRADD;MAP2K3;CREB3L4;CXCL5;TNFRSF1A;MAPK8;MAPK9;TRAF1
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.2068460481428533,1.0656345915362315,0.3404255319148936,1.0,1.0,19/85,15.37%,H2BC11;CATSPER2;H2BC15;RBBP8;H2BC5;BLM;H3-3B;MLH1;SMC1A;POT1;CDK4;H2AC7;OVGP1;HID1;H4C15;H2BC14;H3C13;LMNA;TINF2
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.3000702961068211,-1.0652527869305686,0.39285714285714285,1.0,1.0,5/24,8.88%,UBB;CTSG;RNF213;MAPK1;ENO1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.18090596689021113,-1.065075890370578,0.25757575757575757,1.0,1.0,79/365,19.55%,POLR2I;HEY1;CLCN6;UBB;NCOR2;CREB1;PROC;SKP1;AKT1;CLSTN1;DUSP6;PPP2R5B;PIK3CA;MAML2;FGFR1;CUL1;HDAC11;PSMD11;PSMB7;NRAS;TGFA;RNF213;RNASE3;CARS1;BAD;TSC2;MRAS;JAG1;POLR2D;BCL11A;TENT4A;KSR1;EP300;CNTRL;TBL1X;LRP6;MAPK1;TRIM24;NCSTN;PSMB4;RNMT;MPRIP;MAPKAP1;KLC1;POLR2A;ZC3HC1;AKAP9;PSMD8;NCOR1;CTBP1;FRS2;AGGF1;PSMB10;PIK3R1;MAMLD1;PSMB5;TGFBR2;SHOC2;DUSP7;STAT5A;CNKSR2;AMER1;CBL;SEM1;CPSF6;PHB1;POLR2E;PSMD6;CCNC;NF1;RAP1A;STAT5B;SPTBN1;PPP2CA;EPGN;GOLGA4;KIF5B;PSMD9;HDAC2
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.25561246244519426,-1.0650094665406056,0.40384615384615385,1.0,1.0,9/40,14.72%,HEY1;UBB;MAML2;PBX1;JAG1;EP300;NCSTN;MAMLD1;WWP2
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.20632625295568452,-1.0648599345946832,0.3620689655172414,1.0,1.0,10/106,4.72%,POLR2I;TCEA1;PARP1;COPS2;UBB;AQR;INO80;ERCC5;UBE2N;GTF2H3
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.2515030010579168,-1.0648286296525995,0.4067796610169492,1.0,1.0,20/47,27.49%,XRCC5;UBE2N;RNF168;MDC1;XRCC4;PIAS4;H2BC13;POLL;UIMC1;H2BC3;H2BC12;TDP2;NHEJ1;ABRAXAS1;RAD50;H2BC4;NSD2;H2AX;PRKDC;DCLRE1C
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.22758546455730297,-1.0647392058133258,0.3333333333333333,1.0,1.0,15/54,23.95%,AKT1;PIK3CA;NRAS;SHC4;MAPK1;FOS;PIK3R1;STAT5A;STAT5B;CISH;MAPK8;GALT;MAPK9;HRAS;MAPK14
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.24242962414056618,-1.0639459592176037,0.423728813559322,1.0,1.0,12/54,12.58%,UBB;RANBP10;PIK3CA;NRAS;GGA3;RAB4A;SPINT2;CRK;RNMT;LAMC1;LAMC3;PIK3R1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.25655764259295555,-1.0637216042808886,0.38181818181818183,1.0,1.0,11/38,18.31%,CLTCL1;AP2B1;RAB11A;KLK1;AP2M1;ATP1A3;ATP1B2;PLCB2;GNAQ;FXYD2;DNM3
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.314585589715068,-1.0627414098471972,0.35185185185185186,1.0,1.0,5/21,12.59%,HEY1;MAML2;PBX1;EP300;MAMLD1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.2028376508385454,-1.0624993450263451,0.39344262295081966,1.0,1.0,32/97,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;S100A12;TMED7-TICAM2;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;TANK;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.24490038876198375,-1.0623703180259405,0.40625,0.9991011126236126,1.0,23/60,29.13%,ELOC;UBB;PSMD11;PSMB7;WTIP;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;HIF1A;PSMD13;PSMC1;PSMD3;UBC;CUL2;PSMA2;PSMA7
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.26329807402226546,1.0618486949607513,0.3333333333333333,1.0,1.0,10/34,13.84%,H2BC11;H2BC15;H2BC5;H3-3B;NCOA2;H2AC7;KLK2;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,-0.23595341530798136,-1.0616082839095373,0.3684210526315789,0.9988294299059443,1.0,12/52,15.02%,PIK3CA;ATP6V1E1;FGFR1;NRAS;ATP6V0A1;ATP6V1D;MAPK1;GRB10;FRS2;PIK3R1;PDE3B;ATP6V1E2
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.19507588259131062,-1.0608131744861424,0.32727272727272727,0.9984521400817881,1.0,22/153,10.80%,PXN;PAK1;CCL28;CCR8;AKT1;GNG10;PRKCD;PIK3CA;GNG5;CXCR1;NRAS;BAD;CXCR3;SHC4;PIK3R5;CCR10;ADCY4;MAPK1;CRK;CXCR2;PRKCZ;PF4V1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.21537876017296992,1.060562336147466,0.3333333333333333,1.0,1.0,8/84,5.38%,IL9R;ITGA3;ITGA4;IL1R1;CR1L;CSF1;CD2;CD38
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.33840982301524203,-1.0604820710584655,0.46875,0.9963283278571028,1.0,4/16,10.17%,GNG10;GNG5;KCNJ2;KCNJ15
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.29857315252740035,-1.0604490895981677,0.3888888888888889,0.9932582882512924,1.0,7/29,13.36%,SIRT2;NADK2;NT5E;SIRT3;ENPP1;QPRT;NMNAT1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.1762515991566126,-1.059629551418693,0.2698412698412698,0.9933998725873948,1.0,94/278,30.20%,KLHL25;ELOC;UBB;UBA1;GLMN;FBXO44;SKP1;TRAIP;UBAC1;DET1;UBE2M;SPSB1;CUL1;PSMD11;PSMB7;UBE2N;SMURF2;RNF213;KLHL5;FBXL20;UBA5;ANAPC7;UBE2J1;RLIM;HERC5;FBXW2;PSMB4;MGRN1;ARIH2;ZNRF1;RNF41;PSMD8;UBE2Q1;ASB8;PSMB10;PSMB5;ANAPC5;FBXW11;RNF4;UBE2G1;RNF138;HERC6;UBE2W;RNF144B;UBE2Z;FBXO4;FBXO15;RNF217;UBE2O;SEM1;TRIM41;PSMD6;THOP1;KBTBD6;UBE2D1;ASB13;PSMD9;FBXW4;KBTBD7;NEDD4;UBE3A;PSMA6;ANAPC13;KLHL9;MIB2;PSMA4;PSMD13;KLHL3;PSMC1;SIAH1;PSMD3;HERC1;CUL3;UBC;UBE2A;RNF123;FBXL19;CUL2;NEDD4L;RBBP6;PRKN;TRIM32;FBXO31;FBXL15;PSMA2;BTBD1;ATG7;PSMA7;RNF126;TRIM37;RNF111;LTN1;GAN;HACE1
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.29612810852415833,-1.0595321544378244,0.3333333333333333,0.9904661741064358,1.0,7/25,13.81%,NADK2;NT5E;PARP4;NAXD;QPRT;NMNAT1;PARP6
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.2537006950705539,1.0591768349974584,0.358974358974359,1.0,1.0,10/35,14.78%,PDIA3;OS9;DERL2;UBA52;RNF103;TRIM13;UBXN1;PRKCSH;RPS27A;RNF139
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,0.2193440986108529,1.058605930454132,0.41304347826086957,1.0,1.0,16/68,16.43%,XRCC1;H2BC11;UNG;H2BC15;RFC3;RFC5;H2BC5;PARP2;OGG1;POT1;H2AC7;H4C15;H2BC14;TINF2;SLC19A1;TDG
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,-0.2721212957844904,-1.0585400472638498,0.3090909090909091,0.9906161215941138,1.0,5/29,8.87%,LMAN1;CNIH2;TGFA;CNIH3;MIA3
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.1963785181649346,-1.0578800546210871,0.34285714285714286,0.9900630248714798,1.0,38/159,19.27%,UBB;CHD8;XPO1;PROC;LGR4;BCL9;AKT1;KMT2D;PPP2R5B;YWHAZ;H2AC14;H2AZ2;PSMD11;PSMB7;SMURF2;CCDC88C;EP300;LRP6;PSMB4;TRRAP;PSMD8;CTBP1;USP34;H2AC6;PSMB10;PSMB5;CSNK2A2;RUNX3;ASH2L;H2BC13;AMER1;CSNK1E;SEM1;H2BC3;PSMD6;PPP2CA;PSMD9;H2BC12
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.20038932605710694,-1.0577912237281482,0.39344262295081966,0.987099545933322,1.0,32/98,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;S100A12;TMED7-TICAM2;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;TANK;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__M Phase R-HSA-68886,-0.17676640837497554,-1.0569910297612621,0.328125,0.9868406714352341,1.0,117/360,26.77%,NUP37;SIRT2;UBB;XPO1;TUBGCP4;RAN;PPP2R5B;FBXO5;H2AC14;CEP63;H2AZ2;LPIN1;PSMD11;PSMB7;HAUS8;ITGB3BP;ALMS1;NME7;LEMD2;ACTR1A;ANAPC7;CENPN;NUDC;CNTRL;MAPK1;KIF18A;TNPO1;CHMP4B;PSMB4;SMC4;CLASP2;CENPU;CETN2;ZW10;AKAP9;PSMD8;NUP88;RAB33B;H2AC6;NEDD1;NUP93;PSMB10;PSMB5;CEP192;ANAPC5;TUBB6;CSNK2A2;MAD1L1;ZWINT;STAG2;CEP290;CENPM;NCAPG;H2BC13;GORASP2;PLK1;TUBB4B;RCC2;CSNK1E;CSNK1D;CCP110;B9D2;SEM1;RAB2A;H2BC3;PSMD6;TUBA1A;CEP76;PPP2CA;UBE2D1;PSMD9;H2BC12;CNEP1R1;PMF1-BGLAP;CEP164;RPS27;MAU2;TUBGCP2;CEP70;NUP35;SDCCAG8;CENPA;LEMD3;HAUS2;MAPRE1;NCAPD2;PPP2R1A;NUP54;NUP42;PSMA6;PSMA4;MZT1;PTTG1;PSMD13;H2BC4;SGO1;CCNB2;PPP2R1B;NUP43;CENPH;PSMC1;CEP78;PSMD3;PPP2R2A;LPIN2;PAFAH1B1;H2AX;NDC1;ODF2;NCAPH;SET;NUP85;NUP107;UBC;NCAPG2;H2AB1;MZT2B
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.28041365951538455,1.0568243368649715,0.39622641509433965,1.0,1.0,10/24,20.41%,OSBPL7;NCOA2;BAAT;ABCB11;ACOT8;AMACR;AKR1C1;OSBPL2;HSD3B7;OSBPL6
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.25772586929443225,-1.0564767652939453,0.375,0.9850194805597022,1.0,6/43,5.67%,UBB;AKT1;PRKCD;PIK3CA;NRAS;PTK6
prerank,KEGG_2021_Human__Cellular senescence,-0.19244551451975922,-1.0555103054745139,0.3620689655172414,0.9854619641819368,1.0,25/143,13.31%,SLC25A5;IL6;TRAF3IP2;AKT1;TRPM7;PIK3CA;RRAS2;HUS1;LIN52;ETS1;NRAS;LIN9;TSC2;FOXM1;MRAS;E2F3;RASSF5;MAPK1;E2F4;CALML4;CDK6;PIK3R1;FBXW11;TGFBR2;RAD1
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,-0.24300415475423098,-1.0551116522993915,0.3559322033898305,0.9836571820940007,1.0,11/52,13.23%,CACNG8;CACNG6;DSP;ITGA10;JUP;ITGB5;CACNA2D3;DAG1;SGCB;ATP2A1;ITGB8
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.2243020402165609,-1.0548307462830115,0.32786885245901637,0.9818641575440966,1.0,25/75,26.42%,UBB;SKP1;SRXN1;CUL1;UBL4A;PSMD11;PSMB7;EP300;PSMB4;PSMD8;PSMB10;PSMB5;PHGDH;SEM1;PSMD6;BRIP1;ATF4;PSMD9;NQO1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.23422639432825998,-1.0541034564786453,0.3333333333333333,0.9816264835683454,1.0,22/59,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PTK6;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.19167924184298143,-1.0538475264557894,0.3389830508474576,0.9794413130644879,1.0,27/140,16.25%,CACNG8;CREB1;GNG10;AP2B1;GNG5;NRAS;NBEA;KCNJ2;CHRNB4;COMT;CACNA2D3;SLC22A1;PPM1F;ADCY4;MAPK1;NEFL;GIT1;KCNJ15;CACNA1E;DLG1;CHRNE;AP2M1;SLC6A13;SNAP25;PRKX;PLCB2;CHRNA5
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.29837844985744694,-1.0531310144935602,0.36538461538461536,0.9790425716350236,1.0,8/19,26.42%,UBB;MAPK1;FRS2;MKNK1;CBL;PPP2CA;PPP2R1A;UBC
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.18242554401639707,1.0513430381022668,0.358974358974359,1.0,1.0,46/175,19.46%,SFTPD;RPS20;SIKE1;DDX20;GEMIN8;KPNA2;UVRAG;RPS15;RPS25;MAVS;TLR8;NUP58;NOD2;POM121;TUFM;RPS19;TOMM70;FAU;PIK3R4;RPS10;VPS39;TAB3;TRIM4;PTPN11;ATG14;RPS21;RNF135;RPS27A;NUP210;IRAK2;RPS28;ISG15;STAT1;SEC13;RPS23;NUP155;VPS33A;NOD1;NUP62;SNRPE;PDPK1;NLRP12;TLR7;SEC23A;GEMIN2;IFNAR2
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.28763759821537116,1.0513365772304712,0.38636363636363635,1.0,1.0,2/17,2.72%,B4GALT4;B4GALT2
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.1948711553015623,-1.0504391036407459,0.2857142857142857,0.9856789503034991,1.0,43/129,25.67%,VAMP3;ARHGAP17;ARHGAP42;CDC42BPB;DAAM1;JUP;ARHGAP24;SPATA13;REPS1;SH3PXD2A;CDC42EP1;KCTD3;GIT1;ARHGAP45;SRGAP2;PIK3R1;PKN1;ARHGAP33;RACGAP1;CDC42EP2;WIPF1;FARP1;GOLGA8R;GMIP;VAV2;ARHGAP10;ARHGEF15;PKN2;WASL;SNAP23;DLC1;FAM13B;ARHGAP32;ARHGEF19;WIPF2;TRIO;ARHGAP1;CDC42SE2;CDC42;ARHGDIA;ARHGAP26;TIAM1;ARHGAP5
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.26217219581644763,-1.0500898482824816,0.4339622641509434,0.9838743152854015,1.0,10/34,22.48%,PRKCD;PIK3CA;MAPK1;PRKCZ;CACNA1E;PIK3R1;SLC2A4;MAPK8;HK3;MAPK9
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.28178934410973727,1.0494804475031316,0.38461538461538464,1.0,1.0,6/19,16.19%,RFC3;RFC5;UBA52;RPS27A;SLC19A1;POLH
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.22883556822058632,1.0493057460222979,0.46153846153846156,1.0,1.0,21/52,25.75%,NOD2;MEFV;TAB3;PANX1;RELA;IRAK2;MAP2K6;NLRP1;TNFAIP3;MAPK13;NOD1;MAPK11;P2RX7;IKBKG;CASP1;ITCH;APP;NLRP3;CYLD;CASP4;PYCARD
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.18445339365312502,-1.048833532345665,0.3684210526315789,0.9859632222510908,1.0,41/151,24.31%,PXN;PAK1;CAV2;AKT1;PIK3CA;RRAS2;ANK2;FGFR1;CASP3;NRAS;FASLG;ITGB5;MRAS;RPS6KB1;MAPK1;FAS;FRS2;PIK3R1;TLR2;ITPR1;CTTN;CBL;HPSE;DDX5;FLNA;HGF;VAV2;PLAUR;HCLS1;PLCG2;EIF4B;ITGB1;RRAS;HRAS;ACTB;HIF1A;VEGFA;MAPK14;HBEGF;WNT10B;CDC42
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.28733684918011076,-1.048503155146919,0.3559322033898305,0.9842701237296106,1.0,6/23,22.68%,UBB;EP300;MRPL18;SERPINH1;HSPA6;DNAJB6
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.1972799546454016,-1.0469786579975167,0.3898305084745763,0.9877532873413772,1.0,28/166,12.70%,H1-4;UBB;PROC;AVEN;AKT1;PRKCD;BCAP31;YWHAZ;DFFB;PSMD11;PSMB7;CASP3;CLSPN;FASLG;BAD;REXO2;APPL1;MAPK1;CARD8;PSMB4;TMED7-TICAM2;PSMD8;DFFA;APAF1;PMAIP1;DAPK3;PSMB10;PSMB5
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.2524419654292121,1.0459181560827455,0.4,1.0,1.0,7/30,12.81%,USP9X;UBE2B;USP7;UBE2R2;UBA52;RPS27A;USP5
prerank,KEGG_2021_Human__Amoebiasis,0.20321758652271116,1.0452122512726676,0.46808510638297873,1.0,1.0,17/73,16.55%,PLCB4;CXCL8;ARG1;IL1R1;IL10;IL12A;FN1;TGFB1;SERPINB10;RAB5A;GNA15;PRKACA;RELA;COL4A3;C8G;LAMB3;IL1R2
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.2121517062175631,1.0432275568861102,0.3829787234042553,1.0,1.0,17/74,15.37%,H2BC11;H2BC15;RBBP8;H2BC5;BLM;H3-3B;MLH1;SMC1A;POT1;CDK4;H2AC7;HID1;H4C15;H2BC14;H3C13;LMNA;TINF2
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.2243150939102628,-1.0425330140198412,0.39285714285714285,1.0,1.0,18/60,25.72%,AKT1;PIK3CA;MAP2K7;NRAS;MAPK1;PIK3R1;MAP2K4;INPP5D;LCP2;VAV2;MAP2K3;PLCG2;MAPK8;MAPK9;HRAS;ALOX5AP;MAPK14;IL4
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.24791830869464992,-1.0424143359024165,0.4032258064516129,0.9994866335166808,1.0,17/48,25.29%,OAZ1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;SLC25A21;NQO1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.213273462078512,-1.0423629590267278,0.359375,0.9964432713416261,1.0,27/82,29.13%,UBB;SKP1;AKT1;CUL1;PSMD11;PSMB7;LIN52;PTK6;LIN9;E2F4;PSMB4;PSMD8;PSMB10;PSMB5;CABLES1;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,0.22076883165420907,1.0422890423945979,0.2926829268292683,1.0,1.0,12/56,13.84%,SQSTM1;ULK1;ATG5;UBA52;IFT88;MTERF3;TOMM70;FUNDC1;TOMM6;RPS27A;DYNLL2;PRKAB2
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.2810783122220554,-1.0420520245913574,0.36363636363636365,0.9946444925118939,1.0,5/26,7.53%,UBB;XPO1;SMAD7;SMURF2;SRFBP1
prerank,KEGG_2021_Human__Fat digestion and absorption,0.29310572789526956,1.041979151878033,0.42857142857142855,1.0,1.0,7/19,16.44%,PLPP1;DGAT2;PLPP2;PLA2G2C;PLA2G12A;SLC27A4;PNLIPRP1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.20237432789444573,1.0414865661654131,0.38636363636363635,1.0,1.0,22/95,14.63%,RPL4;RPS20;EIF2AK4;IMPACT;RPL31;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;CEBPB;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3;EIF2S2
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.24267247000429457,-1.0414493010755284,0.3770491803278688,0.9937484471643585,1.0,19/49,29.13%,UBB;SKP1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,-0.3052461501038767,-1.0413654999810709,0.3770491803278688,0.9911463875446765,1.0,15/18,56.10%,PAG1;PTPRC;PTPN22;PTPRJ;HLA-DRB5;HLA-DRA;HLA-DRB3;CD4;CD3E;CSK;CD3D;HLA-DRB4;HLA-DQA1;LCK;HLA-DPA1
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.2668294465468243,-1.0380177587538244,0.46511627906976744,0.9999466380900237,1.0,5/27,7.32%,PCK2;SDHC;SDHD;DLAT;ACLY
prerank,KEGG_2021_Human__Influenza A,-0.19664217503013087,-1.0379877994949878,0.3548387096774194,0.9971125202164676,1.0,22/139,12.58%,SLC25A5;IL6;XPO1;AKT1;PIK3CA;CALCOCO2;RAB11A;CASP3;FASLG;EIF2S1;OAS3;EIF2AK2;BCL2L2-PABPN1;NXF1;EP300;MAPK1;MX1;FAS;CDK6;RSAD2;APAF1;PIK3R1
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.23950870555933299,1.0378493828884083,0.3953488372093023,1.0,1.0,11/46,13.36%,RPS20;DDX20;GEMIN8;RPS15;RPS25;RPS19;FAU;RPS10;RPS21;RPS27A;RPS28
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.3021144386185603,-1.0374830163431183,0.38333333333333336,0.9961873092302568,1.0,5/17,21.33%,PIK3CA;PIK3R1;SPTBN1;NCK2;WASL
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.20872500156419296,1.0368477527363422,0.4444444444444444,1.0,1.0,12/67,12.54%,NKIRAS2;SIKE1;ATG5;MAVS;UBA52;UBA7;TOMM70;TRIM4;RNF135;FADD;RPS27A;RELA
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.23905438606430635,-1.0365336086686368,0.4406779661016949,0.9941918632174521,1.0,20/55,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.23905438606430635,-1.0365336086686368,0.4406779661016949,0.9941918632174521,1.0,20/55,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.29956283642633935,-1.0365267576596384,0.4,0.991183832506134,1.0,7/18,22.48%,MAP2K7;UBE2N;IRAK1;TRAF6;MAP2K4;MAPK8;MAPK9
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.2757517156948581,-1.0361837575817094,0.4074074074074074,0.9893215938161499,1.0,9/25,23.50%,PIGS;PIGL;PIGO;PIGW;PIGQ;PGAP1;PIGV;PIGC;PIGM
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.20228126593529308,-1.0355151400040097,0.3333333333333333,0.988498354327095,1.0,18/119,10.12%,RAB6A;AKT1;TBC1D17;RAB18;RAB11A;RAB35;GGA3;TBC1D2;TRAPPC11;GAPVD1;TSC2;TRAPPC1;RAB39B;RAB4A;RAB27A;TRAPPC5;RAB10;TBC1D10A
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,-0.30904371519810014,-1.0349444535360548,0.375,0.9880322981888241,1.0,4/16,7.89%,LIN52;LIN9;FOXM1;EP300
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,0.2667756811686543,1.0347699690559415,0.4634146341463415,1.0,1.0,9/31,13.84%,H2BC11;H2BC15;H2BC5;H3-3B;H2AC7;DNMT3A;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.2808351076672393,-1.0347640540889989,0.38596491228070173,0.9856538036073235,1.0,9/23,24.93%,CLSTN1;PIK3CA;IL2RB;PIK3R1;INPP5D;JAK3;CSF2RB;IL2RA;IL3RA
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.2003096342754734,1.0338182604196255,0.4222222222222222,1.0,1.0,19/88,14.41%,RPL4;RPS20;EEF1G;RPL31;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.198638260877066,-1.0338063471342986,0.4098360655737705,0.9861220410258981,1.0,34/104,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;S100A12;TLR1;FOS;FBXW11;IRAK1;TRAF6;DUSP7;TLR2;MAP2K4;PPP2CA;TANK;S100A9;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.23746193649765615,-1.0338032206608292,0.4528301886792453,0.98319244276641,1.0,5/42,4.72%,PARP1;UBB;ERCC5;UBE2N;GTF2H3
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.25812902939263344,1.031530817056718,0.42857142857142855,1.0,1.0,9/33,17.48%,RAD51AP1;DNA2;RBBP8;EXO1;BLM;RAD51D;GEN1;PALB2;WRN
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.27978889619946823,1.0306811705356964,0.4523809523809524,1.0,1.0,3/23,3.87%,RNF20;CCT2;STK38
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.21884420916711642,-1.0303862117691929,0.40350877192982454,0.9945474082629924,1.0,17/73,19.55%,AKT1;PIK3CA;NRAS;BAD;SHC4;E2F3;MAPK1;CRK;CDK6;CTBP1;PIK3R1;TGFBR2;STAT5A;CBL;RUNX1;STAT5B;HDAC2
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.25162897496052156,1.0289980881912024,0.425,1.0,1.0,3/34,1.78%,EPS8L2;PJVK;TRIOBP
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,-0.3109119506310329,-1.028742301640034,0.45098039215686275,0.9980442614513639,1.0,8/18,23.98%,SMAD7;SMURF2;ACVR2B;ZFYVE16;UBE2D1;SKI;SMAD5;SMAD1
prerank,KEGG_2021_Human__Ribosome,0.1878607613834169,1.0285298797167306,0.4,1.0,1.0,27/133,14.41%,MRPS16;RPL4;RPS20;MRPL1;MRPL20;RPL31;RPS15;RPS25;RPLP0;MRPS7;UBA52;MRPS18C;RPS19;MRPL28;FAU;MRPS11;RPS10;RPL29;RPS21;RPS27A;RNA5-8SN2;RPL37A;RSL24D1;RPL39;RPS28;MRPS9;RPL3
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.187149085112389,-1.0257305965562808,0.4090909090909091,1.0,1.0,43/194,20.07%,H1-4;UBB;FLOT2;PROC;AVEN;AKT1;PRKCD;BCAP31;YWHAZ;DFFB;PSMD11;PSMB7;CASP3;CLSPN;FASLG;BAD;REXO2;APPL1;RIPK3;MAPK1;CARD8;CHMP4B;PSMB4;TMED7-TICAM2;PSMD8;DFFA;APAF1;PMAIP1;DAPK3;PSMB10;PSMB5;MLKL;SATB1;OGT;BMX;SEM1;PSMD6;DBNL;PSMD9;TANK;DSG2;TRADD;ARHGAP10
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,-0.25294218265857227,-1.0252445392308815,0.4098360655737705,1.0,1.0,8/28,22.92%,PIK3CA;FGFR1;NRAS;FRS2;PIK3R1;PDE3B;FGFR4;HRAS
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.19867829397335368,1.0250244460512719,0.43137254901960786,1.0,1.0,20/88,14.52%,RPL4;RPS20;RPL31;PBRM1;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3;GNL3
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.1735534786076556,1.0247885952667697,0.4418604651162791,1.0,1.0,21/153,11.42%,UQCR10;TMEM126B;NDUFS1;LDHB;SUCLG1;ECSIT;NDUFB10;COQ10A;DLST;GSTZ1;NDUFS6;SLC16A3;NDUFAF5;CYCS;UQCRC1;ATP5F1D;SUCLG2;DMAC2L;COX6B1;ATP5MC1;PDK2
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.21717873011145114,-1.0244545679102555,0.4666666666666667,1.0,1.0,9/76,7.89%,POLR2I;TCEA1;COPS2;UBB;AQR;ERCC5;GTF2H3;POLR2D;EP300
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.28171804228568587,-1.0243308407253662,0.39285714285714285,1.0,1.0,12/23,37.44%,UBB;UBE2N;RIPK3;TMED7-TICAM2;TRAF6;UBE2D1;NDUFA2;UBC;LY96;SARM1;UBE2V1;UBE2D3
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.2183868493792406,1.0238931297686213,0.3888888888888889,1.0,1.0,8/57,9.60%,THOC7;SRSF5;CDC40;WDR33;SRSF7;FYTTD1;POLDIP3;PCF11
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.25652593829851217,-1.0235839566688316,0.38181818181818183,1.0,1.0,11/38,22.37%,CRCP;POLR3GL;POLR3D;POLR3C;POLR3G;POU2F1;POLR2E;POLR3K;POLR3H;SNAPC1;NFIA
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.24956450710191186,-1.0235094897172126,0.4074074074074074,0.9998488723503625,1.0,7/39,8.57%,UBB;DUSP6;PPP2R5B;NRAS;RNASE3;KSR1;MAPK1
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.19561111738265693,1.0227681856181896,0.4186046511627907,1.0,1.0,25/84,23.38%,B3GLCT;NUS1;VCAN;THBS1;ALG8;LARGE1;POMGNT1;HSPG2;ADAMTS10;CFP;AGRN;SLPI;ADAMTSL5;DOLK;GALNT3;B3GALT6;NOTCH4;NOTCH3;DPAGT1;ALG3;GLB1;ALG2;DCN;ALG14;MUC1
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.2725888963864792,-1.0225026046776873,0.4444444444444444,1.0,1.0,8/26,22.92%,PIK3CA;NRAS;CRK;PIK3R1;STAT5A;STAT5B;NCK2;HRAS
prerank,KEGG_2021_Human__Glutathione metabolism,-0.23741581867283873,-1.0211540077759662,0.4230769230769231,1.0,1.0,12/45,15.35%,MGST3;ODC1;GSTA4;RRM2B;GGT1;LAP3;GSTO1;GSTM2;TXNDC12;OPLAH;SRM;NAT8B
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.26402356637247026,1.0206827382525947,0.3877551020408163,1.0,1.0,10/28,20.46%,TTLL4;TPGS1;TUBB4A;TUBB2A;TTLL3;AGBL3;TTLL10;NICN1;VASH1;TTLL1
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.17987605034526302,1.0202774157489451,0.5128205128205128,1.0,1.0,48/155,22.67%,SP3;PHC3;BIRC5;NRIP1;HIPK2;NR3C2;RARA;RING1;PIAS2;NUP58;POM121;PHC1;ZNF350;BLM;NCOA2;SATB2;PIAS1;SMC1A;PPARG;CBX5;CDCA8;DNMT3A;RELA;NUP210;H4C15;RANGAP1;NR5A2;TDG;SEC13;HERC2;NPM1;WRN;SCMH1;NUP155;NUP62;SMC5;DNMT3B;NSMCE4A;SAFB;POLR1A;IKBKG;PARK7;TOP1;NUP98;NUP205;COMMD3-BMI1;NFKBIA;HNRNPK
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.24173617776924894,-1.0202034470815804,0.43636363636363634,1.0,1.0,17/41,31.47%,NUP37;ALYREF;NXF1;NUP88;NUP93;EIF4E;NUP35;NUP54;NUP42;NUP43;NDC1;SYMPK;NUP85;NUP107;CPSF1;CPSF2;NUP214
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,0.21693154446609245,1.0197643741122915,0.4722222222222222,1.0,1.0,14/57,19.46%,IFITM1;IRF5;IP6K2;IFIT2;IRF8;PTPN11;MX2;IFI35;KPNA1;ISG15;STAT1;EGR1;IRF1;IFNAR2
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.2653533330153077,-1.018782731203026,0.4107142857142857,1.0,1.0,6/32,8.08%,VAMP3;VAMP5;STX7;VAMP1;STX8;STX3
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.23957843863730063,-1.0186777889005871,0.4666666666666667,1.0,1.0,20/51,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.22812113953463195,-1.0185430147760919,0.40350877192982454,1.0,1.0,12/54,14.39%,SKP1;PIK3CA;CUL1;RNF213;CARS1;BCL11A;MAPK1;KLC1;ZC3HC1;FRS2;PIK3R1;STAT5A
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.18472785095978467,-1.0173479599769373,0.4782608695652174,1.0,1.0,45/133,28.41%,ELOC;UBB;UBA1;SKP1;DET1;UBE2M;CUL1;UBE2N;SMURF2;ANAPC7;UBE2J1;RHOBTB1;MGRN1;PIAS4;UBE2Q1;UBR5;ANAPC5;FBXW11;TRAF6;UBE2G1;UBE2W;WWP2;UBE2Z;FBXO4;NHLRC1;CBL;UBE2O;FANCL;UBE2D1;NEDD4;UBE3A;ANAPC13;KLHL9;PIAS3;SIAH1;HERC1;CUL3;UBC;UBE2A;CUL2;NEDD4L;SYVN1;PRKN;MAP3K1;TRIM32
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,-0.2593316446449915,-1.0166027569160023,0.40625,1.0,1.0,15/28,37.99%,NCOR2;MAML2;HDAC11;TBL1X;NCOR1;MAMLD1;HDAC2;TBL1XR1;HDAC6;HDAC5;HDAC7;RBPJ;CREBBP;HDAC4;MAML1
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.22298644368838472,-1.0164248742040138,0.45,1.0,1.0,8/65,7.89%,POLR2I;TCEA1;UBB;AQR;ERCC5;GTF2H3;POLR2D;EP300
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.2332268256495275,-1.0148867578743928,0.45161290322580644,1.0,1.0,20/56,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.23734174978227537,-1.0142875665370925,0.4423076923076923,1.0,1.0,12/34,26.33%,NUP37;XPO1;RAN;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.21151001194060648,1.014078706392909,0.391304347826087,1.0,1.0,13/63,13.84%,H2BC11;USP9X;H2BC15;APOE;UBA52;H2BC5;H3-3B;H2AC7;RPS27A;H4C15;H2BC14;HSPG2;H3C13
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.24236403553464095,-1.0132684804459002,0.4909090909090909,1.0,1.0,8/47,10.49%,KCTD11;AOPEP;CTSG;AGXT;KIF5C;RAB27A;ATP6AP2;EXOC2
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.2896241430977842,-1.012831950307352,0.46,1.0,1.0,6/19,24.07%,PIK3CA;NRAS;PIK3R1;ERBIN;HRAS;HBEGF
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.24584693557034556,-1.0117623827634585,0.41818181818181815,1.0,1.0,12/40,18.05%,CREB1;PDE1B;PRKCD;NBEA;ADCY4;MAPK1;GNA11;ITPR1;PRKX;PLCB2;GNAQ;CAMK4
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.2257395110141427,-1.0112438064852676,0.4375,1.0,1.0,23/67,26.42%,UBB;PSMD11;PSMB7;ULK3;SMURF2;EFCAB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;KIF3A;PSMD6;SMOX;PSMD9;PSMA6;PSMA4;PSMD13;SPOPL;PSMC1;PSMD3;CUL3;UBC
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.30913683140599596,-1.011160258248084,0.43548387096774194,0.9997870763123551,1.0,9/17,32.54%,GNG10;GNG5;PKN1;GNG3;CDC42;GNB4;ARHGEF6;GNG8;GNG7
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.30583306046854253,-1.010598183052576,0.4807692307692308,0.9992078848875497,1.0,7/16,26.42%,UBB;MAPK1;MKNK1;CBL;PPP2CA;PPP2R1A;UBC
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.18658815921654603,-1.0104479709623104,0.43283582089552236,0.99689547609918,1.0,36/150,19.70%,UPF3B;ELOC;RPS24;UBB;RPS15A;PSMD11;PSMB7;RPL38;RPL26;RPL23A;RPS3A;DAG1;RPL26L1;PSMB4;RPL8;RPL15;PSMD8;RPS3;RPL36A;RPL32;RPL7;PSMB10;PSMB5;GSPT2;RPL19;RPL22;RPL18A;RPL5;SEM1;RPL21;RPS2;PSMD6;RPSA;PSMD9;RPL36AL;RPS27
prerank,KEGG_2021_Human__Prostate cancer,-0.20348215506636227,-1.0104324871991326,0.43333333333333335,0.9941850210023291,1.0,11/86,8.57%,CREB1;AKT1;PIK3CA;FGFR1;HSP90B1;NRAS;TGFA;BAD;E2F3;EP300;MAPK1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,0.274774540243016,1.0102938665876633,0.4,1.0,1.0,5/19,13.07%,TTC5;UBA52;CHEK2;RPS27A;MDM4
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.21082808041323353,1.0102096957232114,0.3939393939393939,1.0,1.0,9/66,9.60%,THOC7;LSM10;SRSF5;CDC40;WDR33;SRSF7;FYTTD1;POLDIP3;PCF11
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,0.2255760013344439,1.0099657199561392,0.475,1.0,1.0,9/35,15.29%,H2BC11;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13;SIRT1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.175790975063672,1.0088551186873473,0.4634146341463415,1.0,1.0,49/161,22.67%,SP3;PHC3;SAE1;BIRC5;NRIP1;HIPK2;NR3C2;RARA;RING1;PIAS2;NUP58;POM121;PHC1;ZNF350;BLM;NCOA2;SATB2;PIAS1;SMC1A;PPARG;CBX5;CDCA8;DNMT3A;RELA;NUP210;H4C15;RANGAP1;NR5A2;TDG;SEC13;HERC2;NPM1;WRN;SCMH1;NUP155;NUP62;SMC5;DNMT3B;NSMCE4A;SAFB;POLR1A;IKBKG;PARK7;TOP1;NUP98;NUP205;COMMD3-BMI1;NFKBIA;HNRNPK
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.1862042999176317,-1.0081074139604609,0.4915254237288136,0.9995968739967356,1.0,43/131,26.42%,UBB;CREB1;MAP3K8;SKP1;ITGAM;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;RIPK3;MAPK1;S100A12;TMED7-TICAM2;TLR1;FOS;FBXW11;IRAK1;TRAF6;DUSP7;TLR2;MAP2K4;DNM3;PPP2CA;UBE2D1;TANK;TRAF3;S100A9;MAP2K3;PLCG2;PPP2R1A;MAPK8;DNM2;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;ITGB2;MAPKAPK2;UBC
prerank,KEGG_2021_Human__ABC transporters,-0.26928225946829604,-1.0080276630918772,0.46153846153846156,0.9971274301629441,1.0,11/34,23.86%,ABCC9;ABCA7;ABCC5;ABCC3;ABCB1;ABCB4;ABCB9;ABCG1;ABCD2;ABCA10;ABCA13
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.20548727570569666,-1.0076434060495683,0.5535714285714286,0.995632121227251,1.0,30/73,31.83%,POLR2I;NUP37;RAN;H2AC14;H2AZ2;POLR2D;POLR2A;NUP88;H2AC6;NUP93;H2BC13;H2BC3;POLR2E;H2BC12;NUP35;NUP54;NUP42;H2BC4;NUP43;H2AX;NDC1;NUP85;NUP107;H2AB1;TNRC6A;POLR2L;H2AC19;POLR2F;NUP214;H2AC4
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,-0.32088723879628517,-1.0075920684584077,0.3898305084745763,0.9930420030455337,1.0,4/15,16.82%,TSC22D1;PBX1;HHEX;EOMES
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.3092426357638571,-1.007131824384462,0.375,0.989203303941196,1.0,3/18,10.25%,POLR2I;POLR2D;POLR2A
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.3092426357638571,-1.007131824384462,0.375,0.989203303941196,1.0,3/18,10.25%,POLR2I;POLR2D;POLR2A
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.18980974324090882,1.0071277592079515,0.45652173913043476,1.0,1.0,19/88,14.41%,RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;PSTK;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3
prerank,KEGG_2021_Human__Galactose metabolism,-0.2839156199708285,-1.0065641611027143,0.48214285714285715,0.988753523843485,1.0,9/24,22.45%,PFKL;GAA;GLA;B4GALT1;GALK1;AKR1B1;PFKP;GALT;HK3
prerank,KEGG_2021_Human__Purine metabolism,0.18122789384571153,1.0065492331947206,0.4444444444444444,1.0,1.0,16/101,11.02%,PDE2A;PDE6H;ENPP3;ENTPD6;ADCY3;PFAS;PDE6B;ENTPD4;RRM2;ADPRM;PDE10A;NME3;ENTPD5;AK6;PDE7A;CANT1
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.17556647146678836,1.0064375761393256,0.42857142857142855,1.0,1.0,19/169,7.86%,PLCB4;H2BC11;CLEC7A;H4C12;H2AC16;CYBB;H2AC8;H2BC15;H2AC12;CR1L;MTOR;H2AB2;H4C11;H3C1;TLR8;HDAC3;H2BC5;C5AR1;H3-3B
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.304960201117645,1.0063906064413328,0.43902439024390244,1.0,1.0,4/17,10.27%,CLDN4;PARD6B;CLDN7;CLDN10
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.2309989349341191,1.0052630890390597,0.46,1.0,1.0,5/33,7.14%,PHC3;HIPK2;PBRM1;RING1;PHC1
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.20488876503937606,1.0048457757861924,0.4864864864864865,1.0,1.0,11/55,13.84%,H2BC11;TLE2;RBBP5;H2BC15;RUVBL1;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.24541382555412422,1.0047860172724952,0.43137254901960786,1.0,1.0,11/34,19.64%,CLDN4;CDH8;PARD6B;CDH13;CLDN7;PVR;CLDN10;ANG;CDH15;CTNNA1;FZR1
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.23178885835302288,1.0047031883874638,0.45454545454545453,1.0,1.0,13/52,17.28%,RPLP0;RALA;IL10;IL27;EBI3;IL12A;ANXA2;CNN2;TCP1;STAT4;STAT1;JAK2;PSME2
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.18557169483894473,1.0045262473330911,0.40476190476190477,1.0,1.0,34/127,20.49%,SQSTM1;SMPD3;ARHGEF11;NSMAF;RTN4;ARHGEF4;SPPL2A;HDAC3;UBA52;MAGED1;CFLAR;PSEN2;PREX1;ARHGEF18;TAB3;MYD88;FADD;RPS27A;RELA;PRDM4;ECT2;ARHGEF10;ADAM17;BCL2L11;TNFSF10;VAV3;ARHGEF12;TNFAIP3;FASN;SOS1;IKBKG;FGD4;ARHGEF9;RNASE1
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,-0.3061145426144931,-1.0043487298128764,0.4074074074074074,0.9941346164233014,1.0,8/15,35.56%,AKR1B1;HSD17B12;AKR1B15;SRD5A1;TSPO;STARD3NL;TSPOAP1;STARD3
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.19274143943857064,-1.0041096333270818,0.4915254237288136,0.9923281281378974,1.0,32/99,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;S100A12;TMED7-TICAM2;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;TANK;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.1891392061733866,-1.0039938723540596,0.43859649122807015,0.9901030605749918,1.0,39/102,30.74%,NCOR2;AGXT;ACSL1;SREBF1;SLC27A1;MED24;MED9;LIN9;EP300;TBL1X;MED18;MIA3;MED6;NCOR1;PLIN2;NRF1;PPARGC1B;MED16;G0S2;ABCB4;CCNC;MED30;GRHL1;MED20;TBL1XR1;GPS2;NCOA3;MED17;CLOCK;MED25;SIN3B;TRIB3;MED28;MED7;MED14;MED13L;MED12;MED29;MED15
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.20729100231033512,1.0039587182482472,0.47619047619047616,1.0,1.0,24/83,19.29%,ITGA4;CYBB;CD99L2;TXK;CLDN4;GNAI1;ARHGAP35;MYL12A;CLDN7;MMP9;OCLN;CLDN10;PTPN11;CD99;SIPA1;ESAM;VAV3;ICAM1;MAPK13;RAC1;MAPK11;RAC2;CTNNA1;GNAI3
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.21022328002777266,1.0034179322141585,0.4666666666666667,1.0,1.0,12/55,17.53%,NUS1;ST8SIA1;MVD;ST8SIA6;ST6GALNAC4;SLC35A1;NAGK;ST6GALNAC2;SLPI;PMM1;ST3GAL6;DOLK
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.20290188757915772,-1.0032191381009266,0.4318181818181818,0.9899120183460272,1.0,28/74,30.74%,NCOR2;SREBF1;MED24;MED9;LIN9;EP300;TBL1X;MED18;MED6;NCOR1;SLC2A4;MED16;CCNC;MED30;MED20;TBL1XR1;NCOA3;WNT10B;MED17;MED25;MED28;MED7;LPL;MED14;MED13L;MED12;MED29;MED15
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.16916290701089573,1.0031219432459715,0.42857142857142855,1.0,1.0,38/174,18.41%,IFITM1;TRIM35;TRIM14;IRF5;CAMK2A;IP6K2;EIF4G2;KPNA2;PTPN2;NUP58;UBA52;POM121;UBA7;IFIT2;IRF8;GBP5;PIAS1;MID1;PTPN11;MX2;RPS27A;NUP210;IFI35;FCGR1A;MAPK3;GNL3;KPNA1;ISG15;STAT1;SEC13;ICAM1;JAK2;TRIM38;EGR1;CIITA;NUP155;IRF1;NUP62
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,0.20726349211590245,1.002760268502177,0.5555555555555556,1.0,1.0,12/49,17.48%,DNA2;RFC3;RFC5;RUVBL1;BLM;CHTF8;POT1;POLA1;TINF2;PPP6R3;SLC19A1;WRN
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.18207297832138108,-1.0026230460500059,0.43859649122807015,0.9892675593283398,1.0,36/127,22.33%,ORAI3;SLC25A5;PDE1B;CACNA1I;HRH2;FGFR1;ITPKB;PPIF;ADCY4;MCOLN2;CALML4;TNNC1;RYR3;GNA11;CACNA1E;ATP2A1;ORAI2;ITPR1;ADRB2;ADORA2B;PLCB2;GNAQ;F2R;PLCD1;CAMK4;CXCR4;HGF;ATP2A2;SPHK1;FGFR4;MCOLN1;PLCG2;CALM3;ADRA1A;RYR1;TNNC2
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.2243632337136722,1.002323669911133,0.4222222222222222,1.0,1.0,11/49,15.71%,PLB1;BCO2;APOE;GNB5;PDE6B;RDH10;CHURC1-FNTB;HSPG2;RDH5;AGRN;AKR1C1
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.23927005770877255,-1.0019539886107103,0.47540983606557374,0.9894480271629625,1.0,19/47,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PKN2;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.23833087054674862,1.0014726584249551,0.42424242424242425,1.0,1.0,5/45,5.69%,MGAT5;B4GALT2;ALG8;MAN2A1;STT3B
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.32328464476970353,-1.001071448308259,0.4482758620689655,0.9901925470742147,1.0,10/15,43.03%,PARP4;NAXD;PARP6;NAXE;NAMPT;NAPRT;NUDT12;PARP10;PARP14;RNLS
prerank,KEGG_2021_Human__Cholinergic synapse,-0.2081636546022638,-1.0007679199824464,0.41818181818181815,0.9884254747863079,1.0,17/77,15.98%,CREB1;AKT1;GNG10;PIK3CA;GNG5;NRAS;KCNJ2;CHRNB4;PIK3R5;ADCY4;MAPK1;GNA11;FOS;PIK3R1;ITPR1;PLCB2;GNAQ
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.1620990733401216,-1.0003470045422809,0.4626865671641791,0.987229813553998,1.0,103/437,22.02%,PRDX4;RAB6A;CAB39;PFKL;CTSG;DEGS1;XRCC5;ITGAM;SRP14;CTSS;PRKCD;MANBA;SIGLEC9;STBD1;UNC13D;RAB18;DGAT1;ATP11A;PIKFYVE;GAA;PSMD11;PSMB7;RAB37;CXCR1;JUP;NRAS;ATP6V0A1;LOC112694756;RNASE3;CHRNB4;A1BG;CHIT1;PLAC8;TRAPPC1;ADGRE3;ACLY;CD93;ATP6V1D;CREG1;MAPK1;RAB27A;B4GALT1;NCSTN;IRAG2;CPPED1;ATP6AP2;CD33;SYNGR1;IGF2R;HGSNAT;ARHGAP45;RAB10;APRT;CRACR2A;CXCR2;RAP2B;S100A11;S100A12;TMED7-TICAM2;CEACAM6;DYNLT1;ADGRG3;APAF1;ORMDL3;LAMTOR2;SLC11A1;GALNS;CEP290;TLR2;FGL2;CPNE1;CD55;SNAP25;CMTM6;FUCA1;TUBB4B;ERP44;DNAJC3;HPSE;RAB14;DPP7;PYGB;PSMD6;ARL8A;MAN2B1;RAP1A;DBNL;RNASET2;HSPA6;NHLRC3;VAPA;PTPRC;S100A9;PRCP;RAP2C;PLAUR;CTSB;GSTP1;CHI3L1;SIGLEC5;NDUFC2;SNAP23;DLC1
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.23839968439822024,-0.9990561963290827,0.423728813559322,0.9862830170651231,1.0,6/30,14.77%,PIK3CA;FGFR1;NRAS;FRS2;PIK3R1;PDE3B
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,-0.23839968439822024,-0.9990561963290827,0.423728813559322,0.9862830170651231,1.0,6/30,14.77%,PIK3CA;FGFR1;NRAS;FRS2;PIK3R1;PDE3B
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.1826526371448726,-0.9986132639356416,0.4727272727272727,0.9851303512471524,1.0,28/165,13.31%,PARP1;SLC25A5;NDUFS2;CPT1B;AKT1;PRKCD;TBC1D4;NDUFS7;PIK3CA;ATP5F1E;NCF2;NDUFB7;PDK4;COX7B;SDHC;NDUFB3;COX6A1;SDHD;PPIF;NDUFC1;PRKCZ;NDUFA8;UQCRHL;NDUFS3;PIK3R1;SLC2A4;ATP2A1;TGFBR2
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.24463302408449894,-0.9983200529074578,0.4262295081967213,0.9833998514783684,1.0,6/29,14.77%,PIK3CA;FGFR1;NRAS;FRS2;PIK3R1;PDE3B
prerank,KEGG_2021_Human__Steroid biosynthesis,-0.30820232238972384,-0.9982421166636385,0.4666666666666667,0.9811515312576827,1.0,10/16,43.02%,DHCR7;NSDHL;SC5D;SOAT1;TM7SF2;MSMO1;HSD17B7;CYP51A1;LBR;EBP
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.21605455463155737,0.9973733252196161,0.40540540540540543,1.0,1.0,14/52,19.32%,CAMK2A;TNRC6C;AGO4;GNB5;PDE6B;MOV10;PPP3CB;FZD6;LEF1;GNG4;PPP3CA;GNAO1;TCF7L2;GNG11
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.29533321752721187,-0.9961752634259603,0.44642857142857145,0.9859404232804885,1.0,15/19,45.36%,CASP3;STX3;SNAP25;STX4;TXLNA;TYK2;IL16;IFNLR1;VAMP2;CSF1R;IL10RB;JAK1;IL32;CD4;PRTN3
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.15881453707514143,-0.9953050708501386,0.47619047619047616,0.9862628011954867,1.0,74/448,14.72%,ZNF610;ZNF300;ZNF547;IL6;ALYREF;ZNF354C;ZNF26;ZNF599;ZNF543;ZNF83;ZNF589;AKT1;ZNF177;ZNF682;ZNF418;ZNF662;ZNF45;PIK3CA;ZNF132;ZNF570;ZNF616;ZNF473;CASP3;ZNF613;ZNF486;TNFSF14;FASLG;EIF2S1;ZNF606;ZNF665;OAS3;ZNF33A;BAD;ZNF721;TSC2;ZNF619;PILRB;ZNF627;EIF2AK2;ZNF37A;NXF1;ZNF786;ZNF785;ZNF175;ZFP37;ZNF611;POU2F1;ZNF30;ZNF480;FAS;ZNF597;ZNF780A;ZNF823;ZNF275;ZNF667;ZNF713;ZNF354A;APAF1;ZNF484;NECTIN2;PIK3R1;ZNF234;ZNF718;IRAK1;ZNF471;ZNF169;ZNF431;TRAF6;ZNF267;PILRA;TLR2;ZNF91;ZNF57;ZFP82
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.20706239845606933,-0.9926025849951625,0.5,0.9940125926797694,1.0,23/76,26.42%,RASGRP4;UBB;SKP1;CUL1;PSMD11;PSMB7;UBE2N;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;TRAF6;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC
prerank,KEGG_2021_Human__Pathways of neurodegeneration,-0.16015976675265314,-0.9915546669688664,0.4745762711864407,0.9952179709976581,1.0,102/364,25.29%,CDK5R1;UBB;SLC25A5;NDUFS2;UBA1;IL6;NDUFS7;ATP5F1E;NDUFB7;COX7B;MAP2K7;DNAL4;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;SNCA;UCHL1;COX6A1;NRAS;SDHD;FASLG;EIF2S1;BAD;PPIF;VAPB;RAB39B;ACTR1A;ADRM1;TOMM40;LRP6;UBE2J1;MAPK1;CCS;CSNK2A1;NDUFC1;PSMB4;NEFL;KLC1;CALML4;FAS;NDUFA8;UQCRHL;PSMD8;RYR3;SEPTIN5;DDIT3;APAF1;NDUFS3;PSMB5;ATP2A1;TUBB6;CSNK2A2;UBE2G1;NEFH;ITPR1;ATXN3;SPG11;NDUFAB1;PLCB2;WDR41;GNAQ;TUBB4B;CSNK1E;ATP5PO;SEM1;PSMD6;TUBA1A;ATF4;KIF5B;PSMD9;KIF5A;NDUFA12;ATP2A2;TANK;MAP2K3;CALM3;SDHB;TNFRSF1A;NDUFC2;RYR1;MAPK8;MAPK9;PSMA6;NDUFB6;HRAS;CDK5;PSMA4;PSMD13;MAPK14;NDUFB8;WNT10B;NDUFA9;NDUFC2-KCTD14;ATP5PB;BECN1;NDUFA2;ATP5MC2;PSMC1;PSMD3
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.19793047271486325,-0.9914884911087795,0.4426229508196721,0.9929955297982173,1.0,37/81,36.99%,NUP37;EIF4A1;UBB;UBE2N;OAS3;RIGI;EIF2AK2;HERC5;MX1;NUP88;NUP93;EIF4E;OASL;FLNA;NUP35;NUP54;NUP42;NEDD4;NUP43;PDE12;NDC1;NUP85;OAS1;NUP107;UBC;ARIH1;OAS2;NUP214;TRIM25;IFIT1;NUP160;SEH1L;EIF4G3;AAAS;JAK1;EIF4E2;ABCE1
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,0.195255878383412,0.9908288881902383,0.4594594594594595,1.0,1.0,12/54,13.73%,H2BC11;H2BC15;KPNA2;UBA52;H2BC5;CHEK2;APBB1;UBXN1;RPS27A;H4C15;ABL1;H2BC14
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.3424389804376799,-0.9907349236381381,0.4716981132075472,0.9931325342199951,1.0,10/17,33.14%,MBTPS2;CETP;TRNP1;ABCG1;LMF2;PLTP;LPL;LIPC;LCAT;LIPG
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.24038050912699138,-0.9899896022819089,0.46153846153846156,0.9932416009369792,1.0,12/34,26.33%,NUP37;XPO1;RAN;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.18449860410518135,-0.9890334366219502,0.46774193548387094,0.9940834671994891,1.0,41/128,29.13%,UBB;SKP1;AKT1;E2F6;FBXO5;CUL1;PSMD11;PSMB7;LIN52;PTK6;LIN9;E2F4;PSMB4;DHFR;PSMD8;CDC45;ORC6;PSMB10;PSMB5;CABLES1;MCM10;MCM3;SEM1;PSMD6;PPP2CA;PSMD9;PPP2R1A;PSMA6;PSMA4;PSMD13;PPP2R1B;PSMC1;PSMD3;UBC;DBF4;CCNA2;GMNN;SLC25A15;PSMA2;TK1;PSMA7
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.22430381893678417,0.9877911966594044,0.5434782608695652,1.0,1.0,7/41,12.95%,ATP6V0B;SEC61B;TCIRG1;ADCY3;ATP6V1F;PRKACA;ERO1A
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.17110711380295074,-0.9876695039893907,0.5,0.9963839759767735,1.0,49/240,17.68%,UBB;CHD8;XPO1;PROC;LGR4;SKP1;BCL9;AKT1;GNG10;KMT2D;PPP2R5B;AP2B1;YWHAZ;H2AC14;CUL1;H2AZ2;DAAM1;PSMD11;PSMB7;GNG5;SMURF2;NRAS;SNX3;CCDC88C;EP300;LRP6;PSMB4;TRRAP;TMED5;PSMD8;CTBP1;USP34;H2AC6;PSMB10;PSMB5;CSNK2A2;AP2M1;RUNX3;ITPR1;ASH2L;H2BC13;AMER1;PLCB2;CSNK1E;TLE5;SEM1;H2BC3;VPS26A;PSMD6
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.2451567432822318,-0.9870849025579572,0.41818181818181815,0.9958083261788767,1.0,5/29,9.65%,AKT1;ING5;EP300;CHD4;GATAD2A
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.1926699782038591,-0.9863547358851346,0.5087719298245614,0.9960711757144112,1.0,36/103,27.32%,AKT1;PRKCD;PIK3CA;MAP2K7;NRAS;FASLG;BAD;SHC4;MAPK1;CRK;CALML4;FRS2;PIK3R1;IRAK1;TRAF6;MATK;CAMK4;ZNF274;RAP1A;ATF4;MAP3K3;PLCG2;CALM3;MAPK8;MAPK9;HRAS;MAP2K5;MAPK7;MAPK14;CDC42;ARHGDIA;IRAK4;GAB1;MAPKAPK2;SH2B1;FOXO3
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.18465146255502293,0.9856231880204225,0.47368421052631576,1.0,1.0,10/110,4.54%,PLCB4;GNA12;S1PR2;NSMAF;SPTLC2;PPP2R5D;PPP2R2D;MAP3K5;PPP2R5E;GNAI1
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.1856784680926867,0.9855898485221872,0.4864864864864865,1.0,1.0,20/107,13.84%,H2BC11;ORC3;CDC6;ANAPC11;H2BC15;CDC16;PSMD7;PSMA5;UBA52;H2BC5;H3-3B;ANAPC15;H2AC7;MCM7;PSMF1;RPS27A;H4C15;PSMA3;H2BC14;H3C13
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,-0.23561096672152054,-0.9843556264033806,0.45161290322580644,0.9998815128384883,1.0,7/41,9.46%,CCL28;IL6;LTBR;IL15;IL15RA;CCR10;TNFSF13B
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.26851405061294015,-0.9834715144063272,0.4745762711864407,1.0,1.0,7/23,15.94%,TNFSF14;FASLG;TNFSF13B;TNFRSF9;TNFSF9;TNFRSF4;TNFSF4
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.24187882879375996,0.9826277657175914,0.5333333333333333,1.0,1.0,4/34,5.51%,SH3RF1;USP9X;VANGL1;PARD6B
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.27942434017325857,-0.9825397905425678,0.43333333333333335,1.0,1.0,5/19,18.72%,UBB;UBE2N;RIPK3;TRAF6;UBE2D1
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.27909694681012465,-0.9819620077747505,0.4852941176470588,1.0,1.0,10/21,33.19%,GNG10;GNG5;DLG1;PLCB2;GNG3;GNB4;GNG8;GNG7;LLGL1;PLCB3
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.26962493847597835,-0.9817986502276972,0.4727272727272727,0.9982438279116704,1.0,6/22,21.45%,PRKCD;TRPC6;PRKCH;ITPR1;ABHD12;DGKQ
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.18443271400803452,-0.9816767609037611,0.5,0.9961073396220178,1.0,32/102,26.42%,UBB;CREB1;MAP3K8;SKP1;DUSP6;MAPKAPK3;CUL1;MAP2K7;UBE2N;ALPK1;MAPK1;S100A12;TMED7-TICAM2;FOS;FBXW11;IRAK1;TRAF6;DUSP7;MAP2K4;PPP2CA;TANK;MAP2K3;PPP2R1A;MAPK8;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;MAPKAPK2;UBC
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.24646067155712026,0.9811989905666006,0.4594594594594595,1.0,1.0,10/30,19.16%,THBS1;TGFB1;NRXN1;DMD;TRAPPC4;HSPG2;ITGAV;AGRN;LAMB3;LMNB2
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.2565609925781677,-0.9811353220776368,0.45454545454545453,0.9955704057523276,1.0,13/34,20.43%,PLOD3;POFUT1;LFNG;GALNT2;B4GALT3;B4GALT1;POGLUT1;GALNT11;OGT;C1GALT1;COLGALT2;COLGALT1;POMT2
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.21108611552118656,0.9808588881861904,0.4634146341463415,1.0,1.0,8/43,12.48%,SMPD3;NSMAF;SPPL2A;UBA52;CFLAR;TAB3;FADD;RPS27A
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.1826106638193825,0.9803794380520316,0.5192307692307693,1.0,1.0,19/96,13.36%,RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UBA52;EIF3C;RPS19;FAU;EIF1AX;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.24526465714848839,-0.9803520974871671,0.4918032786885246,0.9954587893766428,1.0,9/33,18.58%,NRAS;RNASE3;KSR1;MAPK1;LAMTOR2;CNKSR2;WDR83;RAP1A;IL17RD
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,-0.2744088361528207,-0.9794086083167991,0.5283018867924528,0.9958747032879403,1.0,6/20,24.07%,PIK3CA;NRAS;PIK3R1;ERBIN;HRAS;HBEGF
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,-0.29123916003797884,-0.9793974025101323,0.5263157894736842,0.9933974030310051,1.0,6/19,22.92%,PIK3CA;NRAS;PIK3R1;STAT5A;STAT5B;HRAS
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,-0.24558201311765152,-0.9787795773404622,0.4098360655737705,0.9930036125239745,1.0,10/31,24.31%,PIK3CA;CLEC1B;PIK3R5;PRKCZ;PIK3R1;SPNS1;LCP2;VAV2;PLCG2;CDC42
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,-0.2322681717190741,-0.9787590248847764,0.5283018867924528,0.9905718358113321,1.0,6/33,13.20%,MAP3K8;AKT1;PIK3CA;MAPKAP1;PIK3R1;PKN1
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,0.24629470360205147,0.9786179374143654,0.4878048780487805,1.0,1.0,5/25,12.54%,NKIRAS2;MAVS;TRIM4;RNF135;RELA
prerank,KEGG_2021_Human__Basal transcription factors,-0.22780358762276917,-0.9756308119437117,0.4727272727272727,0.9986135347051399,1.0,11/41,24.31%,GTF2A1;GTF2H3;GTF2E1;TAF10;TAF5L;TAF8;TBPL1;TAF1;TBPL2;GTF2A2;TAF3
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.18328557923560115,-0.9746672116903164,0.55,0.9994849916120303,1.0,38/110,31.16%,SCAP;DHCR7;RAN;SREBF1;NSDHL;CYP27A1;LIN9;MBTPS2;INSIG2;AKR1C3;TBL1X;HSD17B4;PIAS4;ARV1;SCD;ABCC3;SEC24A;AKR1B1;SH3D19;LMBR1;LDLRAP1;OSBPL3;PMVK;SC5D;HSD17B12;TBL1XR1;GGPS1;AKR1B15;SYCP2;SRD5A1;OSBPL1A;TSPO;CUBN;SLCO1A2;SEC24C;UBE2I;STARD3NL;ACOX2
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.19696618068397992,-0.9746025102225384,0.4406779661016949,0.9975224992289837,1.0,37/100,29.81%,LPCAT2;DGAT1;LPIN1;PGS1;MBOAT2;CHPT1;DDHD1;PNPLA2;ABHD3;CEPT1;TMEM86B;PCYT1A;CHKB;MIGA1;PTPMT1;HADHA;CSNK2A2;PEMT;CPNE1;PLD4;STARD7;DDHD2;LPCAT3;MBOAT1;AGK;PNPLA8;PITPNM2;LPIN2;PITPNB;LPGAT1;SH2D3C;PLD6;PLAAT2;MFSD2A;LIPH;PTDSS1;MIGA2
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.24298323811920558,0.9742757914089857,0.4411764705882353,1.0,1.0,7/25,15.99%,RFC3;RFC5;CHTF8;POT1;POLA1;TINF2;SLC19A1
prerank,KEGG_2021_Human__Breast cancer,-0.19250088573521018,-0.9738306332659791,0.5094339622641509,0.997693149677587,1.0,14/94,12.58%,HEY1;AKT1;PIK3CA;FGFR1;NRAS;SHC4;JAG1;E2F3;RPS6KB1;LRP6;MAPK1;CDK6;FOS;PIK3R1
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.16983500884378047,0.9736362653777534,0.5,1.0,1.0,23/143,11.88%,C3AR1;CXCL8;S1PR2;CCR9;FFAR3;P2RY6;PPAN-P2RY11;HEBP1;CCR7;GPER1;LTB4R2;OPN3;ADORA2A;C5AR1;PPBP;MC1R;INSL3;XCL1;PTGDR2;OXER1;C5AR2;PNOC;CCL3
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.193161127037861,0.9728127881143919,0.5319148936170213,1.0,1.0,24/79,24.83%,IFITM1;INPPL1;BCL10;NFKBIE;CD19;RAC3;PPP3CB;RELA;MAPK3;VAV3;PPP3CA;CD79B;RAC1;RAC2;SOS1;CD72;LILRB5;IKBKG;NFKBIA;KRAS;NFATC3;LILRB4;PIK3CB;NFKBIB
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,-0.1861064924762193,-0.9726497750610207,0.46296296296296297,0.9989996309482576,1.0,38/100,30.74%,NCOR2;AGXT;ACSL1;SREBF1;SLC27A1;MED24;MED9;LIN9;EP300;TBL1X;MED18;MIA3;MED6;NCOR1;PLIN2;NRF1;PPARGC1B;MED16;G0S2;ABCB4;CCNC;MED30;GRHL1;MED20;TBL1XR1;GPS2;NCOA3;MED17;CLOCK;MED25;TRIB3;MED28;MED7;MED14;MED13L;MED12;MED29;MED15
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.3021375606421797,0.9726213032460804,0.5263157894736842,1.0,1.0,4/15,11.86%,SIKE1;MAVS;TRIM4;RNF135
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.16944888506037886,-0.9721693172372105,0.5357142857142857,0.9979288720744098,1.0,79/256,26.56%,CREB1;ACSS2;ATP5F1E;CEP63;CRTC2;CCT4;RAB11A;HAUS8;AHI1;MICOS13;ALMS1;LIN9;ARL13B;MTX1;IFT22;ACTR1A;CNTRL;TBL1X;DNAJC11;TNPO1;MEF2D;ARF4;CETN2;EXOC2;AKAP9;ASAP1;C2CD3;NCOR1;SIRT3;NRF1;TFAM;NEDD1;WDR19;MKS1;IFT122;CEP192;CEP290;POLRMT;PPARGC1B;BBS5;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;CEP89;B9D2;TFB2M;ATP5PO;KIF3A;TUBA1A;CEP76;CAMK4;SMOX;DYNLT2B;IDH2;DYNC2H1;CEP164;PRKAG2;B9D1;CEP70;SDCCAG8;HAUS2;MAPRE1;ARL3;PPP2R1A;TBL1XR1;PRKAG1;MAPK14;IMMT;ATP5PB;ATP5MC2;CEP78;PAFAH1B1;WDR35;HDAC6;ODF2;CCT8;DYNC2I2
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.2206962295733451,0.9717528043025312,0.5217391304347826,1.0,1.0,14/49,17.70%,RPS20;RPS15;RPS25;EIF3C;RPS19;FAU;EIF1AX;RPS10;RPS21;RPS27A;RPS28;EIF2S2;RPS23;EIF3E
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.19222007895009055,0.9714761673443719,0.4878048780487805,1.0,1.0,19/69,22.79%,NUS1;ST8SIA1;ALG8;MVD;ST8SIA6;ST6GALNAC4;SLC35A1;NAGK;ST6GALNAC2;SLPI;PMM1;ST3GAL6;DOLK;DPAGT1;ALG3;GLB1;ALG2;ST3GAL1;ALG14
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.19716118808291316,0.97106977556714,0.47368421052631576,1.0,1.0,11/75,11.46%,INPPL1;PNPLA7;PI4KA;GDPD3;INPP5E;PIK3CG;MTM1;PIK3R4;PLEKHA3;RAB5A;SYNJ2
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.29058525965470505,0.9710354068366763,0.4897959183673469,1.0,1.0,6/20,15.71%,PLB1;BCO2;APOE;HSPG2;AGRN;AKR1C1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.1897008710296938,-0.970990427847879,0.5,0.999562620943804,1.0,21/103,16.60%,MTHFD1;PROC;AMN;NADK2;MTHFR;NT5E;THTPA;LMBRD1;PARP4;GSTO1;NAXD;DHFR;ST20-MTHFS;PCCA;ENPP1;QPRT;NMNAT1;PARP6;MMUT;MTHFD2;SLC52A2
prerank,KEGG_2021_Human__Glutamatergic synapse,0.19923753559442564,0.9702651018120793,0.5217391304347826,1.0,1.0,21/65,23.34%,PLCB4;GNAI1;GNB5;ADCY3;PLD1;GRK3;PPP3CB;PRKACA;MAPK3;GLUL;GNG4;GRK2;PPP3CA;GNAO1;GNAI3;GNG11;CACNA1A;ADCY9;GNGT2;PLD2;ADCY7
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.1981604003052017,-0.9700069396996891,0.5555555555555556,1.0,1.0,28/85,29.13%,UBB;SKP1;FBXO5;CUL1;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;PLK1;SEM1;PSMD6;UBE2D1;AURKA;PSMD9;PSMA6;PSMA4;PTTG1;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,0.24852618162954337,0.9698863399025155,0.5121951219512195,1.0,1.0,11/37,21.13%,XRCC1;UNG;RFC3;RFC5;PARP2;OGG1;SLC19A1;TDG;NTHL1;POLR1A;POLE2
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.17386939739046134,0.9695969844581084,0.5238095238095238,1.0,1.0,29/159,14.67%,ABL2;VRK2;YKT6;CYBB;ARHGDIB;CDC42EP4;ARHGEF11;VANGL1;WASF3;FMNL1;ARHGEF4;ARHGAP35;CYFIP2;TAOK3;ABI1;BAIAP2;PREX1;ALS2;ARHGEF18;DOCK10;PRKCSH;PLEKHG3;ECT2;ARHGEF10;BRK1;ARHGAP21;DOCK6;ARAP3;DOCK8
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,-0.2815403162731445,-0.9695547437663256,0.5245901639344263,1.0,1.0,5/23,10.17%,GNG10;GNG5;KCNJ2;ADCY4;KCNJ15
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.21586123729998713,-0.9692718711604438,0.5862068965517241,0.9983169204173037,1.0,19/57,24.19%,ANO9;CLCN6;UBB;TRPM7;RNASE3;TRPC6;MCOLN2;BEST1;RYR3;SLC9B1;ANO10;ANO5;TSC22D3;MCOLN1;SCNN1A;RYR1;CLCN5;SRI;FKBP1B
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.187473909610778,-0.9692702896630043,0.49056603773584906,0.9959113374765391,1.0,15/93,14.47%,PAK1;IL6;AKT1;PRKCD;PIK3CA;RRAS2;NRAS;CLEC1B;MRAS;KSR1;MAPK1;CALML4;PIK3R1;CLEC4M;ITPR1
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.19977284753708296,-0.9689866493390215,0.5223880597014925,0.9942030822341521,1.0,26/78,29.13%,UBB;SKP1;FBXO5;CUL1;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;PLK1;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.2150888534497336,-0.9687511886417466,0.5,0.9927817347549915,1.0,18/45,30.12%,POLR2I;TERF1;H2AC14;H2AZ2;POLR2D;POLR2A;H2AC6;H2BC13;H2BC3;POLR2E;H2BC12;H2BC4;TERF2;H2AX;H2AB1;POLR2L;H2AC19;POLR2F
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.18286350666252982,-0.9675047461243345,0.5576923076923077,0.9945521004160895,1.0,35/89,33.11%,AKT1;PRKCD;MAPKAPK3;PIK3CA;NCF2;NRP2;JUP;NRAS;CRK;MAPKAP1;PRKCZ;PIK3R1;PKN1;ITPR1;WASF1;NRP1;SPHK1;VAV2;NCK2;PKN2;HRAS;VEGFA;MAPK14;HSPB1;CDC42;MAPKAPK2;TRIB3;AHCYL1;FLT1;SH2D2A;NCF4;ELMO1;RHOA;SRC;ITPR3
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2018224176094734,-0.9672829949564162,0.5254237288135594,0.9929097536319852,1.0,43/90,37.67%,NUP37;XPO1;PPP2R5B;ITGB3BP;CENPN;NUDC;KIF18A;CLASP2;CENPU;ZW10;MAD1L1;ZWINT;CENPM;PLK1;RCC2;B9D2;PPP2CA;PMF1-BGLAP;RPS27;CENPA;MAPRE1;PPP2R1A;SGO1;PPP2R1B;NUP43;CENPH;PAFAH1B1;NUP85;NUP107;CENPE;KIF2A;KNTC1;CKAP5;DYNC1H1;SKA2;CENPL;MIS12;CENPQ;NUP160;PPP2CB;SEH1L;ZWILCH;CLASP1
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.3202127838086934,0.9671765372765196,0.4634146341463415,1.0,1.0,3/17,3.80%,FRAT1;PPP2R5D;PPP2R5E
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,0.22770732825202855,0.9670789774143423,0.4666666666666667,1.0,1.0,9/40,13.84%,H2BC11;H2BC15;MCPH1;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.1979857112525606,0.9664166516533892,0.6341463414634146,1.0,1.0,7/63,6.44%,PPIE;XRCC1;USP7;RFC3;RFC5;DDB1;UBA52
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.22817001563599343,-0.9661939680369425,0.532258064516129,0.9947216976050681,1.0,22/54,29.13%,UBB;PSMD11;PSMB7;SMURF2;EP300;PSMB4;PSMD8;PSMB10;PSMB5;RUNX3;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;CBFB;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.2307556848039248,-0.9660606860171779,0.47058823529411764,0.9928106835278486,1.0,12/35,26.33%,NUP37;XPO1;RAN;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.17882053465892858,0.9658977352178181,0.5135135135135135,1.0,1.0,11/113,5.76%,PLCB4;CXCL8;GNA12;DNM1;TSC1;PLPP1;MTOR;PDGFD;PIK3CG;RALA;ADCY3
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.21670765484322613,-0.9656986685817615,0.4807692307692308,0.9917349635465926,1.0,21/46,36.91%,POLR2I;NUP37;POLR2D;POLR2A;NUP88;NUP93;POLR2E;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;POLR2L;POLR2F;NUP214;GTF2F1;NUP160;SEH1L;AAAS
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.24100248895294513,0.9653140235936353,0.5,1.0,1.0,4/28,8.11%,ATP6V0B;CYBB;TCIRG1;ATP6V1F
prerank,KEGG_2021_Human__Lysosome,-0.1775689878711996,-0.9644668686070604,0.47619047619047616,0.9931371813454516,1.0,24/120,16.06%,CLTCL1;CTSG;CTNS;CTSS;AP1S1;MANBA;PSAP;GAA;M6PR;GGA3;ATP6V0A1;SCARB2;TPP1;NAGPA;GLA;IGF2R;HGSNAT;AP1G2;SLC11A1;GALNS;NAPSA;HEXA;GNPTAB;FUCA1
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,-0.15606883965494953,-0.9641036257703057,0.5172413793103449,0.9918913297553039,1.0,86/294,26.33%,NUP37;NDUFS2;ALYREF;HNRNPA3;NDUFS7;ATP5F1E;NDUFB7;COX7B;DNAL4;PSMD11;PSMB7;KIF5C;CASP3;SDHC;NDUFB3;COX6A1;SDHD;EIF2S1;BAD;VAPB;RAB39B;ACTR1A;ADRM1;NXF1;TOMM40;CCS;NDUFC1;PSMB4;NEFL;KLC1;NDUFA8;UQCRHL;PSMD8;NUP88;DDIT3;APAF1;NDUFS3;NUP93;HNRNPA1;PSMB5;TUBB6;NEFH;PFN2;SPG11;NDUFAB1;WDR41;ANXA7;TUBB4B;ATP5PO;SEM1;PSMD6;TUBA1A;ATF4;KIF5B;PSMD9;KIF5A;NDUFA12;HNRNPA1L2;TANK;CHCHD10;MAP2K3;NUP35;SDHB;TNFRSF1A;NDUFC2;NUP54;PSMA6;NDUFB6;ACTB;PSMA4;PSMD13;MAPK14;NDUFB8;NDUFA9;NDUFC2-KCTD14;ATP5PB;BECN1;NDUFA2;NUP43;ATP5MC2;PSMC1;PSMD3;NDC1;HDAC6;NUP85;NUP107
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.20767823703664715,0.9625053993857503,0.5945945945945946,1.0,1.0,11/64,10.95%,PDE2A;PPP2R5D;P2RX1;PPP2R5E;GNB5;KCNMB4;P2RX4;PDE10A;FGR;PTPN11;KCNMA1
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.205621645443041,-0.9619401648202218,0.5172413793103449,0.9973886054362899,1.0,24/79,20.66%,POLR2I;KMT2D;H2AC14;H2AZ2;PBX1;POLR2D;CNOT6;EP300;ZNF335;POLR2A;NCOR1;H2AC6;PKNOX1;ASH2L;H2BC13;EED;H2BC3;POLR2E;PAGR1;HOXB2;H2BC12;RARB;CTCF;HOXB3
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.27504846027498225,-0.9615495145128842,0.4838709677419355,0.9964362517956412,1.0,15/23,48.11%,GNG10;GNG5;ADCY4;GNG3;GNB4;GNG8;GNG7;PRKAR1A;PRKAR2B;PRKAR2A;GNG2;GNAS;CYSLTR2;GNB2;GNB1
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.26599280589946367,0.9605209855826878,0.6052631578947368,1.0,1.0,6/19,20.18%,DNA2;BLM;POT1;TINF2;WRN;POLR1A
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,-0.2162566764210862,-0.9593306537187299,0.5185185185185185,1.0,1.0,20/60,25.55%,PAK1;ATP6V1E1;CASP3;CXCR1;ATP6V0A1;JAM3;ATP6V1D;GIT1;CXCR2;ATP6V1E2;MAP2K4;ATP6AP1;PLCG2;MAPK8;MAPK9;F11R;MAPK14;HBEGF;CDC42;ATP6V0C
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.24264931555751856,0.9591563180274174,0.5405405405405406,1.0,1.0,6/27,15.66%,CTSL;UVRAG;HAVCR1;PIK3R4;HSPG2;AGRN
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.16959814024524336,-0.9590885867183935,0.5964912280701754,0.9994328216262509,1.0,46/151,25.17%,UBB;CREB1;MAP3K8;SKP1;ITGAM;CTSS;DUSP6;MAPKAPK3;CUL1;HSP90B1;MAP2K7;UBE2N;ALPK1;RIPK3;MAPK1;TLR10;S100A12;TMED7-TICAM2;TLR1;FOS;FBXW11;IRAK1;TRAF6;DUSP7;TLR2;MAP2K4;DNM3;PPP2CA;UBE2D1;TLR5;TANK;TRAF3;S100A9;MAP2K3;PLCG2;CTSB;PPP2R1A;MAPK8;DNM2;MAPK9;MAPK7;MAPK14;PPP2R1B;NDUFA2;IRAK4;ITGB2
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,-0.1846442370372288,-0.958336585314371,0.49206349206349204,0.999787697210317,1.0,50/115,32.67%,ANO9;CLCN6;UBB;TRPM7;ATP6V1E1;ATP10D;ATP11A;ATP6V0A1;RNASE3;TRPC6;ATP6V1D;MCOLN2;BEST1;RYR3;ATP2A1;ATP1A3;ATP6V1E2;ATP1B2;FXYD2;SLC9B1;ATP8B2;ANO10;ANO5;TSC22D3;ATP2A2;ATP6AP1;MCOLN1;SCNN1A;RYR1;ATP9A;CLCN5;SRI;FKBP1B;ATP7A;ATP6V0C;ATP1B3;UBC;ATP2A3;ATP13A1;ATP9B;NEDD4L;ATP11C;OSTM1;ATP8B4;ATP6V1C1;TRPC1;TTYH3;CAMK2G;ATP6V0D1;ATP6V0A2
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.21568003792463677,0.957650151838055,0.5277777777777778,1.0,1.0,15/51,24.83%,CXCL8;SIKE1;ATG5;MAVS;IL12A;FADD;RELA;ISG15;MAPK13;MAPK11;IKBKG;TNF;NFKBIA;CYLD;NFKBIB
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,-0.21173315270801701,-0.9573597397265426,0.5087719298245614,1.0,1.0,18/60,23.17%,CACNG8;CACNG6;IL6;ITGA10;ITGB5;CACNA2D3;DAG1;SGCB;TNNC1;ATP2A1;ITGB8;ITGA1;ATP2A2;PRKAG2;ITGB1;TPM1;ACTB;PRKAG1
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,0.288410503648228,0.9572100895340119,0.4782608695652174,1.0,1.0,14/15,58.02%,EXO1;MLH1;POLR1A;MSH3;POLD3;POLR1B;PMS2;PCNA;LRIG1;RPA3;POLD4;POLD1;MSH6;MSH2
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.1835539769065151,-0.9559942459764338,0.5087719298245614,1.0,1.0,29/106,21.57%,EIF4A1;RPS24;RPS15A;RPL38;RPL26;EIF2S1;RPL23A;RPS3A;RPL26L1;RPL8;RPL15;RPS3;RPL36A;RPL32;RPL7;EIF4E;EIF3A;RPL19;RPL22;RPL18A;RPL5;RPL21;RPS2;EIF3F;RPSA;RPL36AL;RPS27;EIF4B;EIF4H
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.22364314436598093,-0.955809635273677,0.5172413793103449,1.0,1.0,5/43,5.67%,KHDRBS2;UBB;AKT1;NRAS;PTK6
prerank,KEGG_2021_Human__Viral myocarditis,0.22013822417477633,0.9556316969594455,0.5263157894736842,1.0,1.0,12/52,19.18%,ABL2;EIF4G2;SGCA;CYCS;RAC3;CD40LG;DMD;ABL1;HLA-DOB;ICAM1;RAC1;RAC2
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.223496594718391,-0.9552576900452302,0.6271186440677966,1.0,1.0,18/54,25.29%,OAZ1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;SMOX;PSMD9;SLC25A21;NQO1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.17491588553962192,-0.955199372016683,0.5,0.9985187386699115,1.0,32/134,20.42%,POLR2I;NUP37;PARP1;RPS24;RPS15A;RPL38;RPL26;RPL23A;POLR2D;RPS3A;RPL26L1;POLR2A;RPL8;RPL15;RPS3;NUP88;RPL36A;NUP93;RPL32;RPL7;RPL19;RPL22;RPL18A;RPL5;DNAJC3;RPL21;RPS2;POLR2E;RPSA;RPL36AL;RPS27;NUP35
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,0.23281453299785018,0.954759344076212,0.5952380952380952,1.0,1.0,11/39,16.43%,H2BC11;UNG;H2BC15;H2BC5;OGG1;POT1;H2AC7;H4C15;H2BC14;TINF2;TDG
prerank,KEGG_2021_Human__GABAergic synapse,0.20934401209439135,0.9544022115644689,0.6,1.0,1.0,18/53,23.34%,GNAI1;GNB5;ADCY3;GABARAPL2;PLCL1;PRKACA;HAP1;GABRG2;GLUL;GNG4;GNAO1;GNAI3;GNG11;CACNA1A;GABRP;ADCY9;GNGT2;ADCY7
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.19661577698956106,0.9540590143077903,0.5581395348837209,1.0,1.0,24/84,20.49%,SQSTM1;ARHGEF11;RTN4;ARHGEF4;HDAC3;UBA52;MAGED1;PSEN2;PREX1;ARHGEF18;MYD88;RPS27A;RELA;PRDM4;ECT2;ARHGEF10;ADAM17;BCL2L11;VAV3;ARHGEF12;SOS1;FGD4;ARHGEF9;RNASE1
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,0.2604006725439333,0.9539187519018998,0.4473684210526316,1.0,1.0,4/22,10.01%,SEC61B;PRNP;SERP1;GET3
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.1965473065613487,-0.9536741728574816,0.49122807017543857,1.0,1.0,12/78,12.58%,CREB1;AKT1;CLSTN1;PIK3CA;FGFR1;TGFA;BAD;TSC2;RNMT;MAPKAP1;FRS2;PIK3R1
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,0.22499526590099705,0.9531126197975753,0.52,1.0,1.0,3/30,1.80%,MGST2;GSTM1;MGST1
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.1569512637683264,-0.9529780414132085,0.6166666666666667,1.0,1.0,107/386,24.71%,VAMP3;ARHGAP17;ARHGAP42;COPS2;FLOT2;MPP7;CDC42BPB;LMAN1;BCAP31;PIK3CA;SLK;RRAS2;STBD1;NCF2;DAAM1;BASP1;RHPN2;JUP;ARHGAP24;SPATA13;ANLN;ARL13B;JAG1;MTX1;VAPB;REPS1;TRA2B;NUDC;TNFAIP1;ARHGAP6;KALRN;SH3PXD2A;FAM91A1;RHOBTB1;EPSTI1;CDC42EP1;RHOH;KCTD3;GIT1;ARHGAP45;RHOQ;TRIP10;FRS2;SRGAP2;NDUFS3;ARHGAP15;PIK3R1;NSFL1C;FAM13A;PKN1;AKAP13;ARHGAP33;DOCK5;WWP2;CAPZB;RACGAP1;CCP110;CDC42EP2;DDRGK1;PLEKHG5;WASF1;WIPF1;FARP1;SPTBN1;GOLGA8R;CCDC88A;NOXA1;PRPF38B;GMIP;ARHGEF40;VAV2;ATP6AP1;DSG2;ARHGAP10;AKAP12;NCK2;HOMER2;BAIAP2L1;LEMD3;FERMT2;ARHGEF15;ERBIN;PKN2;WASL;ITGB1;RHPN1;ZNF512B;SNAP23;DLC1;ARHGEF39;FAM13B;PRAG1;AMIGO2;ARHGAP32;ARHGEF19;HGS;WIPF2;TRIO;NCOA3;ARHGAP1;SEMA4F;CCT7;CDC42SE2;CDC42;STIP1;ARHGDIA;ARHGAP26
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.16240929852738847,-0.9525043843561678,0.6101694915254238,1.0,1.0,22/175,8.57%,CCL28;CCR8;CREB1;RGS12;LPAR2;GNG10;PDE1B;PRKCD;AGXT;HCAR1;GNG5;PCDHA4;SSTR2;CXCR1;NBEA;S1PR4;CXCR3;CNOT6;TAS2R5;RGS6;ADCY4;MAPK1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.21149889925964555,-0.9522523536930013,0.5079365079365079,0.998494171130444,1.0,10/55,11.82%,CLCN6;NRAS;RNASE3;TENT4A;KSR1;MAPK1;TRIM24;MPRIP;AKAP9;AGGF1
prerank,KEGG_2021_Human__Cardiac muscle contraction,-0.20736673598394878,-0.9522172589809303,0.6037735849056604,0.9963400365790811,1.0,11/55,16.15%,CACNG8;CACNG6;COX7B;COX6A1;CACNA2D3;UQCRHL;TNNC1;ATP2A1;ATP1A3;ATP1B2;FXYD2
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.1852588683280653,0.9521714280070908,0.5319148936170213,1.0,1.0,19/90,14.41%,RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UPF1;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.17329543581441703,-0.95209554070882,0.5961538461538461,0.9945078655211642,1.0,38/153,22.24%,POLR2I;NUP37;PARP1;RPS24;XPO1;RAN;RPS15A;RPL38;RPL26;RPL23A;POLR2D;RPS3A;EIF2AK2;RPL26L1;POLR2A;RPL8;RPL15;RPS3;NUP88;RPL36A;NUP93;RPL32;RPL7;RPL19;RPL22;RPL18A;RPL5;DNAJC3;RPL21;RPS2;POLR2E;RPSA;RPL36AL;RPS27;NUP35;CALR;NUP54;NUP42
prerank,Reactome_2022__S Phase R-HSA-69242,0.16870829570961599,0.9517919064875342,0.5555555555555556,1.0,1.0,28/158,16.16%,CDC25B;WAPL;ORC3;DNA2;CDC6;ANAPC11;CDC16;RFC3;RFC5;PSMD7;PSMA5;UBA52;E2F5;GINS4;SMC1A;ANAPC15;CDK4;MCM7;PSMF1;RPS27A;MAX;CCNH;PSMA3;TFDP2;POLA1;SLC19A1;CDKN1B;PSMB2
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.2864534209478596,-0.9515763780408065,0.5483870967741935,0.9938579836975349,1.0,3/20,4.37%,GNG10;SCT;GNG5
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,0.2458929678474256,0.950154881156075,0.5348837209302325,1.0,1.0,5/24,12.48%,ANAPC11;CDC16;UBA52;ANAPC15;RPS27A
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.23494636285352477,-0.948506081724268,0.5737704918032787,1.0,1.0,12/25,33.94%,ATOX1;NCF2;CCS;PRDX2;PRDX3;GSTP1;PRDX5;ATP7A;NCF4;NUDT2;GPX1;PRDX1
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.1961649242783528,-0.9481948506146224,0.5869565217391305,0.9991259400513124,1.0,14/83,13.08%,EXOSC2;KLHDC3;PPP2R5B;EXTL3;HSP90B1;ASNS;EIF2S1;MBTPS2;EXOSC9;TATDN2;EXOSC6;EXOSC4;DDIT3;MYDGF
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.21568538287873928,-0.9480891911909008,0.5263157894736842,0.99706603154879,1.0,19/49,28.92%,PIGS;MELTF;PIGL;PRSS21;PIGO;LYPD2;DPM1;PIGW;PIGQ;PGAP1;PIGV;PLAUR;PIGC;ALPL;PIGM;NEGR1;VNN1;LYPD3;DPM2
prerank,KEGG_2021_Human__Leishmaniasis,0.19731022820159033,0.9473627887877136,0.5909090909090909,1.0,1.0,22/71,22.90%,ITGA4;CYBB;CR1L;IL10;IL12A;TGFB1;MYD88;FCGR2C;RELA;MARCKSL1;FCGR1A;MAPK3;HLA-DOB;STAT1;JAK2;MAPK13;MAPK11;FCGR3A;TLR4;TNF;NFKBIA;PTGS2
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.23117222996251222,0.9467476357311654,0.47058823529411764,1.0,1.0,11/28,25.24%,APBA3;NRXN2;LIN7A;PDLIM5;NRXN1;LRRTM4;STXBP1;LIN7B;EPB41;LIN7C;NLGN2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,0.18261147016549564,0.9465383011118809,0.5952380952380952,1.0,1.0,9/71,9.26%,THOC7;SRSF5;CDC40;GLE1;NUP58;POM121;SRSF7;FYTTD1;POLDIP3
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.22710560189738122,-0.946292795351159,0.5294117647058824,1.0,1.0,9/38,18.39%,FES;PIK3CA;NRAS;GRB10;PIK3R1;STAT5A;FER;CBL;STAT5B
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.21527854615240055,-0.945812329771048,0.5666666666666667,0.9996545572900402,1.0,14/63,18.10%,CREB1;IL6;GNG10;HRH2;SCT;GNG5;GPR15;ADCY4;PRKX;ADRB2;ADORA2B;ADM;RAMP1;PTGER2
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.15428761532538982,0.9456103479024687,0.6285714285714286,1.0,1.0,27/259,8.08%,CDC25C;RAD9B;H2BC11;ORC3;DNA2;CDC6;BIRC5;ANAPC11;H2BC15;RBBP8;PPP2R5D;CDC16;PPP2R5E;RFC3;ZNF385A;SKA1;RFC5;PSMD7;SGO2;PSMA5;UBA52;H2BC5;EXO1;CHEK2;BLM;CENPO;CARD16
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.17689706183240358,0.9452880474525509,0.6190476190476191,1.0,1.0,20/106,13.36%,SEC61B;RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;SPCS3;DDOST;RPS27A;RPL37A;RSL24D1;RPL39;RPS28
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.28929256615526416,0.9446663347933347,0.5106382978723404,1.0,1.0,7/16,19.64%,CDH8;CDH13;PVR;ANG;CDH15;CTNNA1;FZR1
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.19698548544394817,0.9446410474164415,0.6666666666666666,1.0,1.0,10/73,10.23%,ATP6V0B;CTSL;CXCL8;CSF1;TCIRG1;ACP5;ATP6V1F;ANGPT1;TGFB1;CTLA4
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.15407520980044082,-0.9444907009509449,0.65,1.0,1.0,108/341,29.70%,VAMP3;KLHL25;ELOC;UBB;UBA1;GLMN;FBXO44;SKP1;TRAIP;UBAC1;DET1;CTSS;UBE2M;SPSB1;NCF2;CUL1;PSMD11;PSMB7;UBE2N;SMURF2;RNF213;KLHL5;ITGB5;FBXL20;UBA5;ANAPC7;UBE2J1;RLIM;HERC5;FBXW2;PSMB4;MGRN1;ARIH2;ZNRF1;RNF41;SEC61A2;PSMD8;UBE2Q1;TLR1;ASB8;SEC14L2;PSMB10;PSMB5;ANAPC5;FBXW11;RNF4;UBE2G1;TLR2;RNF138;HERC6;UBE2W;RNF144B;UBE2Z;FBXO4;FBXO15;RNF217;SEC24A;UBE2O;SEM1;TRIM41;PSMD6;THOP1;KBTBD6;STX4;UBE2D1;ASB13;PSMD9;S100A9;FBXW4;KBTBD7;CALR;SNAP23;NEDD4;UBE3A;PSMA6;ANAPC13;KLHL9;MIB2;PSMA4;PSMD13;KLHL3;BECN1;NDUFA2;PSMC1;SIAH1;PSMD3;HERC1;CUL3;UBC;UBE2A;RNF123;FBXL19;CUL2;NEDD4L;RBBP6;PRKN;TRIM32;FBXO31;FBXL15;PSMA2;BTBD1;ATG7;SEC24C;PSMA7;RNF126;TRIM37;RNF111;LTN1
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.23214067268347247,-0.9438990972407426,0.5272727272727272,1.0,1.0,12/34,22.70%,FUT1;SLC33A1;B3GALT2;ABO;B4GALT3;GLA;B4GALT1;HEXA;GBGT1;B3GALNT1;A4GALT;ST3GAL5
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,-0.19713878753232195,-0.9437678964054321,0.5789473684210527,0.9996348770285228,1.0,22/65,25.67%,VAMP3;MPP7;LMAN1;STBD1;VAPB;KALRN;CDC42EP1;NDUFS3;PIK3R1;DOCK5;VAV2;DSG2;LEMD3;ERBIN;PKN2;ITGB1;ARHGAP32;TRIO;ARHGAP1;CDC42;ARHGDIA;ARHGAP5
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.19823598433038514,0.9436064766446036,0.5609756097560976,1.0,1.0,9/76,8.53%,PLCB4;GNA12;ARHGEF11;GCM1;GNAI1;ADCY3;PLD1;MAFB;MEF2A
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.20077680637497883,0.9432904976641888,0.5111111111111111,1.0,1.0,19/61,22.15%,CAPN3;CTSL;TIMP2;COL9A1;MMP9;COL9A3;MMP28;COL13A1;ADAM9;KLK2;HSPG2;ADAM17;LAMB3;PLG;COL9A2;FZR1;MMP8;COL17A1;DCN
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.24732395901732004,-0.9431883326073836,0.48214285714285715,0.9991979158947891,1.0,7/31,11.78%,EXOSC2;ASNS;EIF2S1;EXOSC9;EXOSC6;EXOSC4;DDIT3
prerank,KEGG_2021_Human__Histidine metabolism,-0.2973156574494921,-0.9428062645505622,0.5084745762711864,0.998270914160884,1.0,5/16,17.14%,HAL;ALDH7A1;AMDHD1;HNMT;CARNS1
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.19576065352309435,-0.942538774561647,0.5714285714285714,0.996786997180681,1.0,15/74,14.11%,POLR2I;GTF2A1;PHAX;INTS4;INTS14;GTF2E1;POLR2D;INTS5;TAF8;POU2F1;POLR2A;SRRT;CDK9;INTS9;INTS7
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.18866006112950912,-0.942504762587378,0.5555555555555556,0.994773177241941,1.0,10/78,8.33%,AKT1;SLC38A9;RRM2B;YWHAZ;COX7B;UBL4A;COX6A1;TSC2;REXO2;RPTOR
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.180968433262572,-0.9413975413047165,0.5714285714285714,0.9954678657423705,1.0,26/82,26.90%,AKT1;PRKCD;MAPKAPK3;PIK3CA;NCF2;JUP;NRAS;CRK;MAPKAP1;PRKCZ;PIK3R1;PKN1;ITPR1;WASF1;SPHK1;VAV2;NCK2;PKN2;HRAS;VEGFA;MAPK14;HSPB1;CDC42;MAPKAPK2;TRIB3;AHCYL1
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.28675346184466877,0.9409055921126679,0.5454545454545454,1.0,1.0,12/15,46.64%,DNA2;POLA1;POLR1A;PRIM1;POLD3;POLR1B;POLA2;PRIM2;PCNA;LRIG1;RPA3;POLD4
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.19567885556027817,-0.9407590034727663,0.5344827586206896,0.9950680862296728,1.0,12/94,10.33%,PAK1;PIK3CA;KLRK1;HCST;CASP3;NRAS;FASLG;SHC4;KLRC2;MAPK1;CD48;FAS
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.19364509025780646,-0.940670811579698,0.5396825396825397,0.9932334792626041,1.0,34/90,29.13%,UBB;H2AC14;GATA1;SPI1;H2AZ2;PSMD11;PSMB7;PSMB4;PSMD8;H2AC6;PSMB10;PSMB5;H2BC13;TAL1;RUNX1;SEM1;H2BC3;PSMD6;PSMD9;H2BC12;PSMA6;PSMA4;PSMD13;H2BC4;CBFB;PSMC1;PSMD3;H2AX;LMO2;UBC;H2AB1;PSMA2;H2AC19;PSMA7
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.2511010684902475,0.9406549930106345,0.5777777777777777,1.0,1.0,11/28,20.41%,OSBPL7;NCOA2;BAAT;ABCB11;SLC51A;ACOT8;AMACR;AKR1C1;OSBPL2;HSD3B7;OSBPL6
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.19057900230571867,0.939943089029687,0.5333333333333333,1.0,1.0,4/67,1.76%,PLCB4;TRPV3;CAMK2A;IL1R1
prerank,KEGG_2021_Human__Necroptosis,0.1715690088397643,0.9399079989184186,0.6,1.0,1.0,28/133,18.08%,FAF1;SQSTM1;CAMK2A;H2AC16;CYBB;H2AC8;H2AC12;AIFM1;H2AB2;ZBP1;CHMP1A;CFLAR;H2AC7;H2AC17;PYGL;FADD;STAT4;GLUD1;FTL;TICAM1;GLUL;TNFSF10;STAT1;SLC25A4;JAK2;H2AC21;TNFAIP3;ALOX15
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.29571510676290197,-0.9396633183903269,0.5,0.9941350562051033,1.0,5/15,22.86%,AMN;LMBRD1;MMUT;LDLRAP1;MMADHC
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.1722303454510072,0.9389754236149127,0.6388888888888888,1.0,1.0,12/108,7.05%,TTC21B;OS9;IFT172;SMURF1;DERL2;INTU;SCUBE2;PSMD7;PSMA5;OFD1;UBA52;IFT88
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,0.21822962588197894,0.9379854803370451,0.45,1.0,1.0,11/50,14.03%,ATP6V0B;MTOR;TCIRG1;RRAGD;NPRL3;ATP6V1F;NPRL2;WDR59;SH3BP4;FNIP2;LAMTOR3
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,-0.1581998883833775,-0.9378642015742552,0.631578947368421,0.9973857828178876,1.0,52/219,22.56%,NUP37;PCK2;UBB;HMMR;PFKL;PROC;FUT1;RHCE;MANBA;UBL4A;GAA;PCNX4;LOC112694756;DSE;GLCE;XYLB;B3GALT2;ABO;B4GALT3;ABCC5;B4GALNT2;CHSY1;ENO1;B4GALT1;GPC2;EXT1;FBP1;RHD;NUP88;CHPF;NUP93;LYVE1;HEXA;NHLRC1;HPSE;PHGDH;GALK1;AKR1B1;PYGB;MAN2C1;MAN2B1;PPP2CA;PGP;NUP35;PFKP;TAC4;CHST2;PPP2R1A;NUP54;NUP42;GALT;PRPS2
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.22219763249894126,-0.9377817883621306,0.49056603773584906,0.995281886693773,1.0,12/36,26.33%,NUP37;XPO1;RAN;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.18433465559698634,-0.9376609771384462,0.6,0.9935316755729077,1.0,52/114,36.90%,NUP37;XPO1;SRF;PPP2R5B;DAAM1;ITGB3BP;CENPN;NUDC;KIF18A;CLASP2;CENPU;ZW10;SRGAP2;MAD1L1;ZWINT;CENPM;PFN2;PLK1;RCC2;B9D2;PPP2CA;PMF1-BGLAP;RPS27;CENPA;MAPRE1;ITGB1;PPP2R1A;SGO1;CDC42;PPP2R1B;NUP43;CENPH;PAFAH1B1;NUP85;NUP107;CENPE;KIF2A;KNTC1;RHOA;CKAP5;DYNC1H1;SRC;SKA2;DVL2;DIAPH1;CENPL;MIS12;CENPQ;NUP160;PPP2CB;SEH1L;ZWILCH
prerank,KEGG_2021_Human__Wnt signaling pathway,0.16865896881767362,0.9376279678848473,0.5365853658536586,1.0,1.0,25/106,19.18%,PLCB4;CAMK2A;FRAT1;TLE2;VANGL1;RUVBL1;LGR6;WNT7B;RAC3;SMAD4;CCND2;PPP3CB;PRKACA;FZD6;SERPINF1;WNT5B;FRAT2;LEF1;SFRP2;CACYBP;PPP3CA;PRICKLE3;RAC1;TCF7L2;RAC2
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.18766070500983095,0.9366946058669412,0.6585365853658537,1.0,1.0,18/84,14.41%,RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UBA52;RPS19;FAU;RPS10;RPL29;RPS21;RPS27A;RPL37A;RSL24D1;RPL39;RPS28;RPL3
prerank,KEGG_2021_Human__Platelet activation,0.17596970824441702,0.9361917320188711,0.6,1.0,1.0,32/105,23.98%,PLCB4;TLN2;P2RX1;GNAI1;ARHGAP35;MYL12A;APBB1IP;PIK3CG;ADCY3;PPP1R12A;GP1BA;MYLK3;PRKACA;GP1BB;MAPK3;PPP1CA;ARHGEF12;TLN1;MAPK13;MAPK11;GNAI3;GUCY1B1;ITGA2B;ORAI1;FCER1G;ADCY9;VAMP8;P2RY1;ACTG1;ADCY7;MYLK;PIK3CB
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.239647142605572,-0.9358262631300452,0.5357142857142857,0.9975876532550741,1.0,10/27,26.33%,NUP37;RAN;TNPO1;NUP93;NUP35;NUP54;NUP43;NDC1;NUP85;NUP107
prerank,KEGG_2021_Human__Synaptic vesicle cycle,-0.2101621826856951,-0.9351686022351382,0.5423728813559322,0.9976238678133466,1.0,20/50,33.01%,CLTCL1;ATP6V1E1;AP2B1;ATP6V0A1;ATP6V1D;STX3;AP2M1;SLC6A13;SNAP25;ATP6V1E2;DNM3;DNM2;STX2;ATP6V0C;SLC6A9;ATP6V1C1;CLTA;ATP6V0D1;ATP6V0A2;VAMP2
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.28705868358810405,-0.9344956676405464,0.5806451612903226,0.9971806986522637,1.0,4/21,7.06%,UGGT1;UBB;UGGT2;EDEM2
prerank,KEGG_2021_Human__p53 signaling pathway,-0.20362507349784206,-0.9343336819172818,0.5238095238095238,0.9954870256213936,1.0,12/68,12.01%,CCNG2;RRM2B;CASP3;ZMAT3;TSC2;GORAB;FAS;CDK6;ADGRB1;GTSE1;APAF1;PMAIP1
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,-0.26393424796944664,-0.9342843476676396,0.5769230769230769,0.9935052486723476,1.0,10/24,28.25%,SLC38A9;RPS6KB1;RPTOR;LAMTOR2;EIF4E;EIF4B;RRAGC;RHEB;EIF4EBP1;FKBP1A
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,-0.22182007870223924,-0.934157842270812,0.5434782608695652,0.9916453443777656,1.0,7/37,12.64%,CCL28;CCR8;CXCR1;CXCR3;CNOT6;CXCR2;CXCR6
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.2151674765077034,-0.9341336054796884,0.5384615384615384,0.9895445316930518,1.0,9/58,12.58%,PGAM1;PFKL;AKT1;PIK3CA;FGFR1;NRAS;MAPK1;SIRT3;PIK3R1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.2247391315756013,-0.9340938379145807,0.5483870967741935,0.98752042645966,1.0,20/52,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;CUL3;UBC;DACT1;PSMA2;PSMA7
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.22778908807352882,-0.933334721498503,0.5714285714285714,0.9873297533806334,1.0,11/38,19.04%,CLSTN1;PIK3CA;IL15;IL15RA;IL2RB;PIK3R1;STAT5A;INPP5D;JAK3;STAT5B;CSF2RB
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.18852970982365616,-0.9331286147389247,0.582089552238806,0.9860608291453722,1.0,14/84,12.70%,UBB;SKP1;AKT1;CUL1;PSMD11;PSMB7;LIN52;PTK6;LIN9;E2F4;PSMB4;PSMD8;PSMB10;PSMB5
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.27340996068210055,-0.9329531667026137,0.5272727272727272,0.9844832347611523,1.0,4/18,12.89%,RAB6A;LFNG;B4GALT1;ATP2A1
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.17305188440519587,-0.932778448896334,0.7017543859649122,0.9831361772306035,1.0,18/113,12.58%,CAV2;DUSP1;MGST3;GSTA4;SUMO4;AKT1;PIK3CA;NCF2;HSP90B1;MAP2K7;GSTO1;GSTM2;ACVR2B;CALML4;PRKCZ;PIAS4;FOS;PIK3R1
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,0.22263336485947474,0.9325827656225621,0.5869565217391305,1.0,1.0,9/34,15.37%,H2BC11;H2BC15;H2BC5;OGG1;POT1;H2AC7;H4C15;H2BC14;TINF2
prerank,KEGG_2021_Human__Alcoholism,0.17170066205375442,0.9325310045413143,0.6136363636363636,1.0,1.0,26/140,14.52%,H2BC11;H4C12;H2AC16;H2AC8;H2BC15;SLC29A1;H2AC12;H2AB2;H4C11;GNAI1;H3C1;GNB5;HDAC3;H2BC5;ADORA2A;FOSB;H3-3B;H2AC7;H2AC17;PRKACA;H4C15;H3C8;H2BC14;H3C13;MAPK3;PPP1CA
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.19859944838307264,0.9323026462212193,0.5384615384615384,1.0,1.0,3/46,1.78%,EPS8L2;PJVK;TRIOBP
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.17866035486543858,-0.9318078359993437,0.5925925925925926,0.9844306861858884,1.0,29/107,21.57%,EIF4A1;RPS24;RPS15A;RPL38;RPL26;EIF2S1;RPL23A;RPS3A;RPL26L1;RPL8;RPL15;RPS3;RPL36A;RPL32;RPL7;EIF4E;EIF3A;RPL19;RPL22;RPL18A;RPL5;RPL21;RPS2;EIF3F;RPSA;RPL36AL;RPS27;EIF4B;EIF4H
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.20999148748008756,-0.931802283992112,0.5769230769230769,0.9823761189589487,1.0,12/62,13.86%,LTBP1;IL6;PROC;MELTF;HSP90B1;PNPLA2;MIA3;LAMC1;MXRA8;APOL1;TIMP1;FSTL3
prerank,KEGG_2021_Human__Chagas disease,0.18455712047109213,0.9317554316400333,0.5789473684210527,1.0,1.0,27/91,20.93%,PLCB4;CXCL8;PPP2R2D;GNAI1;IL10;CFLAR;IL12A;TGFB1;ACE;MYD88;GNA15;CCL3;SMAD2;FADD;RELA;TGFBR1;TICAM1;MAPK3;GNAO1;SERPINE1;MAPK13;C1QC;MAPK11;GNAI3;IKBKG;TLR4;TLR6
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.1651460045072879,0.9317388274782454,0.5833333333333334,1.0,1.0,28/150,16.16%,H2BC11;ORC3;DNA2;CDC6;ANAPC11;H2BC15;CDC16;RFC3;RFC5;PSMD7;PSMA5;UBA52;H2BC5;H3-3B;GINS4;ANAPC15;H2AC7;MCM7;PSMF1;RPS27A;H4C15;PSMA3;H2BC14;H3C13;POLA1;KPNA1;SLC19A1;PSMB2
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.18620176659193463,0.931505991848588,0.625,1.0,1.0,6/77,5.76%,CDC25B;CDC25C;ANAPC11;CDC16;GNAI1;ADCY3
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.24993384277875844,-0.9313415516574083,0.5625,0.9817538078454936,1.0,5/20,13.86%,DGAT1;LPIN1;LIPE;PLIN3;MOGAT3
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.207133202846556,-0.9312637347482458,0.5573770491803278,0.9799132708671716,1.0,22/63,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;PPARGC1B;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;CBFB;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.2967265561306137,0.9307514490953944,0.5471698113207547,1.0,1.0,4/16,10.82%,PPP2R5D;PPP2R5E;FGR;PTPN11
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.17150504730022378,-0.9300189227447407,0.6666666666666666,0.982421962221714,1.0,45/167,24.17%,POLR2I;CAV2;CREB1;XPO1;GTF2A1;AKT1;GNG10;SRF;PIK3CA;H2AC14;H2AZ2;ZDHHC21;GNG5;NRAS;TGFA;POLR2D;EP300;MAPK1;POU2F1;POLR2A;PRKCZ;H2AC6;CDK9;FOS;PIK3R1;STAG2;H2BC13;TFF3;RUNX1;DDX5;H2BC3;POLR2E;GREB1;EPGN;H2BC12;SPHK1;JUND;CHD1;HRAS;GTF2A2;NCOA3;H2BC4;HBEGF;GNG3;CBFB
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.197962343580341,-0.9296124266140505,0.5185185185185185,0.9817371482384436,1.0,11/68,10.80%,CCL28;CCR8;IL6;LTBR;CXCR1;TNFSF14;CXCR3;CCR10;IL2RB;CXCR2;PF4V1
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.22810688371266807,-0.9293683781151665,0.5370370370370371,0.9804155092657998,1.0,4/33,10.25%,POLR2I;GTF2H3;POLR2D;POLR2A
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.175403957111528,0.9280043597226871,0.5641025641025641,1.0,1.0,10/80,9.26%,THOC7;SRSF5;CDC40;GLE1;NUP58;WDR33;POM121;SRSF7;FYTTD1;POLDIP3
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.15598852307036828,0.9274335374745662,0.6388888888888888,1.0,1.0,20/167,10.40%,COPZ2;ACTR10;YKT6;STX18;COG2;SEC22B;MAN2A1;VPS51;NAPG;PAFAH1B2;RIC1;COPZ1;USP6NL;KIF9;TRIP11;RGPD1;RAB1B;SNAP29;NAA35;TMED3
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.2565661727156659,-0.9267680281047153,0.5166666666666667,0.986055209028023,1.0,10/21,32.54%,GNG10;GNG5;GNA11;GNAQ;MAPK14;GNG3;GNB4;GNG8;SRC;GNG7
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.1706875844101702,0.9265085380404048,0.5681818181818182,1.0,1.0,20/107,14.72%,VRK2;H2BC11;H2BC15;PPP2R2D;GOLGA2;MCPH1;NEK9;NUP58;H2BC5;POM121;H3-3B;RAB1B;H2AC7;NUP210;H4C15;MASTL;H2BC14;H3C13;MAPK3;LMNA
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.17567293464460415,0.9264108254789414,0.6190476190476191,1.0,1.0,27/110,18.73%,H2BC11;DAND5;NRIP1;H2BC15;TNRC6C;KPNA2;AGO4;H2BC5;FOSB;H3-3B;NCOA2;MOV10;KCTD6;SMC1A;H2AC7;H4C15;KANK1;GPAM;H2BC14;H3C13;ZNF217;CARM1;NR5A2;EBAG9;MYB;GATA3;KDM1A
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.16358241936500834,0.925960084860556,0.6511627906976745,1.0,1.0,42/142,24.14%,CDC25B;CDC25C;THBS1;RECK;MTOR;ZFPM2;MMP9;MCL1;ERBB2;CCND2;RPS6KA5;KIF23;DNMT3A;BCL2L2;MDM4;ABL1;RASSF1;MAPK3;EFNA4;SIRT1;IRS1;BCL2L11;CDKN1B;ST14;ITGA5;TP63;DNMT3B;SOS1;NOTCH4;NOTCH3;ERBB3;APC;RDX;COMMD3-BMI1;BAK1;HNRNPK;KRAS;PTGS2;DICER1;CCNG1;PIK3CB;TNXB
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.189885699529399,0.9251435655077938,0.6818181818181818,1.0,1.0,14/85,11.88%,C3AR1;CXCL8;CCR9;HEBP1;CCR7;GPER1;C5AR1;PPBP;MC1R;INSL3;XCL1;C5AR2;PNOC;CCL3
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.2724968586113019,-0.9250819301389366,0.5254237288135594,0.9895846544075331,1.0,9/17,32.55%,UBB;TMED7-TICAM2;TANK;TRAF3;NDUFA2;UBC;IKBKE;LY96;SARM1
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.26434388119604646,-0.9243823007356775,0.5636363636363636,0.9896140492294272,1.0,4/24,5.96%,LTBP1;MFAP5;BMP7;ITGB5
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.16175026761877304,0.9241886791929113,0.631578947368421,1.0,1.0,45/168,21.26%,C3AR1;CD163;WASF3;GNAI1;CYFIP2;PPAN-P2RY11;GNB5;ABI1;RHBDF2;IL10;ADORA2A;P2RX4;MC1R;BAIAP2;MEFV;FGR;INSL3;ENTPD5;PLK2;ELMO2;RELA;ARPC3;MYO1E;ABL1;CPAMD8;YES1;BRK1;FCGR1A;MAPK3;ADAM17;NCKAP1L;VAV3;GNG4;MYO9B;NCKIPSD;ARPC5;GPR27;GNAI3;GNG11;P2RX7;ADM2;RNASE1;TARP;CASP1;ADCY9
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.26167591218338165,-0.9240811902989909,0.4444444444444444,0.9882870472234494,1.0,9/21,32.00%,POLR2I;POLR2D;POLR2A;TDRKH;POLR2E;PLD6;POLR2L;POLR2F;TDRD12
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.22088930411297703,-0.923919876090611,0.6,0.9868127172416387,1.0,8/41,11.86%,EXTL3;DSE;GLCE;B4GALT3;CHSY1;B4GALT1;EXT1;CHPF
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.16252165303859742,-0.9235006627005627,0.65,0.9860633784769534,1.0,66/219,26.42%,NUP37;SIRT2;UBB;XPO1;RAN;PPP2R5B;FBXO5;PSMD11;PSMB7;ITGB3BP;LEMD2;ANAPC7;CENPN;NUDC;KIF18A;TNPO1;CHMP4B;PSMB4;CLASP2;CENPU;ZW10;PSMD8;NUP93;PSMB10;PSMB5;ANAPC5;TUBB6;MAD1L1;ZWINT;STAG2;CENPM;PLK1;TUBB4B;RCC2;B9D2;SEM1;PSMD6;TUBA1A;PPP2CA;UBE2D1;PSMD9;PMF1-BGLAP;RPS27;NUP35;CENPA;LEMD3;MAPRE1;PPP2R1A;NUP54;PSMA6;PSMA4;PTTG1;PSMD13;SGO1;CCNB2;PPP2R1B;NUP43;CENPH;PSMC1;PSMD3;PPP2R2A;PAFAH1B1;NDC1;NUP85;NUP107;UBC
prerank,KEGG_2021_Human__Pathways in cancer,-0.14796368266937004,-0.923321497159852,0.6923076923076923,0.9844909892886158,1.0,99/391,24.31%,RALBP1;HEY1;RASGRP4;ELOC;MGST3;IL6;TRAF4;SKP1;GSTA4;LPAR2;AKT1;GNG10;PIK3CA;IL15;FGFR1;CUL1;SPI1;HSP90B1;GNG5;CASP3;IL15RA;ETS1;LPAR6;JUP;NRAS;TGFA;FASLG;BAD;JAG1;APPL1;E2F3;RPS6KB1;GSTO1;EP300;NCOA4;LRP6;GSTM2;ADCY4;RASSF5;MAPK1;IL2RB;CRK;LAMC1;CALML4;FAS;CDK6;GNA11;CTBP1;APAF1;PMAIP1;LAMC3;DAPK3;FOS;PIK3R1;PIM2;TGFBR2;TRAF6;LAMB2;STAT5A;IFNGR2;PLCB2;RALB;GNAQ;CBL;F2R;JAK3;PPARD;RUNX1;IL23R;CCDC6;IL4R;PLEKHG5;PTGER2;STAT5B;CXCR4;CSF2RB;HGF;RARB;HDAC2;TRAF3;FGFR4;LAMB4;PLCG2;CALM3;GSTP1;ITGB1;NQO1;MAPK8;MAPK9;IL2RA;TRAF1;HRAS;HIF1A;VEGFA;RUNX1T1;NCOA3;GNG3;WNT10B;CDC42
prerank,KEGG_2021_Human__Salmonella infection,-0.16070424047169482,-0.9228184882407419,0.6229508196721312,0.9837928867594853,1.0,56/226,23.08%,PAK1;IL6;MYL9;SKP1;AKT1;PIK3CA;HSP90B1;MAP2K7;KIF5C;CASP3;SNX33;M6PR;SNX18;CD14;ACTR1A;RIPK3;MAPK1;RHOH;KLC1;EXOC2;ACTR3;MYL12B;RPS3;DYNLT1;FOS;TUBB6;IRAK1;PKN1;TRAF6;ACBD3;TLR2;PFN2;MLKL;MAP2K4;FHOD1;TUBB4B;CYTH4;TUBA1A;ARL8A;FLNA;TLR5;KIF5B;KIF5A;DYNC2H1;PTPRC;TRADD;MAP2K3;WASL;TNFRSF1A;RRAS;MAPK8;DNM2;MAPK9;DYNLT3;HRAS;ACTB
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.27824317638228857,0.9225225321871285,0.5263157894736842,1.0,1.0,7/17,19.64%,STAM;UBA52;SH3GL1;CBLL1;RPS27A;SH3KBP1;FZR1
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.17147259633093653,0.9219655526891777,0.6304347826086957,1.0,1.0,10/90,9.17%,UQCR10;TMEM126B;NDUFS1;ECSIT;NDUFB10;COQ10A;NDUFS6;NDUFAF5;CYCS;UQCRC1
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.20986142224103305,-0.9218325594392496,0.5961538461538461,0.984504977970367,1.0,14/47,24.39%,CREB1;NRAS;NBEA;PPM1F;MAPK1;NEFL;GIT1;DLG1;PRKX;CAMK4;PRKAG2;HRAS;PRKAG1;NRGN
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.24265862370508573,0.9215951438211235,0.6590909090909091,1.0,1.0,3/20,6.39%,CAMK2A;LGALS12;AKAP5
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.23687141528358374,0.921470645563809,0.5365853658536586,1.0,1.0,7/34,12.35%,RPLP0;RALA;IL10;ANXA2;CNN2;TCP1;STAT4
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.1717781163952174,-0.9206770134866238,0.6833333333333333,0.9858839735916525,1.0,32/119,25.29%,UBB;SKP1;PRKCD;UBE2M;CUL1;PSMD11;PSMB7;UBE2N;NRAS;RNASE3;EP300;PSMB4;PSMD8;CLEC10A;PSMB10;PSMB5;FBXW11;PKN1;TRAF6;ITPR1;SEM1;PSMD6;UBE2D1;PSMD9;PLCG2;PKN2;PSMA6;HRAS;PSMA4;PSMD13;PSMC1;PSMD3
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.1833541632253964,-0.9202768769506099,0.5166666666666667,0.9850794878384448,1.0,26/90,26.33%,NUP37;UBB;HSPA4L;EP300;RPTOR;MAPK1;HSPA12A;NUP88;MRPL18;SERPINH1;NUP93;BAG3;HSPA6;HSPA4;NUP35;CCAR2;NUP54;NUP42;DNAJB6;NUP43;NDC1;HIKESHI;HDAC6;NUP85;MAPKAPK2;NUP107
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.16459825384165166,-0.9188499152207791,0.5555555555555556,0.9874200505200735,1.0,16/128,8.87%,TPST2;AS3MT;MTARC2;MGST3;ADH5;GSTA4;ACSS2;GGT1;CYP27A1;COMT;BPNT1;FMO3;GSTO1;GSTM2;SLC35D1;MIA3
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.3050135492557082,-0.918716550729299,0.5576923076923077,0.9858426041009851,1.0,2/15,3.10%,UBB;AP2B1
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.2448266419934744,-0.9182345092180526,0.5409836065573771,0.9850430977123825,1.0,8/29,19.99%,UBB;FLOT2;FASLG;RIPK3;MLKL;OGT;TANK;TRADD
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.1921891317161109,0.9181464719652698,0.5769230769230769,1.0,1.0,7/46,11.42%,LDHB;SUCLG1;DLST;GSTZ1;SLC16A3;SUCLG2;PDK2
prerank,Reactome_2022__Translation R-HSA-72766,-0.15093714462749688,-0.9170864783042267,0.6909090909090909,0.9861076103650882,1.0,71/276,22.82%,PPA1;MRPL55;EIF4A1;RPS24;PPA2;CARS2;SRP14;FARS2;RPS15A;MRPL50;RPL38;AARS2;RPL26;EIF2S1;CARS1;RPL23A;RARS2;MRPS18A;AIMP2;RPS3A;MRPS27;RPL26L1;DTD1;MRPL45;RPL8;SEC61A2;TRAM1;RPL15;PTCD3;MRPL12;RPS3;RPL36A;MRPL18;RPL32;RPL7;EIF4E;EIF3A;TARS1;GSPT2;MRPL46;RPL19;RPL22;RPL18A;RPL5;EARS2;MRPL24;RPL21;GARS1;RPS2;EIF3F;EIF2B5;GFM2;RPSA;MRPL44;MRPL19;RPN2;GADD45GIP1;RPL36AL;MRPL34;RPS27;LARS1;MTRF1L;MRPL37;EIF2B2;MRPL10;EIF4B;EIF4H;MRPS14;EEF1D;MRPL15;NARS1
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,0.23241253112101015,0.9170676020172831,0.5777777777777777,1.0,1.0,5/26,12.48%,ANAPC11;CDC16;UBA52;ANAPC15;RPS27A
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.23398407037390612,-0.9168968808584559,0.6078431372549019,0.9846064108980433,1.0,11/27,28.76%,UBB;TGFA;SPRY1;CBL;EPGN;HGS;HBEGF;CDC42;UBC;PTPRK;EPS15
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.2131041901089305,-0.9162299235592573,0.5925925925925926,0.9844745963470979,1.0,17/37,36.91%,NUP37;SLC25A5;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;PSIP1;NUP214;BANF1;NUP160;SEH1L;AAAS
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.2780484596527687,0.9161763383046062,0.68,1.0,1.0,7/16,19.55%,NCOA2;BAAT;ABCB11;ACOT8;AMACR;AKR1C1;HSD3B7
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.14800193272421236,-0.9157228766366042,0.71875,0.9839606467015977,1.0,148/500,27.07%,NUP37;SIRT2;UBB;HMMR;XPO1;SKP1;AKT1;E2F6;TUBGCP4;RAN;PPP2R5B;FBXO5;H2AC14;CEP63;CUL1;H2AZ2;LPIN1;ESCO2;PSMD11;PSMB7;LIN52;HAUS8;PTK6;ITGB3BP;ALMS1;LIN9;NME7;FOXM1;LEMD2;E2F3;ACTR1A;ANAPC7;CENPN;EP300;NUDC;CNTRL;CDK11A;MAPK1;KIF18A;TNPO1;E2F4;CHMP4B;PSMB4;SMC4;CLASP2;CENPU;DHFR;CETN2;CDK6;ZW10;AKAP9;PSMD8;CDC45;NUP88;ORC6;GTSE1;RAB33B;H2AC6;NEDD1;NUP93;PSMB10;POLD2;PSMB5;CEP192;ANAPC5;FBXW11;TUBB6;CSNK2A2;MAD1L1;ZWINT;STAG2;CEP290;CENPM;NCAPG;CDK11B;RFC4;H2BC13;CABLES1;MCM10;GORASP2;PLK1;MCM3;TUBB4B;RCC2;CSNK1E;CSNK1D;CCP110;B9D2;SEM1;RAB2A;H2BC3;PSMD6;TUBA1A;CEP76;PPP2CA;UBE2D1;AURKA;PSMD9;H2BC12;CNEP1R1;PMF1-BGLAP;CEP164;RPS27;MAU2;TUBGCP2;CEP70;NUP35;SDCCAG8;CENPA;LEMD3;HAUS2;BORA;MAPRE1;NCAPD2;PPP2R1A;NUP54;NUP42;PSMA6;PSMA4;MZT1;PTTG1;PSMD13;H2BC4;SGO1;CCNB2;CDKN2C;PPP2R1B;NUP43;CENPH;PSMC1;CEP78;PSMD3;PPP2R2A;LPIN2;PAFAH1B1;H2AX;NDC1;ODF2;NCAPH;SET;NUP85;NUP107;UBC;NCAPG2;H2AB1;MZT2B;DBF4;CCNA2
prerank,KEGG_2021_Human__African trypanosomiasis,-0.24209386577688236,-0.9153726940036907,0.5806451612903226,0.9828759154148271,1.0,8/26,17.80%,IL6;FASLG;IDO1;FAS;APOL1;PLCB2;GNAQ;THOP1
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",0.2214696240229765,0.9149658975094493,0.6511627906976745,1.0,1.0,11/41,16.43%,H2BC11;UNG;H2BC15;H2BC5;OGG1;POT1;H2AC7;H4C15;H2BC14;TINF2;TDG
prerank,KEGG_2021_Human__Protein digestion and absorption,0.19688425795997724,0.9148571730150371,0.575,1.0,1.0,8/49,13.08%,COL9A1;PGA4;KCNE3;SLC36A1;COL9A3;COL13A1;COL6A1;COL4A3
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.18365612538258505,-0.9147316861712984,0.6206896551724138,0.9830236231226984,1.0,7/80,4.72%,PARP1;COPS2;UBB;INO80;ERCC5;UBE2N;GTF2H3
prerank,KEGG_2021_Human__Cushing syndrome,0.17641223917109408,0.9141821468966287,0.6382978723404256,1.0,1.0,27/102,22.38%,PLCB4;CAMK2A;USP8;FH;RBBP5;GNAI1;ADCY3;CDKN2B;NR4A1;WNT7B;AHR;CDK4;PRKACA;FZD6;MAPK3;WNT5B;LEF1;CDKN1B;AIP;TCF7L2;GNAI3;APC;ORAI1;ADCY9;WDR5B;WNT10A;KMT2A
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.1847836820394631,-0.9135261437546223,0.5740740740740741,0.9843963751912439,1.0,44/107,32.91%,PROC;ITGAM;PIK3CA;L1CAM;NRAS;VPREB3;JAM3;CD48;GLG1;PF4V1;CEACAM6;DOK2;PIK3R1;JCHAIN;EPCAM;ATP1B2;JAML;INPP5D;BSG;SLC7A8;SIRPG;S100A9;TREM1;TNFRSF10D;ITGB1;GYPB;HRAS;F11R;CEACAM1;ITGB2;CD74;ATP1B3;GRB14;CD84;ITGAL;GAS6;PTPN6;SELENOP;PICK1;SLC16A1;OLR1;SRC;CD47;TNFRSF10A
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.20395222246953368,0.9133263425794711,0.6190476190476191,1.0,1.0,15/54,18.41%,PHC3;RING1;PIAS2;NUP58;POM121;PHC1;SATB2;PIAS1;CBX5;NUP210;H4C15;SEC13;SCMH1;NUP155;NUP62
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.24197103097718636,0.9129248897503897,0.5217391304347826,1.0,1.0,3/20,8.11%,ATP6V0B;TCIRG1;ATP6V1F
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.24397141687117727,0.9126101437893082,0.6382978723404256,1.0,1.0,5/27,13.34%,MARCO;CD163;APOE;FTL;HPX
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.24217890080256294,0.9122913488184542,0.575,1.0,1.0,6/25,15.22%,DTX4;UBA52;PSEN2;CNTN1;RPS27A;ADAM17
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.2808924269333154,-0.9122137483665089,0.5862068965517241,0.9861010786085433,1.0,6/15,24.91%,PROC;PPP2R5B;AMER1;PPP2CA;PPP2R1A;PPP2R1B
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.164738291040578,-0.911947300499665,0.6818181818181818,0.9849786318875244,1.0,45/181,21.36%,UPF3B;ELOC;RPS24;UBB;RPS15A;PSMD11;PSMB7;RPL38;RPL26;RPL23A;RPS3A;DAG1;RPL26L1;PSMB4;CLASP2;RPL8;RPL15;PSMD8;RPS3;RPL36A;SRGAP2;RPL32;RPL7;PSMB10;PSMB5;PKN1;GSPT2;RPL19;RPL22;PFN2;RPL18A;RPL5;SEM1;RPL21;RPS2;PSMD6;CXCR4;NRP1;RPSA;PSMD9;RPL36AL;RPS27;NCK2;PKN2;ROBO3
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.17351413806995092,0.9118492125165009,0.5714285714285714,1.0,1.0,31/122,20.53%,COPZ2;ACTR10;YKT6;COG2;SEC22B;NAPG;GOLGA2;COPZ1;RAB1B;SEC22A;TMED3;LMAN2;DYNLL2;TRAPPC4;SEC22C;PPP6R3;SEC13;TMED7;DCTN2;GOSR1;GOSR2;TMED2;DCTN1;COPG2;TRAPPC6A;SEC23A;COG4;TMED9;TRAPPC2;SERPINA1;CNIH1
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.277929703749629,-0.911681449459123,0.6,0.9836715977070508,1.0,3/16,9.10%,LIN52;LIN9;E2F4
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.24531817300605488,-0.9112488422444238,0.6440677966101694,0.9828309566256292,1.0,5/29,10.18%,GNG10;PRKCD;GNG5;ADCY4;PRKCH
prerank,KEGG_2021_Human__Oocyte meiosis,-0.1707984029890278,-0.9112044091857707,0.6721311475409836,0.9811149032992036,1.0,28/99,24.91%,SKP1;PPP2R5B;SPDYA;YWHAZ;FBXO5;SLK;CUL1;ANAPC7;ADCY4;MAPK1;CALML4;ANAPC5;FBXW11;CPEB2;MAD1L1;ITPR1;PLK1;FBXO43;PPP2CA;AURKA;CALM3;PPP2R1A;ANAPC13;PTTG1;MAPK14;SGO1;CCNB2;PPP2R1B
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.18576036247700634,-0.9107217359334799,0.6612903225806451,0.9806167347601409,1.0,28/90,29.13%,UBB;SKP1;PIK3CA;CUL1;PSMD11;PSMB7;UBE2N;PSMB4;PSMD8;PSMB10;PIK3R1;PSMB5;FBXW11;TRAF6;INPP5D;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;HLA-DRB5;PSMA2;PSMA7
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.155015632201911,-0.9104800120094533,0.7076923076923077,0.9793911354824256,1.0,72/244,27.64%,PCK2;CREB1;IL6;LPAR2;AKT1;GNG10;PPP2R5B;PIK3CA;YWHAZ;TCL1A;FGFR1;CRTC2;HSP90B1;ITGA10;GNG5;LPAR6;NRAS;MTCP1;TGFA;FASLG;ITGB5;BAD;TSC2;PIK3R5;RPS6KB1;RPTOR;MAPK1;IL2RB;LAMC1;CDK6;LAMC3;PIK3R1;EIF4E;PKN1;ITGB8;LAMB2;TLR2;ITGA1;F2R;JAK3;IL4R;PPP2CA;ATF4;COL6A3;HGF;FGFR4;RELN;PPP2R3A;LAMB4;CREB3L4;PKN2;EIF4B;ITGB1;PPP2R1A;IL2RA;HRAS;VEGFA;GNG3;RHEB;PPP2R1B;IL3RA;EIF4EBP1;PPP2R2A;IL4;STK11;ITGB4;PPP2R3C;PIK3AP1;GNB4;PDGFRA;FOXO3;OSM
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.1642444058268208,-0.9103265780916563,0.696969696969697,0.9778375796470187,1.0,45/146,29.13%,UBB;SKP1;AKT1;E2F6;FBXO5;CUL1;PSMD11;PSMB7;LIN52;PTK6;LIN9;E2F3;E2F4;PSMB4;DHFR;CDK6;PSMD8;CDC45;ORC6;PSMB10;PSMB5;CABLES1;MCM10;MCM3;SEM1;PSMD6;PPP2CA;PSMD9;PPP2R1A;PSMA6;PSMA4;PSMD13;CDKN2C;PPP2R1B;PSMC1;PSMD3;PPP2R2A;UBC;DBF4;CCNA2;GMNN;SLC25A15;PSMA2;TK1;PSMA7
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.23364016129461537,-0.9102414000309483,0.5882352941176471,0.9761655801730502,1.0,3/29,5.08%,ELOC;UBB;NRAS
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.15957692672627427,-0.9096068441790444,0.6923076923076923,0.976074652004565,1.0,25/159,13.68%,IL6;ITGAM;H3C11;DUSP6;BMP2K;SLC45A3;DOT1L;SPI1;PBX1;JUP;CD14;PAX5;H3C6;IL2RB;JMJD1C;CDK14;NCOR1;ETV5;DDIT3;H3-3A;HHEX;CDK9;TCF3;TGFBR2;H3C2
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.15992625413702266,0.909541446710167,0.6590909090909091,1.0,1.0,14/110,11.09%,UQCR10;TMEM126B;NDUFS1;ECSIT;NDUFB10;COQ10A;NDUFS6;NDUFAF5;CYCS;UQCRC1;ATP5F1D;DMAC2L;COX6B1;ATP5MC1
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.1950507954977274,-0.9093708038794577,0.6060606060606061,0.9748055048169029,1.0,22/64,29.13%,UBB;AKT1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;CSNK2A2;WWP2;SEM1;PSMD6;PSMD9;NEDD4;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.18976533989563094,-0.9089603079957604,0.6557377049180327,0.9738508607613144,1.0,21/66,26.33%,NUP37;SIRT2;RAN;LEMD2;TNPO1;CHMP4B;NUP93;TUBB6;TUBB4B;TUBA1A;PPP2CA;NUP35;LEMD3;PPP2R1A;NUP54;CCNB2;NUP43;PPP2R2A;NDC1;NUP85;NUP107
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.17423574369219663,-0.9088029458935656,0.6346153846153846,0.9724880156838599,1.0,31/114,21.57%,EIF4A1;RPS24;RPS15A;RPL38;RPL26;EIF2S1;RPL23A;RPS3A;RPL26L1;RPL8;RPL15;RPS3;RPL36A;RPL32;RPL7;EIF4E;EIF3A;RPL19;RPL22;RPL18A;RPL5;RPL21;RPS2;EIF3F;EIF2B5;RPSA;RPL36AL;RPS27;EIF2B2;EIF4B;EIF4H
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.24100315197631372,-0.9087904158847143,0.4716981132075472,0.9705960156533465,1.0,5/29,12.01%,AKT1;YWHAZ;BAD;REXO2;PMAIP1
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.17260887094629762,0.9083973142502935,0.6153846153846154,1.0,1.0,21/112,14.82%,H2BC11;H4C12;H2AC16;H2AC8;H2BC15;H2AC12;H2AB2;H4C11;H3C1;H2BC5;IL10;H3-3B;CD40LG;H2AC7;H2AC17;H4C15;H3C8;H2BC14;H3C13;FCGR1A;C8G
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.20119343083422708,0.9075700627434995,0.5581395348837209,1.0,1.0,14/58,17.27%,H2BC11;SAP30;H2BC15;MTA2;H2AC12;HDAC3;H2BC5;H2AC7;H4C15;H2BC14;H3C13;SUDS3;HDAC10;H2AC21
prerank,Reactome_2022__RAF Activation R-HSA-5673000,-0.23080777703072802,-0.9075446383337384,0.6140350877192983,0.9715631089543755,1.0,11/31,24.91%,PPP2R5B;NRAS;RNASE3;MRAS;KSR1;SHOC2;PHB1;PPP2CA;PPP2R1A;HRAS;PPP2R1B
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.18749655740738946,-0.9072659459608852,0.6896551724137931,0.9705197669704978,1.0,43/94,36.90%,NUP37;XPO1;PPP2R5B;ITGB3BP;CENPN;NUDC;KIF18A;CLASP2;CENPU;ZW10;MAD1L1;ZWINT;CENPM;PLK1;RCC2;B9D2;PPP2CA;PMF1-BGLAP;RPS27;CENPA;MAPRE1;PPP2R1A;SGO1;PPP2R1B;NUP43;CENPH;PAFAH1B1;NUP85;NUP107;CENPE;KIF2A;KNTC1;NEK6;CKAP5;DYNC1H1;SKA2;CENPL;MIS12;CENPQ;NUP160;PPP2CB;SEH1L;ZWILCH
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,0.23221195918446313,0.9072069820632342,0.55,1.0,1.0,3/20,10.53%,ANAPC11;CDC16;ANAPC15
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.21173221944502874,0.9071896590654693,0.6388888888888888,1.0,1.0,8/36,16.01%,ANAPC11;CDC16;ANAPC15;CDK4;CDKN1C;CCND2;TFDP2;CDKN1B
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.2466078423246433,-0.906258715601209,0.6101694915254238,0.9711154043546703,1.0,2/24,0.93%,ELOC;UBB
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.21459353323574065,-0.9058741388153397,0.5882352941176471,0.9702605310466909,1.0,18/34,40.75%,NUP37;PIAS4;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;UBE2I;NUP214;NUP160;SEH1L;AAAS;SUMO2;NUP153
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.2614731943755882,-0.9057518509002938,0.6491228070175439,0.968635346685131,1.0,5/23,17.58%,POLR2I;POLR2D;POLR2A;HNRNPA1;POLR2E
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.2216946168576151,-0.9051546252158291,0.603448275862069,0.9679510817794917,1.0,13/37,27.32%,UBB;AKT1;PIK3CA;NRAS;GRB10;PIK3R1;STAT5A;CBL;STAT5B;HRAS;PTPRJ;UBC;FOXO3
prerank,KEGG_2021_Human__Apoptosis,-0.17169894111796932,-0.9049010236125786,0.6,0.966620487257894,1.0,33/129,23.08%,PARP1;AKT1;CTSS;PIK3CA;DFFB;CASP3;NRAS;FASLG;EIF2S1;BAD;PARP4;MAPK1;FAS;DFFA;DDIT3;APAF1;PMAIP1;FOS;PIK3R1;ITPR1;HRK;TUBA1A;ATF4;CSF2RB;PRF1;TRADD;CTSB;TNFRSF1A;MAPK8;MAPK9;TRAF1;HRAS;ACTB
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.20824640831505742,-0.9047405825631445,0.7058823529411765,0.9651330625142882,1.0,8/46,14.64%,RPA1;ERCC5;GTF2H3;LIG1;CETN2;POLD2;RAD23B;RFC4
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.20282745774715513,-0.9043498771189125,0.5357142857142857,0.9642371935017792,1.0,10/62,10.59%,CRCP;UBB;XRCC5;POLR3GL;POLR3D;POLR3C;EP300;RIPK3;POLR3G;AIM2
prerank,KEGG_2021_Human__HIF-1 signaling pathway,-0.17860979652262524,-0.902363127444293,0.578125,0.9680429045305916,1.0,14/90,12.90%,ELOC;IL6;PFKL;AKT1;LTBR;PIK3CA;RPS6KB1;EP300;MAPK1;ENO1;TIMP1;PIK3R1;EIF4E;MKNK1
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.16087628226115466,0.9016407251684441,0.6578947368421053,1.0,1.0,46/151,25.02%,PLCB4;IFI16;CXCL8;CYBB;ATG5;MAVS;NOD2;CARD16;GBP5;MEFV;GABARAPL2;TAB3;MYD88;PANX1;MCU;FADD;RELA;TICAM1;MAPK3;CAMP;NLRP1;STAT1;TNFAIP3;MAPK13;NAIP;NOD1;GBP3;MAPK11;NLRP12;P2RX7;IFNAR2;BRCC3;NLRP6;DNM1L;IKBKG;TLR4;CASP1;GBP4;TNF;NFKBIA;NLRP3;CASP4;CARD6;NFKBIB;CYBA;VDAC3
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.18035423567881756,-0.8998640724995283,0.631578947368421,0.9725988817715309,1.0,42/118,29.13%,SLC25A5;AKT1;PIK3CA;PSMD11;PSMB7;KCND3;PPIF;ADRM1;NOP56;PSMB4;PSMD8;PIK3R1;PSMB5;TBPL1;ATP2A1;ITPR1;ATXN3;PLCB2;GNAQ;DAB1;SEM1;PSMD6;PSMD9;ATP2A2;RELN;RYR1;MAPK8;MAPK9;PSMA6;PSMA4;TBPL2;PSMD13;BECN1;PSMC1;PSMD3;ATP2A3;ERN1;PUM1;ATG101;PSMA2;ATXN1L;PSMA7
prerank,KEGG_2021_Human__Tuberculosis,0.1784961500374671,0.8997423757589255,0.7352941176470589,1.0,1.0,43/148,21.07%,ATP6V0B;CLEC7A;CAMK2A;BCL10;CR1L;TCIRG1;NOD2;IL10;CORO1A;IL12A;CYCS;TGFB1;EEA1;MYD88;RAB5A;FCGR2C;RFXANK;CEBPB;FADD;PPP3CB;RELA;CLEC4E;IRAK2;FCGR1A;MAPK3;CAMP;NFYC;HLA-DOB;STAT1;PPP3CA;JAK2;ARHGEF12;MAPK13;CIITA;MAPK11;FCGR3A;PLK3;RAB5B;LAMP2;TLR4;IL23A;TLR6;FCER1G
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.19782024738235085,0.8986232244045359,0.5813953488372093,1.0,1.0,18/63,20.53%,YKT6;SEC22B;NAPG;GOLGA2;RAB1B;SEC22A;LMAN2;TRAPPC4;SEC22C;PPP6R3;SEC13;GOSR2;TMED2;TRAPPC6A;SEC23A;TRAPPC2;SERPINA1;CNIH1
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.20516387728403343,0.8980735736216947,0.6326530612244898,1.0,1.0,4/35,4.70%,UBXN11;KIDINS220;VANGL1;ARHGAP35
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.18615668264241558,-0.8977246751074262,0.7209302325581395,0.9761331803331865,1.0,23/88,24.07%,CREB1;AKT1;PRKCD;PIK3CA;HSP90B1;NRAS;TGFA;SHC4;ADCY4;MAPK1;CALML4;FOS;PIK3R1;ITPR1;PLCB2;GNAQ;HSPA6;ATF4;CREB3L4;CALM3;HRAS;NCOA3;HBEGF
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,0.22679233300560442,0.8975568837254986,0.675,1.0,1.0,8/30,15.37%,H2BC11;H2BC15;H2BC5;POT1;H2AC7;H4C15;H2BC14;TINF2
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,0.1858279969530027,0.8972127941440967,0.6388888888888888,1.0,1.0,13/57,15.02%,USP9X;ACOX1;PEX2;UBA52;MPV17;ZNF260;BAAT;CROT;RPS27A;ACOT8;ECH1;AMACR;LONP2
prerank,KEGG_2021_Human__Hepatitis B,-0.16872407219320243,-0.8970315545189984,0.7068965517241379,0.9765063737071716,1.0,33/140,22.92%,CREB1;IL6;AKT1;PIK3CA;YWHAZ;MAP2K7;CASP3;NRAS;FASLG;BAD;E2F3;EP300;MAPK1;FAS;APAF1;FOS;PIK3R1;IRAK1;TGFBR2;TRAF6;TLR2;STAT5A;MAP2K4;JAK3;STAT5B;ATF4;ATP6AP1;TRAF3;MAP2K3;CREB3L4;MAPK8;MAPK9;HRAS
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.20114443422482975,0.8966945816304324,0.5,1.0,1.0,8/38,16.01%,ANAPC11;CDC16;ANAPC15;CDK4;CDKN1C;CCND2;TFDP2;CDKN1B
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,-0.23303722917860784,-0.8962963153598017,0.6065573770491803,0.9764579219681021,1.0,5/25,14.77%,PIK3CA;FGFR1;FRS2;PIK3R1;PDE3B
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.18260727403772775,0.8946001867258065,0.6857142857142857,1.0,1.0,22/82,18.32%,PLCB4;CXCL8;CYBB;FN1;TGFB1;SMAD4;CDK4;SMAD2;RELA;TGFBR1;COL4A3;MAPK3;CDKN1B;THBD;STAT1;ICAM1;JAK2;SERPINE1;MAPK13;EGR1;RAC1;MAPK11
prerank,KEGG_2021_Human__Drug metabolism,0.20019022606707843,0.8943680172810297,0.7446808510638298,1.0,1.0,10/59,11.77%,MGST2;GSTM1;MGST1;UCKL1;TK2;GSTO2;RRM2;NME3;UGT2B4;UPP1
prerank,KEGG_2021_Human__Pertussis,-0.19322149489910256,-0.8943167605974368,0.6470588235294118,0.9800447750601624,1.0,27/68,31.47%,IL6;C4BPA;ITGAM;CASP3;CD14;MAPK1;CALML4;FOS;IRAK1;TRAF6;C4B;C1S;CALM3;ITGB1;CXCL5;MAPK8;MAPK9;MAPK14;C1QA;IRAK4;ITGB2;C4A;C4BPB;C1QB;TICAM2;LY96;RHOA
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,0.23317973649517898,0.8940823555079422,0.5238095238095238,1.0,1.0,3/20,10.53%,ANAPC11;CDC16;ANAPC15
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.25657630096565276,0.8939255306618128,0.5238095238095238,1.0,1.0,3/18,6.15%,ALDH1B1;ENPP3;ALDH2
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.251999529304736,0.8932374777087115,0.5581395348837209,1.0,1.0,7/22,14.41%,HDAC3;RBM14-RBM4;SATB2;SMAD4;ABL1;YES1;MAPK3
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.21493015224445858,0.8923058959018076,0.6976744186046512,1.0,1.0,10/42,17.28%,RPLP0;RALA;IL10;IL12A;ANXA2;CNN2;TCP1;STAT4;JAK2;PSME2
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.23572450339749568,-0.891701926146998,0.6307692307692307,0.9849936430887309,1.0,4/28,8.35%,GNG10;RAB11A;GNG5;ADCY4
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.21418835365936967,-0.8913211278533046,0.6229508196721312,0.9838748892652264,1.0,19/51,29.13%,ELOC;UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,0.21426463493680298,0.8906352661660439,0.723404255319149,1.0,1.0,9/43,13.84%,H2BC11;H2BC15;MTA2;H2BC5;H3-3B;H2AC7;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.25495152774484914,0.8901665847923891,0.5853658536585366,1.0,1.0,6/17,19.16%,ITGA3;HSPG2;ITGAV;LAMB3;ITGA7;LMNB2
prerank,KEGG_2021_Human__Notch signaling pathway,-0.2085174543219428,-0.8892364921606587,0.6326530612244898,0.9876261797249389,1.0,8/48,11.63%,HEY1;NCOR2;MAML2;JAG1;LFNG;EP300;NCSTN;CTBP1
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.20632233734034283,-0.8888210201490921,0.6949152542372882,0.9867643877007295,1.0,22/51,33.52%,CREB1;DUOX1;HSP90B1;IYD;ADCY4;ATP1A3;ITPR1;ATP1B2;PLCB2;GNAQ;FXYD2;ATF4;CREB3L4;ATP1B3;TSHR;PAX8;TG;ASGR2;CREB3L2;ITPR3;PLCB3;GPX1
prerank,KEGG_2021_Human__Endocytosis,-0.1529729240253447,-0.8880373674147966,0.7540983606557377,0.9872117113033603,1.0,57/234,23.01%,CAV2;RAB22A;CLTCL1;VPS37B;ASAP2;AP2B1;SMAP2;RAB11A;KIF5C;AGAP5;RAB35;SMURF2;CXCR1;SNX3;RAB4A;CAPZA2;CHMP4B;IL2RB;ARF4;IGF2R;GIT1;RAB10;CXCR2;VPS28;ACTR3;PRKCZ;RNF41;IQSEC1;ASAP1;TGFBR2;AP2M1;TRAF6;ZFYVE16;CAPZB;SH3GLB2;CBL;CYTH4;TSG101;VPS26A;WIPF1;DNM3;HSPA6;CXCR4;KIF5B;KIF5A;LDLRAP1;RAB11B;RAB11FIP4;FGFR4;SNX12;WASL;NEDD4;DNM2;IL2RA;HGS;HRAS;WIPF2
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.21915259603390733,-0.8876188166808612,0.6041666666666666,0.9863736648363217,1.0,10/39,20.06%,CLTCL1;AP2B1;EPHB4;EPHB3;NCSTN;AP2M1;EPHA4;EPHB1;VAV2;EPHB6
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,0.24472438567220914,0.887569926802499,0.5957446808510638,1.0,1.0,1/15,0.94%,NUS1
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.20490369241911016,-0.8871697102923891,0.5967741935483871,0.9856570195197172,1.0,18/49,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.16137094500457488,0.8870405145983989,0.7027027027027027,1.0,1.0,22/136,13.34%,PTPN4;SQSTM1;NKIRAS2;IL1R1;LRRC14;PSMD7;TNIP2;PTPN2;PSMA5;UBA52;NOD2;SIGIRR;PTPN23;TAB3;MYD88;PTPN11;PSMF1;IL18R1;RPS27A;RELA;IRAK2;PSMA3
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.2278585656314383,0.8866543361819915,0.625,1.0,1.0,7/27,20.95%,PDIA3;PIK3R4;ATG14;SEC13;ERAP2;SEC23A;B2M
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.15667569892838817,-0.8865786440322814,0.6949152542372882,0.9851594753528594,1.0,65/218,26.42%,NUP37;SIRT2;UBB;XPO1;RAN;PPP2R5B;PSMD11;PSMB7;ITGB3BP;LEMD2;ANAPC7;CENPN;NUDC;KIF18A;TNPO1;CHMP4B;PSMB4;CLASP2;CENPU;ZW10;PSMD8;NUP93;PSMB10;PSMB5;ANAPC5;TUBB6;MAD1L1;ZWINT;STAG2;CENPM;PLK1;TUBB4B;RCC2;B9D2;SEM1;PSMD6;TUBA1A;PPP2CA;UBE2D1;PSMD9;PMF1-BGLAP;RPS27;NUP35;CENPA;LEMD3;MAPRE1;PPP2R1A;NUP54;PSMA6;PSMA4;PTTG1;PSMD13;SGO1;CCNB2;PPP2R1B;NUP43;CENPH;PSMC1;PSMD3;PPP2R2A;PAFAH1B1;NDC1;NUP85;NUP107;UBC
prerank,KEGG_2021_Human__Legionellosis,0.19822589736667373,0.8863969029683932,0.625,1.0,1.0,10/56,12.77%,CXCL8;EEF1G;SEC22B;CR1L;IL12A;RAB1B;CYCS;MYD88;RELA;CLK4
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,-0.2215173280407866,-0.8862644123046067,0.6101694915254238,0.984251360285237,1.0,6/34,13.20%,VAMP3;JUP;FAM91A1;RHOH;NSFL1C;PKN1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.23769943983045966,0.8853445330024284,0.6097560975609756,1.0,1.0,5/17,16.01%,CDK4;CDKN1C;CCND2;TFDP2;CDKN1B
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.20181310479048886,-0.8852524286888115,0.6101694915254238,0.9849736336059239,1.0,20/54,29.13%,UBB;PSMD11;PSMB7;SMURF2;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PRICKLE1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.1947769013871931,0.8848484189316703,0.7380952380952381,1.0,1.0,23/59,23.34%,ITGA3;ITGA4;SGCA;ADCY3;TGFB1;DES;PRKACA;DMD;LMNA;TTN;ITGAV;TNNT2;ITGA5;TPM2;ITGA7;CACNB3;ITGA2B;ITGA9;ADCY9;CACNB2;TNF;ACTG1;ADCY7
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.1590443346396334,-0.8839112654020546,0.711864406779661,0.9864367525502827,1.0,42/166,26.42%,CCR8;UBB;CREB1;IL6;AKT1;GNG10;PIK3CA;MAP2K7;GNG5;CASP3;NRAS;EIF2AK2;PIK3R5;E2F3;EP300;MAPK1;CALML4;FAS;CDK6;FOS;PIK3R1;ATG3;ITPR1;MAP2K4;TRAF3;TRADD;CD200R1;PLCG2;CALM3;TNFRSF1A;MAPK8;MAPK9;CD86;HRAS;HIF1A;VEGFA;MAPK14;GNG3;BECN1;MAPKAPK2;TYK2;UBC
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.20616462016640272,-0.883771510719008,0.5967741935483871,0.9849649374274461,1.0,20/52,30.44%,UBB;PSMD11;PSMB7;SMURF2;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7;AXIN2
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.1616406099526176,-0.8832438231072138,0.7540983606557377,0.9847071896633995,1.0,50/165,26.42%,NUP37;UBB;XPO1;PPP2R5B;PSMD11;PSMB7;ITGB3BP;ANAPC7;CENPN;NUDC;KIF18A;PSMB4;CLASP2;CENPU;ZW10;PSMD8;PSMB10;PSMB5;ANAPC5;MAD1L1;ZWINT;STAG2;CENPM;PLK1;RCC2;B9D2;SEM1;PSMD6;PPP2CA;UBE2D1;PSMD9;PMF1-BGLAP;RPS27;CENPA;MAPRE1;PPP2R1A;PSMA6;PSMA4;PTTG1;PSMD13;SGO1;PPP2R1B;NUP43;CENPH;PSMC1;PSMD3;PAFAH1B1;NUP85;NUP107;UBC
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.15699389346157747,0.8831940145439745,0.7619047619047619,1.0,1.0,24/130,15.83%,MGST2;FRAT1;GSTM1;MGST1;NFE2L2;MTOR;PBRM1;KEAP1;TERC;GSTO2;WNT7B;TGFB1;GADD45B;SMAD4;CDK4;SMAD2;TGFBR1;FZD6;TXNRD2;GADD45G;MAPK3;WNT5B;FRAT2;LEF1
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.2723643455050783,-0.8819978646191113,0.5555555555555556,0.9859097587350066,1.0,5/18,15.54%,SLC39A6;SLC11A1;SLC30A6;SLC39A14;SLC39A7
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.2083089355788662,0.8816458300632087,0.675,1.0,1.0,3/35,3.87%,RNF20;CCT2;STK38
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,0.2118090917643425,0.8809882548145798,0.5135135135135135,1.0,1.0,7/30,15.41%,CRABP2;RARA;RDH10;PDK2;CPT1A;RDH14;RDH5
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.22368214831070196,0.8803860168128412,0.5641025641025641,1.0,1.0,13/32,24.54%,NOD2;TAB3;IRAK2;MAP2K6;TNFAIP3;MAPK13;NOD1;MAPK11;IKBKG;CASP1;ITCH;CYLD;CASP4
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.1455512856630806,0.8795640804402101,0.8181818181818182,1.0,1.0,28/174,13.73%,H2BC11;USP8;USP9X;H2BC15;ATXN7;H2AC12;USP7;USP48;PSMD7;KEAP1;PSMA5;RUVBL1;UBA52;H2BC5;TNKS2;TOMM70;MAT2B;SMAD4;H2AC7;PSMF1;USP33;SMAD2;RPS27A;TGFBR1;USP5;MDM4;PSMA3;H2BC14
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,0.1645148361325587,0.8794123879329612,0.717391304347826,1.0,1.0,18/97,13.84%,PIWIL2;H2BC11;H2BC15;TNRC6C;AGO4;NUP58;H2BC5;POM121;TARBP2;ELAC2;H3-3B;H2AC7;IPO8;TSN;NUP210;H4C15;H2BC14;H3C13
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.2666846373334763,-0.8793286222876032,0.6153846153846154,0.9908758646842676,1.0,2/17,1.60%,KLKB1;CTSG
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.18547151899766387,0.878997489564298,0.6097560975609756,1.0,1.0,14/56,17.12%,MTOR;ACSL5;NFKBIE;ACSL6;ADIPOR2;G6PC3;PTPN11;CPT1A;RELA;ACSL3;PRKAB2;IRS1;JAK2;ACSL4
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.2461420561331026,0.8779118179363349,0.6041666666666666,1.0,1.0,6/15,16.55%,NDST2;HSPG2;HS2ST1;HS3ST3A1;AGRN;SLC35D2
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.2011328868118737,-0.877332405007538,0.625,0.9938269032291424,1.0,13/40,30.15%,PTGDS;GGT1;PRXL2B;AKR1C3;PTGR2;TBXAS1;CYP4F22;CYP4F2;ALOX5AP;MAPKAPK2;CYP2C9;DPEP2;HPGDS
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.18244662145519036,-0.8768981610060426,0.6470588235294118,0.9932064892639212,1.0,23/87,19.70%,RPS24;RPS15A;RPL38;RPL26;RPL23A;RPS3A;RPL26L1;RPL8;RPL15;RPS3;RPL36A;RPL32;RPL7;GSPT2;RPL19;RPL22;RPL18A;RPL5;RPL21;RPS2;RPSA;RPL36AL;RPS27
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.20767067523835445,-0.8768634809813474,0.62,0.9914873349930221,1.0,11/44,19.71%,CARS2;FARS2;GATB;AARS2;CARS1;RARS2;QRSL1;TARS1;EARS2;GARS1;LARS1
prerank,KEGG_2021_Human__Glioma,-0.1875683338104713,-0.8766056250044489,0.6181818181818182,0.9903721565390045,1.0,10/65,12.58%,AKT1;PIK3CA;NRAS;TGFA;SHC4;E2F3;MAPK1;CALML4;CDK6;PIK3R1
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,-0.1800049194832733,-0.8760734359784229,0.6833333333333333,0.9896267065888488,1.0,25/82,25.29%,VAMP3;UBB;PSMD11;PSMB7;PSMB4;SEC61A2;PSMD8;TLR1;SEC14L2;PSMB10;PSMB5;TLR2;SEM1;PSMD6;STX4;PSMD9;S100A9;CALR;SNAP23;PSMA6;PSMA4;PSMD13;NDUFA2;PSMC1;PSMD3
prerank,KEGG_2021_Human__Coronavirus disease,0.15529842843796066,0.8749822207174394,0.6944444444444444,1.0,1.0,40/188,18.32%,C3AR1;RPL4;CXCL8;RPS20;CYBB;F13A1;RPL31;RPS15;RPS25;RPLP0;MAVS;TLR8;UBA52;C5AR1;RPS19;IL12A;FAU;RPS10;ACE;MYD88;RPL29;RPS21;MX2;RPS27A;RELA;RPL37A;RSL24D1;RPL39;RPS28;RPL3;MAPK3;C8G;ADAM17;ISG15;STAT1;RPS23;MAPK13;C1QC;RPL35A;MAPK11
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,-0.15761462178144156,-0.8745767400313268,0.6984126984126984,0.9916118701431164,1.0,21/162,10.84%,PXN;PAK1;MYL9;LPAR2;ITGAM;PIK3CA;RRAS2;FGFR1;ITGA10;PIKFYVE;NRAS;SPATA13;ITGB5;MRAS;SSH3;MAPK1;CRK;GIT1;TMSB4X;ACTR3;MYL12B
prerank,KEGG_2021_Human__Mitophagy,-0.19129837578888556,-0.8741671602992296,0.6792452830188679,0.990943578938445,1.0,25/65,28.14%,UBB;TBC1D17;CALCOCO2;RRAS2;USP30;NRAS;MRAS;CSNK2A1;BNIP3;BCL2L13;BNIP3L;CSNK2A2;TFEB;ATF4;RRAS;MAPK8;MAPK9;TAX1BP1;HRAS;HIF1A;BECN1;ATG9B;UBC;FOXO3;PRKN
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.15085450964602765,0.8733320733203916,0.7560975609756098,1.0,1.0,37/163,18.38%,CXCL8;GAPDH;GNA12;IL1R1;ARHGEF11;WASF3;CLDN4;CYFIP2;ABI1;CLDN7;OCLN;BAIAP2;CYCS;TAB3;CLDN10;MYD88;PTPN11;FADD;TUBB4A;RELA;ARPC3;MYO1E;ABL1;BRK1;MAPK3;TUBB2A;TMED10;ARPC5L;NCKAP1L;TNFSF10;MYH11;ARHGEF12;MAPK13;NAIP;RAC1;MAPK11;ARPC5
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.22621618238877178,-0.8729002882962751,0.6296296296296297,0.9921918070164765,1.0,4/26,10.48%,UBB;VPS37B;CHMP4B;VPS28
prerank,KEGG_2021_Human__Hedgehog signaling pathway,-0.22079892537158957,-0.8723279882801501,0.6896551724137931,0.9915057777013522,1.0,9/36,16.98%,DISP1;CUL1;SMURF2;EFCAB7;MGRN1;FBXW11;CSNK1E;CSNK1D;KIF3A
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.21423534519318188,-0.8721990301479676,0.711864406779661,0.9899449186213807,1.0,4/41,4.72%,PARP1;UBB;ERCC5;GTF2H3
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.19961829409332227,0.8720398730497346,0.7317073170731707,1.0,1.0,11/46,13.85%,PLPP1;AKR1A1;ALDH1B1;ALDH2;DGAT2;GPAT2;AGPAT3;PLPP2;AGPAT5;GPAM;DGKA
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.18863376267136178,-0.8714555974330471,0.6909090909090909,0.9901411356042401,1.0,25/82,25.29%,UBB;PROC;SKP1;PPP2R5B;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;CTBP1;PSMB10;PSMB5;AMER1;TLE5;SEM1;PSMD6;PPP2CA;PSMD9;PPP2R1A;PSMA6;PSMA4;PSMD13;PPP2R1B;PSMC1;PSMD3
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.24461764199652009,-0.871437506001307,0.6470588235294118,0.9884553225961071,1.0,3/21,6.65%,UBB;UBE2N;ARL13B
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.2520715176249338,0.8714244896421393,0.5526315789473685,1.0,1.0,6/19,19.16%,CDC6;E2F5;MAX;TFDP2;RBL1;RBL2
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,-0.24435996198740872,-0.8705679205108122,0.5964912280701754,0.9880654654729527,1.0,5/27,10.17%,GNG10;GNG5;KCNJ2;ADCY4;KCNJ15
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,-0.1693491374094206,-0.870417487143175,0.6415094339622641,0.9866923772426157,1.0,33/103,26.89%,CACNG8;CACNG6;CREB1;AKT1;PPP2R5B;CACNA2D3;PIK3R5;ADCY4;MAPK1;CALML4;TNNC1;ATP2A1;ATP1A3;ADRB2;ATP1B2;PLCB2;GNAQ;FXYD2;PPP2CA;ATF4;ATP2A2;PPP2R3A;CREB3L4;CALM3;ADRA1A;PPP2R1A;TPM1;MAPK14;PPP2R1B;PPP2R2A;ATP1B3;PPP2R3C;ATP2A3
prerank,KEGG_2021_Human__Hepatitis C,-0.16655428159513813,-0.8694308430543884,0.7,0.9872521331613598,1.0,20/124,13.45%,AKT1;PIK3CA;YWHAZ;CASP3;NRAS;FASLG;EIF2S1;OAS3;BAD;EIF2AK2;E2F3;MAPK1;MX1;FAS;CDK6;RSAD2;CLDN9;APAF1;PIK3R1;TRAF6
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.19846013346551036,-0.86882951528994,0.7704918032786885,0.9873004664578161,1.0,19/53,26.42%,UBB;BAZ1B;UBE2N;RNF168;MDC1;PIAS4;H2BC13;EYA3;UIMC1;H2BC3;CNKSR3;H2BC12;ABRAXAS1;MAPK8;RAD50;H2BC4;NSD2;H2AX;UBC
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.1951138035704903,-0.8685194169341761,0.7142857142857143,0.986312762676739,1.0,24/66,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;ORC6;PSMB10;PSMB5;MCM3;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;SLC25A15;PSMA2;PSMA7
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.19792385981229307,-0.8685056185723612,0.6031746031746031,0.9846141589386118,1.0,19/52,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;HSPB1;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.14621997880584414,0.868111338476105,0.6818181818181818,1.0,1.0,26/200,10.63%,C3AR1;CXCL8;CRHBP;S1PR2;TAS2R13;CCR9;FFAR3;P2RY6;PPAN-P2RY11;HEBP1;CCR7;GNB5;GPER1;ADGRE1;LTB4R2;OPN3;ADORA2A;C5AR1;PPBP;MC1R;WNT7B;INSL3;XCL1;PTGDR2;OXER1;C5AR2
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.18192230120173264,-0.868008694107839,0.6545454545454545,0.9842352792690924,1.0,4/54,4.07%,NUP37;RTCB;RAN;ZBTB8OS
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.15439511677744383,-0.8679111140657185,0.8305084745762712,0.9826213173276843,1.0,31/157,17.92%,UBB;PROC;AMN;GGT1;CYP27A1;GAA;MPDU1;LFNG;LMBRD1;FMO3;CHSY1;DAG1;SLC35D1;B4GALT1;GPC2;HGSNAT;EXT1;APRT;PCCA;OPLAH;GALNS;HEXA;AHCY;NHLRC1;MMUT;SEMA5B;GALK1;DPM1;TBXAS1;C1GALT1;SPON2
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.1588013814818307,0.8661572473925276,0.6842105263157895,1.0,1.0,22/124,15.11%,H2BC11;ORC3;CDC6;ANAPC11;H2BC15;CDC16;PSMD7;PSMA5;UBA52;H2BC5;H3-3B;ANAPC15;H2AC7;MCM7;PSMF1;RPS27A;H4C15;PSMA3;H2BC14;H3C13;POLA1;KPNA1
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.17046889585295585,-0.8656026673245241,0.7413793103448276,0.9865297359273891,1.0,25/95,24.12%,CREB1;AKT1;GNG10;PIK3CA;ACTA2;MAP2K7;GNG5;NRAS;SHC4;ADCY4;MAPK1;PRKCZ;FOS;PIK3R1;TGFBR2;MAP2K4;PLCB2;ATF4;CREB3L4;MAPK8;MAPK9;HRAS;VEGFA;MAPK14;GNG3
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.18666521355693533,0.8655701371657158,0.6923076923076923,1.0,1.0,3/49,1.78%,EPS8L2;PJVK;TRIOBP
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.1818259122795521,-0.8653918048636502,0.703125,0.9853467763559499,1.0,44/89,38.11%,UBB;MAML2;PSMD11;PSMB7;SMURF2;NRAS;JAG1;EP300;PSMB4;PSMD8;PSMB10;MAMLD1;PSMB5;RUNX3;RUNX1;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;CBFB;PSMC1;PSMD3;UBC;CXXC1;FOXO3;ITGAL;PSMA2;RORC;PSMA7;SRC;PSMC5;RBPJ;PSMC2;TP53;GATD3;PSMC3;CREBBP;SMAD3;PSME1;HDAC4;MAML1;CDKN1A
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.24217414497049494,-0.8647196148720523,0.5535714285714286,0.9850438158817151,1.0,6/26,11.78%,EXOSC2;ASNS;EXOSC9;EXOSC6;EXOSC4;DDIT3
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.2622399721304637,0.8646643246777622,0.6285714285714286,1.0,1.0,4/16,15.13%,THBS1;TGFB1;TRAPPC4;ITGAV
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.1930953740285048,-0.8638813557047182,0.7142857142857143,0.9855790030284094,1.0,14/48,23.61%,CLSTN1;PIK3CA;PIK3R5;RAB4A;PIK3R1;MTMR9;INPP5D;BMX;RAB14;PLEKHA1;INPP5K;PLEKHA5;PI4K2B;PLEKHA8
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.2517259742482691,-0.8628162845776424,0.6557377049180327,0.9865022602254578,1.0,3/17,9.41%,UBB;JAG1;NCSTN
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.2603472071444837,-0.8618321362168783,0.6875,0.9872554491769944,1.0,6/16,26.26%,MAPKAPK3;NRAS;RALB;HRAS;MAPK14;MAPKAPK2
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.1884197988032669,-0.8617742737189621,0.6666666666666666,0.9856374797803595,1.0,17/51,26.33%,NUP37;LPIN1;LEMD2;NUP88;NUP93;PLK1;CNEP1R1;NUP35;LEMD3;NUP54;NUP42;CCNB2;NUP43;LPIN2;NDC1;NUP85;NUP107
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.2325809866620013,0.8612004589500528,0.6888888888888889,1.0,1.0,4/24,6.15%,ACOX1;ALDH1B1;CNDP2;ALDH2
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.23079019086391445,0.8603679757571403,0.6341463414634146,1.0,1.0,5/23,17.10%,CCT2;STK38;TXNL1;RHOBTB2;MSI2
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,0.17663842286974007,0.8595129977075598,0.7727272727272727,1.0,1.0,14/76,14.08%,H2BC11;RFNG;MAML3;H2BC15;TNRC6C;AGO4;H2BC5;H3-3B;MOV10;H2AC7;H4C15;H2BC14;H3C13;TFDP2
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.1715432881326833,-0.8585701379726226,0.75,0.9917094007949604,1.0,28/110,19.97%,RPS24;RPS15A;RPL38;RPL26;RPL23A;AIMP2;RPS3A;RPL26L1;RPL8;RPL15;RPS3;RPL36A;RPL32;RPL7;HNMT;RPL19;INMT;RPL22;AHCY;RPL18A;RPL5;RPL21;RPS2;RPSA;RPL36AL;RPS27;LARS1;SECISBP2
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.21125599534332665,0.8584352558634969,0.7111111111111111,1.0,1.0,5/38,6.57%,ARG1;ALDH1B1;CNDP2;ALDH2;HOGA1
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.20447004953124293,-0.8580717555500624,0.6538461538461539,0.9911772348949129,1.0,11/33,26.33%,NUP37;RAN;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",-0.2297897506832422,-0.8570296619419691,0.6415094339622641,0.9916777349989073,1.0,4/25,9.47%,AGXT;PPAT;ASNS;ALDH4A1
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.2085657867994123,0.8569276156978853,0.7111111111111111,1.0,1.0,20/30,40.27%,ST6GALNAC4;B3GNT8;GALNT14;B3GNT9;ST6GALNAC2;GALNT3;ST3GAL1;MUC1;GALNT1;B3GNT2;GALNT10;GALNT6;C1GALT1C1;B3GNT5;MUC20;ST6GAL1;GALNT12;B4GALT5;ST6GALNAC3;ST3GAL2
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.18433188925039623,0.856837258342318,0.7083333333333334,1.0,1.0,18/55,23.39%,PHC3;MTA2;MTOR;RING1;RRAGD;HDAC3;PHC1;PPARG;LAMTOR3;MAPK3;SCMH1;EGR1;LAMTOR4;KDM1A;MECOM;COMMD3-BMI1;DPEP3;MLST8
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.24247284948849923,-0.8565440783317667,0.6909090909090909,0.9911842258620406,1.0,3/23,10.25%,POLR2I;POLR2D;POLR2A
prerank,KEGG_2021_Human__Fatty acid degradation,-0.2096287213836594,-0.8564316762757985,0.6379310344827587,0.9896468543000654,1.0,4/36,3.83%,CPT1B;ADH5;ALDH7A1;ACSL1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.1776207735635954,-0.8562553951907548,0.7068965517241379,0.9882796164099649,1.0,11/73,12.78%,NUP37;EIF4A1;UBB;UBE2N;RIGI;EIF2AK2;HERC5;MX1;NUP88;NUP93;EIF4E
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.1786345876076446,-0.8561214655558698,0.6129032258064516,0.9867708697151045,1.0,27/85,26.42%,UBB;SKP1;CUL1;PSMD11;PSMB7;ADCY4;PSMB4;PSMD8;TULP3;WDR19;MKS1;PSMB10;PSMB5;IFT122;SEM1;KIF3A;PSMD6;SMOX;PSMD9;DYNC2H1;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;WDR35;UBC
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,0.23620761479358732,0.8555462837187355,0.6666666666666666,1.0,1.0,3/21,10.53%,ANAPC11;CDC16;ANAPC15
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.26067261640343337,-0.8547845333353388,0.6567164179104478,0.9879133518333212,1.0,4/16,16.28%,HGSNAT;GALNS;HEXA;HPSE
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.2506179480262935,-0.8529385703579917,0.6491228070175439,0.9896712700493345,1.0,5/20,23.51%,AP1S1;AP2B1;AP2M1;AP1M2;CD8B
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.19493040085920577,0.8525692281786724,0.7631578947368421,1.0,1.0,16/59,18.73%,CDC25C;H2BC11;H2BC15;PPP1R12A;H2BC5;H3-3B;NCOA2;H2AC7;KLK2;H4C15;H2BC14;H3C13;RHOC;MYH11;PDPK1;KDM1A
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.25790717873819907,-0.8524052906876297,0.5892857142857143,0.9892226820157445,1.0,2/16,5.08%,PRKCD;NRAS
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,0.237962589548992,0.8521933485203307,0.6862745098039216,1.0,1.0,3/19,9.66%,SUCLG1;DLST;SUCLG2
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.1913193112057474,0.8512965407048224,0.7209302325581395,1.0,1.0,16/47,19.16%,CDKN2B;UBA52;E2F5;CDK4;CDKN1C;CCND2;RPS27A;CCNH;ABL1;TFDP2;CDKN1B;RBL1;JAK2;PPP2R3B;CKS1B;RBL2
prerank,KEGG_2021_Human__Human papillomavirus infection,-0.14352716337363655,-0.8508848125943588,0.8125,0.9910086182293839,1.0,71/253,26.54%,PXN;HEY1;CREB1;AKT1;BCAP31;PPP2R5B;PIK3CA;ATP6V1E1;MAML2;ITGA10;CASP3;NRAS;ATP6V0A1;FASLG;ITGB5;BAD;TSC2;JAG1;LFNG;EIF2AK2;RPS6KB1;ATP6V1D;EP300;MAPK1;CHD4;MX1;LAMC1;FAS;CDK6;PRKCZ;DLG1;LAMC3;PIK3R1;TBPL1;ITGB8;LAMB2;ATP6V1E2;ITGA1;OASL;HES4;PPP2CA;COL6A3;PATJ;HDAC2;PALS1;ATP6AP1;TRAF3;TRADD;RELN;PPP2R3A;LAMB4;CREB3L4;ITGB1;TNFRSF1A;PPP2R1A;UBE3A;HES2;HRAS;TBPL2;VEGFA;WNT10B;CDC42;RHEB;PPP2R1B;PSMC1;EIF4EBP1;PPP2R2A;ATP6V0C;TYK2;ITGB4;PPP2R3C
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,0.21460251533325508,0.8507591863245777,0.6382978723404256,1.0,1.0,3/26,6.57%,GCSH;DLST;HOGA1
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.16665243953620668,0.8506093288264346,0.7,1.0,1.0,18/88,15.99%,H2BC11;DNA2;H2BC15;RFC3;RFC5;RUVBL1;H2BC5;BLM;CHTF8;H3-3B;POT1;H2AC7;H4C15;H2BC14;POLA1;TINF2;PPP6R3;SLC19A1
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.23294190628497397,-0.8489617050022839,0.6666666666666666,0.9936039713475036,1.0,7/24,22.82%,PPA1;CARS1;AIMP2;TARS1;GARS1;LARS1;NARS1
prerank,KEGG_2021_Human__Mismatch repair,0.22775409125722113,0.848625435479724,0.6521739130434783,1.0,1.0,6/23,18.11%,RFC3;RFC5;EXO1;MLH1;RPA2;RPA4
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.1391552292452015,-0.8483048685364873,0.8387096774193549,0.9934947046401372,1.0,63/304,19.97%,OAZ1;RPS24;HAL;DUOX1;ALDH7A1;RPS15A;KYAT3;ALDH6A1;AGXT;PSMD11;PSMB7;IYD;RPL38;RPL26;ASNS;DLAT;RPL23A;BCKDHA;DMGDH;AIMP2;RPS3A;RPL26L1;AASS;PSMB4;ALDH4A1;IDO1;RPL8;RPL15;PSMD8;RPS3;RPL36A;AMDHD1;RPL32;RPL7;PSMB10;PSMB5;HNMT;PEMT;RPL19;IVD;INMT;RPL22;AHCY;RPL18A;SBDS;PXMP2;RPL5;NDUFAB1;PHGDH;FAH;SEM1;CARNS1;RPL21;HECA;RPS2;PSMD6;SMOX;RPSA;PSMD9;RPL36AL;RPS27;LARS1;SECISBP2
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.16540919010458988,-0.8480404210372163,0.8103448275862069,0.9923743825120782,1.0,38/96,33.50%,NDUFS2;GNG10;NDUFS7;NDUFB7;GNG5;NDUFB3;FAAH;ADCY4;MAPK1;NDUFC1;NDUFA8;NDUFS3;ITPR1;NDUFAB1;PLCB2;GNAQ;NDUFA12;NDUFC2;MAPK8;MAPK9;NDUFB6;MAPK14;NDUFB8;GNG3;NDUFA9;NDUFC2-KCTD14;NDUFA2;GNB4;NDUFV2;NDUFA10;GNG8;NDUFB4;NDUFB2;GNG7;ABHD6;ITPR3;PLCB3;NDUFA13
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.18038335299188338,-0.8474064882454831,0.7538461538461538,0.9921233437182251,1.0,20/51,31.98%,NDUFS2;NDUFS7;NDUFB7;NDUFB3;NDUFAF1;NDUFC1;NDUFA8;NDUFS3;NDUFAB1;NDUFA12;NDUFC2;NDUFB6;NDUFB8;NDUFA9;NDUFA2;NDUFV2;NDUFAF7;NDUFA10;NDUFB4;NDUFB2
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,-0.23753598705376064,-0.847261685464275,0.746031746031746,0.990667180727246,1.0,3/22,5.29%,TERF1;WRAP53;RTEL1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.23783146513460127,0.8469968044348966,0.6530612244897959,1.0,1.0,5/17,17.09%,IL24;PTPN11;STAT4;STAT1;JAK2
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.19973405707143374,-0.8465151246619891,0.6666666666666666,0.9907433426994953,1.0,16/34,36.91%,NUP37;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;PSIP1;NUP214;BANF1;NUP160;SEH1L;AAAS
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,-0.19714875847336893,-0.846331301130061,0.7454545454545455,0.9894379757898951,1.0,12/41,24.39%,CREB1;NRAS;MAPK1;NEFL;GIT1;DLG1;PRKX;CAMK4;PRKAG2;HRAS;PRKAG1;NRGN
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.16856004691895926,-0.8455570913430306,0.8076923076923077,0.9895338711547024,1.0,23/104,19.61%,HRG;CHID1;PHACTR2;NHLRC2;PIKFYVE;LOC112694756;FAM3C;A1BG;SRGN;SYTL4;MAGED2;TMSB4X;SPARC;TIMP1;SCCPDH;TEX264;MMRN1;VTI1B;STX4;CYB5R1;TOR4A;FLNA;PCYOX1L
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.1788445740139539,0.8455222835322268,0.6428571428571429,1.0,1.0,8/44,13.31%,NKIRAS2;LRRC14;UBA52;NOD2;TAB3;RPS27A;RELA;IRAK2
prerank,KEGG_2021_Human__Homologous recombination,-0.20153421811091649,-0.8449242752156576,0.6875,0.9892718846192422,1.0,11/41,23.55%,RPA1;EME1;TOP3A;POLD2;UIMC1;SEM1;BRIP1;RAD52;ABRAXAS1;XRCC2;RAD50
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.16813652125101364,-0.8439193579614441,0.6792452830188679,0.9898853190014777,1.0,23/83,25.80%,CREB1;AKT1;PIK3CA;NRAS;TSC2;APPL1;RPS6KB1;RPTOR;ADCY4;PIK3R1;EIF4E;CLPB;CAMK4;HSPA6;ATF4;HDAC2;PRKAG2;CREB3L4;HRAS;PRKAG1;RHEB;EIF4EBP1;STK11
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.26033533651565566,-0.8435093267322868,0.65625,0.987441750639219,1.0,8/17,33.19%,GNG10;GNG5;PLCB2;GNG3;GNB4;GNG8;GNG7;PLCB3
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.26033533651565566,-0.8435093267322868,0.65625,0.987441750639219,1.0,8/17,33.19%,GNG10;GNG5;PLCB2;GNG3;GNB4;GNG8;GNG7;PLCB3
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.2311960499927148,0.8434345157570708,0.7441860465116279,1.0,1.0,2/22,2.72%,B4GALT4;B4GALT2
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.14766967598296388,-0.8433966941083316,0.7424242424242424,0.9860130345339658,1.0,63/210,29.22%,KLHL25;COPS2;ELOC;UBB;FBXO44;SKP1;NEURL2;UBE2M;SPSB1;CUL1;PSMD11;PSMB7;KLHL5;FBXL20;ANKRD9;DDA1;FBXW2;DCAF17;COMMD7;PSMB4;DCAF4;PSMD8;ASB8;PSMB10;PSMB5;FBXW11;FBXO4;NPLOC4;NAE1;FBXO15;SEM1;PSMD6;KBTBD6;UBE2D1;ASB13;COMMD6;PSMD9;CISH;FBXW4;KBTBD7;COPS3;PSMA6;KLHL9;PSMA4;HIF1A;PSMD13;KLHL3;PSMC1;PSMD3;CUL3;UBC;FBXL19;UBXN7;CUL2;SOCS5;SENP8;FBXO31;FBXL15;PSMA2;BTBD1;DCAF16;PSMA7;WSB2
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.16563594632024037,0.8432467657853083,0.8108108108108109,1.0,1.0,16/70,19.65%,COPZ2;STX18;SEC22B;NAPG;COPZ1;KIF9;RAB1B;TMED3;KIF23;KIFC2;KIF19;TMED7;TMED2;COPG2;TMED9;KIF20B
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.17137813940123872,-0.8428268615176553,0.8518518518518519,0.9855109628989555,1.0,11/87,10.01%,RAB6A;AKT1;RAB18;RAB35;TRAPPC11;GAPVD1;TRAPPC1;RAB39B;RAB27A;TRAPPC5;RAB10
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,-0.21608927823540436,-0.8426847475632735,0.7241379310344828,0.9842141546065427,1.0,7/34,15.57%,MYL9;CALD1;ACTA2;ITGB5;MYL12B;PKN1;ITGA1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.13683051745917799,-0.8417193438993352,0.9344262295081968,0.9847062116968119,1.0,48/336,13.63%,POLR2I;TCEA1;CDK5R1;ELOC;UBB;CNOT6L;CNOT10;AKT1;SLC38A9;RRM2B;YWHAZ;COX7B;UBL4A;ELOA;HUS1;GTF2H3;COX6A1;PRDM1;TSC2;TOP3A;ING5;REXO2;POLR2D;TAF10;TP53RK;CNOT6;EP300;RPTOR;CHD4;MDC1;E2F4;GATAD2A;MAPKAP1;POLR2A;DYRK2;TRIAP1;APAF1;RABGGTB;PMAIP1;CDK9;FOS;LAMTOR2;BANP;BCL2L14;BNIP3L;CSNK2A2;CNOT11;FANCD2
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.22073713677282722,-0.841673813873301,0.7419354838709677,0.9831328512139554,1.0,8/31,19.99%,UBB;FLOT2;FASLG;RIPK3;MLKL;OGT;TANK;TRADD
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.1913412170830072,0.8416415880582084,0.6170212765957447,1.0,1.0,11/37,19.48%,ADD3;VANGL1;RHOF;TOR1AIP1;FAM169A;ARHGAP21;DIAPH2;MYO9B;ARHGAP12;DIAPH3;DEPDC1B
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,-0.14659456903544535,-0.8413223914877478,0.8421052631578947,0.982374781513301,1.0,73/254,26.66%,NUP37;KLKB1;XPO1;MYL9;SRF;PRKCD;PPP2R5B;YWHAZ;H2AC14;NCF2;H2AZ2;DAAM1;RHPN2;ITGB3BP;REXO2;CENPN;NUDC;MAPK1;KIF18A;CLASP2;CENPU;KLC1;RHOQ;ACTR3;PRKCZ;MYL12B;ZW10;SRGAP2;H2AC6;MAD1L1;PKN1;ZWINT;CENPM;PFN2;H2BC13;CTTN;PLK1;RCC2;B9D2;H2BC3;WASF1;WIPF1;PPP2CA;FLNA;KIF5B;PPP1R14A;NOXA1;H2BC12;KIF5A;PMF1-BGLAP;RPS27;S100A9;CENPA;PKN2;WASL;MAPRE1;ITGB1;RHPN1;PPP2R1A;WIPF2;MYH9;MAPK14;H2BC4;SGO1;CDC42;PPP2R1B;NUP43;CENPH;PAFAH1B1;H2AX;NUP85;NUP107;H2AB1
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.146574170969825,-0.8410664175199596,0.7894736842105263,0.981144563697435,1.0,53/141,33.66%,PTGDS;GGT1;PRXL2B;ACSL1;ACBD4;ACOT13;ACLY;AKR1C3;ACOXL;HSD17B4;DECR2;HADHA;ACSF2;PCCA;ACSF3;SCD;PTGR2;MMUT;NDUFAB1;MORC2;PPARD;SLC25A20;TBXAS1;ELOVL5;CYP4F22;ELOVL3;ACOT9;PRKAG2;CRAT;CYP4F2;HSD17B12;MID1IP1;ALOX5AP;ECI1;MAPKAPK2;PCCB;SYCP2;CYP2C9;ELOVL1;HACD2;OLAH;HACD3;DPEP2;HPGDS;SLC25A1;ALDH3A2;ACOX2;SLC25A17;HTD2;ACBD7;MLYCD;GPX1;THEM5
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,-0.2756457010791132,-0.8410514881562335,0.75,0.9795147554520903,1.0,10/16,41.39%,MBOAT2;LPCAT3;MBOAT1;PNPLA8;PLAAT2;PLA2G6;PLAAT4;PLA2G4C;LPCAT4;PLA2G4A
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.1684090092656021,-0.8404286153535677,0.8113207547169812,0.9788891120353146,1.0,22/100,19.61%,HRG;CHID1;PHACTR2;NHLRC2;PIKFYVE;LOC112694756;FAM3C;A1BG;SRGN;SYTL4;MAGED2;TMSB4X;SPARC;TIMP1;SCCPDH;TEX264;MMRN1;VTI1B;CYB5R1;TOR4A;FLNA;PCYOX1L
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.1713995512927627,0.8395670759830157,0.7297297297297297,1.0,1.0,14/57,18.49%,OS9;DERL2;SCUBE2;PSMD7;PSMA5;UBA52;PSMF1;RPS27A;PSMA3;HHAT;ADAM17;PSMB2;PSME2;PSMD12
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.1653619386758489,0.8392702746903605,0.7727272727272727,1.0,1.0,11/56,14.32%,H2BC11;H2BC15;H2BC5;H3-3B;H2AC7;SF3B1;H4C15;MYO1E;H2BC14;H3C13;DDX56
prerank,KEGG_2021_Human__Proteasome,-0.2131697747760583,-0.8392022833961134,0.711864406779661,0.979560028241799,1.0,17/44,29.13%,PSMD11;PSMB7;ADRM1;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;PSMA2;PSMA7
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,-0.1783671065427978,-0.839095336631022,0.7407407407407407,0.9781679549191077,1.0,17/63,21.31%,CREB1;CACNA1I;LIPE;ADCY4;CALML4;STAR;PRKD3;GNA11;ATP1A3;ITPR1;ATP1B2;PLCB2;GNAQ;CAMK4;ATF4;CREB3L4;CALM3
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.1630010070860386,-0.8383693624942599,0.8,0.9780706916166491,1.0,26/102,20.95%,RAB6A;BICD1;RAB18;KIF5C;KIF13B;GALNT2;ACTR1A;KIF18A;CAPZA2;ARF4;KLC1;ZW10;KIF21B;NAPSA;UBE2Z;COPA;CAPZB;RACGAP1;KIF3A;KDELR2;KIF21A;KIF5B;KIF5A;NBAS;KIF6;KDELR1
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.17744679696951107,-0.8381504643900899,0.72,0.9770860109750917,1.0,26/78,27.38%,NUP37;PCK2;PFKL;PROC;PCNX4;LOC112694756;ENO1;FBP1;NUP88;NUP93;PPP2CA;PGP;NUP35;PFKP;TAC4;PPP2R1A;NUP54;NUP42;SLC25A10;PPP2R1B;NUP43;SLC37A4;NDC1;NUP85;NUP107;GNPDA1
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.2270261000619607,-0.8378136221620095,0.8,0.9761567033978968,1.0,10/29,26.26%,MAPKAPK3;NRAS;MAPK1;CRK;FRS2;RALB;RAP1A;HRAS;MAPK14;MAPKAPK2
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.21370948032610948,0.8378097038679121,0.7272727272727273,1.0,1.0,7/35,13.07%,RICTOR;USP7;MTOR;UBA52;CHEK2;RPS27A;MDM4
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.18462743358907527,-0.8365608904981353,0.6896551724137931,0.9770521409436564,1.0,19/59,28.29%,MTARC2;ADH5;ACSS2;CYP27A1;FMO3;MIA3;CMBL;TBXAS1;CBR3;SMOX;CYP4F22;FMO4;CYP4F2;MTARC1;CES1;AOC3;CYP4F12;CYP3A5;CYP2C9
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.19805235855344686,-0.836279823849098,0.7619047619047619,0.9759180835923448,1.0,18/49,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__Tight junction,-0.16199918631751295,-0.8354389426187826,0.8245614035087719,0.9759117618462217,1.0,39/129,25.82%,ARHGAP17;TJP3;MYL9;MAP2K7;JAM3;ACTR3;PRKCZ;MYL12B;DLG1;CLDN9;CD1C;CTTN;RUNX1;TUBA1A;RAP1A;PPP2CA;RAPGEF6;PATJ;PALS1;PRKAG2;HSPA4;RAP2C;HCLS1;ITGB1;CLDN5;PPP2R1A;NEDD4;MAPK8;MAPK9;ACTB;F11R;PRKAG1;MYH9;CDC42;PPP2R1B;TIAM1;PPP2R2A;STK11;SYMPK
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.21052946762669988,-0.8353854300952559,0.8043478260869565,0.9744207212610132,1.0,7/34,16.46%,PGAM1;ALDH7A1;AGXT;DMGDH;CBS;SDS;PHGDH
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.18697707437417793,-0.8346589159802978,0.7368421052631579,0.974313445325861,1.0,8/46,14.19%,VAMP3;RAB6A;M6PR;COG3;IGF2R;PLIN3;NAPSA;COG6
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.20254865053793655,-0.83433780131766,0.734375,0.973311693624937,1.0,4/29,8.68%,ATP5F1E;MICOS13;MTX1;DNAJC11
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.17203981254761447,-0.834180478440831,0.7321428571428571,0.9722101184763761,1.0,22/78,27.26%,AKT1;CLSTN1;PPP2R5B;PIK3CA;FGFR1;TGFA;MAPK1;RNMT;FRS2;PIK3R1;IRAK1;TRAF6;PPP2CA;EPGN;FGFR4;PPP2R1A;CD86;HBEGF;PPP2R1B;IRAK4;PIK3AP1;PDGFRA
prerank,KEGG_2021_Human__Inflammatory bowel disease,0.18832940762692946,0.8340724945758063,0.6739130434782609,1.0,1.0,17/54,22.21%,NOD2;IL10;IL12A;TGFB1;SMAD2;STAT4;IL18R1;RELA;HLA-DOB;STAT1;IL21R;GATA3;IL18RAP;MAF;TLR4;IL23A;TNF
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.1605829495365938,-0.8335689537856691,0.7758620689655172,0.9719868874864754,1.0,28/112,24.27%,PCK2;IL6;AKT1;CCNG2;PIK3CA;NRAS;S1PR4;FASLG;HOMER3;EP300;MAPK1;BNIP3;PIK3R1;SLC2A4;SETD7;TGFBR2;PLK1;CSNK1E;PRKAG2;HOMER2;NLK;MAPK8;MAPK9;HRAS;PRKAG1;MAPK14;S1PR1;CCNB2
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.1771481300095418,-0.8332494849545679,0.75,0.9709424037775983,1.0,22/76,26.42%,UBB;AP2B1;DAAM1;PSMD11;PSMB7;SMURF2;PSMB4;PSMD8;PSMB10;PSMB5;AP2M1;SEM1;PSMD6;PSMD9;PRICKLE1;PSMA6;PSMA4;NCOA3;PSMD13;PSMC1;PSMD3;UBC
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.15962964239085148,-0.8326710180794208,0.8032786885245902,0.9703800105940895,1.0,34/104,28.85%,CTSG;LPAR2;HRH2;SCT;SSTR2;LPAR6;S1PR4;CHRNB4;CNR2;CHRNE;UTS2R;GZMA;ADRB2;ADORA2B;CHRNA5;F2R;ADM;THRA;PTGER2;CHRNA2;TAC4;ADRA1A;GHRL;S1PR1;F2RL1;OPRL1;CHRNA7;FPR3;PTGDR;NPFF;RLN2;TSHR;GIPR;TSPO
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.19966638734737147,0.8319116106530353,0.7333333333333333,1.0,1.0,4/32,8.78%,TECR;ACSL5;ACSL6;HACD1
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.19823528015840336,-0.8317803570192669,0.6949152542372882,0.9704680632422306,1.0,18/49,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.19641549522514593,0.8315641761206899,0.7111111111111111,1.0,1.0,12/44,19.88%,COL9A1;THBS1;PDGFD;COL9A3;THBS4;PTPN11;COL6A1;COL4A3;STAT1;PLG;COL9A2;SOS1
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.2311355919827751,-0.8302995283366695,0.6727272727272727,0.9724304129266792,1.0,14/21,43.92%,ALDH6A1;BCKDHA;IVD;HIBCH;BCAT1;BCAT2;HIBADH;SOAT1;DBT;LDHD;BCKDHB;ACAD8;AUH;SLC25A44
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.24881756014249526,0.8300292247902622,0.65,1.0,1.0,3/25,3.80%,FRAT1;PPP2R5D;PPP2R5E
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.19389532211487134,0.8297117114239508,0.6744186046511628,1.0,1.0,13/38,22.05%,COL9A1;PRNP;COL9A3;COL6A1;RPS6KA5;COL4A3;MAPK3;AGRN;COL9A2;SOS1;CACNB3;CACNB2;PSPN
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.2398243177428995,-0.8293819985781616,0.7115384615384616,0.9726680080513402,1.0,8/20,24.91%,DUSP6;MAPK1;DUSP7;PPP2CA;PPP2R1A;MAPK7;MAPK14;PPP2R1B
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.16725784865328505,-0.8280820167909595,0.8070175438596491,0.973958023896209,1.0,27/96,26.42%,HEY1;UBB;SKP1;AKT1;CUL1;PSMD11;PSMB7;MAPK1;PSMB4;PSMD8;PSMB10;PSMB5;PPARGC1B;RUNX1;SEM1;PSMD6;PSMD9;PPM1D;PSMA6;PSMA4;PSMD13;SMAD1;CBFB;PSMC1;PSMD3;HDAC6;UBC
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.2530112651649906,-0.8280053329854099,0.7321428571428571,0.9725812438045308,1.0,7/19,25.37%,SIRT2;LEMD2;PPP2CA;LEMD3;PPP2R1A;CCNB2;PPP2R2A
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.16436853233002335,-0.8277940351168978,0.7903225806451613,0.9714120653275649,1.0,34/110,28.61%,GATA1;KIF5C;CARMIL1;AK3;CABLES2;KIF13B;KIF18A;CAPZA2;JMJD1C;KLC1;KIF21B;DOCK5;HBG2;CAPZB;CABLES1;RACGAP1;KIF3A;KIF21A;KIF5B;HBE1;KIF5A;HDAC2;PHF21A;KIF6;ZFPM1;CDK5;KIF11;CDC42;MICAL1;EHD1;SH2B1;KIF1C;CENPE;KIF2A
prerank,KEGG_2021_Human__Gastric cancer,0.1581134468557615,0.8269429470578412,0.8095238095238095,1.0,1.0,28/96,22.89%,FRAT1;MTOR;CDKN2B;TERC;ERBB2;WNT7B;TGFB1;GADD45B;MLH1;SMAD4;SMAD2;TGFBR1;FZD6;GADD45G;MAPK3;WNT5B;FRAT2;LEF1;CDKN1B;FGFR2;TCF7L2;CTNNA1;SOS1;EGF;APC;WNT10A;BAK1;KRAS
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.24365071337077016,0.8269276691175627,0.6744186046511628,1.0,1.0,3/20,8.60%,ITGA3;PPIL2;SLC16A3
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.1950373309877244,-0.8266928572689353,0.82,0.972140023276189,1.0,5/56,2.27%,KLKB1;C4BPA;PROC;ITGAM;A2M
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,0.19228221464294112,0.8264021238231888,0.7391304347826086,1.0,1.0,6/28,13.89%,UBA52;ST6GALNAC4;PARP9;PRKCSH;RPS27A;ST6GALNAC2
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.22375373007631721,0.8259098925936516,0.7777777777777778,1.0,1.0,5/17,20.18%,DNA2;POT1;TINF2;WRN;POLR1A
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.1646176680618,-0.824751991625859,0.8166666666666667,0.9746716344038232,1.0,32/107,26.33%,NUP37;XPO1;PPP2R5B;ITGB3BP;ANAPC7;CENPN;NUDC;KIF18A;CLASP2;CENPU;ZW10;ANAPC5;MAD1L1;ZWINT;CENPM;PLK1;RCC2;B9D2;PPP2CA;UBE2D1;PMF1-BGLAP;RPS27;CENPA;MAPRE1;PPP2R1A;SGO1;PPP2R1B;NUP43;CENPH;PAFAH1B1;NUP85;NUP107
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.23188332558791197,-0.8220938282474869,0.7358490566037735,0.9784590243575767,1.0,7/21,23.95%,PRKCD;NCF2;MAPK1;PRKCZ;NOXA1;S100A9;MAPK14
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,0.1808082066101663,0.8211405487249528,0.8809523809523809,1.0,1.0,12/51,17.08%,H2BC11;H2BC15;RUVBL1;H2BC5;CENPO;CENPT;H2AC7;H4C15;RSF1;H2BC14;CENPK;NPM1
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,0.22710783614149588,0.8201544781934273,0.7727272727272727,1.0,1.0,3/20,10.53%,ANAPC11;CDC16;ANAPC15
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.2139154551171043,-0.8198640238834918,0.6774193548387096,0.9812080546974616,1.0,4/27,11.67%,GP9;AKT1;CRK;MPL
prerank,KEGG_2021_Human__Fanconi anemia pathway,0.17301659637110506,0.8193427757566004,0.7560975609756098,1.0,1.0,13/54,18.11%,FAAP100;FANCE;REV1;ERCC4;BLM;POLI;MLH1;RPA2;FAAP24;PALB2;POLH;REV3L;RPA4
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,-0.16676197020918276,-0.8180370079427935,0.7796610169491526,0.9830076668891752,1.0,28/94,25.29%,VAMP3;UBB;CTSS;NCF2;PSMD11;PSMB7;ITGB5;PSMB4;SEC61A2;PSMD8;TLR1;SEC14L2;PSMB10;PSMB5;TLR2;SEM1;PSMD6;STX4;PSMD9;S100A9;CALR;SNAP23;PSMA6;PSMA4;PSMD13;NDUFA2;PSMC1;PSMD3
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.23926233360498528,-0.8172806004424704,0.7068965517241379,0.9829567402043962,1.0,8/18,32.54%,GNG10;GNG5;GNA11;GNAQ;GNG3;GNB4;GNG8;GNG7
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.15777024112802465,0.8169547713459907,0.7948717948717948,1.0,1.0,20/110,13.36%,RPL4;RPS20;RPL31;RPS15;RPS25;RPLP0;UPF1;UBA52;RPS19;FAU;SMG1;RPS10;RPL29;RPS21;SMG5;RPS27A;RPL37A;RSL24D1;RPL39;RPS28
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,0.18478623520941279,0.8168293551587456,0.6595744680851063,1.0,1.0,10/50,14.21%,ATP6V0B;CYBRD1;TCIRG1;UBA52;GLRX3;ATP6V1F;ALAD;RPS27A;FTL;SLC22A17
prerank,KEGG_2021_Human__Melanogenesis,0.1797819735814003,0.8168112001200133,0.675,1.0,1.0,18/63,23.34%,PLCB4;CAMK2A;GNAI1;ADCY3;MC1R;WNT7B;PRKACA;FZD6;MAPK3;WNT5B;LEF1;GNAO1;TCF7L2;GNAI3;ADCY9;WNT10A;KRAS;ADCY7
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.16700624260614028,-0.8160839689229851,0.8518518518518519,0.983609246672168,1.0,23/88,24.77%,AKT1;PIK3CA;PCGF5;HESX1;FGFR1;NRAS;ACVR1B;MAPK1;ACVR2B;PIK3R1;TCF3;JAK3;KAT6A;PCGF1;PCGF3;FGFR4;SETDB1;HRAS;SMAD5;MAPK14;SMAD1;WNT10B;ID2
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.20962615965510048,-0.8151538504146534,0.7592592592592593,0.9838083003399727,1.0,11/33,26.71%,AKT1;PIK3CA;PIK3R1;ATP1A3;ATP1B2;PLCB2;FXYD2;HK3;SLC37A4;ATP1B3;HK1
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.12962357505956665,-0.8147912491713234,0.9655172413793104,0.9828550005640665,1.0,94/381,24.31%,GPR132;CCL28;CCR8;CREB1;RGS12;LPAR2;AKT1;GNG10;PDE1B;PRKCD;HRH2;PIK3CA;SCT;AGXT;HCAR1;NLN;GNG5;PCDHA4;SSTR2;CXCR1;LPAR6;NRAS;NBEA;S1PR4;CXCR3;GPR15;PDE3A;ADGRE3;PIK3R5;TRPC6;CNOT6;TAS2R5;RGS6;ADCY4;KALRN;MAPK1;CXCR2;PRKCH;CMKLR1;TAS2R50;GNA11;GPR68;UTS2R;PIK3R1;CXCR6;PKN1;AKAP13;ITPR1;CD55;PDE3B;PRKX;ADRB2;ADORA2B;PLCB2;GNAQ;DHX34;F2R;RGS5;ADM;GPSM1;RGS1;PLEKHG5;ABHD12;RAMP1;CAMK4;PTGER2;PPP2CA;SMOX;CXCR4;PRPF38B;ARHGEF40;VAV2;CD200R1;ARHGEF15;ITGB1;DGKQ;ADRA1A;CXCL5;PPP2R1A;ARHGEF39;ARHGEF19;TAS2R4;HRAS;CDK5;CCRL2;GHRL;TRIO;MAPK7;HBEGF;GNG3;WNT10B;S1PR1;CXCR5;CDC42
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.13157728359220514,-0.8138602872778745,0.9830508474576272,0.9830379506327483,1.0,90/351,25.37%,GPR132;CCL28;CCR8;CREB1;RGS12;LPAR2;AKT1;GNG10;PDE1B;PRKCD;HRH2;PIK3CA;SCT;AGXT;HCAR1;GNG5;PCDHA4;SSTR2;CXCR1;LPAR6;NRAS;NBEA;S1PR4;CXCR3;GPR15;PDE3A;PIK3R5;TRPC6;CNOT6;TAS2R5;RGS6;ADCY4;KALRN;MAPK1;CXCR2;PRKCH;TAS2R50;GNA11;GPR68;UTS2R;PIK3R1;CXCR6;PKN1;AKAP13;ITPR1;PDE3B;PRKX;ADRB2;ADORA2B;PLCB2;GNAQ;DHX34;F2R;RGS5;ADM;GPSM1;RGS1;PLEKHG5;ABHD12;RAMP1;CAMK4;PTGER2;PPP2CA;CXCR4;PRPF38B;ARHGEF40;VAV2;CD200R1;ARHGEF15;ITGB1;DGKQ;ADRA1A;CXCL5;PPP2R1A;ARHGEF39;ARHGEF19;TAS2R4;HRAS;CDK5;GHRL;TRIO;MAPK7;HBEGF;GNG3;CXCR5;CDC42;PPP2R1B;F2RL1;TIAM1;OPRL1
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.23665938114529275,0.8134204410785159,0.7111111111111111,1.0,1.0,5/20,15.18%,CCT2;CCT3;TCP1;TUBB4A;TUBB2A
prerank,KEGG_2021_Human__Propanoate metabolism,0.19811880653266994,0.8126404841367952,0.7894736842105263,1.0,1.0,5/31,10.41%,LDHB;SUCLG1;ACOX1;SUCLG2;MCEE
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,-0.23969347114234993,-0.8125048397512629,0.7931034482758621,0.9842519479110069,1.0,12/15,56.10%,PTPN22;HLA-DRB5;HLA-DRA;HLA-DRB3;CD4;CD3E;ZAP70;CD3D;HLA-DRB4;HLA-DQA1;LCK;HLA-DPA1
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.15023559636719983,-0.8124876051130324,0.8541666666666666,0.9827209948806694,1.0,16/136,8.57%,CREB1;MGST3;GSTA4;AKT1;PIK3CA;HSP90B1;NRAS;CHRNB4;BAD;JAG1;RPS6KB1;NR1I3;GSTO1;GSTM2;ADCY4;MAPK1
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.1639008802413024,-0.8120196020287543,0.8,0.9821568856522369,1.0,45/103,36.90%,NUP37;XPO1;PPP2R5B;ITGB3BP;CENPN;NUDC;KIF18A;CLASP2;CENPU;ZW10;MAD1L1;ZWINT;STAG2;CENPM;PLK1;RCC2;B9D2;PPP2CA;PMF1-BGLAP;RPS27;CENPA;MAPRE1;PPP2R1A;SGO1;CCNB2;PPP2R1B;NUP43;CENPH;PAFAH1B1;NUP85;NUP107;CENPE;KIF2A;KNTC1;PMEPA1;CKAP5;DYNC1H1;SKA2;CENPL;MIS12;CENPQ;NUP160;PPP2CB;SEH1L;ZWILCH
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.2387575410703514,-0.8119781179615485,0.7321428571428571,0.9807002590337884,1.0,2/15,5.93%,PDK4;DLAT
prerank,KEGG_2021_Human__Taste transduction,0.19420089304135335,0.8112615971734769,0.8269230769230769,1.0,1.0,2/33,2.08%,PLCB4;TAS2R13
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.14726339220847728,-0.8112264266507688,0.7894736842105263,0.9806536605931697,1.0,44/173,21.43%,CEP63;CCT4;RAB11A;HAUS8;AHI1;ALMS1;ARL13B;IFT22;ACTR1A;CNTRL;TNPO1;ARF4;CETN2;EXOC2;AKAP9;ASAP1;C2CD3;NEDD1;WDR19;MKS1;IFT122;CEP192;CEP290;BBS5;PLK1;TUBB4B;CSNK1E;CSNK1D;CCP110;CEP89;B9D2;KIF3A;TUBA1A;CEP76;SMOX;DYNLT2B;DYNC2H1;CEP164;B9D1;CEP70;SDCCAG8;HAUS2;MAPRE1;ARL3
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.15976598422145183,-0.8110474801994609,0.8245614035087719,0.9793690256691904,1.0,27/95,26.90%,UBB;SKP1;PRKCD;UBE2M;CUL1;PSMD11;PSMB7;UBE2N;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;TRAF6;ITPR1;SEM1;PSMD6;UBE2D1;PSMD9;PLCG2;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;AHCYL1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,0.20534496692863882,0.8106381413923153,0.7777777777777778,1.0,1.0,6/30,12.48%,H2AC12;MYSM1;STAM;UBA52;H2AC7;RPS27A
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.2126019589650171,-0.8105127844144863,0.7704918032786885,0.9789784992992437,1.0,4/28,10.48%,UBB;VPS37B;CHMP4B;VPS28
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.13535574822376265,0.8104097700391465,0.972972972972973,1.0,1.0,31/157,18.18%,SEC61B;GFER;USP9X;ACOX1;COQ2;PEX2;PRNP;UBA52;BCS1L;SERP1;PMPCA;TOMM70;MPV17;TOMM6;ZNF260;BAAT;GET3;CROT;ATP5MC1;RPS27A;ACOT8;ECH1;AMACR;LONP2;COA6;SLC25A4;HSCB;TOMM7;ACBD5;SLC25A13;TOMM22
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.2233182814242514,-0.8098519482003624,0.7307692307692307,0.9784410705417459,1.0,5/21,14.59%,CHSY1;B4GALT1;GPC2;EXT1;HEXA
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.17010538177110554,-0.8095296395787561,0.7241379310344828,0.9772973268460011,1.0,4/67,3.02%,SLC25A26;SLC9A4;CTNS;SLC26A6
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.18878012782850437,-0.8094681842234748,0.7796610169491526,0.9758618171817715,1.0,7/40,14.99%,SPTLC1;DEGS1;PSAP;CERS2;GLA;SGMS1;UGT8
prerank,KEGG_2021_Human__Focal adhesion,0.14113806562657982,0.8078263371788212,0.9523809523809523,1.0,1.0,38/154,20.54%,ITGA3;ITGA4;TLN2;COL9A1;THBS1;PDGFD;ARHGAP35;MYL12A;PPP1R12A;PARVB;COL9A3;ERBB2;FN1;THBS4;RAC3;COL6A1;CCND2;MYLK3;COL4A3;MAPK3;PPP1CA;PGF;ITGAV;ZYX;PARVG;LAMB3;VAV3;TLN1;ITGA5;RAC1;ITGA7;PDPK1;COL9A2;RAC2;SOS1;EGF;ITGA2B;ITGA9
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.2240250540023998,0.8076469405629099,0.7058823529411765,1.0,1.0,2/19,4.06%,UCKL1;TK2
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.1464343557497945,0.8056677324832452,0.8378378378378378,1.0,1.0,30/130,18.73%,PHC3;MTA2;TNRC6C;USP7;MTOR;AGO4;RING1;PSMD7;RRAGD;PSMA5;HDAC3;UBA52;PHC1;TNKS2;MOV10;PPARG;MKRN1;PSMF1;RPS27A;PSMA3;FRK;LAMTOR3;MAPK3;PSMB2;PSME2;SCMH1;EGR1;LAMTOR4;PSMD12;KDM1A
prerank,KEGG_2021_Human__Primary immunodeficiency,0.20923044039794408,0.8044344201791811,0.6176470588235294,1.0,1.0,9/32,20.85%,UNG;ICOS;CD19;CD40LG;RFXANK;CIITA;IKBKG;AICDA;ORAI1
prerank,KEGG_2021_Human__Long-term depression,0.1814464416751857,0.8033807996391441,0.7333333333333333,1.0,1.0,3/44,4.54%,PLCB4;GNA12;GNAI1
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.20528117437881102,0.8028479242591957,0.6744186046511628,1.0,1.0,6/23,17.14%,ARHGEF11;ARHGAP35;ERBB2;RHOC;MYH11;ARHGEF12
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,0.21085572228682897,0.8017973466811534,0.7111111111111111,1.0,1.0,2/31,1.97%,ORC3;CDC6
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.12328395203591505,0.8016733679978864,0.9473684210526315,1.0,1.0,48/381,12.54%,IL9R;PTPN4;INPPL1;SQSTM1;CXCL8;NKIRAS2;F13A1;IL1R1;IL24;BIRC5;PPP2R5D;CSF1;LRRC14;PSMD7;TNIP2;PTPN2;RPLP0;PSMA5;RALA;UBA52;NOD2;MMP9;IL10;IL27;SIGIRR;TEC;MCL1;STXBP2;EBI3;IL12A;FN1;PTPN23;MEF2A;TGFB1;ANXA2;TAB3;CNN2;MYD88;BCL6;PTPN11;PSMF1;RPS6KA5;CCL3;TCP1;STAT4;IL18R1;RPS27A;RELA
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.1741459210420204,-0.8009093301904978,0.7627118644067796,0.9892884320422356,1.0,19/64,26.42%,UBB;SKP1;CUL1;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.17054300268800068,0.8000664230744052,0.8095238095238095,1.0,1.0,18/66,20.49%,SQSTM1;ARHGEF11;ARHGEF4;UBA52;MAGED1;PSEN2;PREX1;ARHGEF18;RPS27A;ECT2;ARHGEF10;BCL2L11;VAV3;ARHGEF12;SOS1;FGD4;ARHGEF9;RNASE1
prerank,KEGG_2021_Human__RNA transport,-0.14337252858811556,-0.7999653337167117,0.896551724137931,0.9897524284557988,1.0,11/164,3.13%,NUP37;UPF3B;EIF4A1;ALYREF;XPO1;SUMO4;EIF1AY;RAN;PHAX;TGS1;FXR2
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.15217469712879603,-0.7995916801659396,0.8275862068965517,0.9889575436015228,1.0,13/85,12.97%,AKT1;PIK3CA;NRAS;CHPT1;TSC2;SLC22A1;RPS6KB1;MAPK1;PCYT1A;CHKB;FOS;PIK3R1;LYPLA1
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.20838596529368084,0.799257342302044,0.7,1.0,1.0,6/37,8.54%,NRIP1;TNRC6C;AGO4;APOE;HDAC3;MOV10
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.21158249557108397,-0.7992058268851696,0.7735849056603774,0.988067280423188,1.0,3/30,5.06%,KRT5;KRT73;JUP
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.1671735926565336,-0.7975286197713048,0.7586206896551724,0.9892473404261214,1.0,22/71,24.31%,PRKCD;MAP2K7;NRAS;ADCY4;MAPK1;CALML4;GNA11;ITPR1;MAP2K4;PLCB2;GNAQ;ATF4;MAP3K3;MAP2K3;CALM3;MAPK8;MAPK9;HRAS;MAPK7;MAPK14;HBEGF;CDC42
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.14315918464630747,-0.7955475943734517,0.859375,0.9912365249072321,1.0,37/159,22.94%,UGGT1;SKP1;HSPA4L;LMAN1;BCAP31;SELENOS;CUL1;UBXN4;HSP90B1;UGGT2;MAP2K7;EIF2S1;MBTPS2;STT3A;EDEM2;EIF2AK2;UBE2J1;SEC61A2;TRAM1;DDIT3;NSFL1C;RAD23B;UBE2G1;ATXN3;NPLOC4;DNAJC3;SEC24A;HSPA6;UBE2D1;ATF4;RPN2;CALR;DNAJB12;SAR1A;MAPK8;MAPK9;DAD1
prerank,KEGG_2021_Human__Fructose and mannose metabolism,-0.20873520421390543,-0.7952351873698776,0.8085106382978723,0.990249482749682,1.0,8/29,26.71%,PFKL;GMDS;FBP1;AKR1B1;PFKP;HK3;GMPPB;HK1
prerank,KEGG_2021_Human__Circadian entrainment,-0.1796545139147343,-0.7945419517337022,0.7924528301886793,0.9901891673704316,1.0,12/57,15.98%,CREB1;GNG10;CACNA1I;GNG5;ADCY4;MAPK1;CALML4;RYR3;FOS;ITPR1;PLCB2;GNAQ
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.1603886608203839,-0.794427381257513,0.8135593220338984,0.9888184219158794,1.0,19/82,20.65%,GNG10;CCT4;GNG5;WRAP53;RGS6;NOP56;TBCA;FBXW2;GNA11;TUBB6;CSNK2A2;FBXO4;GNAQ;TUBB4B;XRN2;TUBA1A;KIF13A;SPHK1;FBXW4
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.17303119630278205,-0.7944204401071006,0.828125,0.9873064671423077,1.0,22/71,26.42%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;PLK1;SEM1;PSMD6;UBE2D1;AURKA;PSMD9;PSMA6;PSMA4;PTTG1;PSMD13;PSMC1;PSMD3;UBC
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.16738498411290023,-0.794014284758764,0.8181818181818182,0.9863637148589987,1.0,26/91,25.29%,ABCC9;UBB;PSMD11;PSMB7;EIF2S1;ABCA7;ABCC5;PSMB4;PSMD8;PSMB10;PSMB5;ABCC3;ABCB1;SEM1;ABCB4;ABCB9;PSMD6;ABCG1;PSMD9;PSMA6;ABCD2;PSMA4;ABCA10;PSMD13;PSMC1;PSMD3
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.14815227206723147,0.7937289383664665,0.9117647058823529,1.0,1.0,10/116,6.44%,ORC3;DNA2;CDC6;ANAPC11;CDC16;RFC3;RFC5;PSMD7;PSMA5;UBA52
prerank,KEGG_2021_Human__Cocaine addiction,-0.20968008738933427,-0.7936251057858152,0.8269230769230769,0.985488262555922,1.0,2/25,1.23%,CDK5R1;CREB1
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.1638163033076756,-0.793132750293857,0.8333333333333334,0.9848406221146964,1.0,24/77,29.13%,UBB;SKP1;CUL1;PSMD11;PSMB7;NRAS;PSMB4;PSMD8;PSMB10;PSMB5;FBXW11;SEM1;PSMD6;PSMD9;PSMA6;HRAS;PSMA4;PSMD13;PSMC1;PSMD3;UBC;FKBP1A;PSMA2;PSMA7
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.15466098689286753,-0.7925133371468027,0.8596491228070176,0.9844036974012761,1.0,43/107,37.36%,UBB;SKP1;CLSTN1;CUL1;PSMD11;PSMB7;NRAS;PSMB4;PSMD8;PSMB10;PIK3R1;PSMB5;FBXW11;ORAI2;ITPR1;SEM1;PSMD6;PSMD9;PLCG2;PSMA6;HRAS;PSMA4;PSMD13;PSMC1;PSMD3;UBC;AHCYL1;PIK3AP1;FKBP1A;PSMA2;PSMA7;PTPN6;TRPC1;BLK;ITPR3;PSMC5;BTK;PSMC2;MALT1;PSMC3;STIM1;PSME1;CARD11
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.15856137767753276,-0.7908436082457053,0.8214285714285714,0.9856676085524507,1.0,23/85,27.26%,AKT1;CLSTN1;PPP2R5B;PIK3CA;FGFR1;TGFA;MAPK1;RNMT;FRS2;PIK3R1;IRAK1;TRAF6;PPP2CA;EPGN;FGFR4;PPP2R1A;CD86;HBEGF;PPP2R1B;IRAK4;TRIB3;PIK3AP1;PDGFRA
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.15859459345392704,0.7896609998375328,0.8947368421052632,1.0,1.0,25/81,23.82%,PDE2A;GNAI1;PPAN-P2RY11;GNB5;GPER1;ADORA2A;PDE10A;MC1R;GRK3;INSL3;PDE7A;CPAMD8;GNG4;GRK2;ITGA5;GRK5;GPR27;GNAI3;GNG11;ADM2;ADCY9;GNGT2;GRK6;ADCY7;NLRP3
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.17443114750749966,0.7893935070929929,0.813953488372093,1.0,1.0,14/49,20.49%,ARHGEF11;ARHGEF4;MAGED1;PREX1;ARHGEF18;ECT2;ARHGEF10;BCL2L11;VAV3;ARHGEF12;SOS1;FGD4;ARHGEF9;RNASE1
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.20966295347848074,-0.788192229218429,0.7962962962962963,0.9887366862299193,1.0,6/26,25.90%,UBB;MRPL18;SERPINH1;HSPA6;DNAJB6;HDAC6
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.250693699662379,-0.7880561296086227,0.75,0.9874166973351397,1.0,2/15,4.37%,GNG10;GNG5
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.1588799757159247,-0.7855914092349792,0.8596491228070176,0.9895641148626475,1.0,29/92,27.21%,CREB1;AKT1;GNG10;PPP2R5B;GNG5;KIF5C;COMT;CALML4;FOS;ITPR1;PLCB2;GNAQ;PPP2CA;ATF4;KIF5B;KIF5A;PPP2R3A;CREB3L4;CALM3;PPP2R1A;MAPK8;MAPK9;MAPK14;GNG3;CLOCK;PPP2R1B;PPP2R2A;PPP2R3C;GNB4
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.23382975117167132,0.785512727254556,0.6829268292682927,1.0,1.0,5/15,14.13%,UBA52;TAB3;RPS27A;IRAK2;TICAM1
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.19983015629723228,-0.7854921006349449,0.7586206896551724,0.9882149870657926,1.0,14/31,39.02%,CLSTN1;PIK3R1;ORAI2;ITPR1;PLCG2;AHCYL1;PIK3AP1;PTPN6;TRPC1;BLK;ITPR3;BTK;STIM1;NCK1
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.24151395391677713,-0.7854901453088297,0.7761194029850746,0.9867426238633087,1.0,2/16,4.37%,GNG10;GNG5
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,-0.2064751365014481,-0.7850367258792496,0.7575757575757576,0.9859420038071327,1.0,8/25,24.91%,PROC;PPP2R5B;LRP6;CTBP1;AMER1;PPP2CA;PPP2R1A;PPP2R1B
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.14496127456921484,0.7846848486282787,0.8857142857142857,1.0,1.0,24/114,17.48%,H2BC11;DNA2;H2BC15;RFC3;RFC5;RUVBL1;H2BC5;BLM;CHTF8;CENPO;H3-3B;CENPT;POT1;H2AC7;H4C15;RSF1;H2BC14;POLA1;TINF2;PPP6R3;SLC19A1;CENPK;NPM1;WRN
prerank,Reactome_2022__Drug ADME R-HSA-9748784,0.17990696484832902,0.7841627193770843,0.86,1.0,1.0,7/44,12.65%,GSTM1;SLC28A2;SLC29A1;CNDP2;ACSM2B;UGT2B4;ABCC2
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.14906171768253917,0.7837867771774513,0.8461538461538461,1.0,1.0,12/108,10.12%,IFITM1;LAIR2;ITGA4;NPDC1;KLRD1;CD300LD;PVR;CD19;ICAM4;TREML1;SIGLEC1;CD40LG
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.1782184642698573,0.7835481034506163,0.717948717948718,1.0,1.0,2/35,3.41%,ACTR10;NR3C2
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.15960528817455802,-0.7820221824128186,0.7962962962962963,0.9888878325581476,1.0,19/89,22.36%,PAK1;AKT1;ASAP2;PRKCD;PIK3CA;RPS6KB1;MAPK1;CRK;ACTR3;ASAP1;PIK3R1;INPP5D;WASF1;SPHK1;VAV2;PTPRC;PLCG2;FCGR3B;DNM2
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.17751120052080727,0.7817909857703345,0.8536585365853658,1.0,1.0,12/57,19.19%,C3AR1;IL10;C5AR1;FCGR2C;KRT15;FCGR1A;CAMP;HLA-DOB;ICAM1;PLG;C1QC;FCGR3A
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,-0.14809824668852267,-0.7815345394408094,0.8833333333333333,0.9881972826305062,1.0,29/94,29.12%,CTSS;AP1S1;AP2B1;KIF5C;ACTR1A;KIF18A;CAPZA2;KLC1;IFI30;AP2M1;CAPZB;RACGAP1;SEC24A;KIF3A;DNM3;KIF5B;KIF5A;PRICKLE1;CTSB;DNM2;AP1M2;KIF11;CD74;HLA-DRB5;OSBPL1A;CENPE;KIF2A;DCTN6;SEC24C
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.18217459234124772,-0.780702096048669,0.7884615384615384,0.9879833131195536,1.0,4/38,7.50%,PTGDS;GGT1;PRXL2B;AKR1C3
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.2056294108927273,0.7799183118666849,0.8723404255319149,1.0,1.0,2/23,2.69%,TAS2R13;SCNN1D
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.16271038754905356,-0.7795921441949305,0.8833333333333333,0.9882437868933763,1.0,18/76,20.65%,GNG10;CCT4;GNG5;WRAP53;RGS6;NOP56;FBXW2;GNA11;TUBB6;CSNK2A2;FBXO4;GNAQ;TUBB4B;XRN2;TUBA1A;KIF13A;SPHK1;FBXW4
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.22475222310740184,-0.7794670807743262,0.7704918032786885,0.9870211142709426,1.0,6/20,19.35%,KIF5C;RAB27A;EXOC2;SLC30A6;KIF5B;KIF5A
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.15869039954085168,-0.7786965413631111,0.9,0.9867311223662646,1.0,22/84,24.98%,MAP3K8;IL6;AKT1;PIK3CA;MAP2K7;CD14;MAPK1;TLR1;FOS;PIK3R1;IRAK1;TRAF6;TLR2;MAP2K4;TLR5;TRAF3;MAP2K3;MAPK8;MAPK9;CD86;MAPK14;IRAK4
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.24599344299928855,0.776503534620983,0.825,1.0,1.0,4/17,11.78%,EXOC7;EXOC5;RAB11FIP3;EXOC4
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.21148359663645383,0.7763932123790641,0.7446808510638298,1.0,1.0,2/20,2.81%,ADD3;NIPAL2
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.22919177870656054,0.7758192644485371,0.7692307692307693,1.0,1.0,8/27,17.89%,ENTPD6;ENTPD4;ADPRM;ENTPD5;UPP1;NT5C1A;GDA;UPB1
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,0.14593951268658778,0.7750200698796021,0.9047619047619048,1.0,1.0,18/83,18.41%,H2BC11;H2BC15;H2AC12;UBAP1;CHMP1A;NUP58;H2BC5;POM121;H2AC7;NUP210;H4C15;H2BC14;H3C13;IRS1;SEC13;H2AC21;NUP155;NUP62
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.14356092607622334,-0.7738969689599252,0.8947368421052632,0.9926525577343513,1.0,45/174,23.61%,CLSTN1;LPCAT2;PIK3CA;DGAT1;LPIN1;PGS1;PIKFYVE;MBOAT2;CHPT1;DDHD1;PNPLA2;PIK3R5;RAB4A;ABHD3;CEPT1;TMEM86B;PCYT1A;CHKB;MIGA1;PTPMT1;TNFAIP8L1;HADHA;PIK3R1;MTMR9;CSNK2A2;PEMT;CPNE1;PLD4;STARD7;INPP5D;BMX;RAB14;DDHD2;MTMR12;LPCAT3;TNFAIP8L2;MBOAT1;PLEKHA1;INPP5K;PLEKHA5;MTMR10;AGK;PI4K2B;PNPLA8;PLEKHA8
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.18506662850570882,-0.7718144878202748,0.85,0.9946158001671346,1.0,17/41,29.37%,ATP10D;ATP11A;ATP2A1;ATP1A3;ATP1B2;FXYD2;ATP8B2;ATP2A2;ATP9A;SRI;ATP7A;ATP1B3;ATP2A3;ATP13A1;ATP9B;ATP11C;ATP8B4
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.13165669509604533,-0.7714354906243215,0.9491525423728814,0.9936260741121525,1.0,71/257,27.32%,UBB;CREB1;CNOT6L;AKT1;SLC38A9;CLSTN1;PDE1B;PRKCD;PPP2R5B;PIK3CA;FGFR1;PSMD11;PSMB7;NBEA;TGFA;BAD;TSC2;PHC2;RPTOR;ADCY4;MAPK1;CHD4;PSMB4;GATAD2A;RNMT;MAPKAP1;PSMD8;FRS2;PSMB10;LAMTOR2;PIK3R1;PSMB5;CSNK2A2;IRAK1;TRAF6;ITPR1;WWP2;PRKX;EED;ATN1;CBX4;SEM1;PSMD6;CAMK4;PPP2CA;EPGN;PSMD9;VAPA;HDAC2;FGFR4;CBX8;PPP2R1A;NEDD4;PSMA6;CD86;PSMA4;PSMD13;HBEGF;RRAGC;RHEB;PPP2R1B;IRAK4;PSMC1;PSMD3;UBC;TRIB3;HDAC5;AHCYL1;PIK3AP1;PDGFRA;FOXO3
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.1973315822935029,-0.7712201327072508,0.7666666666666667,0.9925923213760751,1.0,16/44,29.13%,PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;PSMA2;PSMA7
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.16835949300234088,0.7707976846603882,0.8260869565217391,1.0,1.0,12/56,14.63%,RPS20;RPS15;RPS25;EIF3C;RPS19;FAU;EIF1AX;RPS10;RPS21;RPS27A;RPS28;EIF2S2
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.17908435126182198,-0.7707370874379141,0.8367346938775511,0.9920617842689887,1.0,16/35,36.91%,NUP37;NUP88;NUP93;NUP35;NUP54;NUP42;CCNB2;NUP43;NDC1;NUP85;NUP107;NEK6;NUP214;NUP160;SEH1L;AAAS
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.16090912622876977,0.7703966148506821,0.8571428571428571,1.0,1.0,6/70,5.40%,PLCB4;CAMK2A;PPP2R5D;KPNA2;GNAI1;GNB5
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.14828402800419516,-0.7701633294837066,0.8571428571428571,0.9914391735289857,1.0,30/109,26.33%,NUP37;NCOR2;CREB1;VPS37B;H2AC14;TBL1X;CHMP4B;HSD17B4;VPS28;NCOR1;NUP88;H2AC6;NUP93;H2BC13;EED;TSG101;H2BC3;H2BC12;NUP35;ITGB1;NUP54;NUP42;TBL1XR1;GPS2;H2BC4;TARBP1;NUP43;NDC1;NUP85;NUP107
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.13849975437478754,-0.769875162252773,0.9322033898305084,0.9903820528247057,1.0,29/164,15.94%,CCL28;CCR8;IL6;LTBR;IL15;IL15RA;BMP7;CXCR1;TNFSF14;FASLG;CXCR3;IL17RA;CCR10;ACVR1B;IL2RB;TNFSF13B;TNFRSF9;TNFSF9;ACVR2B;CXCR2;FAS;PF4V1;MPL;CXCR6;TGFBR2;TNFRSF4;IFNGR2;TNFRSF10C;TNFSF4
prerank,KEGG_2021_Human__Pancreatic secretion,0.1644621179970524,0.7694701722033702,0.8809523809523809,1.0,1.0,18/54,25.14%,PLCB4;TPCN2;CD38;ADCY3;KCNMA1;PLA2G2C;PLA2G12A;PNLIPRP1;RAB8A;RAB3D;RAC1;SLC9A1;ATP1A4;ADCY9;ADCY7;ATP1B1;SLC4A2;ATP2B4
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.19693971989765988,0.7688786627040096,0.8333333333333334,1.0,1.0,7/36,13.07%,RICTOR;USP7;MTOR;UBA52;CHEK2;RPS27A;MDM4
prerank,KEGG_2021_Human__Adherens junction,-0.16663794667018192,-0.7675899521658927,0.819672131147541,0.9924090951888513,1.0,19/61,26.86%,FGFR1;EP300;MAPK1;CSNK2A1;SSX2IP;CTNND1;NECTIN2;CSNK2A2;TGFBR2;FER;WASF1;NECTIN3;WASL;NLK;NECTIN1;ACTB;CDC42;PTPRJ;PTPRF
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.19474604509766708,-0.7675593420745772,0.8571428571428571,0.9910273599063414,1.0,5/30,12.44%,UBB;EP300;RPTOR;MRPL18;SERPINH1
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,-0.2058735185360513,-0.7663418078943656,0.7857142857142857,0.9912787738680163,1.0,9/26,27.43%,PIK3CA;MAPK1;PIK3R1;ATP1A3;ATP1B2;FXYD2;SCNN1A;ATP1B3;NEDD4L
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.22878817491321554,-0.7656862753359448,0.7966101694915254,0.9907703226711454,1.0,7/19,26.26%,MAPKAPK3;UBE2N;IRAK1;TRAF6;MAP2K3;MAPK14;MAPKAPK2
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.16437011792290088,-0.7646957921523259,0.85,0.9907429217546595,1.0,24/74,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;PLK1;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PTTG1;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,0.21598138224015484,0.7623334490860475,0.75,1.0,1.0,2/19,4.72%,GSTM1;CNDP2
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.14994706912053696,-0.761943506929026,0.8703703703703703,0.9934651858550696,1.0,13/85,15.24%,AKT1;BATF2;PIK3CA;NRAS;RPS6KB1;MAPK1;CSNK2A1;FOS;PIK3R1;CSNK2A2;TRAF6;TLR2;IFNGR2
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.1716829569325683,0.7619150213178533,0.868421052631579,1.0,1.0,11/47,17.27%,PRMT7;H2AC12;PBRM1;CDK4;H2AC7;DNMT3A;H4C15;H3C13;CARM1;JAK2;H2AC21
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.24059914892443024,0.7611479733955807,0.7142857142857143,1.0,1.0,6/15,24.91%,LIN7A;PPFIA4;STXBP1;LIN7B;LIN7C;SLC18A2
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.1465765468556179,0.7610809298397114,0.9166666666666666,1.0,1.0,15/101,13.84%,H2BC11;H2BC15;ATXN7;H2AC12;DMAP1;RUVBL1;ELP2;H2BC5;NCOA2;MORF4L1;HCFC1;H2AC7;H4C15;H2BC14;H3C13
prerank,KEGG_2021_Human__Colorectal cancer,-0.16234606358641127,-0.760588095595283,0.82,0.9937886956142433,1.0,13/82,13.31%,AKT1;PIK3CA;CASP3;NRAS;TGFA;BAD;APPL1;RPS6KB1;MAPK1;PMAIP1;FOS;PIK3R1;TGFBR2
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.14828027233106417,0.7597827036810877,0.9130434782608695,1.0,1.0,14/86,14.52%,PLCB4;GNA12;ARHGEF11;KCNMB4;ADCY3;PPP1R12A;ADORA2A;KCNMA1;PLA2G2C;MYLK3;PRKACA;PLA2G12A;MAPK3;PPP1CA
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,-0.22206071528324567,-0.7587554334454916,0.8135593220338984,0.9948043553854008,1.0,7/18,26.89%,TRPC6;ATP2A1;ORAI2;ITPR1;ATP2A2;SRI;ATP2A3
prerank,KEGG_2021_Human__Protein export,0.2036855533154413,0.7579438933499831,0.8181818181818182,1.0,1.0,2/23,5.31%,SEC61B;SEC62
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.13009596998509226,-0.7575707831145992,0.9692307692307692,0.9951095943881479,1.0,29/238,12.78%,POLR2I;NUP37;METTL14;UPF3B;SNRNP35;ALYREF;AQR;SNRPB;HNRNPA3;SNRNP27;PDCD7;CHTOP;SNRNP70;POLR2D;RNPC3;ELAVL1;NXF1;TRA2B;LSM6;POLR2A;WBP11;NUP88;SUGP1;SRRT;SNRNP48;NUP93;HNRNPA1;PAPOLA;EIF4E
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.21637336344152874,-0.7572760213993106,0.796875,0.9941239330859745,1.0,9/20,35.15%,GNG10;GNG5;GNA11;GNAQ;GNG3;GNB4;GNG8;GNG7;AAMP
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,0.19519565904053274,0.7569614756689985,0.8378378378378378,1.0,1.0,7/35,12.48%,ATG5;MAVS;UBA52;UBA7;TRIM4;RNF135;RPS27A
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.16693976197392696,0.7565940855110024,0.8222222222222222,1.0,1.0,12/54,16.35%,CLDN4;CDH8;PARD6B;CDH13;CLDN7;PARVB;PVR;CLDN10;PLEC;ANG;CDH15;LAMB3
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.15825628710903863,0.7565485154133378,0.868421052631579,1.0,1.0,10/57,13.34%,OS9;DERL2;PSMD7;PSMA5;UBA52;DERL3;ERLIN2;PSMF1;RPS27A;PSMA3
prerank,KEGG_2021_Human__Lipid and atherosclerosis,-0.1377993378792588,-0.7564598802985429,0.9827586206896551,0.9937085282212641,1.0,61/177,33.19%,IL6;AKT1;PIK3CA;NCF2;HSP90B1;MAP2K7;CASP3;NRAS;CD14;FASLG;EIF2S1;BAD;MAPK1;POU2F1;CALML4;FAS;DDIT3;APAF1;FOS;PIK3R1;IRAK1;TRAF6;TLR2;ITPR1;MAP2K4;PLCB2;ABCG1;RAP1A;HSPA6;ATF4;VAV2;TANK;TRAF3;HSPA4;MAP2K3;CALM3;TNFRSF1A;MAPK8;MAPK9;HRAS;MIB2;MAPK14;CDC42;IRAK4;ERN1;CYP2C9;IL18;IKBKE;TICAM2;NCF4;LY96;RHOA;CASP8;CAMK2G;POU2F2;OLR1;SRC;EIF2AK3;VLDLR;TNFRSF10A;PLCB3
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.1533548187570727,-0.7547011968197126,0.8833333333333333,0.9943662222737703,1.0,23/83,23.09%,PIK3CA;JUP;TESK1;CADM1;RSU1;CLDN9;NECTIN2;PIK3R1;CD151;SKAP2;SPTBN1;FLNA;PATJ;SIRPG;PALS1;NCK2;FERMT2;NECTIN3;WASL;ITGB1;CLDN5;NECTIN1;F11R
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.19576569855542073,-0.7543063518171839,0.9148936170212766,0.9936611472626482,1.0,6/24,21.19%,AKT1;JUP;MAPKAP1;PKN1;VAV2;PKN2
prerank,KEGG_2021_Human__Hippo signaling pathway,0.13705603689993132,0.7538377644684542,0.9473684210526315,1.0,1.0,20/111,15.83%,AMOT;BIRC5;PPP2R2D;PARD6B;TP53BP2;WNT7B;RASSF4;TGFB1;SMAD4;CCND2;SMAD2;TGFBR1;BBC3;FZD6;BMPR1A;LATS2;RASSF1;PPP1CA;WNT5B;LEF1
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.16668791725753243,0.7536077582211834,0.8636363636363636,1.0,1.0,12/56,14.63%,RPS20;RPS15;RPS25;EIF3C;RPS19;FAU;EIF1AX;RPS10;RPS21;RPS27A;RPS28;EIF2S2
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.17528499320454588,-0.7533121552331241,0.8627450980392157,0.9935535825897674,1.0,14/44,26.33%,NUP37;TOP2B;PIAS4;NUP88;NUP93;AURKA;NUP35;NUP54;NUP42;PIAS3;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.2209447616982464,-0.7526437204007056,0.7704918032786885,0.993004180011359,1.0,11/23,32.91%,CASP3;FASLG;APPL1;TMED7-TICAM2;DAPK3;TANK;TRADD;NDUFA2;LY96;CASP8;TNFRSF10A
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.16354415265176445,0.7512497550174602,0.8297872340425532,1.0,1.0,13/40,21.88%,KPNA2;NUP58;POM121;NUP210;GNL3;KPNA1;ISG15;SEC13;PABPN1;NUP155;NUP62;NUP98;NUP205
prerank,KEGG_2021_Human__PPAR signaling pathway,-0.17555851266946626,-0.7485457261206698,0.8727272727272727,0.9959580015639808,1.0,5/50,5.03%,PCK2;CPT1B;ACSL1;CYP27A1;SLC27A1
prerank,KEGG_2021_Human__Insulin secretion,0.1667225688783226,0.7484265249797324,0.8292682926829268,1.0,1.0,4/51,5.76%,PLCB4;CAMK2A;KCNMB4;ADCY3
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.21723651132290783,0.7482694439593278,0.75,1.0,1.0,5/16,14.13%,UBA52;TAB3;RPS27A;IRAK2;TICAM1
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.16378896827637834,-0.7481638862718318,0.8392857142857143,0.994859426099229,1.0,28/51,41.89%,NUP37;SNRPB;PHAX;LIN9;NUP88;NUP93;GEMIN7;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;NUP214;GEMIN6;NUP160;SEH1L;SNRPD3;AAAS;PRMT5;SNRPD2;SMN1;GEMIN4;SNRPF;NUP153;NCBP2;GEMIN5
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.1362176332885288,-0.7480200857650721,0.9661016949152542,0.9936121996930477,1.0,59/227,24.81%,KMT5B;NCOR2;SMARCD1;KMT2D;DOT1L;H2AC14;SUV39H1;H2AZ2;SETDB2;KMT2B;ING5;TAF10;TAF5L;EP300;TBL1X;SETD6;CHD4;ELP3;KDM5A;ARID4A;GATAD2A;TRRAP;SAP18;NCOR1;H2AC6;SETD7;ARID5B;MSL3;ASH2L;KDM5D;H2BC13;EED;ARID1B;SETD1A;OGT;SUPT20H;KAT6A;H2BC3;SMYD3;KDELR2;RPS2;PRDM16;H2BC12;HDAC2;PHF21A;PRMT3;KMT5C;MCRS1;SETDB1;TBL1XR1;GPS2;SMARCE1;KDM2B;MORF4L2;H2BC4;JADE2;ELP5;CLOCK;JADE3
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.19160166200790893,-0.7479045763467802,0.8421052631578947,0.9923382341356177,1.0,21/29,56.10%,PKN1;SPNS1;LCP2;PLCG2;PKN2;HLA-DRB5;CD101;GRAP2;HLA-DRA;NCK1;HLA-DRB3;CD4;CD3E;ITK;ARHGEF7;ZAP70;CD3D;HLA-DRB4;HLA-DQA1;LCK;HLA-DPA1
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.19936959333744805,0.7476307676691809,0.7391304347826086,1.0,1.0,3/25,8.11%,ATP6V0B;TCIRG1;ATP6V1F
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.16656029576921605,-0.7469579259707937,0.8923076923076924,0.9917490964562019,1.0,22/65,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PTTG1;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.1580373688580103,-0.7468906348153391,0.8636363636363636,0.9904360945218083,1.0,13/75,14.58%,LYPLA2;LPCAT2;LPIN1;PGS1;MBOAT2;CHPT1;CEPT1;PCYT1A;CHKB;LYPLA1;PEMT;PLPP5;PLD4
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.1556042143082212,-0.7447141746944248,0.9206349206349206,0.9918739573817837,1.0,26/84,26.54%,UPF3B;ALYREF;PPP2R5B;BCL2L2-PABPN1;NXF1;RNMT;SAP18;PAPOLA;GSPT2;WDR82;CPSF6;DDX19B;SSU72;PPP2CA;PABPC1L;PABPC4;PPP2R3A;SMG6;PPP2R1A;HBS1L;PPP2R1B;CSTF2T;PPP2R2A;CASC3;SYMPK;PPP2R3C
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.12707742002291175,-0.7445739042950565,0.9545454545454546,0.9907001758874628,1.0,85/248,32.27%,UBB;INO80;PROC;USP37;USP12;H2AC14;PSMD11;PSMB7;SMAD7;CLSPN;SMURF2;USP30;UCHL1;SNX3;RIGI;TAF10;ADRM1;EP300;PSMB4;TRRAP;PSMD8;USP34;H2AC6;PSMB10;PSMB5;FOXK1;USP20;TGFBR2;RAD23B;TRAF6;USP44;H2BC13;ADRB2;ATXN3;OTUD7B;UIMC1;CCP110;OGT;SEM1;H2BC3;ASXL2;PSMD6;ASXL1;UBE2D1;CNKSR3;PSMD9;H2BC12;TANK;TRAF3;JOSD2;ABRAXAS1;MCRS1;PSMA6;HGS;PSMA4;HIF1A;PSMD13;H2BC4;SMAD1;BECN1;PSMC1;PSMD3;MBD6;UBC;RNF123;CCNA2;JOSD1;SENP8;PRKN;STAMBP;OTUB1;PSMA2;H2AC19;PSMA7;INO80C;AXIN2;TFPT;UFD1;UCHL5;WDR48;FOXK2;RHOA;H2AC4;TRIM25;YOD1
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.13371481795861379,-0.7440207593398837,0.9016393442622951,0.9900565244281326,1.0,41/152,25.28%,LPAR2;ITGAM;AKT1;PIK3CA;FGFR1;NRAS;RAPGEF5;MRAS;RAP1GAP;ADCY4;RASSF5;MAPK1;CRK;CALML4;PRKCZ;PRKD3;CTNND1;PIK3R1;PFN2;ADORA2B;PLCB2;RALB;GNAQ;F2R;LCP2;RAP1A;RAPGEF6;HGF;VAV2;FGFR4;MAP2K3;CALM3;ITGB1;RRAS;HRAS;ACTB;VEGFA;MAPK14;CDC42;ITGB2;TIAM1
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.19897408144253825,0.7436383599980623,0.7450980392156863,1.0,1.0,5/24,15.18%,CCT2;CCT3;TCP1;TUBB4A;TUBB2A
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.16345827765757034,0.7423109794540982,0.8409090909090909,1.0,1.0,12/57,14.63%,RPS20;RPS15;RPS25;EIF3C;RPS19;FAU;EIF1AX;RPS10;RPS21;RPS27A;RPS28;EIF2S2
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.15265311039605162,-0.7419220151483836,0.9827586206896551,0.9911881989085708,1.0,25/86,26.33%,NUP37;NCOR2;CREB1;H2AC14;TBL1X;HSD17B4;NCOR1;NUP88;H2AC6;NUP93;H2BC13;EED;H2BC3;H2BC12;NUP35;ITGB1;NUP54;NUP42;TBL1XR1;GPS2;H2BC4;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.14599848458567027,0.741659364247103,0.868421052631579,1.0,1.0,7/92,5.85%,ITGA4;SAP30;IL1R1;MTA2;NFE2L2;KEAP1;ZBP1
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,-0.18700499181121003,-0.7409199679890408,0.8627450980392157,0.9911310052389257,1.0,13/30,38.72%,KALRN;ACTR3;PKN1;WASL;HRAS;CDC42;TIAM1;RHOA;LIMK2;SRC;ITSN1;PTK2;SDC2
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.19795597391518793,-0.7406490212022426,0.7868852459016393,0.9900398722285796,1.0,14/31,32.54%,GNG10;CCT4;GNG5;RGS6;GNA11;CSNK2A2;GNAQ;CCT7;GNG3;CCT8;GNB4;GNG8;CCT6B;GNG7
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.15735944305831726,0.7403247844006127,0.8043478260869565,1.0,1.0,9/65,10.82%,PPP2R5D;BTLA;PPP2R5E;RICTOR;MTOR;ICOS;ICOSLG;CTLA4;PTPN11
prerank,KEGG_2021_Human__Small cell lung cancer,-0.1562746604651627,-0.7399890006208976,0.8333333333333334,0.9896103233161705,1.0,12/79,14.02%,TRAF4;AKT1;PIK3CA;CASP3;E2F3;LAMC1;CDK6;APAF1;LAMC3;PIK3R1;TRAF6;LAMB2
prerank,KEGG_2021_Human__Yersinia infection,-0.14186410685706033,-0.7394635098080131,0.9285714285714286,0.9888382641118901,1.0,32/128,25.41%,PXN;IL6;AKT1;PIK3CA;MAP2K7;MAPK1;CRK;ACTR3;FOS;PIK3R1;IRAK1;PKN1;TRAF6;MAP2K4;GNAQ;SKAP2;WIPF1;LCP2;VAV2;MAP2K3;PKN2;WASL;ITGB1;MAPK8;MAPK9;WIPF2;ACTB;CD8B;MAPK14;CDC42;IRAK4;CD8A
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.16462174382055486,-0.7386603761071411,0.8524590163934426,0.988486243178328,1.0,15/43,29.02%,ALDH7A1;ALDH6A1;BCKDHA;HADHA;PCCA;ACSF3;IVD;MMUT;ACAT2;HIBCH;BCAT1;ABAT;BCAT2;PCCB;HIBADH
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.21766380610480224,0.7386143712041117,0.78125,1.0,1.0,5/16,19.77%,ATP5F1D;DMAC2L;ATP5MC1;ATP5MF;ATP5PF
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.20103899854869384,-0.736236690694116,0.7636363636363637,0.9902364574334587,1.0,8/25,27.25%,LIN9;TBL1X;HSD17B4;BHLHE41;NOCT;TBL1XR1;CLOCK;NAMPT
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,-0.18910891619192585,-0.7352847179344487,0.8703703703703703,0.9898983402592795,1.0,9/25,32.28%,AP2B1;L1CAM;MAPK1;AP2M1;DNM3;DNM2;MSN;CLTA;SRC
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,-0.22808935195354804,-0.7345477246026116,0.8297872340425532,0.9893531270875173,1.0,2/16,6.95%,TPST2;BPNT1
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.20425172824160598,0.7338390419112286,0.8636363636363636,1.0,1.0,5/19,17.14%,ARHGEF11;ERBB2;RHOC;MYH11;ARHGEF12
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.1955945805688479,0.7321515900092053,0.7941176470588235,1.0,1.0,5/32,8.54%,TNRC6C;AGO4;APOE;HDAC3;MOV10
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.12684290377902369,-0.7321513882305166,0.9666666666666667,0.9910057114966183,1.0,63/229,27.32%,UBB;CREB1;CNOT6L;AKT1;SLC38A9;CLSTN1;PPP2R5B;PIK3CA;FGFR1;PSMD11;PSMB7;TGFA;BAD;TSC2;PHC2;RPTOR;MAPK1;CHD4;PSMB4;GATAD2A;RNMT;MAPKAP1;PSMD8;FRS2;PSMB10;LAMTOR2;PIK3R1;PSMB5;CSNK2A2;IRAK1;TRAF6;WWP2;EED;ATN1;CBX4;SEM1;PSMD6;PPP2CA;EPGN;PSMD9;VAPA;HDAC2;FGFR4;CBX8;PPP2R1A;NEDD4;PSMA6;CD86;PSMA4;PSMD13;HBEGF;RRAGC;RHEB;PPP2R1B;IRAK4;PSMC1;PSMD3;UBC;TRIB3;HDAC5;PIK3AP1;PDGFRA;FOXO3
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.1419088384345658,0.7321157397877958,0.9090909090909091,1.0,1.0,19/81,18.38%,WASF3;CYFIP2;ABI1;BAIAP2;FGR;PRKCSH;ELMO2;ARPC3;MYO1E;ABL1;YES1;BRK1;FCGR1A;MAPK3;NCKAP1L;VAV3;MYO9B;NCKIPSD;ARPC5
prerank,KEGG_2021_Human__Pancreatic cancer,-0.15855487528465212,-0.7312759259399674,0.9433962264150944,0.9905493874956902,1.0,11/74,13.31%,RALBP1;AKT1;PIK3CA;TGFA;BAD;E2F3;RPS6KB1;MAPK1;CDK6;PIK3R1;TGFBR2
prerank,KEGG_2021_Human__Mineral absorption,-0.1768052614268379,-0.7304883993673437,0.8135593220338984,0.9901683320537032,1.0,11/36,27.18%,TRPM7;ATOX1;SLC26A6;ATP1A3;ATP1B2;FXYD2;MT1E;ATP7A;ATP1B3;SLC40A1;MT1X
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.2505275673133125,-0.7297311633253126,0.8421052631578947,0.9896553461576412,1.0,3/15,9.23%,LPCAT2;MBOAT2;TMEM86B
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,0.17246775814914705,0.7295148811680575,0.95,1.0,1.0,7/36,12.48%,TNIP2;MAVS;UBA52;NOD2;TRIM4;RNF135;RPS27A
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.17812956916468473,0.7294321842287523,0.8181818181818182,1.0,1.0,6/27,14.06%,GPAT2;AGPAT3;PRKCSH;AGPAT5;GPAM;PLA2G12A
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.2229598815662685,-0.7280494542863848,0.75,0.9901620077396871,1.0,9/16,43.19%,H1-4;CABIN1;H1-0;HIRA;EP400;TP53;CDKN1A;HMGA2;RB1
prerank,KEGG_2021_Human__Shigellosis,-0.12669243935373253,-0.7277626756774315,1.0,0.9890610155276542,1.0,53/224,24.94%,PXN;SEPTIN6;UBB;GLMN;MYL9;SKP1;AKT1;H3C11;PRKCD;PIK3CA;CALCOCO2;CUL1;UBE2N;CD14;RPS6KB1;H3C6;RPTOR;MAPK1;BNIP3;CRK;ACTR3;MYL12B;H3-3A;PIK3R1;SEPTIN7;FBXW11;TRAF6;H3C2;ITPR1;PFN2;CTTN;PLCB2;CYTH4;PLCD1;WASF1;UBE2D1;TLR5;H3C10;TRADD;HCLS1;PLCG2;WASL;ITGB1;TNFRSF1A;MAPK8;HK3;MAPK9;ACTB;MAPK14;CDC42;RRAGC;CAST;BECN1
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.2150816303920987,0.7256792638408512,0.8846153846153846,1.0,1.0,9/15,34.29%,TAS2R13;TAS2R43;TAS1R3;TAS2R46;TAS2R31;TAS2R20;CASR;TAS2R30;TAS2R14
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.14972465548026992,-0.7250661061330671,0.9322033898305084,0.9909356469213905,1.0,26/73,31.47%,NUP37;PARP1;RNF168;PHC2;MDC1;XRCC4;CETN2;PIAS4;NUP88;NUP93;STAG2;CBX4;NUP35;CBX8;RAD52;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107;HDAC7;UBE2I;PMEPA1;NSMCE1;NUP214
prerank,KEGG_2021_Human__Fatty acid elongation,0.194741903259945,0.7227372680014231,0.7959183673469388,1.0,1.0,1/25,0.12%,TECR
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.1634874641469243,-0.7217802442989983,0.8545454545454545,0.9934222605169383,1.0,10/55,17.71%,NCOR2;COX7B;COX6A1;PTK6;LIN9;TBL1X;NCOR1;BLVRA;COX19;BRIP1
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.12432315874569723,0.7211134593941,0.9743589743589743,1.0,1.0,28/136,18.49%,MAP4K5;OS9;DERL2;SLC5A5;PSMD7;PSMA5;NUP58;UBA52;POM121;SLC35A1;SLC4A1;DERL3;ABCB11;ERLIN2;PSMF1;RPS27A;ABCC2;NUP210;PSMA3;SLC2A9;SLC27A4;RHAG;PSMB2;SEC13;PSME2;NUP155;NUP62;PSMD12
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.1511978864609782,-0.7205874395396462,0.9047619047619048,0.9932458369475355,1.0,30/87,30.63%,UBB;SKP1;CUL1;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;ORC6;PSMB10;PSMB5;ANAPC5;MCM3;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;GMNN;SLC25A15;PSMA2;PSMA7;MCM4;ANAPC16
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.17949011580790147,0.7204632831492582,0.84,1.0,1.0,8/37,17.81%,C3AR1;C5AR1;CD19;C5AR2;CFHR1;C8G;AKR1C1;C1QC
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.17786506696474386,0.7195497761738587,0.9230769230769231,1.0,1.0,6/36,10.50%,NR3C2;RARA;NR4A1;NR1D1;NR2C2AP;PPARG
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,0.23507485746448972,0.7190964933229232,0.8,1.0,1.0,4/15,18.23%,LSM1;EDC3;LSM7;XRN1
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,0.16215964768922697,0.7159410819957145,0.8372093023255814,1.0,1.0,14/44,22.67%,PHC3;RING1;NUP58;POM121;PHC1;NUP210;SEC13;SCMH1;NUP155;NUP62;NUP98;NUP205;COMMD3-BMI1;HNRNPK
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.13990798101791146,0.7154411896786519,0.9555555555555556,1.0,1.0,12/71,14.32%,H2BC11;H2BC15;MTA2;H2BC5;H3-3B;H2AC7;SF3B1;H4C15;MYO1E;H2BC14;H3C13;DDX56
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,-0.2078708384011021,-0.7153465600693254,0.76,0.9979058539475637,1.0,3/18,13.20%,MYL9;MYL12B;PKN1
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.20196212983206932,0.7151994275365767,0.75,1.0,1.0,4/27,7.84%,APOE;TFAP2E;ATAD2;ERBB2
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.18932821201774752,-0.7149005641077649,0.835820895522388,0.9969334676917637,1.0,6/27,16.59%,GNG10;GNG5;MAPK1;GNA11;GNAQ;F2R
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.2236061311438137,-0.7132265680392491,0.8846153846153846,0.9971182662232517,1.0,2/15,6.32%,ADH5;COMT
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,0.20757256340583824,0.7127361383119625,0.7948717948717948,1.0,1.0,4/21,11.90%,AKAP1;PMPCA;MCUB;MCU
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.23227369455739819,0.7124874640171857,0.775,1.0,1.0,5/21,14.16%,PPP2R5D;PPP2R5E;CTLA4;PTPN11;YES1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.1578195545277019,-0.7116364369562714,0.9104477611940298,0.9972441795620207,1.0,21/63,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.1516262277001827,-0.7115219233138463,0.8813559322033898,0.9959998322599322,1.0,20/62,27.38%,NUP37;PFKL;LOC112694756;ENO1;NUP88;NUP93;PPP2CA;PGP;NUP35;PFKP;TAC4;PPP2R1A;NUP54;NUP42;PPP2R1B;NUP43;NDC1;NUP85;NUP107;GNPDA1
prerank,KEGG_2021_Human__Long-term potentiation,0.16737516882316716,0.7112914933072363,0.8723404255319149,1.0,1.0,2/46,0.89%,PLCB4;CAMK2A
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.1744823221347452,0.7110620444920845,0.8857142857142857,1.0,1.0,4/37,6.16%,CCT2;FKBP9;CCT3;HDAC3
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.15422415906599887,-0.7107733129661368,0.95,0.9953847122045524,1.0,23/73,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PTTG1;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,0.2266691086838873,0.7105641339150389,0.8620689655172413,1.0,1.0,4/15,15.71%,STS;DHRS11;UGT2B4;AKR1C1
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,0.1877100190706793,0.7100694721801779,0.7894736842105263,1.0,1.0,6/20,19.91%,COX15;CPOX;ALAD;ABCC2;UROS;ALAS1
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.21277762817386076,-0.709057128231333,0.8979591836734694,0.9957450257412102,1.0,4/17,17.70%,TBCA;TUBB6;TUBB4B;TUBA1A
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.1377161000157033,-0.7078304894517171,0.9516129032258065,0.9955238098112054,1.0,7/95,4.37%,CREB1;IL6;GNG10;GGT1;HRH2;SCT;GNG5
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.18473678361417922,-0.7071637772626532,0.92,0.994839406188655,1.0,3/25,5.93%,PDK4;HAGH;DLAT
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.16919858647528216,0.7071048959471481,0.851063829787234,1.0,1.0,3/34,4.70%,UBXN11;VANGL1;ARHGAP35
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.18786350439492927,-0.7036134852654223,0.7966101694915254,0.997312150102579,1.0,6/27,23.51%,AP1S1;AP2B1;AP2M1;PKN2;AP1M2;CD8B
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,0.20266610812385463,0.703542662422762,0.813953488372093,1.0,1.0,2/21,4.74%,RFC3;RFC5
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.2085313820160013,-0.7032871936294762,0.84375,0.9963670018779194,1.0,7/18,31.21%,PIK3CA;NRAS;PIK3R1;GOLGA4;HRAS;PDGFRA;WDR48
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.14287044315438036,0.7032650575693079,0.9090909090909091,1.0,1.0,18/67,22.56%,GNA12;ARHGEF11;ARHGEF4;GNB5;PREX1;ARHGEF18;ECT2;ARHGEF10;RHOC;VAV3;GNG4;ARHGEF12;GNG11;SOS1;FGD4;ARHGEF9;GNGT2;ABR
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.1709823019087314,-0.7031973625206154,0.8983050847457628,0.9951068840397186,1.0,19/52,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;SYVN1;PSMA2;PSMA7
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.14115978001889326,0.7025103745445457,0.9777777777777777,1.0,1.0,24/67,27.46%,MAP4K5;SLC5A5;NUP58;POM121;SLC35A1;SLC4A1;NUP210;SLC2A9;SLC27A4;RHAG;SEC13;NUP155;NUP62;SLC9A7;NUP98;NUP205;SLC36A2;NLRP3;SLC11A2;MAP4K2;NUP133;SLC22A5;SLC35A3;POM121C
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.15606919364322486,-0.701790272390971,0.9347826086956522,0.9951186795029121,1.0,3/44,3.23%,KLHDC3;PPP2R5B;EXTL3
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.20060077952370603,-0.7013628062565679,0.8771929824561403,0.994151592959507,1.0,4/20,14.72%,UBB;JAG1;NCSTN;WWP2
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.1868090054547788,-0.7008932260094749,0.85,0.9931727626779662,1.0,4/29,8.57%,NRAS;RNASE3;KSR1;MAPK1
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.15659469498560655,0.69934077497657,0.88,1.0,1.0,10/51,15.37%,H2BC11;H2BC15;H2BC5;SMC1A;POT1;H2AC7;H4C15;H2BC14;LMNA;TINF2
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.18768747934838106,-0.6982621247788078,0.9491525423728814,0.9943499524412992,1.0,5/22,17.91%,GALNT2;GCNT1;ST6GALNAC1;GALNT11;C1GALT1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.12400878933402992,-0.6980654003426565,1.0,0.9930724478967141,1.0,20/186,10.50%,PXN;CREB1;IL6;AKT1;GNG10;PIK3CA;GNG5;CASP3;NRAS;FASLG;TSC2;E2F3;RPS6KB1;ADCY4;MAPK1;CRK;CXCR2;CALML4;FAS;CDK6
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.12613611816681763,-0.6965843438552559,1.0,0.9931155537935932,1.0,30/188,18.25%,POLR2I;UPF3B;SNRNP35;ALYREF;AQR;SNRPB;HNRNPA3;SNRNP27;PDCD7;SNRNP70;POLR2D;RNPC3;ELAVL1;TRA2B;LSM6;POLR2A;WBP11;SUGP1;SRRT;SNRNP48;HNRNPA1;PAPOLA;CWC15;TXNL4A;CHERP;DDX5;CPSF6;POLR2E;HNRNPR;PHF5A
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.17492083983657472,-0.6965142019389793,0.8076923076923077,0.9918574744565227,1.0,13/27,37.62%,TLR10;TLR1;TLR2;TLR5;TRAF3;S100A9;NDUFA2;IRAK4;LY96;S100A8;TLR3;BTK;NFKB2
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.13003426195337886,0.6953720463870959,0.9722222222222222,1.0,1.0,16/110,13.34%,SQSTM1;NKIRAS2;IL1R1;LRRC14;PSMD7;TNIP2;PSMA5;UBA52;NOD2;TAB3;MYD88;PSMF1;RPS27A;RELA;IRAK2;PSMA3
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.18426920932296365,-0.6947720115162909,0.8666666666666667,0.9920163307947231,1.0,5/26,15.23%,UBB;GAA;HGSNAT;GALNS;NHLRC1
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.15208250051092534,-0.6922248276353529,0.953125,0.9930017726701386,1.0,22/70,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,KEGG_2021_Human__DNA replication,0.17410871832146727,0.6918187797640384,0.9285714285714286,1.0,1.0,9/36,21.72%,DNA2;RFC3;RFC5;MCM7;POLA1;RPA2;RPA4;POLE2;RNASEH2C
prerank,KEGG_2021_Human__Serotonergic synapse,-0.1395035536370575,-0.6912674557431199,0.8775510204081632,0.9924466761219355,1.0,5/64,5.08%,DUSP1;GNG10;GNG5;CASP3;NRAS
prerank,KEGG_2021_Human__Th17 cell differentiation,0.1315758172655246,0.6909870492978577,1.0,1.0,1.0,20/98,18.47%,IL1R1;MTOR;RARA;NFKBIE;AHR;TGFB1;SMAD4;SMAD2;PPP3CB;RELA;TGFBR1;MAPK3;HLA-DOB;STAT1;PPP3CA;JAK2;MAPK13;IL21R;MAPK11;GATA3
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.15425226019962884,0.690549733263443,0.9459459459459459,1.0,1.0,6/44,11.22%,LRFN1;APBA3;NRXN2;LIN7A;PDLIM5;NRXN1
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.1936466763862325,0.6896226607892557,0.8333333333333334,1.0,1.0,4/21,17.14%,ORC3;TFDP2;POLA1;PPP2R3B
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.15301417613350013,-0.6884171264584309,0.9104477611940298,0.9932013584294628,1.0,22/55,35.81%,UBB;FLOT2;CASP3;FASLG;RIPK3;CHMP4B;MLKL;OGT;TANK;TRADD;ELANE;SDCBP;UBC;IL18;CASP8;RRM1;TNFRSF10A;CHMP2B;IRF2;TP53;XIAP;CHMP6
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.14232393964176562,0.6877545074539876,0.8974358974358975,1.0,1.0,14/64,19.41%,GFER;COQ2;BCS1L;PMPCA;TOMM70;TOMM6;ATP5MC1;COA6;SLC25A4;HSCB;TOMM7;SLC25A13;TOMM22;SLC25A12
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.1740784222590901,-0.6872725755600232,0.8793103448275862,0.992718492674834,1.0,12/35,26.06%,STT3A;B4GALT3;B4GALT1;HEXA;RPN2;MGAT4B;B4GALNT3;DAD1;ALG11;MAN1C1;HEXD;RPN1
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.16527552139752621,0.6868411115880112,0.8695652173913043,1.0,1.0,2/32,2.55%,STS;SMPD3
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.16504248491470117,0.6865856341273665,0.926829268292683,1.0,1.0,7/33,17.21%,CAMK2A;APBB1IP;FN1;CNKSR1;MAPK3;JAK2;TLN1
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,0.18466328806992538,0.6861041417195437,0.8333333333333334,1.0,1.0,7/22,22.94%,COX15;CPOX;ALAD;UGT2B4;UROS;ALAS1;MMAB
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.18498847735742519,0.6855345901196294,0.82,1.0,1.0,5/26,15.18%,CCT2;CCT3;TCP1;TUBB4A;TUBB2A
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.13971019825765765,0.6849292648610363,1.0,1.0,1.0,12/69,13.34%,OS9;DERL2;PSMD7;PSMA5;UBA52;DERL3;ABCB11;ERLIN2;PSMF1;RPS27A;ABCC2;PSMA3
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.13257674007372708,-0.68484722999328,0.9545454545454546,0.9935984249211263,1.0,25/110,23.93%,CACNG8;CACNG6;MYL9;NRAS;KCNJ2;CACNA2D3;PIK3R5;ADCY4;MAPK1;CALML4;RYR3;FOS;ITPR1;PLCB2;GNAQ;RGS2;CAMK4;PRKAG2;CALM3;RYR1;HRAS;ACTB;PRKAG1;MAP2K5;MAPK7
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.14901845747428116,-0.6848349669794077,0.9166666666666666,0.9922948501440642,1.0,3/46,3.23%,KLHDC3;PPP2R5B;EXTL3
prerank,KEGG_2021_Human__Peroxisome,0.13442515128112018,0.684079762888927,0.9714285714285714,1.0,1.0,15/75,17.12%,PEX11A;ACOX1;PEX2;ACSL5;ACSL6;MPV17;BAAT;CROT;ACOT8;ECH1;ACSL3;AMACR;PEX11G;MPV17L2;ACSL4
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.19430749264308642,-0.6829104632051101,0.8888888888888888,0.9925223540499047,1.0,2/24,2.04%,UBB;AKT1
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.21536275261623763,-0.6805294557312068,0.9038461538461539,0.9932012633727425,1.0,8/16,36.65%,FASLG;EP300;DDIT3;STK11;FOXO3;PINK1;NFYA;CREBBP
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,0.143217010301565,0.6804156737506654,0.9772727272727273,1.0,1.0,24/83,24.20%,UCKL1;TK2;ENTPD6;PFAS;ENTPD4;RRM2;ADPRM;NME3;ENTPD5;AK6;UPP1;AK7;UMPS;NT5C1A;GDA;UPB1;DCTD;AMPD3;NUDT13;ADSS1;DNPH1;ENTPD7;AK1;UCK1
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.1327763413379482,0.6801647728521332,0.9743589743589743,1.0,1.0,22/79,22.76%,VCAN;B4GALT4;B4GALT2;CHST7;NDST2;HSPG2;NAGLU;HS2ST1;XYLT2;HS3ST3A1;AGRN;SLC35D2;ST3GAL6;B3GALT6;SLC9A1;SLC35B2;SLC35B3;IDUA;GLB1;SGSH;DCN;ST3GAL1
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.15885963439659007,0.677110716689834,0.9056603773584906,1.0,1.0,11/34,21.88%,PBRM1;NUP58;POM121;NUP210;GNL3;KPNA1;SEC13;NUP155;NUP62;NUP98;NUP205
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.18387806729716544,-0.6760011933211117,0.9491525423728814,0.9955288284946141,1.0,5/22,17.70%,LEMD2;CHMP4B;TUBB6;TUBB4B;TUBA1A
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.19720994816967882,0.6753133269751858,0.8627450980392157,1.0,1.0,5/18,14.41%,HDAC3;SATB2;ABL1;YES1;MAPK3
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.1619873581497876,-0.673928403297741,0.9354838709677419,0.9959342513043818,1.0,19/53,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;SYVN1;PSMA2;PSMA7
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.2021236671424451,-0.6732552147730796,0.8360655737704918,0.9951005222368328,1.0,2/18,4.37%,GNG10;GNG5
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.14853745612779112,-0.6705037443382265,0.9666666666666667,0.996067448085557,1.0,22/71,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.1591941781590258,0.6697814184199496,0.8636363636363636,1.0,1.0,3/38,5.06%,USP9X;VANGL1;STAM
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.1598167272059389,0.668285284194255,0.9347826086956522,1.0,1.0,4/37,7.42%,FAAP100;FANCE;UBA52;ERCC4
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.1301682972789838,0.667989281745598,0.9393939393939394,1.0,1.0,13/90,14.13%,CXCL8;IL1R1;BCL10;EDARADD;EDA;CFLAR;GADD45B;TAB3;CD40LG;MYD88;RELA;GADD45G;TICAM1
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,0.16415167735274833,0.6678449861398467,0.8636363636363636,1.0,1.0,9/31,21.88%,MAP4K5;NUP58;POM121;NUP210;SEC13;NUP155;NUP62;NUP98;NUP205
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.17248372055465871,0.6673072233139506,0.9024390243902439,1.0,1.0,6/25,18.73%,UTY;PHF2;H4C15;H3C13;KDM7A;KDM1A
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.15618984162274568,-0.6667987158344387,0.90625,0.9974948496695333,1.0,18/54,29.13%,UBB;PSMD11;PSMB7;PSMB4;PSMD8;PSMB10;PSMB5;SEM1;PSMD6;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;PSMA2;PSMA7
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.1260398482469945,-0.665749842869443,0.984375,0.9970126936845413,1.0,22/96,25.72%,PAK1;MAP3K8;AKT1;PIK3CA;MAP2K7;NRAS;MAPK1;DLG1;FOS;PIK3R1;LCP2;VAV2;PTPRC;NCK2;MAPK8;MAPK9;HRAS;CD8B;MAPK14;CDC42;CD8A;IL4
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.14892285374666503,-0.6650453301493137,0.9615384615384616,0.9961959477885238,1.0,19/69,25.57%,AP1S1;TBC1D8B;M6PR;IGF2R;AP1G2;NAPSA;ACBD3;SH3D19;STX4;HOMER2;CLINT1;TGOLN2;SNAP23;DNM2;AP1M2;HGS;AP4B1;HIP1R;GAK
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.1265753525732719,0.6650318735393886,1.0,1.0,1.0,21/112,17.05%,H2BC11;SAP30;H2BC15;MTA2;H2BC5;JARID2;PHF19;H3-3B;H2AC7;SF3B1;DNMT3A;H4C15;CCNH;MYO1E;H2BC14;H3C13;DDX56;SIRT1;SUDS3;TDG;POLR1G
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.20429286961722123,0.6617678530419292,0.9166666666666666,1.0,1.0,4/17,15.96%,KIN;EEF2KMT;EEF1AKMT2;METTL21A
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,0.17093624857117057,0.6615826761184117,0.9038461538461539,1.0,1.0,4/28,11.27%,GCSH;HOGA1;MCEE;SHMT2
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.12820230196558166,0.6615367578874326,0.9545454545454546,1.0,1.0,10/87,10.69%,CXCL8;F13A1;BIRC5;MMP9;IL10;MCL1;IL12A;FN1;TGFB1;BCL6
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.2163255109633578,-0.659328390187088,0.8888888888888888,0.9995182447420492,1.0,8/16,32.91%,FASLG;TMED7-TICAM2;TANK;TRADD;NDUFA2;LY96;CASP8;TNFRSF10A
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.15002177365553138,-0.6592894665259277,0.8421052631578947,0.998211834670549,1.0,11/38,26.33%,NUP37;PIAS4;NUP88;NUP93;NUP35;NUP54;NUP42;NUP43;NDC1;NUP85;NUP107
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.17915276259511742,-0.6572448070558259,0.8596491228070176,0.9980936931644042,1.0,4/26,9.87%,ACBD4;ACOXL;HSD17B4;DECR2
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.14010284072714044,0.6567510308585239,0.95,1.0,1.0,9/57,13.84%,H2BC11;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;CCNH;H2BC14;H3C13
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.1101998469587954,0.6501812894058173,1.0,1.0,1.0,43/180,22.67%,PPIE;SRSF5;CDC40;HNRNPA0;YBX1;DHX9;DHX15;CDC5L;WDR33;PPIL3;CWC22;SRSF7;SNRPC;HNRNPD;RBM17;PCF11;SF3B4;PLRG1;HNRNPM;SF3B1;SF3A1;SF1;LSM7;CSTF1;LSM8;U2SURP;PABPN1;BCAS2;SF3B6;PTBP1;SNRPE;RBM42;SNRPB2;SF3B2;GCFC2;TFIP11;SNRPA1;GPKOW;NCBP1;SRRM2;POLR2K;POLR2J;HNRNPK
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.14653470130448523,-0.6477691431920934,0.8947368421052632,1.0,1.0,32/56,44.92%,H1-4;TERF1;H2AC14;H2AZ2;CABIN1;H2AC6;H2BC13;H2BC3;H2BC12;RAD50;H2BC4;TERF2;H2AX;H2AB1;CCNA2;H2AC19;H1-0;HIRA;H2AC4;MRE11;H2BC9;EP400;TP53;H2AZ1;CDKN1A;HMGA2;H2AC20;CCNE1;TERF2IP;RB1;ATM;CCNE2
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.15060134768500535,0.6472355648455453,0.92,1.0,1.0,5/41,10.66%,C3AR1;C5AR1;CD19;C5AR2;CFHR1
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.11814217960427263,0.6458865844595626,0.9787234042553191,1.0,1.0,13/108,12.35%,IL9R;IL24;MTOR;PIAS2;STAM;PTPN2;IL10;MCL1;IL12A;PIAS1;PTPN11;CCND2;STAT4
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.1921820463916639,-0.6451425284504285,0.953125,1.0,1.0,5/21,20.10%,PIK3R1;STAT5A;JAK3;STAT5B;CISH
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.1853410581547879,0.6442886548719277,0.9318181818181818,1.0,1.0,22/22,81.49%,PPP2R5D;PPP3CB;PPP1CA;PPP3CA;PDE4D;PDE4A;PPP3R1;PRKACB;PDE4B;PRKAR1B;PDE4C;PRKCA;CALM1;PPP3CC;PRKAR2A;PRKAR2B;PPP2CB;PRKAR1A;PPP2R1B;CDK5;PPP2R1A;PPP2CA
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.15372000218662873,0.6430206936166244,0.9591836734693877,1.0,1.0,25/25,84.65%,TAB3;TNFAIP3;IKBKG;TNF;CYLD;USP4;CHUK;RBCK1;BIRC2;BIRC3;MAP3K7;TAB2;IKBKB;RIPK1;RNF31;RACK1;TAB1;USP25;XIAP;SHARPIN;TRAF1;TNFRSF1A;TRADD;TANK;OTUD7B
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.1818080468233123,-0.6406004856169482,0.9166666666666666,1.0,1.0,6/22,21.42%,CRK;RNMT;LAMC1;LAMC3;RAP1A;ITGB1
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.19046433665427948,0.6390469181662382,0.9782608695652174,1.0,1.0,9/16,32.12%,PMPCA;MCUB;MCU;YME1L1;MICU3;SMDT1;SPG7;PMPCB;MICU2
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.15548544096240907,-0.6373184117732955,0.9245283018867925,1.0,1.0,7/52,12.58%,CLSTN1;PIK3CA;FGFR1;TGFA;RNMT;FRS2;PIK3R1
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.16822201483763027,-0.6365320868008725,0.9032258064516129,1.0,1.0,4/25,15.65%,PARP1;POLD2;RFC4;APEX1
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.12786198370288096,0.6361142070577352,0.9545454545454546,1.0,1.0,10/72,13.84%,H2BC11;SAP30;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;CCNH;H2BC14;H3C13
prerank,KEGG_2021_Human__Selenocompound metabolism,0.19159034923798196,0.6361029804128728,0.9024390243902439,1.0,1.0,4/16,13.94%,PSTK;KYAT1;TXNRD2;MARS1
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.1833613890836201,-0.635287606286183,0.9056603773584906,1.0,1.0,5/19,19.55%,SREBF1;PLXNA4;SIRT3;ATXN3;HDAC2
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",0.1866937366843122,0.633070515676995,0.8571428571428571,1.0,1.0,3/20,12.05%,GNB5;PDE6B;CHURC1-FNTB
prerank,Reactome_2022__tRNA Processing R-HSA-72306,0.1187366246429519,0.6307593883800964,0.9787234042553191,1.0,1.0,10/101,8.82%,URM1;CTU2;TRMT11;FTSJ1;NUP58;POM121;ELAC2;NSUN6;LCMT2;ADAT3
prerank,KEGG_2021_Human__Osteoclast differentiation,0.11926359321519653,0.629497801713407,1.0,1.0,1.0,26/117,20.22%,SQSTM1;IL1R1;CSF1;TEC;FOSB;ACP5;TGFB1;PPARG;FCGR2C;PPP3CB;RELA;TGFBR1;FCGR1A;MAPK3;MAP2K6;STAT1;PPP3CA;MAPK13;RAC1;MAPK11;TYROBP;FCGR3A;IFNAR2;FHL2;LILRB5;IKBKG
prerank,KEGG_2021_Human__Endometrial cancer,-0.1457470034829026,-0.628913576441758,0.9482758620689655,1.0,1.0,5/54,8.57%,AKT1;PIK3CA;NRAS;BAD;MAPK1
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.16491197640206604,0.6256050779397838,0.9354838709677419,1.0,1.0,6/27,19.16%,CDC6;E2F5;MAX;TFDP2;RBL1;RBL2
prerank,KEGG_2021_Human__Spliceosome,-0.119899184303149,-0.6256017885811875,1.0,1.0,1.0,30/139,22.04%,ALYREF;AQR;SNRPB;HNRNPA3;SNRNP27;SNRNP70;TRA2B;LSM6;RNU2-1;WBP11;HNRNPA1;CWC15;TXNL4A;ISY1;CHERP;RBM25;DDX5;CCDC12;TCERG1;PHF5A;RBMXL1;HSPA6;PRPF38B;HNRNPA1L2;LSM4;SMNDC1;SLU7;SNRPD1;PUF60;RNU1-1
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.19311141794933046,0.6250661448921522,0.9210526315789473,1.0,1.0,10/18,30.82%,PPP1R12A;RHOC;CDKN1B;MYH11;RNASE1;PRC1;KIF14;MYH10;PPP1CB;MYL6
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.14622470618839745,0.6236312326587014,0.9736842105263158,1.0,1.0,7/36,17.21%,CAMK2A;APBB1IP;FN1;CNKSR1;MAPK3;JAK2;TLN1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.1852210505238498,0.6222525746832063,0.8478260869565217,1.0,1.0,5/18,18.26%,TP53BP2;PRELID1;BBC3;PPP1R13B;TP63
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.1852926520278396,-0.6215744793011405,0.9032258064516129,1.0,1.0,2/20,4.37%,GNG10;GNG5
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.14413772639058975,-0.6214063512345646,0.9433962264150944,1.0,1.0,14/40,29.73%,KYAT3;DNMT1;CBS;SDS;SRM;AHCY;PHGDH;BCAT1;AMD1;CTH;BCAT2;AHCYL1;MRI1;MDH2
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.18997298561434212,0.6184959557649534,0.9069767441860465,1.0,1.0,3/15,12.39%,NCOA2;AHR;ARNT2
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.15220583171836094,-0.6181879516470725,0.9615384615384616,1.0,1.0,16/34,41.09%,ACOT13;HADHA;ACSF2;PCCA;MMUT;NDUFAB1;ACOT9;ECI1;PCCB;ACBD7;THEM5;THEM4;ACADS;ACADVL;ACADL;HADH
prerank,KEGG_2021_Human__Gap junction,0.12862339849870957,0.6164081533877035,0.98,1.0,1.0,4/61,5.76%,PLCB4;PDGFD;GNAI1;ADCY3
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.2045221367523718,-0.6084819846249819,0.8867924528301887,1.0,1.0,3/15,16.59%,PROC;PF4V1;F2R
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,-0.1544794657312233,-0.6078499337794581,0.9629629629629629,1.0,1.0,15/30,41.07%,TRPC6;PKN1;WASL;MAPK8;TRIO;MAPK14;CDC42;SIAH1;PITPNA;TRPC1;SRC;PRKCQ;PTK2;NCK1;SIAH2
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.15078381097764193,-0.6060663823021263,1.0,1.0,1.0,15/34,36.41%,UBB;OTULIN;OTUD7B;TANK;TRADD;TNFRSF1A;TAX1BP1;TRAF1;UBC;CLIP3;CASP8;SHARPIN;XIAP;SPPL2B;USP25
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.15407993907883388,-0.6054085648685558,0.9473684210526315,1.0,1.0,3/32,10.33%,IL6;FASLG;FAS
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.11923003454920737,0.6044944543364523,0.9782608695652174,1.0,1.0,11/76,14.41%,H2BC11;H2BC15;MTA2;H2BC5;H3-3B;H2AC7;H4C15;CCNH;H2BC14;H3C13;MAPK3
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.11923003454920737,0.6044944543364523,0.9782608695652174,1.0,1.0,11/76,14.41%,H2BC11;H2BC15;MTA2;H2BC5;H3-3B;H2AC7;H4C15;CCNH;H2BC14;H3C13;MAPK3
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.15060200627514625,-0.6044170178962264,0.9444444444444444,1.0,1.0,11/31,31.12%,ALDH7A1;KYAT3;IDO1;HADHA;INMT;ACAT2;ALDH8A1;KYNU;GCDH;CAT;ALDH3A2
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.15685315963619206,-0.6042632054980566,0.9285714285714286,1.0,1.0,7/32,23.44%,AP1S1;M6PR;AP1G2;DNM2;AP1M2;HGS;AP4B1
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,0.17968309506582514,0.5994240154566424,0.9285714285714286,1.0,1.0,3/21,12.05%,GNB5;PDE6B;CHURC1-FNTB
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.12816277201967474,0.5980146141108243,0.9705882352941176,1.0,1.0,14/63,18.49%,ZNF385A;PSMD7;PSMA5;UBA52;CHEK2;CARD16;PSMF1;RPS27A;MDM4;PSMA3;CDKN1B;PSMB2;PSME2;PSMD12
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.19559635032508332,-0.5962086783864678,0.9803921568627451,1.0,1.0,15/15,80.46%,SNAP25;ARL6IP5;VAMP2;TSPOAP1;SLC1A2;SLC1A3;STX1A;PPFIA3;RAB3A;SLC1A7;SLC38A2;GLS2;PPFIA1;STXBP1;PPFIA4
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.1220286285781769,0.5945743464768192,0.9743589743589743,1.0,1.0,12/75,15.75%,H2BC11;SAP30;H2BC15;H2BC5;H3-3B;H2AC7;H4C15;CCNH;H2BC14;H3C13;SIRT1;SUDS3
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.13115352661442614,-0.593418700163123,0.984375,1.0,1.0,22/70,29.13%,UBB;PSMD11;PSMB7;ANAPC7;PSMB4;PSMD8;PSMB10;PSMB5;ANAPC5;SEM1;PSMD6;UBE2D1;PSMD9;PSMA6;PSMA4;PSMD13;PSMC1;PSMD3;UBC;CCNA2;PSMA2;PSMA7
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.14074005111800997,-0.5897346897145558,0.9833333333333333,1.0,1.0,10/42,23.46%,DHCR7;SREBF1;LIN9;TBL1X;SCD;LMBR1;PMVK;SC5D;TBL1XR1;GGPS1
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.16790380059453824,-0.5896827884757306,0.9433962264150944,1.0,1.0,14/19,56.10%,PDCD1LG2;HLA-DRB5;PTPN6;PDCD1;HLA-DRA;HLA-DRB3;CD4;CD3E;CSK;CD3D;HLA-DRB4;HLA-DQA1;LCK;HLA-DPA1
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.15172313316300334,-0.5874049529815787,0.9523809523809523,1.0,1.0,10/29,29.78%,SNRPB;ZNF473;PAPOLA;SLBP;CPSF6;LSM11;CSTF2T;SYMPK;CPSF1;CPSF2
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.11347748771637345,-0.5852303250232006,0.984375,1.0,1.0,42/125,33.28%,UBB;GNG10;AP2B1;DAAM1;PSMD11;PSMB7;GNG5;SMURF2;NRAS;PSMB4;PSMD8;PSMB10;PSMB5;AP2M1;ITPR1;PLCB2;SEM1;PSMD6;PSMD9;PRICKLE1;NLK;PSMA6;PSMA4;NCOA3;PSMD13;GNG3;PSMC1;PSMD3;UBC;GNB4;PDE6G;TNRC6A;PSMA2;PSMA7;AXIN2;GNG8;RHOA;CLTA;GNG7;ITPR3;PLCB3;DVL2
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.12216078361073479,0.5848747075333637,0.9166666666666666,1.0,1.0,14/65,18.49%,ZNF385A;PSMD7;PSMA5;UBA52;CHEK2;CARD16;PSMF1;RPS27A;MDM4;PSMA3;CDKN1B;PSMB2;PSME2;PSMD12
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.13674338088783505,-0.5810559834651744,0.9433962264150944,1.0,1.0,22/54,36.75%,AP1S1;TBC1D8B;IGF2R;NAPSA;ACBD3;SH3D19;HOMER2;CLINT1;TGOLN2;DNM2;AP1M2;AP4B1;HIP1R;GAK;PUM1;CLTA;NECAP1;BLOC1S4;VAMP2;RAB5C;HSPA8;DNAJC6
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.1541695108522588,-0.5764052827069912,0.9565217391304348,1.0,1.0,3/25,10.63%,AKR1C3;ADCY4;STAR
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.14507208906353553,0.5757956565222965,0.9347826086956522,1.0,1.0,14/33,31.22%,VCAN;CHST7;HSPG2;XYLT2;AGRN;B3GALT6;IDUA;DCN;HEXB;B3GAT3;ARSB;XYLT1;CSGALNACT2;CHST15
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.15500251099635323,0.5755947352669233,0.9523809523809523,1.0,1.0,5/18,20.22%,LRRC14;UBA52;RPS27A;IKBIP;IKBKG
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.14484116135381925,0.5749750963584065,0.9361702127659575,1.0,1.0,29/29,85.54%,TXK;TEC;PPP3CB;VAV3;PPP3CA;SOS1;NFATC3;IGLL5;PLCG1;PPP3R1;LYN;NFATC2;GRB2;SHC1;CALM1;ITPR2;VAV1;ITK;SYK;NFATC1;GRAP2;BTK;ITPR3;AHCYL1;PLCG2;VAV2;LCP2;SPNS1;ITPR1
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.1516496954476544,-0.5749510726429704,0.8870967741935484,1.0,1.0,18/30,49.44%,GNG10;GNG5;ITPR1;RAP1A;GNG3;GNB4;GNG8;GNG7;ITPR3;PRKAR1A;PRKAR2B;PRKAR2A;RAPGEF3;GNG2;GNAS;GNB2;GNB1;IQGAP1
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.17344224114046097,-0.5745569844286129,0.9827586206896551,1.0,1.0,1/17,1.34%,IL6
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.16889680766451723,-0.5744138681357265,0.9824561403508771,1.0,1.0,6/17,29.88%,GGT1;CYP4F22;CYP4F2;ALOX5AP;MAPKAPK2;DPEP2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.1703057267362877,0.5729264488595623,0.9545454545454546,1.0,1.0,6/19,22.79%,ALG8;DPAGT1;ALG3;GLB1;ALG2;ALG14
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.16278204641227959,-0.5685856643793891,0.9444444444444444,1.0,1.0,6/17,28.26%,ENPP1;ENPP2;PANK3;SLC25A16;VNN1;AASDHPPT
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.14335906597742884,0.5657149243669696,0.9772727272727273,1.0,1.0,10/34,22.78%,ARHGDIB;ADCY3;RAB5A;PRKACA;DYNLL2;DCTN2;DCTN1;RAB5B;ADCY9;DYNC1LI1
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.1644554173178896,0.5633362274634174,0.9583333333333334,1.0,1.0,14/15,70.30%,YES1;SOS1;FYN;KIT;SOCS1;LYN;PRKCA;SH2B2;LCK;GRB2;SOCS6;SH2B3;SRC;PTPN6
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.16622713681600768,-0.5539651178065215,0.9615384615384616,1.0,1.0,4/16,24.07%,NRAS;ERBIN;HRAS;HBEGF
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.10064900243957238,-0.5532377889225704,1.0,1.0,1.0,40/181,26.31%,NCOR2;IL6;AKT1;PIK3CA;MAP2K7;PSMD11;CASP3;OAS3;EIF2AK2;E2F3;ADRM1;FAS;CDK6;PSMD8;APAF1;PIK3R1;IRAK1;TRAF6;RUNX3;TLR2;MAP2K4;JAK3;SEM1;PSMD6;HDAC2;TRAF3;TRADD;MAP2K3;PLCG2;CALR;NEDD4;MAPK8;MAPK9;PSMD13;MAPK14;IRAK4;PSMC1;PSMD3;OAS1;TYK2
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.13872029047122167,-0.5498296891896391,0.9692307692307692,1.0,1.0,11/28,35.15%,GNG10;GNG5;GNA11;GNAQ;MAPK14;GNG3;GNB4;GNG8;SRC;GNG7;AAMP
prerank,KEGG_2021_Human__Amphetamine addiction,0.13493654719414927,0.5456284807482226,0.9811320754716981,1.0,1.0,7/38,16.98%,CAMK2A;FOSB;PPP3CB;PRKACA;PPP1CA;SIRT1;PPP3CA
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.14137622084888252,0.544760832609014,0.9743589743589743,1.0,1.0,10/33,23.34%,GNAI1;GNB5;GPER1;GNG4;ITGA5;GNAI3;GNG11;ADCY9;GNGT2;ADCY7
prerank,KEGG_2021_Human__Salivary secretion,-0.12564414164959584,-0.5445494881859884,1.0,1.0,1.0,10/53,16.15%,ADCY4;CALML4;RYR3;ATP1A3;ITPR1;ADRB2;ATP1B2;PLCB2;GNAQ;FXYD2
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,-0.11430320018244816,-0.5431301093392008,1.0,1.0,1.0,26/78,33.19%,GNG10;GNG5;ACLY;ADCY4;GNA11;CACNA1E;ITPR1;SNAP25;PLCB2;GNAQ;RAP1A;PPP2CA;PRKAG2;PPP2R1A;GNG3;PPP2R1B;MLXIPL;STK11;AHCYL1;GNB4;ADIPOR1;GNG8;GNG7;VAMP2;ITPR3;PLCB3
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.1330283576585035,0.540847682703027,0.9782608695652174,1.0,1.0,4/29,12.39%,CYP4B1;NCOA2;AHR;ARNT2
prerank,KEGG_2021_Human__Toxoplasmosis,-0.10536224487728421,-0.5389859557739398,1.0,1.0,1.0,20/102,22.48%,AKT1;CASP3;BAD;PIK3R5;PPIF;MAPK1;LAMC1;LAMC3;IRAK1;TRAF6;LAMB2;TLR2;IFNGR2;HSPA6;MAP2K3;LAMB4;ITGB1;TNFRSF1A;MAPK8;MAPK9
prerank,KEGG_2021_Human__Antigen processing and presentation,0.11918383478885484,0.538615646530734,1.0,1.0,1.0,3/63,4.45%,CTSL;PDIA3;KLRD1
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.12451953684913923,-0.5352276645718528,0.9824561403508771,1.0,1.0,19/46,42.32%,GTF2H3;TAF1B;CHD4;GATAD2A;POLR2E;HDAC2;POLR1E;RRN3;POLR2L;POLR2F;GTF2H5;RBBP4;CHD3;POLR1D;RBBP7;POLR1H;MTA1;ERCC6;GATAD2B
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.12567357513768945,-0.5306821492513562,0.9811320754716981,1.0,1.0,4/43,7.22%,GNG10;SCT;GNG5;ADGRE3
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.16603894483006454,-0.5231320486870092,1.0,1.0,1.0,1/15,2.15%,CCNG2
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.15026485789651767,0.5213345168631248,0.8974358974358975,1.0,1.0,6/22,20.54%,APBB1IP;FN1;TLN1;PDPK1;SOS1;ITGA2B
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.14582589896272796,-0.5206596427952469,1.0,1.0,1.0,9/20,39.53%,ATAD1;PEX14;PXMP2;ABCD2;PXMP4;ALDH3A2;SLC25A17;PEX13;PEX19
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.12856938851430796,-0.5198716186513775,1.0,1.0,1.0,31/32,80.46%,SLC22A1;SLC6A13;SNAP25;ABAT;ARL6IP5;SH2D3C;VAMP2;TSPOAP1;HSPA8;SLC1A2;NAAA;SYN3;SLC1A3;SLC6A12;CASK;SLC6A1;STX1A;PPFIA3;RAB3A;SLC1A7;SLC38A2;GLS2;PPFIA1;DNAJC5;SLC18A2;LIN7C;ALDH5A1;LIN7B;MAOA;STXBP1;PPFIA4
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.15000559740249408,-0.5138969831303076,0.9814814814814815,1.0,1.0,7/20,33.02%,MAPK1;STAT5A;STAT5B;CISH;SH2B1;PTPN6;PRLR
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.13826470973259453,0.5083651327957234,0.9574468085106383,1.0,1.0,1/20,2.08%,TAS2R13
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.1333588495817158,-0.5042854519185813,1.0,1.0,1.0,29/29,86.69%,GTF2H3;TAF1B;POLR2E;POLR1E;POLR2L;POLR2F;GTF2H5;POLR1D;POLR1H;UBTF;GTF2H4;ERCC3;TTF1;ERCC2;TBP;TAF1D;GTF2H2;TAF1A;POLR1B;POLR2H;CDK7;MNAT1;POLR1F;GTF2H1;POLR2K;TAF1C;POLR1A;POLR1G;CCNH
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.12368962641073203,-0.5010168668597471,1.0,0.99998039339662,1.0,4/31,14.88%,CREB1;ADCY4;ITPR1;PRKX
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,0.1329092281515629,0.4981041630231073,0.9714285714285714,1.0,1.0,8/24,24.54%,GSDME;CYCS;TP63;IRF1;CASP1;BAK1;GZMB;CASP4
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.13826878506076362,0.49579685664423184,1.0,1.0,1.0,6/21,19.33%,DES;DMD;TNNT2;TPM2;TNNI2;TMOD1
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.1404448330509864,-0.4917046152807443,1.0,0.9999455743234463,1.0,19/19,85.98%,JUP;DSG2;CAPNS1;TGM1;PPL;PKP4;EVPL;FURIN;CAPN1;LIPN;RCAN1;KAZN;PKP2;PCSK6;PERP;CSTA;SPINK9;ST14;PI3
prerank,KEGG_2021_Human__Asthma,0.14033673238926342,0.4916127029439021,1.0,1.0,1.0,21/22,74.29%,IL10;CD40LG;HLA-DOB;FCER1G;TNF;FCER1A;HLA-DRB1;HLA-DQB1;CD40;HLA-DPB1;HLA-DMA;HLA-DPA1;HLA-DQA1;HLA-DRB4;HLA-DOA;HLA-DMB;HLA-DRB3;HLA-DRA;MS4A2;HLA-DRB5;IL4
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.14318961667241323,0.4891253867174961,1.0,1.0,1.0,5/20,21.24%,WDR33;PCF11;CSTF1;PABPN1;NCBP1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.11648253528400465,0.4789267154398061,1.0,1.0,1.0,10/42,20.83%,BIRC5;TP53BP2;BCL6;PRELID1;BBC3;TMEM219;PPP1R13B;TP63;FASN;CASP1
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.12776508198715486,-0.47549114958979277,1.0,1.0,1.0,2/27,5.75%,RRM2B;AK5
prerank,KEGG_2021_Human__Pentose phosphate pathway,-0.12851071465130198,-0.4653059240459493,1.0,1.0,1.0,9/24,36.86%,PFKL;FBP1;PFKP;PRPS2;PGD;GLYCTK;RPE;RPIA;PGM2
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.09008837428924318,0.4481407896249164,1.0,1.0,1.0,17/81,20.22%,MAML3;NFKBIE;IL12A;PPP3CB;STAT4;RELA;MAPK3;HLA-DOB;STAT1;PPP3CA;JAK2;MAPK13;MAPK11;GATA3;MAF;NOTCH3;IKBKG
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.13410113146905536,0.4400086498363391,1.0,1.0,1.0,2/16,9.21%,MTM1;PIK3R4
prerank,KEGG_2021_Human__Thyroid cancer,-0.10540073602300878,-0.4388435827184267,0.9833333333333333,1.0,1.0,3/35,8.57%,NRAS;NCOA4;MAPK1
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.09966476210888131,-0.43537632210561483,1.0,0.9997678351518606,1.0,9/56,18.38%,GNG10;GNG5;GNA11;CACNA1E;ITPR1;SNAP25;PLCB2;GNAQ;RAP1A
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.11764897455962132,-0.4314647302960834,1.0,0.9988562833306199,1.0,10/23,43.59%,SLC6A15;SLC43A2;SLC7A8;SLC7A1;SLC7A7;SLC7A11;SLC7A6;SLC36A4;SLC43A1;SLC1A4
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.10983161925047852,-0.42747386280592364,1.0,0.997894681783113,1.0,33/35,77.80%,FASLG;FAS;PRF1;CD86;HLA-DRB5;HLA-DRA;HLA-DRB3;IL1B;HLA-DMB;HLA-DOA;HLA-G;CD80;PTPRN2;HLA-DRB4;HLA-DQA1;HLA-DPA1;HLA-E;HLA-B;HLA-A;HLA-DMA;HLA-DPB1;HLA-C;LTA;HLA-F;HLA-DQB1;IFNG;HLA-DRB1;ICA1;HSPD1;PTPRN;CD28;GZMB;TNF
prerank,KEGG_2021_Human__Allograft rejection,0.09716072214366915,0.38044193617566197,1.0,1.0,1.0,25/33,53.31%,IL10;IL12A;CD40LG;HLA-DOB;TNF;GZMB;CD28;HLA-DRB1;IFNG;HLA-DQB1;CD40;HLA-F;HLA-C;HLA-DPB1;HLA-DMA;HLA-A;HLA-B;HLA-E;HLA-DPA1;HLA-DQA1;HLA-DRB4;CD80;HLA-G;HLA-DOA;HLA-DMB
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.07905597733988858,0.31756376410380754,1.0,0.9999470217387465,1.0,3/33,10.23%,IL10;CD40LG;CTLA4
